您好！歡迎訪問上海起發(fā)實(shí)驗(yàn)試劑有限公司網(wǎng)站！
全國服務(wù)咨詢熱線:
15921799099
15921799099
R&D Systems位于美國的明尼蘇達(dá)州，一直致力于生物制品的開發(fā)與生產(chǎn)。公司成立之初主要生產(chǎn)用于醫(yī)院及臨床應(yīng)用的血控品。1997年，公司推出*個(gè)產(chǎn)品--富血小板血漿質(zhì)控品；1981年，公司成為第二家生產(chǎn)含血小板全血控品的供應(yīng)商。40多年的發(fā)展中，R&D Systems仍持續(xù)開發(fā)各種血控品產(chǎn)品。
1985年，作為公司推出的*個(gè)科研試劑產(chǎn)品，也是*家將該產(chǎn)品進(jìn)行商業(yè)化生產(chǎn)的產(chǎn)品，R&D Systems成功上市了TGF-beta1蛋白。作為胞外信號分子，TGF-beta1蛋白在多種細(xì)胞中進(jìn)行表達(dá)，并作為胞外信號分子參與免疫功能，細(xì)胞增殖和細(xì)胞分化等生物學(xué)過程。該產(chǎn)品推出后，公司陸續(xù)從生物材料中純化了幾種細(xì)胞因子產(chǎn)品并推向市場。
天然蛋白類產(chǎn)品的成功推廣，加速了R&D Systems在細(xì)胞因子市場的開拓。公司于1985年形成Growth Factor事業(yè)部（現(xiàn)Biotechnology事業(yè)部）。Biotechnology事業(yè)部的目標(biāo)是生產(chǎn)和營銷重組人細(xì)胞因子。與天然來源提取蛋白相比較，DNA重組技術(shù)生產(chǎn)的蛋白產(chǎn)品其成本更低，產(chǎn)量更高，*擺脫原料的限制。1989年，Biotechnology事業(yè)部開始開發(fā)抗細(xì)胞因子的單克隆和多克隆抗體，并于1990年開發(fā)了*個(gè)ELISA試劑盒。
| 供應(yīng)商 | 貨號 | 品名 | 規(guī)格 | 價(jià)格 |
| R&D Systems | 4867-100 | Hydrophobic Coverslips (100 EA) | 100 EA | 1350 |
| R&D Systems | 7620 | Human IL-18/IL-1F4 ELISA (1 KT) | 1 KT | 9390 |
| R&D Systems | 7625 | Mouse IL-18/IL-1F4 ELISA (1 KT) | 1 KT | 9390 |
| R&D Systems | 640188 | Plate Sealer;Excel (100 EA) | 100 EA | 440 |
| R&D Systems | 886000 | Color Reagent A (50 VL) | 50 VL | 1890 |
| R&D Systems | 886001 | Color Reagent B (50 VL) | 50 VL | 2370 |
| R&D Systems | 886003 | Wash Buffer Concentrate; 25x (50 VL) | 50 VL | 2100 |
| R&D Systems | 886032 | Stop;2N Sulfuric Acid;6mL (50 VL) | 50 VL | 1790 |
| R&D Systems | 886151 | Calibrator Diluent; RD5P (50 VL) | 50 VL | 5100 |
| R&D Systems | 886174 | Stop;0.075M Citric Acid (50 VL) | 50 VL | 2710 |
| R&D Systems | 890039 | Human IL-1 beta Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890040 | Human IL-1 beta Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890041 | Human IL-1 beta Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890042 | Human IL-2 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890043 | Human IL-2 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890044 | Human IL-2 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890045 | Human IL-6 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890046 | Human IL-6 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890047 | Human IL-6 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890123 | Human TNF-alpha Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890210 | Human IFN-gamma Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890218 | Human VEGF Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890219 | Human VEGF Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890220 | Human VEGF Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890247 | Human G-CSF Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890270 | Human G-CSF Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890327 | Mouse IL-2 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890328 | Mouse IL-2 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890329 | Mouse IL-2 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890401 | Mouse IL-4 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890403 | Mouse IL-10 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890408 | Mouse IL-4 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890462 | Human IL-8 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890465 | Human IL-8 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890466 | Human IL-8 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890475 | Mouse IFN-gamma Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890477 | Mouse IFN-gamma Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890573 | Human Leptin Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890574 | Human Leptin Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890575 | Human Leptin Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890582 | Human IFN-gamma Plate; 2nd Gen (1 EA) | 1 EA | 410 |
| R&D Systems | 890583 | Human IFN-gamma Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890652 | Mouse IL-12p70 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890653 | Mouse IL-12p70 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890654 | Mouse IL-12p70 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890669 | Mouse IL-17 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890670 | Mouse IL-17 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890671 | Mouse IL-17 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890713 | Cell Lysis Buffer 1 (1 x 21 mL) (1 EA) | 1 EA | 530 |
| R&D Systems | 890783 | Mouse VEGF Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890784 | Mouse VEGF Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 890989 | Human CD40 Ligand Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 890990 | Human CD40 Ligand Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 890991 | Human CD40 Ligand Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 892152 | Human G-CSF Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 892369 | Mouse IL-6 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 892371 | Mouse IL-6 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 892539 | Human TNF-alpha Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 892540 | Human TNF-alpha Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 892665 | Mouse IL-6 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 892666 | Mouse IFN-gamma Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 892667 | Mouse VEGF Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 892701 | Mouse IL-4 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 893829 | Mouse IL-1 beta Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 893830 | Mouse IL-1 beta Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 893831 | Mouse IL-1 beta Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 893961 | Mouse TNF-alpha Plate, 2nd Gen (1 EA) | 1 EA | 410 |
| R&D Systems | 893962 | Mouse TNF-alpha Conjugate, 2nd Gen (1 VL) | 1 VL | 110 |
| R&D Systems | 893963 | Mouse TNF-alpha Standard, 2nd Gen (1 VL) | 1 VL | 90 |
| R&D Systems | 894178 | Epo QC Patient Level 1, Access (400 ML) | 400 ML | 12010 |
| R&D Systems | 894179 | Epo QC Patient Level 2, Access (400 ML) | 400 ML | 12010 |
| R&D Systems | 894180 | Epo QC Patient Level 3, Access (400 ML) | 400 ML | 12010 |
| R&D Systems | 894181 | Epo QC Patient Level 4, Access (400 ML) | 400 ML | 12010 |
| R&D Systems | 894182 | Epo QC Patient Level 5, Access (400 ML) | 400 ML | 12010 |
| R&D Systems | 894508 | Mouse IL-10 Plate (1 EA) | 1 EA | 410 |
| R&D Systems | 894509 | Mouse IL-10 Conjugate (1 VL) | 1 VL | 110 |
| R&D Systems | 894510 | Mouse IL-10 Standard (1 VL) | 1 VL | 90 |
| R&D Systems | 895000 | Color Reagent A (50 VL) | 50 VL | 1890 |
| R&D Systems | 895001 | Color Reagent B (50 VL) | 50 VL | 2370 |
| R&D Systems | 895003 | Quantikine kit component wash buffer - 21 ml at 25x (21 ML) | 21 ML | 340 |
| R&D Systems | 895032 | Stop;2N Sulfuric Acid;6ml (50 VL) | 50 VL | 1790 |
| R&D Systems | 895064 | Wash Buffer; 10x Triton; 1 L (1 L) | 1 L | 4100 |
| R&D Systems | 895151 | Calibrator Diluent; RD5P (50 VL) | 50 VL | 5100 |
| R&D Systems | 895174 | Stop;0.075M Citric Acid (50 VL) | 50 VL | 2710 |
| R&D Systems | 895347 | Cell Lysis Buffer 2 (1 x 21 mL) (1 EA) | 1 EA | 530 |
| R&D Systems | 895366 | Cell Lysis Buffer 3 Concentrate (5X, 1 x 21 mL) (1 EA) | 1 EA | 750 |
| R&D Systems | 895561 | Lysis Buffer 6 (1 x 21 mL) (1 EA) | 1 EA | 530 |
| R&D Systems | 895890 | Cell Lysis Buffer 5 (1 x 21 mL) (1 EA) | 1 EA | 530 |
| R&D Systems | 895935 | Lysis Buffer 16 (1 x 21 mL) (1 EA) | 1 EA | 530 |
| R&D Systems | 895943 | Lysis Buffer 17 (1 x 21 mL) (1 EA) | 1 EA | 530 |
| R&D Systems | 1-001-A | Normal Human IgG Control (1 MG) | 1 MG | 1030 |
| R&D Systems | 100-B-010 | Human TGF-beta 1 (10 UG) | 10 UG | 22480 |
| R&D Systems | 100-B-001 | Human TGF-beta 1 (1 UG) | 1 UG | 3760 |
| R&D Systems | 100-B-010/CF | Human TGF-beta 1, CF (10 UG) | 10 UG | 22480 |
| R&D Systems | 100-B-001/CF | Human TGF-beta 1, CF (1 UG) | 1 UG | 3760 |
| R&D Systems | 1002-VC-050 | Recombinant Mouse VE-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1003-RT-050 | Recombinant Human TGF-beta RII Isoform 2 Fc Chimera, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 1004-MR-050 | Recombinant Mouse ST2/IL-1 R4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1005-UN-050 | Recombinant Human UNC5H3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1006-UN-050 | Recombinant Rat UNC5H2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1007-MR-100 | Recombinant Human IL-1 RAPL2/IL-1 R9 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1008-LR-050 | Recombinant Mouse Lymphotoxin beta R/TNFRSF3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1008-LY-010 | Recombinant Mouse Lymphotoxin alpha2/beta1 (10 UG) | 10 UG | 4280 |
| R&D Systems | 1008-LY-010/CF | Recombinant Mouse Lymphotoxin alpha2/beta1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1009-CL-010 | Recombinant Cotton Rat IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3370 |
| R&D Systems | 1009-CL-010/CF | Recombinant Cotton Rat IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 101-B1-010 | Porcine TGF-beta 1 (10 UG) | 10 UG | 20660 |
| R&D Systems | 101-B1-001 | Porcine TGF-beta 1 (1 UG) | 1 UG | 3370 |
| R&D Systems | 101-B1-010/CF | Porcine TGF-beta 1, CF (10 UG) | 10 UG | 20660 |
| R&D Systems | 101-B1-001/CF | Porcine TGF-beta 1, CF (1 UG) | 1 UG | 3370 |
| R&D Systems | 1010-CR-025 | Recombinant Cotton Rat CCL5/RANTES (25 UG) | 25 UG | 3630 |
| R&D Systems | 1010-CR-025/CF | Recombinant Cotton Rat CCL5/RANTES, CF (25 UG) | 25 UG | 3630 |
| R&D Systems | 1011-CR-025 | Recombinant Cotton Rat TNF-alpha (25 UG) | 25 UG | 2720 |
| R&D Systems | 1011-CR-025/CF | Recombinant Cotton Rat TNF-alpha, CF (25 UG) | 25 UG | 2720 |
| R&D Systems | 1012-PS-010 | Recombinant Pro-TNF-alpha Fusion Protein, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1013-CY-010 | Recombinant Mouse Cathepsin H, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1014-AS-010 | Recombinant Human Cathepsin D, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 1015-P2-020 | Recombinant Porcine IL-2 (Cys146Ala) (20 UG) | 20 UG | 4280 |
| R&D Systems | 1015-P2-020/CF | Recombinant Porcine IL-2 (Cys146Ala), CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1017-MP-025 | Recombinant Mouse CCL24/Eotaxin-2/MPIF-2 (aa 27-119) (25 UG) | 25 UG | 4280 |
| R&D Systems | 1017-MP-025/CF | Recombinant Mouse CCL24/Eotaxin-2/MPIF-2 (aa 27-119), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1019-B7-100 | Recombinant Mouse B7-H1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 102-B2-001 | Porcine TGF-beta 2 (1 UG) | 1 UG | 4800 |
| R&D Systems | 102-B2-001/CF | Porcine TGF-beta 2, CF (1 UG) | 1 UG | 4800 |
| R&D Systems | 1020-RL-050 | Recombinant Human CD25/IL-2 R alpha Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1021-PD-100 | Recombinant Mouse PD-1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1022-PL-100 | Recombinant Mouse PD-L2/B7-DC Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 1023-ML-010 | Recombinant Mouse IL-10 (Cys167Tyr) (10 UG) | 10 UG | 3760 |
| R&D Systems | 1023-ML-010/CF | Recombinant Mouse IL-10 (Cys167Tyr), CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 1024-MB-025 | Recombinant Cotton Rat CCL4/MIP-1 beta (25 UG) | 25 UG | 4280 |
| R&D Systems | 1024-MB-025/CF | Recombinant Cotton Rat CCL4/MIP-1 beta, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1025-CE-025 | Recombinant Mouse Betacellulin (25 UG) | 25 UG | 4150 |
| R&D Systems | 1025-CE-025/CF | Recombinant Mouse Betacellulin, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1026-GR-100 | Recombinant Mouse IFN-gamma R1 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 1027-B3-100 | Recombinant Human B7-H3 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 1028-CL-050 | Recombinant Human CD30 Ligand/TNFSF8, CF (50 UG) | 50 UG | 4750 |
| R&D Systems | 1029-AS-010 | Recombinant Mouse Cathepsin D, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1030-FN-01M | Bovine Fibronectin, CF (1 MG) | 1 MG | 1810 |
| R&D Systems | 1030-FN-05M | Bovine Fibronectin, CF (5 MG) | 5 MG | 4280 |
| R&D Systems | 1031-AD-020 | Recombinant Human ADAM8, CF (20 UG) | 20 UG | 4800 |
| R&D Systems | 1033-CY-010 | Recombinant Mouse Cathepsin X/Z/P, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1034-CY-010 | Recombinant Mouse Cathepsin C/DPPI, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1035-IL-025 | Recombinant Human IL-19 (25 UG) | 25 UG | 4360 |
| R&D Systems | 1035-IL-025/CF | Recombinant Human IL-19, CF (25 UG) | 25 UG | 4360 |
| R&D Systems | 1039-2B-050 | Recombinant Human 2B4/CD244/SLAMF4 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1040-BR-050 | Recombinant Mouse IL-17 RB Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1041-TC-050 | Recombinant Mouse TACI/TNFRSF13B Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1042-PR-100 | Recombinant Mouse PDGF R beta Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 1048-PI-010 | Recombinant Human HAI-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1049-SE-010 | Recombinant Human Cathepsin A/Lysosom Carboxypeptidase A, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 1051-CA-050 | Recombinant Chicken Caronte Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1052-ER-050 | Recombinant Human EN-RAGE, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1054-OX-010 | Recombinant Human OX40 Ligand/TNFSF4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1055-AA-050 | Recombinant Rat PDGF-AA, CF (50 UG) | 50 UG | 3500 |
| R&D Systems | 1056-TK-050 | Recombinant Rat TrkA Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1057-TK-050 | Recombinant Rat Notch-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1060-DE-100 | Recombinant Mouse Decorin, CF (100 UG) | 100 UG | 3760 |
| R&D Systems | 1061-RM-025 | Recombinant Cotton Rat CCL3/MIP-1 alpha (25 UG) | 25 UG | 4280 |
| R&D Systems | 1061-RM-025/CF | Recombinant Cotton Rat CCL3/MIP-1 alpha, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1062-PR-050 | Recombinant Mouse PDGF R alpha Fc Chimera, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 1063-SE-010 | Recombinant Human Coagulation Factor Xa, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1064-IL-010 | Recombinant Human IL-10 (aa 19-178) (10 UG) | 10 UG | 3760 |
| R&D Systems | 1064-IL-010/CF | Recombinant Human IL-10 (aa 19-178), CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 1065-AP-050 | Recombinant Human Adiponectin/Acrp30, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1066-AB-005 | Recombinant Human Activin AB (5 UG) | 5 UG | 4540 |
| R&D Systems | 1066-AB-005/CF | Recombinant Human Activin AB, CF (5 UG) | 5 UG | 4540 |
| R&D Systems | 1067-GH-025 | Recombinant Human Growth Hormone (GH) (25 UG) | 25 UG | 2460 |
| R&D Systems | 1067-GH-025/CF | Recombinant Human Growth Hormone (GH), CF (25 UG) | 25 UG | 2460 |
| R&D Systems | 1068-EP-050 | Recombinant Mouse Epiregulin (50 UG) | 50 UG | 4280 |
| R&D Systems | 1068-EP-050/CF | Recombinant Mouse Epiregulin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1069-RN-050 | Recombinant Mouse Resistin (50 UG) | 50 UG | 4150 |
| R&D Systems | 1069-RN-050/CF | Recombinant Mouse Resistin, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1070-RM-025 | Recombinant Rhesus Macaque TNF-alpha (25 UG) | 25 UG | 2720 |
| R&D Systems | 1070-RM-025/CF | Recombinant Rhesus Macaque TNF-alpha, CF (25 UG) | 25 UG | 2720 |
| R&D Systems | 1071-CY-010 | Recombinant Human Cathepsin C/DPPI, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1072-SL-050 | Recombinant Human Siglec-5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1073-BP-010 | Recombinant Human BMP-8a (10 UG) | 10 UG | 3760 |
| R&D Systems | 1073-BP-010/CF | Recombinant Human BMP-8a, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 1073-BPC-025 | Recombinant Human BMP-8a (CHO-expressed), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1074-VJ-050 | Recombinant Human JAM-B/VE-JAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1077-JM-050 | Recombinant Mouse JAM-A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1078-IL-025 | Recombinant Human IL-36 alpha/IL-1F6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1078-IL-025/CF | Recombinant Human IL-36 alpha/IL-1F6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1079-NE-050 | Recombinant Mouse Neogenin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1080-CY-010 | Recombinant Human Cathepsin V, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1081-IL-020 | Recombinant Human IL-2 (Cys145Ser) (20 UG) | 20 UG | 2850 |
| R&D Systems | 1081-IL-020/CF | Recombinant Human IL-2 (Cys145Ser), CF (20 UG) | 20 UG | 2850 |
| R&D Systems | 1082-CR-025 | Recombinant Cotton Rat IFN-alpha (Cys109Tyr) (25 UG) | 25 UG | 3760 |
| R&D Systems | 1082-CR-025/CF | Recombinant Cotton Rat IFN-alpha (Cys109Tyr), CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 1083-AB-050 | Recombinant Mouse IFN-alpha/beta R2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1084-M2-025 | Recombinant Cotton Rat MIP-2 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1084-M2-025/CF | Recombinant Cotton Rat MIP-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1085-AR-025 | Recombinant Mouse Artemin (25 UG) | 25 UG | 4280 |
| R&D Systems | 1085-AR-025/CF | Recombinant Mouse Artemin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1086-PD-050 | Recombinant Human PD-1 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1087-BP-025 | Recombinant Human IL-22BP Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1088-B2-200 | Recombinant Zebrafish Ephrin-B2 Fc Chimera, CF (200 UG) | 200 UG | 4280 |
| R&D Systems | 1089-R2-025 | Recombinant Human TNF RII/TNFRSF1B (aa 24-206) (25 UG) | 25 UG | 4150 |
| R&D Systems | 1089-R2-025/CF | Recombinant Human TNF RII/TNFRSF1B (aa 24-206), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 109-OP-050 | Bovine Osteopontin (OPN) (50 UG) | 50 UG | 3110 |
| R&D Systems | 109-OP-050/CF | Bovine Osteopontin (OPN), CF (50 UG) | 50 UG | 3110 |
| R&D Systems | 1090-TW-025 | Recombinant Human TWEAK/TNFSF12 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1090-TW-025/CF | Recombinant Human TWEAK/TNFSF12, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1091-CK-025 | Recombinant Mouse CXCL7/Thymus Chemokine-1 (aa 48-109) (25 UG) | 25 UG | 4280 |
| R&D Systems | 1091-CK-025/CF | Recombinant Mouse CXCL7/Thymus Chemokine-1 (aa 48-109), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1093-XD-050 | Recombinant Human EDA2R/TNFRSF27/XEDAR Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1095-ER-002 | Recombinant Human EGF R/ErbB1 (2 UG) | 2 UG | 1420 |
| R&D Systems | 1097-EN-025 | Recombinant Human Endoglin/CD105 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1097-EN-025/CF | Recombinant Human Endoglin/CD105, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1098-ES-050 | Recombinant Human Endostatin, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1099-IL-025 | Recombinant Human IL-36 beta/IL-1F8 (25 UG) | 25 UG | 4150 |
| R&D Systems | 1099-IL-025/CF | Recombinant Human IL-36 beta/IL-1F8, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 110-HG-100 | Recombinant Human IgG1 Fc, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 11002-1 | Recombinant Human IFN-alpha Sampler (12x100,000 U) (1 KT) | 1 KT | 27830 |
| R&D Systems | 1102-IL-025 | Recombinant Human IL-20 (25 UG) | 25 UG | 4360 |
| R&D Systems | 1102-IL-025/CF | Recombinant Human IL-20, CF (25 UG) | 25 UG | 4360 |
| R&D Systems | 1103-JM-050 | Recombinant Human JAM-A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1106-PI-010 | Recombinant Human HAI-2A, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1107-PI-010 | Recombinant Mouse HAI-2B, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1108-SE-010 | Recombinant Human Kallikrein 5, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1109-N1-025 | Recombinant Mouse Netrin-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1109-N1-025/CF | Recombinant Mouse Netrin-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 111-BM-010 | Recombinant Zebrafish BMP-2a (10 UG) | 10 UG | 4280 |
| R&D Systems | 111-BM-010/CF | Recombinant Zebrafish BMP-2a, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 11100-1 | Recombinant Human IFN-alpha A (alpha 2a) (5 MU) | 5 MU | 3400 |
| R&D Systems | 11101-1 | Recombinant Human IFN-alpha A, CF (5 UG) | 5 UG | 3130 |
| R&D Systems | 11101-2 | Recombinant Human IFN-alpha A, CF (20 UG) | 20 UG | 4410 |
| R&D Systems | 11105-1 | Recombinant Human IFN-alpha 2 (alpha 2b) (100000 UN) | 100000 UN | 3260 |
| R&D Systems | 11115-1 | Recombinant Human IFN-alpha B2 (alpha 8) (100000 UN) | 100000 UN | 4160 |
| R&D Systems | 1112-PR-050 | Recombinant Rat Prolactin R Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 11120-1 | Recombinant Human IFN-alpha C (alpha 10) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 11125-1 | Recombinant Human IFN-alpha D (alpha 1 [Val 114]) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 11130-1 | Recombinant Human IFN-alpha F (alpha 21) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 11135-1 | Recombinant Human IFN-alpha G (alpha 5) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 1114-GR-025 | Recombinant Cotton Rat GRO (25 UG) | 25 UG | 4280 |
| R&D Systems | 1114-GR-025/CF | Recombinant Cotton Rat GRO, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 11145-1 | Recombinant Human IFN-alpha H2 (alpha 14) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 1115-AB-010 | Recombinant Rat PDGF-AB, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 11150-1 | Recombinant Human IFN-alpha I (alpha 17) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 1116-CK-025 | Recombinant Rat CXCL7/Thymus Chemokine-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1116-CK-025/CF | Recombinant Rat CXCL7/Thymus Chemokine-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 11160-1 | Recombinant Human IFN-alpha J1 (alpha 7) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 11165-1 | Recombinant Human IFN-alpha K (alpha 6) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 1117-IP-025 | Recombinant Cotton Rat CXCL10/IP-10, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 11175-1 | Recombinant Human IFN-alpha 1 (Alpha D (Ala 114)) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 11177-1 | Recombinant Human IFN-alpha 4a (alpha M1) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 1118-DK-050 | Recombinant Human Dkk-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 11180-1 | Recombinant Human IFN-alpha 4b (alpha 4) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 1119-AC-025 | Recombinant Mouse gAdiponectin/gAcrp30, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 11190-1 | Recombinant Human IFN-alpha WA (alpha 16) (100000 UN) | 100000 UN | 3810 |
| R&D Systems | 112-FZ-050 | Recombinant Mouse Frizzled-8 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1120-FZ-050 | Recombinant Mouse Frizzled-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 11200-1 | Universal Type I IFN (100000 UN) | 100000 UN | 4550 |
| R&D Systems | 11200-2 | Universal Type I IFN (1 MU) | 1 MU | 7820 |
| R&D Systems | 1121-TL-010 | Recombinant Mouse TRAIL/TNFSF10 (10 UG) | 10 UG | 4150 |
| R&D Systems | 1121-TL-010/CF | Recombinant Mouse TRAIL/TNFSF10, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 1126-ZN-010 | Recombinant Mouse Neprilysin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1126-ZNC-010 | Recombinant Mouse Neprilysin (CHO-expressed), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1127-EP-025 | Recombinant Mouse Epigen (25 UG) | 25 UG | 4280 |
| R&D Systems | 1127-EP-025/CF | Recombinant Mouse Epigen, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1128-BM-010 | Recombinant Zebrafish BMP-4 (10 UG) | 10 UG | 4280 |
| R&D Systems | 1128-BM-010/CF | Recombinant Zebrafish BMP-4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1129-ER-050 | Recombinant Human ErbB2/Her2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 113-BP-100 | Recombinant Human BMP-3 (100 UG) | 100 UG | 5270 |
| R&D Systems | 113-BP-100/CF | Recombinant Human BMP-3, CF (100 UG) | 100 UG | 5270 |
| R&D Systems | 1130-AS-010 | Recombinant Mouse Cathepsin E, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1131-ER-050 | Recombinant Human ErbB4/Her4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1132-N4-025 | Recombinant Mouse Netrin-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1132-N4-025/CF | Recombinant Mouse Netrin-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1134-RA-050 | Recombinant Mouse Rae-1 delta Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1135-RA-050 | Recombinant Mouse Rae-1 epsilon Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1136-RA-050 | Recombinant Mouse Rae-1 gamma Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1137-SL-050 | Recombinant Human Siglec-3/CD33 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1138-SL-050 | Recombinant Human Siglec-7/CD328 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1139-SL-050 | Recombinant Human Siglec-9 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 11395-1 | Recombinant Human IFN-omega (25 UG) | 25 UG | 4760 |
| R&D Systems | 114-CD-050 | Recombinant Mouse CD45, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1141-PI-010 | Recombinant Mouse HAI-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 11410-2 | Recombinant Human IFN-beta 1a (Mammalian), CF (1 MU) | 1 MU | 7360 |
| R&D Systems | 11415-1 | Recombinant Human IFN-beta 1a (Mammalian) (100000 UN) | 100000 UN | 4260 |
| R&D Systems | 1144-PR-025 | Recombinant Human Pref-1/DLK1/FA1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1144-PR-025/CF | Recombinant Human Pref-1/DLK1/FA1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1145-RG-050 | Recombinant Human RAGE Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1146-S6-025 | Recombinant Human Semaphorin 6A Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 115-CD-050 | Recombinant Mouse CD5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1150-ML-020 | Recombinant Mouse IL-2 (Cys160Ser) (20 UG) | 20 UG | 2720 |
| R&D Systems | 1150-ML-020/CF | Recombinant Mouse IL-2 (Cys160Ser), CF (20 UG) | 20 UG | 2720 |
| R&D Systems | 1151-CL-025 | Recombinant Human CLF-1/CLC Complex (25 UG) | 25 UG | 4280 |
| R&D Systems | 1151-CL-025/CF | Recombinant Human CLF-1/CLC Complex, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1152-GA-050 | Recombinant Human Galectin-1 (50 UG) | 50 UG | 4150 |
| R&D Systems | 1152-GA-050/CF | Recombinant Human Galectin-1, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1153-GA-050 | Recombinant Human Galectin-2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1154-GA-050 | Recombinant Human Galectin-3 (50 UG) | 50 UG | 4150 |
| R&D Systems | 1154-GA-050/CF | Recombinant Human Galectin-3, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1155-H6-050 | Recombinant Mouse H60 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1156-NG-100 | Recombinant Mouse beta-NGF (100 UG) | 100 UG | 3760 |
| R&D Systems | 1156-NG-100/CF | Recombinant Mouse beta-NGF, CF (100 UG) | 100 UG | 3760 |
| R&D Systems | 1157-NR-050 | Recombinant Mouse NGF R/TNFRSF16 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1158-RA-050 | Recombinant Mouse Rae-1 alpha Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1159-SB-025 | Recombinant Human PDGF-DD (25 UG) | 25 UG | 4280 |
| R&D Systems | 1159-SB-025/CF | Recombinant Human PDGF-DD, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1160-A1-050 | Recombinant Human Bcl-2 related protein A1 (aa 1-152), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1161-LV-100 | Recombinant Human Livin alpha/KIAP, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1162-BR-050 | Recombinant Human BAFF R/TNFRSF13C Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1164-CX-025 | Recombinant Human CXCL16 (Histidine-tagged) (25 UG) | 25 UG | 4280 |
| R&D Systems | 1164-CX-025/CF | Recombinant Human CXCL16 (Histidine-tagged), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1165-CX-025 | Recombinant Mouse CXCL16 (Histidine-tagged) (25 UG) | 25 UG | 4280 |
| R&D Systems | 1165-CX-025/CF | Recombinant Mouse CXCL16 (Histidine-tagged), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1166-NG-025 | Recombinant Mouse Netrin-G1a (25 UG) | 25 UG | 4280 |
| R&D Systems | 1166-NG-025/CF | Recombinant Mouse Netrin-G1a, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1167-PR-050 | Recombinant Human Prolactin R Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1168-CR-050 | Recombinant Human Ret (50 UG) | 50 UG | 4280 |
| R&D Systems | 1168-CR-050/CF | Recombinant Human Ret, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1169-FR-025 | Recombinant Mouse sFRP-2 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1169-FR-025/CF | Recombinant Mouse sFRP-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 117-VL-025 | Recombinant Viral HCMV IL-10 (25 UG) | 25 UG | 4280 |
| R&D Systems | 117-VL-025/CF | Recombinant Viral HCMV IL-10, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1172-AL-050 | Recombinant Mouse ALCAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1173-M5-050 | Recombinant Mouse ICAM-5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1176-IR-050 | Recombinant Human IL-20 R alpha Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1177-SF-025 | Recombinant Human Serpin F1/PEDF, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1179-RG-050 | Recombinant Mouse RAGE Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 118-AP-100 | Recombinant Human IL-18 R beta/IL-1 R7 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1180-SE-010 | Recombinant Human DPPIV/CD26, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 1182-ZNC-010 | Recombinant Human Neprilysin (CHO-expressed), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1183-CY-010 | Recombinant Human Cathepsin S, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1184-PI-050 | Recombinant Human Fetuin A/AHSG, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1185-GR-050 | Recombinant Mouse IFN-gamma R2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1186-LM-050 | Recombinant Mouse CD300a/LMIR1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1187-TR-025 | Recombinant Mouse TREM-1 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1189-J3-050 | Recombinant Human JAM-C Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 119-BP-100 | Recombinant Human IL-18 BPa Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 1190-NT-050 | Recombinant Rat Notch-2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1195-EP-025 | Recombinant Human Epiregulin (25 UG) | 25 UG | 4280 |
| R&D Systems | 1195-EP-025/CF | Recombinant Human Epiregulin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1196-PI-010 | Recombinant Human Cystatin C, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1197-GA-050 | Recombinant Mouse Galectin-3 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1197-GA-050/CF | Recombinant Mouse Galectin-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1198-RA-050 | Recombinant Mouse Rae-1 beta Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1199-TW-050 | Recombinant Human TWEAK R/TNFRSF12 Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 120-HD-001 | Human PDGF, CF (1 UG) | 1 UG | 3890 |
| R&D Systems | 120-HD-005 | Human PDGF, CF (5 UG) | 5 UG | 14030 |
| R&D Systems | 1200-SE-010 | Recombinant Mouse HGF Activator, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1201-PI-010 | Recombinant Human Cystatin SA, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1202-PI-010 | Recombinant Human Cystatin D, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1204-ML-025 | Recombinant Mouse IL-20 (25 UG) | 25 UG | 4410 |
| R&D Systems | 1204-ML-025/CF | Recombinant Mouse IL-20, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1206-F3-025 | Recombinant Human FGF-3 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1206-F3-025/CF | Recombinant Human FGF-3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1207-BR-050 | Recombinant Human IL-17 RB Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1208-NG-050 | Recombinant Human Nogo Receptor Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1209-EV-025 | Recombinant Human EG-VEGF/PK1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1209-EV-025/CF | Recombinant Human EG-VEGF/PK1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1210-GR-050 | Recombinant Human Growth Hormone R (GHR) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 12100-1 | Recombinant Mouse IFN-alpha A (100000 UN) | 100000 UN | 5310 |
| R&D Systems | 12105-1 | Recombinant Mouse IFN-alpha 1 (100000 UN) | 100000 UN | 4550 |
| R&D Systems | 1211-GR-050 | Recombinant Rat Growth Hormone R (GHR) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 12115-1 | Recombinant Mouse IFN-alpha 4 (Mammalian) (100000 UN) | 100000 UN | 4550 |
| R&D Systems | 1212-FG-025 | Recombinant Human FGF-16 (25 UG) | 25 UG | 4150 |
| R&D Systems | 1212-FG-025/CF | Recombinant Human FGF-16, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 12125-1 | Recombinant Mouse IFN-alpha 11 (100000 UN) | 100000 UN | 4550 |
| R&D Systems | 1213-J3-050 | Recombinant Mouse JAM-C Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 12130-1 | Recombinant Mouse IFN-alpha 13 (100000 UN) | 100000 UN | 4550 |
| R&D Systems | 1214-B7-050 | Recombinant Rat B7-1/CD80 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1215-CD-050 | Recombinant Mouse CD40/TNFRSF5 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 122-BP-100 | Recombinant Mouse IL-18 BPd Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1220-PG-025 | Recombinant Human Aggrecan G1-IGD-G2 Domains, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1224-PL-100 | Recombinant Human PD-L2/B7-DC Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1225-KR-050 | Recombinant Human KIR3DL1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1227-GA-050 | Recombinant Human Galectin-4 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1227-GA-050/CF | Recombinant Human Galectin-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 123-FE-050 | Recombinant Human CD23/Fc epsilon RII, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1230-KS-010 | Recombinant Human Active ERK2, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 1234-IL-025 | Recombinant Human IL-17C (25 UG) | 25 UG | 4280 |
| R&D Systems | 1234-IL-025/CF | Recombinant Human IL-17C, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1236-OX-025 | Recombinant Mouse OX40 Ligand/TNFSF4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1236-OX-025/CF | Recombinant Mouse OX40 Ligand/TNFSF4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1237-TW-025 | Recombinant Mouse TWEAK/TNFSF12 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1237-TW-025/CF | Recombinant Mouse TWEAK/TNFSF12, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1238-PI-010 | Recombinant Mouse Cystatin C, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1239-PI-010 | Recombinant Mouse Serpin F2/alpha 2-Antiplasmin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 12400-1 | Recombinant Mouse IFN-beta (100000 UN) | 100000 UN | 7080 |
| R&D Systems | 12401-1 | Recombinant Mouse IFN-beta, CF (100000 UN) | 100000 UN | 5170 |
| R&D Systems | 12405-1 | Recombinant Mouse IFN-beta (Mammalian) (100000 UN) | 100000 UN | 3540 |
| R&D Systems | 12410-1 | Recombinant Mouse IFN-beta (Mammalian), CF (1 MU) | 1 MU | 9810 |
| R&D Systems | 1245-GA-050 | Recombinant Mouse Galectin-1 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1245-GA-050/CF | Recombinant Mouse Galectin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1246-4L-025 | Recombinant Mouse 4-1BB Ligand/TNFSF9 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1246-4L-025/CF | Recombinant Mouse 4-1BB Ligand/TNFSF9, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1247-ZV-010 | Recombinant Zebrafish VEGF 165 (10 UG) | 10 UG | 4280 |
| R&D Systems | 1247-ZV-010/CF | Recombinant Zebrafish VEGF 165, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1248-IB-025 | Recombinant Human IL-17B (25 UG) | 25 UG | 4150 |
| R&D Systems | 1248-IB-025/CF | Recombinant Human IL-17B, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 125-PD-005 | Porcine PDGF, CF (5 UG) | 5 UG | 5060 |
| R&D Systems | 1250-S3-025 | Recombinant Human Semaphorin 3A Fc Chimera, CF (25 UG) | 25 UG | 4230 |
| R&D Systems | 1254-N4-025 | Recombinant Human Netrin-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1254-N4-025/CF | Recombinant Human Netrin-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1255-F3-025 | Recombinant Mouse FLRG (25 UG) | 25 UG | 4280 |
| R&D Systems | 1255-F3-025/CF | Recombinant Mouse FLRG, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1256-OX-050 | Recombinant Mouse OX40/TNFRSF4 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1257-FC-050 | Recombinant Human Fc gamma RI/CD64, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1258-GMP-01M | Recombinant Human IL-17E GMP, CF (1 MG) | 1 MG | 77680 |
| R&D Systems | 1258-GMP-025 | Recombinant Human IL-17E GMP, CF (25 UG) | 25 UG | 4810 |
| R&D Systems | 1258-IL-025 | Recombinant Human IL-17E (25 UG) | 25 UG | 4280 |
| R&D Systems | 1258-IL-025/CF | Recombinant Human IL-17E, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 126-FL-010 | Recombinant Human Fas Ligand/TNFSF6 (10 UG) | 10 UG | 4670 |
| R&D Systems | 126-FL-010/CF | Recombinant Human Fas Ligand/TNFSF6, CF (10 UG) | 10 UG | 4670 |
| R&D Systems | 1264-FR-050 | Recombinant Human FGF R3 (IIIb) Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1265-PI-010 | Recombinant Mouse Serpin D1/Heparin Cofactor II, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1266-PI-010 | Recombinant Human Serpin A5, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1267-PI-010 | Recombinant Human Serpin C1/Antithrombin-III, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1268-PI-010 | Recombinant Human Serpin A1/alpha-1-Antitrypsin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1269-DK-010 | Recombinant Human Dkk-4 (10 UG) | 10 UG | 4280 |
| R&D Systems | 1269-DK-010/CF | Recombinant Human Dkk-4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 127-N2-025 | Recombinant Chicken Netrin-2 (25 UG) | 25 UG | 4280 |
| R&D Systems | 127-N2-025/CF | Recombinant Chicken Netrin-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1274-PI-100 | Recombinant Human SLPI, CF (100 UG) | 100 UG | 3240 |
| R&D Systems | 1275-IL-025 | Recombinant Human IL-36Ra/IL-1F5 (25 UG) | 25 UG | 4410 |
| R&D Systems | 1275-IL-025/CF | Recombinant Human IL-36Ra/IL-1F5, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1277-JG-050 | Recombinant Human Jagged 1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1278-TR-050 | Recombinant Human TREM-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 128-N1-025 | Recombinant Chicken Netrin-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 128-N1-025/CF | Recombinant Chicken Netrin-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1280-ER-050 | Recombinant Mouse EGF R/ErbB1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1284-PI-010 | Recombinant Mouse Cystatin E/M, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1285-PI-010 | Recombinant Human Cystatin SN, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1286-PI-010 | Recombinant Human Cystatin E/M, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1288-F3-025 | Recombinant Human FLRG (25 UG) | 25 UG | 4280 |
| R&D Systems | 1288-F3-025/CF | Recombinant Human FLRG, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1290-IL-010 | Recombinant Human IL-23 (10 UG) | 10 UG | 4150 |
| R&D Systems | 1290-IL-010/CF | Recombinant Human IL-23, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 1294-AS-010 | Recombinant Human Cathepsin E, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1295-PI-010 | Recombinant Human Serpin A3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1296-PI-050 | Recombinant Human Cystatin S, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1297-NE-025 | Recombinant Human Neurturin (25 UG) | 25 UG | 4280 |
| R&D Systems | 1297-NE-025/CF | Recombinant Human Neurturin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1298-UL-050 | Recombinant Human ULBP-2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1299-NK-050 | Recombinant Human NKG2D Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 130-MD-050 | Recombinant Mouse MD-1 (50 UG) | 50 UG | 4280 |
| R&D Systems | 130-MD-050/CF | Recombinant Mouse MD-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1300-MA-050 | Recombinant Human MICA Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1304-GA-050 | Recombinant Mouse Galectin-7 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1304-GA-050/CF | Recombinant Mouse Galectin-7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1305-GA-050 | Recombinant Human Galectin-8 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1305-GA-050/CF | Recombinant Human Galectin-8, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1306-RE-010 | Recombinant Rat Erythropoietin (10 UG) | 10 UG | 4280 |
| R&D Systems | 1306-RE-010/CF | Recombinant Rat Erythropoietin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1307-FZ-050 | Recombinant Human/Mouse Frizzled-2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1308-NT-050 | Recombinant Mouse Notch-3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1309-PR-050 | Recombinant Mouse Prolactin R Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 131-M1-025 | Recombinant Human CCL23/MPIF-1 (aa 46-120) (25 UG) | 25 UG | 3760 |
| R&D Systems | 131-M1-025/CF | Recombinant Human CCL23/MPIF-1 (aa 46-120), CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 1310-SE-010 | Recombinant Human u-Plasminogen Activator/Urokinase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 13100-1 | Recombinant Rat IFN-alpha (100000 UN) | 100000 UN | 5170 |
| R&D Systems | 1314-GMP-01M | Recombinant Human Sonic Hedgehog/Shh, N-Terminus GMP, CF (1 MG) | 1 MG | 53950 |
| R&D Systems | 1314-GMP-025 | Recombinant Human Sonic Hedgehog/Shh, N-Terminus GMP, CF (25 UG) | 25 UG | 4020 |
| R&D Systems | 1314-SH-025 | Recombinant Human Sonic Hedgehog/Shh, N-Terminus (25 UG) | 25 UG | 3110 |
| R&D Systems | 1314-SH-025/CF | Recombinant Human Sonic Hedgehog/Shh, N-Terminus, CF (25 UG) | 25 UG | 3110 |
| R&D Systems | 1315-ND-025 | Recombinant Mouse Nodal (25 UG) | 25 UG | 4280 |
| R&D Systems | 1315-ND-025/CF | Recombinant Mouse Nodal, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1316-RL-010 | Recombinant Rat IL-22 (10 UG) | 10 UG | 4280 |
| R&D Systems | 1316-RL-010/CF | Recombinant Rat IL-22, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1317-TR-050 | Recombinant Mouse Thrombopoietin R Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1318-RL-010 | Recombinant Rhesus Macaque IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3760 |
| R&D Systems | 1318-RL-010/CF | Recombinant Rhesus Macaque IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 1319-TL-010 | Recombinant Human TL1A/TNFSF15 (10 UG) | 10 UG | 4410 |
| R&D Systems | 1319-TL-010/CF | Recombinant Human TL1A/TNFSF15, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 132-FA-025 | Bovine FGF acidic (25 UG) | 25 UG | 4670 |
| R&D Systems | 132-FA-025/CF | Bovine FGF acidic, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 1320-EN-025 | Recombinant Mouse Endoglin/CD105 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1324-WN-010 | Recombinant Mouse Wnt-3a (10 UG) | 10 UG | 9820 |
| R&D Systems | 1324-WN-002 | Recombinant Mouse Wnt-3a (2 UG) | 2 UG | 3110 |
| R&D Systems | 1324-WN-010/CF | Recombinant Mouse Wnt-3a, CF (10 UG) | 10 UG | 9820 |
| R&D Systems | 1324-WN-002/CF | Recombinant Mouse Wnt-3a, CF (2 UG) | 2 UG | 3110 |
| R&D Systems | 1324-WN-500/CF | Recombinant Mouse Wnt-3a, CF (500 UG) | 500 UG | 95680 |
| R&D Systems | 1324-WNP-010 | Recombinant Mouse Wnt-3a (High Purity) (10 UG) | 10 UG | 11430 |
| R&D Systems | 1324-WNP-010/CF | Recombinant Mouse Wnt-3a (High Purity), CF (10 UG) | 10 UG | 11430 |
| R&D Systems | 1325-BL-050 | Recombinant Human BIM (Long Form), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1328-PI-050 | Recombinant E. coli Ecotin, CF (50 UG) | 50 UG | 1940 |
| R&D Systems | 133-FB-025 | Bovine FGF basic (25 UG) | 25 UG | 5190 |
| R&D Systems | 133-FB-025/CF | Bovine FGF basic, CF (25 UG) | 25 UG | 5190 |
| R&D Systems | 1330-CD-050 | Recombinant Human Fc gamma RIIA/CD32a (R167) (50 UG) | 50 UG | 4410 |
| R&D Systems | 1330-CD-050/CF | Recombinant Human Fc gamma RIIA/CD32a (R167), CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1334-B7-025 | Recombinant Human IGFBP-rp1/IGFBP-7, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1335-IL-025 | Recombinant Human IL-17F (25 UG) | 25 UG | 4280 |
| R&D Systems | 1335-IL-025/CF | Recombinant Human IL-17F, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1335-INS-025 | Recombinant Human IL-17F (NS0-expressed) (25 UG) | 25 UG | 3760 |
| R&D Systems | 1335-INS-025/CF | Recombinant Human IL-17F (NS0-expressed), CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 1336-PN-050 | Recombinant Human Proinsulin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1339-GA-050 | Recombinant Human Galectin-7 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1339-GA-050/CF | Recombinant Human Galectin-7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1340-B2-050 | Recombinant Rat B7-2/CD86 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 13400-1 | Recombinant Rat IFN-beta (100000 UN) | 100000 UN | 4820 |
| R&D Systems | 1341-WF-050 | Recombinant Human WIF-1 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1341-WF-050/CF | Recombinant Human WIF-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1344-SE-010 | Recombinant Human Kallikrein 3/PSA, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1346-SE-010 | Recombinant Mouse Granzyme G, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 135-WF-050 | Recombinant Mouse WIF-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1356-SR-050 | Recombinant Mouse CD117/c-kit Fc Chimera, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 1357-BR-050 | Recombinant Mouse BAFF R/TNFRSF13C Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1358-KS-010 | Recombinant Human Active Chk2, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 1359-RN-005 | Recombinant Human Resistin, CF (5 UG) | 5 UG | 2980 |
| R&D Systems | 136-AN-050 | Recombinant Mouse Angiopoietin-like 3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1360-GR-050 | Recombinant Mouse Growth Hormone R (GHR) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1365-SE-010 | Recombinant Mouse Granzyme D, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1366-PT-050 | Recombinant Human PTP1B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 137-PS-050 | Recombinant Human P-Selectin/CD62P Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 1375-IL-025 | Recombinant Human IL-26/AK155 Monomer (25 UG) | 25 UG | 4280 |
| R&D Systems | 1375-IL-025/CF | Recombinant Human IL-26/AK155 Monomer, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1377-SE-010 | Recombinant Human Granzyme H, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1378-RP-050 | Recombinant Mouse RP105/CD180 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1379-RG-050 | Recombinant Human Reg4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1380-UL-050 | Recombinant Human ULBP-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1384-SF-025 | Recombinant Human sFRP-1 (Histidine-tagged) (25 UG) | 25 UG | 4230 |
| R&D Systems | 1384-SF-025/CF | Recombinant Human sFRP-1 (Histidine-tagged), CF (25 UG) | 25 UG | 4230 |
| R&D Systems | 1385-RT-050 | Recombinant Human RELT/TNFRSF19L Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1388-NC-050 | Recombinant Human N-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1389-D4-050 | Recombinant Mouse DLL4 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1389-D4-050/CF | Recombinant Mouse DLL4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 139-NK-050 | Recombinant Mouse NKG2D Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1390-ER-050 | Recombinant Mouse Erythropoietin R Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1394-NP-050 | Recombinant Mouse Nope Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1395-KC-025 | Recombinant Mouse CXCL1/KC (aa 29-96) (25 UG) | 25 UG | 4150 |
| R&D Systems | 1395-KC-025/CF | Recombinant Mouse CXCL1/KC (aa 29-96), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1396-KN-050 | Recombinant Human Kininostatin (50 UG) | 50 UG | 4280 |
| R&D Systems | 1396-KN-050/CF | Recombinant Human Kininostatin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1397-B3-050 | Recombinant Mouse B7-H3 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1397-B3-050/CF | Recombinant Mouse B7-H3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1398-TS-010 | Recombinant Human TSLP (10 UG) | 10 UG | 4280 |
| R&D Systems | 1398-TS-010/CF | Recombinant Human TSLP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1399-IL-025 | Recombinant Mouse IL-17E (25 UG) | 25 UG | 4280 |
| R&D Systems | 1399-IL-025/CF | Recombinant Mouse IL-17E, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 140-B1-100 | Recombinant Human B7-1/CD80 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 1400-IR-050 | Recombinant Human IL-23 R Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1404-TC-050 | Recombinant Mouse TrkC (50 UG) | 50 UG | 4280 |
| R&D Systems | 1404-TC-050/CF | Recombinant Mouse TrkC, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1405-UN-050 | Recombinant Rat UNC5H1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1406-ST-025 | Recombinant Human SOST/Sclerostin (25 UG) | 25 UG | 4410 |
| R&D Systems | 1406-ST-025/CF | Recombinant Human SOST/Sclerostin, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1407-PI-050 | Recombinant Human Cystatin A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1408-PI-050 | Recombinant Human Cystatin B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1409-PI-050 | Recombinant Mouse Cystatin B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 141-B2-100 | Recombinant Human B7-2/CD86 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 1410-CR-050 | Recombinant Human Cryptic (50 UG) | 50 UG | 4280 |
| R&D Systems | 1410-CR-050/CF | Recombinant Human Cryptic, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 14110-1 | Recombinant Rhesus Macaque/Cynomolgus IFN-alpha (100000 UN) | 100000 UN | 3890 |
| R&D Systems | 1413-FB-025 | Recombinant Rat FGF-BP (25 UG) | 25 UG | 3370 |
| R&D Systems | 1413-FB-025/CF | Recombinant Rat FGF-BP, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 142-DC-100 | Recombinant Human DcR3/TNFRSF6B Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 1429-UN-050 | Recombinant Human UNC5H4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 143-DE-100 | Recombinant Human Decorin, CF (100 UG) | 100 UG | 3760 |
| R&D Systems | 1430-CD-050 | Recombinant Human cd45, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1433-OP-050 | Recombinant Human Osteopontin (OPN) (50 UG) | 50 UG | 3110 |
| R&D Systems | 1433-OP-050/CF | Recombinant Human Osteopontin (OPN), CF (50 UG) | 50 UG | 3110 |
| R&D Systems | 1437-CD-050 | Recombinant Mouse CD83 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 144-DR-100 | Recombinant Human DR6/TNFRSF21 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 1440-NG-050 | Recombinant Mouse Nogo Receptor Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1445-PL-050 | Recombinant Mouse Prolactin (50 UG) | 50 UG | 3760 |
| R&D Systems | 1445-PL-050/CF | Recombinant Mouse Prolactin, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 1447-PC-025 | Recombinant Mouse PDGF-CC (25 UG) | 25 UG | 4280 |
| R&D Systems | 1447-PC-025/CF | Recombinant Mouse PDGF-CC, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 145-CR-010 | Recombinant Human Cripto-1 (10 UG) | 10 UG | 4280 |
| R&D Systems | 145-CR-010/CF | Recombinant Human Cripto-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1454-ZN-010 | Recombinant Mouse Kell, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1458-HT-100 | Recombinant Human HTRA2/Omi, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1459-S4-050 | Recombinant Mouse IGSF4A/SynCAM1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 146-IR-100 | Recombinant Human IL-13 R alpha 1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1460-CD-050 | Recombinant Mouse Fc gamma RIIB/CD32b, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 147-IR-100 | Recombinant Human IL-15 R alpha Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1470-PI-010 | Recombinant Human Serpin F2/alpha 2-Antiplasmin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1473-SE-010 | Recombinant Human Coagulation Factor II/Thrombin, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 1476-TR-050 | Recombinant Mouse TLR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1477-AR-050 | Recombinant Mouse Activin RIB/ALK-4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1478-TR-050 | Recombinant Human TLR4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1479-TC-050 | Recombinant Human IL-27 Ra/WSX-1/TCCR Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 148-BC-100 | Recombinant Human BCAM Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1484-TR-050 | Recombinant Human TLR1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1487-TR-050 | Recombinant Human TLR3, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1493-CD-050 | Recombinant Human CD40/TNFRSF5 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1494-TB-025 | Recombinant Mouse TrkB (25 UG) | 25 UG | 4280 |
| R&D Systems | 1494-TB-025/CF | Recombinant Mouse TrkB, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1503-SE-010 | Recombinant Human Furin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1504-IL-025 | Recombinant Human IL-17D (25 UG) | 25 UG | 4280 |
| R&D Systems | 1504-IL-025/CF | Recombinant Human IL-17D, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1505-LR-025 | Recombinant Human LRP-6 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1506-D4-050 | Recombinant Human DLL4 (50 UG) | 50 UG | 4150 |
| R&D Systems | 1506-D4-050/CF | Recombinant Human DLL4, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1507-CT-025 | Recombinant Canine TNF-alpha (25 UG) | 25 UG | 4280 |
| R&D Systems | 1507-CT-025/CF | Recombinant Canine TNF-alpha, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1508-S1-025 | Recombinant Mouse Soggy-1/DkkL1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1508-S1-025/CF | Recombinant Mouse Soggy-1/DkkL1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 15100-1 | Recombinant Feline IFN-alpha (100000 UN) | 100000 UN | 3890 |
| R&D Systems | 1513-ZN-010 | Recombinant Mouse ACE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1514-SE-010 | Recombinant Human HGF Activator, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1515-CY-010 | Recombinant Mouse Cathepsin L, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1517-UL-050 | Recombinant Human ULBP-3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1524-EG-050 | Recombinant Human Endoglycan/PODXL2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1525-DC-050 | Recombinant Mouse Dectin-2/CLEC6A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1529-TM-050 | Recombinant Mouse TIM-3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1530-TR-050 | Recombinant Mouse TLR2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1533-TR-050 | Recombinant Mouse TLR6 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1534-LS-050 | Recombinant Rat L-Selectin/CD62L Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1535-LM-010 | Recombinant Mouse Limitin/IFN-zeta (10 UG) | 10 UG | 4280 |
| R&D Systems | 1535-LM-010/CF | Recombinant Mouse Limitin/IFN-zeta, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1538-CR-010 | Recombinant Mouse Cripto (10 UG) | 10 UG | 4280 |
| R&D Systems | 1538-CR-010/CF | Recombinant Mouse Cripto, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1539-PG-025 | Recombinant Mouse GDF-8 Propeptide (25 UG) | 25 UG | 4280 |
| R&D Systems | 1539-PG-025/CF | Recombinant Mouse GDF-8 Propeptide, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 154-AL-100 | Recombinant Human Axl Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 1543-BP-025 | Recombinant Human BMP-3b/GDF-10 (25 UG) | 25 UG | 5320 |
| R&D Systems | 1543-BP-025/CF | Recombinant Human BMP-3b/GDF-10, CF (25 UG) | 25 UG | 5320 |
| R&D Systems | 1544-IR-050 | Recombinant Human Insulin R/CD220 (aa 28-944) (50 UG) | 50 UG | 4410 |
| R&D Systems | 1544-IR-050/CF | Recombinant Human Insulin R/CD220 (aa 28-944), CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1545-RA-025 | Recombinant Rat IL-1ra/IL-1F3 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1545-RA-025/CF | Recombinant Rat IL-1ra/IL-1F3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1546-GM-025 | Recombinant Canine GM-CSF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1546-GM-025/CF | Recombinant Canine GM-CSF, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1548-TR-100 | Recombinant Human TROY/TNFRSF19 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1549-S1-025 | Recombinant Human Soggy-1/DkkL1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1549-S1-025/CF | Recombinant Human Soggy-1/DkkL1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1556-PD-050 | Recombinant Mouse Podocalyxin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1557-CD-050 | Recombinant Human CD320/TCblR/8D6A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1559-NT-050 | Recombinant Human Notch-3 (aa 40-467) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 156-B7-100 | Recombinant Human B7-H1 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 1563-PI-050 | Recombinant Mouse Fetuin A/AHSG, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1564-LX-050 | Recombinant Mouse LOX-1/OLR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1568-HP-050 | Recombinant Mouse Hip (50 UG) | 50 UG | 4280 |
| R&D Systems | 1568-HP-050/CF | Recombinant Mouse Hip, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1569-PI-010 | Recombinant Human Kininogen HMW (HKa), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 157-ER-100 | Recombinant Human EDAR Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 1577-IL-010 | Recombinant Rhesus Macaque IL-4 (10 UG) | 10 UG | 3890 |
| R&D Systems | 1577-IL-010/CF | Recombinant Rhesus Macaque IL-4, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 1578-HC-025 | Recombinant Human CCL14a/HCC-1 (aa 28-93) (25 UG) | 25 UG | 4150 |
| R&D Systems | 1578-HC-025/CF | Recombinant Human CCL14a/HCC-1 (aa 28-93), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 158-B7-100 | Recombinant Mouse B7-H2 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1580-HS-050 | Recombinant Human HSP27, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1585-SE-010 | Recombinant Human Enteropeptidase/Enterokinase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1586-HG-025 | Recombinant Equine IFN-gamma (25 UG) | 25 UG | 3760 |
| R&D Systems | 1586-HG-025/CF | Recombinant Equine IFN-gamma, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 1587-IL-025 | Recombinant Human IL-28A/IFN-lambda 2 (25 UG) | 25 UG | 4150 |
| R&D Systems | 1587-IL-025/CF | Recombinant Human IL-28A/IFN-lambda 2, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1588-B1-025 | Recombinant Mouse IGFBP-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1589-ST-025 | Recombinant Mouse SOST/Sclerostin (25 UG) | 25 UG | 4280 |
| R&D Systems | 1589-ST-025/CF | Recombinant Mouse SOST/Sclerostin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 159-DP-020 | Recombinant Drosophila Decapentaplegic (Dpp) (20 UG) | 20 UG | 4670 |
| R&D Systems | 159-DP-020/CF | Recombinant Drosophila Decapentaplegic (Dpp) , CF (20 UG) | 20 UG | 4670 |
| R&D Systems | 1593-FB-025 | Recombinant Human FGF-BP, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 1595-SE-010 | Recombinant Human Kallikrein 11, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1596-B1-200 | Recombinant Rat EphB1 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 1597-FC-050 | Recombinant Human Fc gamma RIIIB/CD16b (50 UG) | 50 UG | 4410 |
| R&D Systems | 1597-FC-050/CF | Recombinant Human Fc gamma RIIIB/CD16b, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1598-IL-025 | Recombinant Human IL-29/IFN-lambda 1 (25 UG) | 25 UG | 4150 |
| R&D Systems | 1598-IL-025/CF | Recombinant Human IL-29/IFN-lambda 1, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1599-MB-050 | Recombinant Human MICB (aa 23-298) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1600-R2-050 | Recombinant Mouse TGF-beta RII/(mouse) Fc Chimera, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 1603-CV-010 | Recombinant Canine VEGF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1603-CV-010/CF | Recombinant Canine VEGF, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1605-IL-010 | Recombinant Equine IL-10 (10 UG) | 10 UG | 3890 |
| R&D Systems | 1605-IL-010/CF | Recombinant Equine IL-10, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 1607-CD-050 | Recombinant Human CD163, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1608-CL-025 | Recombinant Canine CXCL8/IL-8 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1608-CL-025/CF | Recombinant Canine CXCL8/IL-8, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1609-CL-025 | Recombinant Canine IL-6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1609-CL-025/CF | Recombinant Canine IL-6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 161-DC-050 | Recombinant Human DC-SIGN/CD209 Fc Chimera (50 UG) | 50 UG | 4280 |
| R&D Systems | 1610-TW-050 | Recombinant Mouse TWEAK R/TNFRSF12 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1613-IL-020 | Recombinant Equine IL-2 (Cys141Ser) (20 UG) | 20 UG | 4280 |
| R&D Systems | 1613-IL-020/CF | Recombinant Equine IL-2 (Cys141Ser), CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1614-FL-025 | Recombinant Rat Fas Ligand/TNFSF6 (25 UG) | 25 UG | 4410 |
| R&D Systems | 1614-FL-025/CF | Recombinant Rat Fas Ligand/TNFSF6, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1616-RG-050 | Recombinant Rat RAGE Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1617-FZ-050 | Recombinant Human Frizzled-5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1617-FZC-050 | Recombinant Human Frizzled-5 Fc Chimera, CF (CHO-expressed) (50 UG) | 50 UG | 4280 |
| R&D Systems | 1618-MR-050 | Recombinant Rat MIS RII Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 162-D2-050 | Recombinant Human DC-SIGNR/CD299 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1627-WS-050 | Recombinant Human WISP-1/CCN4, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1628-ZN-020 | Recombinant E. coli Methionine Aminopeptidase/METAP, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1629-AC-010 | Recombinant Human Activin C (10 UG) | 10 UG | 3760 |
| R&D Systems | 1629-AC-010/CF | Recombinant Human Activin C, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 1630-KS-010 | Recombinant Human Active Chk1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 1635-T2-050 | Recombinant Human Thrombospondin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1636-CD-050 | Recombinant Human CD5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 164-SL-050 | Recombinant Human SLAM/CD150, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1640-NV-050 | Recombinant Human NOV/CCN3, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1645-ZN-010 | Recombinant Human ECE-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1647-KR-025 | Recombinant Mouse Kremen-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1647-KR-025/CF | Recombinant Mouse Kremen-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1649-CD-050 | Recombinant Human CDC25B (aa 377-566), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 165-B7-100 | Recombinant Human B7-H2 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 1654-VH-050 | Recombinant Human VHR, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1658-PD-050 | Recombinant Human Podocalyxin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1667-SE-010 | Recombinant Human Tryptase gamma-1/TPSG1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1668-ZN-020 | Recombinant Human Pappalysin-2/PAPP-A2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1669-PI-020 | Recombinant Human Serpin A4/Kallistatin, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1670-SE-020 | Recombinant E. coli HTRA/Protease Do, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1673-OM-025 | Recombinant Human OMgp, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1674-MG-025 | Recombinant Mouse OMgp, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 168-CS-100 | Recombinant Mouse ICOS Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1680-WS-050 | Recombinant Mouse WISP-1/CCN4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1686-MR-050 | Recombinant Mouse IL-23 R Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1687-CC-025 | Recombinant Human PDGF-CC (25 UG) | 25 UG | 4150 |
| R&D Systems | 1687-CC-025/CF | Recombinant Human PDGF-CC, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1688-AC-025 | Recombinant Human gAdiponectin/gAcrp30, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1689-CD-050 | Recombinant Human CD58/LFA-3 (50 UG) | 50 UG | 4800 |
| R&D Systems | 1689-CD-050/CF | Recombinant Human CD58/LFA-3, CF (50 UG) | 50 UG | 4800 |
| R&D Systems | 169-CS-050 | Recombinant Human ICOS Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1690-HMB-050 | Recombinant Human HMGB1, CF (50 UG) | 50 UG | 4800 |
| R&D Systems | 1694-FN-050 | Recombinant Human Follistatin-like 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1695-CR-050 | Recombinant Human CRTAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1696-CD-050 | Recombinant Mouse C1q R1/CD93 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1697-CR-025 | Recombinant Mouse CREG (25 UG) | 25 UG | 4280 |
| R&D Systems | 1697-CR-025/CF | Recombinant Mouse CREG, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1704-CL-050 | Recombinant Human CLEC-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1705-HH-025 | Recombinant Human/Mouse Indian Hedgehog/Ihh (C28II) N-Term (25 UG) | 25 UG | 4280 |
| R&D Systems | 1705-HH-025/CF | Recombinant Human/Mouse Indian Hedgehog (C28II) N-Term, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1706-SF-050 | Recombinant Mouse Siglec-F Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1707-CR-200 | Recombinant Human C-Reactive Protein/CRP (200 UG) | 200 UG | 3110 |
| R&D Systems | 1707-CR-200/CF | Recombinant Human C-Reactive Protein/CRP, CF (200 UG) | 200 UG | 3110 |
| R&D Systems | 1708-PI-050 | Recombinant Human Lipocalin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1709-ML-025 | Recombinant Mouse IL-17B (25 UG) | 25 UG | 4280 |
| R&D Systems | 1709-ML-025/CF | Recombinant Mouse IL-17B, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 17105-1 | Recombinant Porcine IFN-alpha (Mammalian) (100000 UN) | 100000 UN | 4820 |
| R&D Systems | 1714-CN-025 | Recombinant Human Contactin-2/TAG1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1718-CL-050 | Recombinant Human CLEC-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1719-SE-010 | Recombinant Human Kallikrein 4/Prostase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1720-DM-050 | Recombinant Human Desmoglein-3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1724-SE-020 | Recombinant Human Complement MASP3 Catalytic Domain, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1725-PI-050 | Recombinant Human Fetuin B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1726-JG-050 | Recombinant Human Jagged 2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1728-S3-050 | Recombinant Mouse Semaphorin 3C Fc Chimera (Truncated), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1729-T2-050 | Recombinant Mouse TREM-2b Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1737-MS-010 | Recombinant Human MIS/AMH (10 UG) | 10 UG | 4280 |
| R&D Systems | 1737-MS-010/CF | Recombinant Human MIS/AMH, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1738-FN-050 | Recombinant Mouse Follistatin-like 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 174-TC-050 | Recombinant Human TACI/TNFRSF13B Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1744-CR-200 | Recombinant Rat C-Reactive Protein/CRP (200 UG) | 200 UG | 3110 |
| R&D Systems | 1744-CR-200/CF | Recombinant Rat C-Reactive Protein/CRP, CF (200 UG) | 200 UG | 3110 |
| R&D Systems | 1745-RG-050 | Recombinant Rat Reg3G, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1747-PI-010 | Recombinant Human Trappin-2/Elafin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1749-RB-050 | Recombinant Rat ROBO1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 175-TK-050 | Recombinant Human TrkA Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1750-TM-050 | Recombinant Human TIM-1/KIM-1/HAVCR, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1756-DC-050 | Recombinant Mouse Dectin-1/CLEC7A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1757-LC-050 | Recombinant Human Lipocalin-2/NGAL, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 176-GB-025 | Recombinant Human CXCL2/GRO beta (aa 39-107) (25 UG) | 25 UG | 3500 |
| R&D Systems | 176-GB-025/CF | Recombinant Human CXCL2/GRO beta (aa 39-107), CF (25 UG) | 25 UG | 3500 |
| R&D Systems | 1760-RL-010 | Recombinant Rat IL-12 (10 UG) | 10 UG | 3760 |
| R&D Systems | 1760-RL-010/CF | Recombinant Rat IL-12, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 1764-KR-025 | Recombinant Mouse Kremen-2 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1764-KR-025/CF | Recombinant Mouse Kremen-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1765-DK-010 | Recombinant Mouse Dkk-1 (Histidine-tagged) (10 UG) | 10 UG | 4280 |
| R&D Systems | 1765-DK-010/CF | Recombinant Mouse Dkk-1 (Histidine-tagged), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 177-IR-100 | Recombinant Human IL-17 RA/IL-17 R Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 1774-MC-025 | Recombinant Canine CCL2/MCP-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1774-MC-025/CF | Recombinant Canine CCL2/MCP-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1775-KS-010 | Recombinant Human Active Akt1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 1776-KS-010 | Recombinant Mouse Active JNK1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 1784-ZN-010 | Recombinant Human ECE-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1785-MP-010 | Recombinant Human MMP-16/MT3-MMP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1786-PI-010 | Recombinant Human Serpin E1/PAI-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1787-MD-050 | Recombinant Human MD-2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1787-MD-050/CF | Recombinant Human MD-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1788-IR-050 | Recombinant Human IL-20 R beta Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1789-ML-025 | Recombinant Mouse IL-28B/IFN-lambda 3 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1789-ML-025/CF | Recombinant Mouse IL-28B/IFN-lambda 3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1790-CA-050 | Recombinant Human Cadherin-11 (CAD-11) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1794-LT-025 | Recombinant Mouse LIGHT/TNFSF14 (25 UG) | 25 UG | 4150 |
| R&D Systems | 1794-LT-025/CF | Recombinant Mouse LIGHT/TNFSF14, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1795-FL-010 | Recombinant Feline IL-5 (10 UG) | 10 UG | 3110 |
| R&D Systems | 1795-FL-010/CF | Recombinant Feline IL-5, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 1796-FL-010 | Recombinant Feline IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3760 |
| R&D Systems | 1796-FL-010/CF | Recombinant Feline IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 1797-MS-050 | Recombinant Mouse SR-AI/MSR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1798-LX-050 | Recombinant Human LOX-1/OLR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1806-T5-050 | Recombinant Human LILRB3/CD8/ILT5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1807-SE-010 | Recombinant Human Complement Component C1r, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1808-NR-050 | Recombinant Human Chordin-Like 1 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1808-NR-050/CF | Recombinant Human Chordin-Like 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1809-EL-020 | Recombinant Equine IL-4 (20 UG) | 20 UG | 4410 |
| R&D Systems | 1809-EL-020/CF | Recombinant Equine IL-4, CF (20 UG) | 20 UG | 4410 |
| R&D Systems | 1810-EC-050 | Recombinant Human Endocan (50 UG) | 50 UG | 4280 |
| R&D Systems | 1810-EC-050/CF | Recombinant Human Endocan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1814-ET-025 | Recombinant Equine TNF-alpha (25 UG) | 25 UG | 4280 |
| R&D Systems | 1814-ET-025/CF | Recombinant Equine TNF-alpha, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1815-CL-020 | Recombinant Canine IL-2 (Cys147Ser) (20 UG) | 20 UG | 4280 |
| R&D Systems | 1815-CL-020/CF | Recombinant Canine IL-2 (Cys147Ser), CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1816-DT-050 | Recombinant Mouse DcTRAIL R2/TNFRSF22 (50 UG) | 50 UG | 4540 |
| R&D Systems | 1816-DT-050/CF | Recombinant Mouse DcTRAIL R2/TNFRSF22, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 1817-TM-050 | Recombinant Mouse TIM-1/KIM-1/HAVCR (50 UG) | 50 UG | 4280 |
| R&D Systems | 1817-TM-050/CF | Recombinant Mouse TIM-1/KIM-1/HAVCR, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1818-DL-050 | Recombinant Human DLL1, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1819-KL-050 | Recombinant Mouse Klotho (aa 35-982), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1820-SB-050 | Recombinant Human S100B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1824-SE-010 | Recombinant Human Complement Factor D, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1826-TS-025 | Recombinant Human Pentraxin 3/TSG-14 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1826-TS-025/CF | Recombinant Human Pentraxin 3/TSG-14, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1827-SF-025 | Recombinant Human sFRP-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1827-SF-025/CF | Recombinant Human sFRP-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1828-T2-050 | Recombinant Human TREM-2 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1829-CR-200 | Recombinant Mouse C-Reactive Protein/CRP, CF (200 UG) | 200 UG | 3110 |
| R&D Systems | 1830-SR-025 | Recombinant Mouse IL-6 R alpha (aa 20-357) (25 UG) | 25 UG | 4280 |
| R&D Systems | 1830-SR-025/CF | Recombinant Mouse IL-6 R alpha (aa 20-357), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1835-S3-050 | Recombinant Mouse Semaphorin 7A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1836-SR-050 | Recombinant Mouse SIGNR1/CD209b Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1844-KR-050 | Recombinant Human KIR2DL1/CD158a Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1845-SH-100 | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus (100 UG) | 100 UG | 9480 |
| R&D Systems | 1845-SH-025 | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus (25 UG) | 25 UG | 3890 |
| R&D Systems | 1845-SH-500 | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus (500 UG) | 500 UG | 24570 |
| R&D Systems | 1845-SH-100/CF | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus, CF (100 UG) | 100 UG | 9480 |
| R&D Systems | 1845-SH-025/CF | Recombinant Human Sonic Hedgehog/Shh (C24II) N-Terminus, CF (25 UG) | 25 UG | 3890 |
| R&D Systems | 1847-KR-050 | Recombinant Human KIR2DS4/CD158i Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1849-NK-025 | Recombinant Human NKp30 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 185-OS-025 | Recombinant Human Osteoprotegerin/TNFRSF11B (25 UG) | 25 UG | 4800 |
| R&D Systems | 185-OS-025/CF | Recombinant Human Osteoprotegerin/TNFRSF11B, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 1850-NK-025 | Recombinant Human NKp46/NCR1 Fc Chimera, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1855-CD-050 | Recombinant Human CD84/SLAMF5 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1855-CD-050/CF | Recombinant Human CD84/SLAMF5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1857-LC-050 | Recombinant Mouse Lipocalin-2/NGAL, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1859-DC-050 | Recombinant Human Dectin-1/CLEC7A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1860-AM-050 | Recombinant Human Amnionless, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1865-SE-010 | Recombinant Mouse Granzyme B, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1866-CD-050 | Recombinant Mouse CD47 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1869-HP-025 | Recombinant Human HPRG, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1870-IL-010 | Recombinant Human IL-26/AK155 Dimer (10 UG) | 10 UG | 4410 |
| R&D Systems | 1870-IL-010/CF | Recombinant Human IL-26/AK155 Dimer, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 1875-CD-050 | Recombinant Human FC gamma RIIB/C (CD32b/c), CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1878-SH-010 | Recombinant Human Active SHP-1 (aa 205-595), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1879-KS-010 | Recombinant Human Active ERK1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 188-C8-005 | Recombinant Human Cadherin-8 (CAD-8) Fc Chimera, CF (5 UG) | 5 UG | 3890 |
| R&D Systems | 1885-TM-050 | Recombinant Mouse TIM-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1886-EL-025 | Recombinant Equine IL-6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1886-EL-025/CF | Recombinant Equine IL-6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1887-ML-010 | Recombinant Mouse IL-23 (10 UG) | 10 UG | 4280 |
| R&D Systems | 1887-ML-010/CF | Recombinant Mouse IL-23, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1888-LM-050 | Recombinant Mouse LIMPII/SR-B2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1889-PI-010 | Recombinant Human Cystatin F, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1890-FL-020 | Recombinant Feline IL-2 (Cys146Ser) (20 UG) | 20 UG | 4280 |
| R&D Systems | 1890-FL-020/CF | Recombinant Feline IL-2 (Cys146Ser), CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1894-SH-100 | Recombinant Human Active SHP-2, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 1895-SA-050 | Recombinant Rat Pentraxin 2/SAP (50 UG) | 50 UG | 4280 |
| R&D Systems | 1895-SA-050/CF | Recombinant Rat Pentraxin 2/SAP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1896-TL-010 | Recombinant Mouse TL1A/TNFSF15 (10 UG) | 10 UG | 4280 |
| R&D Systems | 1896-TL-010/CF | Recombinant Mouse TL1A/TNFSF15, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1898-CD-050 | Recombinant Human CD229/SLAMF3, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1899-FR-050 | Recombinant Mouse FGF R5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1900-NK-050 | Recombinant Human NKp80/KLRF1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1904-SC-025 | Recombinant Human SCGF-alpha/CLEC11a (25 UG) | 25 UG | 4150 |
| R&D Systems | 1904-SC-025/CF | Recombinant Human SCGF-alpha/CLEC11a, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1905-HP-025 | Recombinant Mouse HPRG, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1907-BL-050 | Recombinant Human BLAME/SLAMF8, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1908-NT-050 | Recombinant Human NTB-A/SLAMF6 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 191-ED-010 | Recombinant Mouse EDA-A1/Ectodysplasin A1 (10 UG) | 10 UG | 4280 |
| R&D Systems | 191-ED-010/CF | Recombinant Mouse EDA-A1/Ectodysplasin A1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1915-MF-050 | Recombinant Human MFRP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1917-CM-050 | Recombinant Human CRIM1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1918-FN-02M | Human Fibronectin, CF (2 MG) | 2 MG | 3370 |
| R&D Systems | 192-SF-010 | Recombinant Human sFRP-3 (10 UG) | 10 UG | 4280 |
| R&D Systems | 192-SF-010/CF | Recombinant Human sFRP-3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1920-SP-050 | Recombinant Human SP-D, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1927-ZN-010 | Recombinant Human BMP-1/PCP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1928-SE-010 | Recombinant Mouse Spinesin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 193-BC-050 | Recombinant Human BCMA/TNFRSF17 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1930-PT-050 | Recombinant Human TC-PTP (aa 2-314), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1934-DP-010 | Recombinant Human DEP-1/CD148 (aa 997-1337), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1936-SE-010 | Recombinant Human Complement Component C2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1937-SE-020 | Recombinant Mouse Tryptase beta-1/Mcpt7, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 1938-PI-050 | Human alpha 2-Macroglobulin, CF (50 UG) | 50 UG | 1940 |
| R&D Systems | 1939-SE-200 | Human Plasminogen, CF (200 UG) | 200 UG | 1940 |
| R&D Systems | 194-FZ-050 | Recombinant Mouse Frizzled-4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1945-RL-025 | Recombinant Rat IL-13 (25 UG) | 25 UG | 4150 |
| R&D Systems | 1945-RL-025/CF | Recombinant Rat IL-13, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1946-KR-025 | Recombinant Human Kremen-2 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1946-KR-025/CF | Recombinant Human Kremen-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1947-MS-050 | Recombinant Human MSP R/Ron, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1948-SA-050 | Recombinant Human Pentraxin 2/SAP (50 UG) | 50 UG | 4280 |
| R&D Systems | 1948-SA-050/CF | Recombinant Human Pentraxin 2/SAP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1949-B3-050 | Recombinant Human B7-H3 (50 UG) | 50 UG | 4410 |
| R&D Systems | 1949-B3-050/CF | Recombinant Human B7-H3, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1950-M5-050 | Recombinant Human ICAM-5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1954-FL-025 | Recombinant Feline IL-12 (25 UG) | 25 UG | 4670 |
| R&D Systems | 1954-FL-025/CF | Recombinant Feline IL-12, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 1955-CD-050 | Recombinant Human CD36/SR-B3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1956-CV-050 | Recombinant Human Crossveinless-2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 1956-CV-050/CF | Recombinant Human Crossveinless-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1957-KG-025 | Recombinant Canine KGF/FGF-7 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1957-KG-025/CF | Recombinant Canine KGF/FGF-7, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1958-GD-010 | Recombinant Human/Mouse/Rat GDF-11/BMP-11 (10 UG) | 10 UG | 4410 |
| R&D Systems | 1958-GD-010/CF | Recombinant Human/Mouse/Rat GDF-11/BMP-11, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 1959-B2-050 | Recombinant Human IL-12 R beta 2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1960-FC-050 | Recombinant Mouse Fc gamma RIII/CD16, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 1964-CL-025 | Recombinant Canine IL-5 (25 UG) | 25 UG | 3760 |
| R&D Systems | 1964-CL-025/CF | Recombinant Canine IL-5, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 1965-IL-025 | Recombinant Human IL-24 (25 UG) | 25 UG | 4150 |
| R&D Systems | 1965-IL-025/CF | Recombinant Human IL-24, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 1966-LM-050 | Recombinant Human LIMPII/SR-B2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1967-NG-025 | Recombinant Mouse Noggin (25 UG) | 25 UG | 4410 |
| R&D Systems | 1967-NG-025/CF | Recombinant Mouse Noggin, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 1968-SL-050 | Recombinant Human Siglec-2/CD22 Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 1969-CL-025 | Recombinant Canine IL-12/IL-23 p40 (25 UG) | 25 UG | 4670 |
| R&D Systems | 1969-CL-025/CF | Recombinant Canine IL-12/IL-23 p40, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 1970-TX-500 | Recombinant Human Thioredoxin-1, CF (500 UG) | 500 UG | 4280 |
| R&D Systems | 1974-CD-050 | Recombinant Mouse FcgR4/CD16-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1975-IL-025 | Recombinant Human IL-37/IL-1F7, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1976-NV-050 | Recombinant Mouse NOV/CCN3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1978-MF-025 | Recombinant Mouse MIF (25 UG) | 25 UG | 2980 |
| R&D Systems | 1978-MF-025/CF | Recombinant Mouse MIF, CF (25 UG) | 25 UG | 2980 |
| R&D Systems | 198-FZ-050 | Recombinant Mouse Frizzled-7 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1986-CB-025 | Recombinant Mouse Cerberus 1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 1986-CB-025/CF | Recombinant Mouse Cerberus 1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 1987-CD-050 | Recombinant Human CD59, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1988-SE-010 | Recombinant Human Marapsin/Pancreasin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1989-SE-010 | Recombinant Mouse Marapsin/Pancreasin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 1998-B1-050 | Recombinant Mouse IL-12 R beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 1999-EC-050 | Recombinant Mouse Endocan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 200-LA-010 | Recombinant Human IL-1 alpha/IL-1F1 (10 UG) | 10 UG | 7920 |
| R&D Systems | 200-LA-002 | Recombinant Human IL-1 alpha/IL-1F1 (2 UG) | 2 UG | 2330 |
| R&D Systems | 200-LA-010/CF | Recombinant Human IL-1 alpha/IL-1F1, CF (10 UG) | 10 UG | 7920 |
| R&D Systems | 200-LA-002/CF | Recombinant Human IL-1 alpha/IL-1F1, CF (2 UG) | 2 UG | 2330 |
| R&D Systems | 2009-CD-050 | Recombinant Human CD55/DAF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2009-CD-050/CF | Recombinant Human CD55/DAF, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 201-GMP-01M | Recombinant Human IL-1 beta/IL-1F2 GMP, CF (1 MG) | 1 MG | 71500 |
| R&D Systems | 201-GMP-025 | Recombinant Human IL-1 beta/IL-1F2 GMP, CF (25 UG) | 25 UG | 14300 |
| R&D Systems | 201-GMP-005 | Recombinant Human IL-1 beta/IL-1F2 GMP, CF (5 UG) | 5 UG | 4280 |
| R&D Systems | 201-LB-025 | Recombinant Human IL-1 beta/IL-1F2 (25 UG) | 25 UG | 11040 |
| R&D Systems | 201-LB-005 | Recombinant Human IL-1 beta/IL-1F2 (5 UG) | 5 UG | 3370 |
| R&D Systems | 201-LB-025/CF | Recombinant Human IL-1 beta/IL-1F2, CF (25 UG) | 25 UG | 11040 |
| R&D Systems | 201-LB-500/CF | Recombinant Human IL-1 beta/IL-1F2, CF (500 UG) | 500 UG | 32500 |
| R&D Systems | 201-LB-005/CF | Recombinant Human IL-1 beta/IL-1F2, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 2014-KR-050 | Recombinant Human KIR2DL3/CD158b2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2017-T2-050 | Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 202-GMP-010 | Recombinant Human IL-2 GMP, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 202-GMP-01M | Recombinant Human IL-2 GMP, CF (1 MG) | 1 MG | 31850 |
| R&D Systems | 202-GMP-050 | Recombinant Human IL-2 GMP, CF (50 UG) | 50 UG | 10600 |
| R&D Systems | 202-IL-010 | Recombinant Human IL-2 (10 UG) | 10 UG | 2590 |
| R&D Systems | 202-IL-500 | Recombinant Human IL-2 (500 UG) | 500 UG | 11570 |
| R&D Systems | 202-IL-050 | Recombinant Human IL-2 (50 UG) | 50 UG | 8130 |
| R&D Systems | 202-IL-010/CF | Recombinant Human IL-2, CF (10 UG) | 10 UG | 2590 |
| R&D Systems | 202-IL-050/CF | Recombinant Human IL-2, CF (50 UG) | 50 UG | 8130 |
| R&D Systems | 2025-SE-010 | Recombinant Human Kallikrein 8/Neuropsin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2026-EM-050 | Recombinant Mouse Pro-EMAP-II, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2028-EG-200 | Recombinant Mouse EGF, CF (200 UG) | 200 UG | 3110 |
| R&D Systems | 203-GMP-010 | Recombinant Human IL-3 GMP, CF (10 UG) | 10 UG | 3060 |
| R&D Systems | 203-GMP-01M | Recombinant Human IL-3 GMP, CF (1 MG) | 1 MG | 55900 |
| R&D Systems | 203-GMP-050 | Recombinant Human IL-3 GMP, CF (50 UG) | 50 UG | 9430 |
| R&D Systems | 203-IL-010 | Recombinant Human IL-3 (10 UG) | 10 UG | 2330 |
| R&D Systems | 203-IL-050 | Recombinant Human IL-3 (50 UG) | 50 UG | 7270 |
| R&D Systems | 203-IL-010/CF | Recombinant Human IL-3, CF (10 UG) | 10 UG | 2330 |
| R&D Systems | 203-IL-050/CF | Recombinant Human IL-3, CF (50 UG) | 50 UG | 7270 |
| R&D Systems | 2034-NR-050 | Recombinant Human NrCAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2036-BC-050 | Recombinant Human BOC, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2037-C5-025 | Recombinant Human Complement Component C (25 UG) | 25 UG | 3760 |
| R&D Systems | 2037-C5-025/CF | Recombinant Human Complement Component C, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 204-GMP-010 | Recombinant Human IL-4 GMP, CF (10 UG) | 10 UG | 3450 |
| R&D Systems | 204-GMP-01M | Recombinant Human IL-4 GMP, CF (1 MG) | 1 MG | 71500 |
| R&D Systems | 204-GMP-050 | Recombinant Human IL-4 GMP, CF (50 UG) | 50 UG | 11510 |
| R&D Systems | 204-IL-010 | Recombinant Human IL-4 (10 UG) | 10 UG | 2720 |
| R&D Systems | 204-IL-050 | Recombinant Human IL-4 (50 UG) | 50 UG | 8830 |
| R&D Systems | 204-IL-010/CF | Recombinant Human IL-4, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 204-IL-001MG/CF | Recombinant Human IL-4, CF (1 MG) | 1 MG | 55900 |
| R&D Systems | 204-IL-050/CF | Recombinant Human IL-4, CF (50 UG) | 50 UG | 8830 |
| R&D Systems | 2044-CD-050 | Recombinant Human CD83 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2045-GA-050 | Recombinant Human Galectin-9, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2048-FC-050 | Recombinant Human FCRL2/FcRH2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2049-FC-050 | Recombinant Human FCRL1/FcRH1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 205-IL-025 | Recombinant Human IL-5 (25 UG) | 25 UG | 7140 |
| R&D Systems | 205-IL-005 | Recombinant Human IL-5 (5 UG) | 5 UG | 2330 |
| R&D Systems | 205-IL-025/CF | Recombinant Human IL-5, CF (25 UG) | 25 UG | 7140 |
| R&D Systems | 205-IL-005/CF | Recombinant Human IL-5, CF (5 UG) | 5 UG | 2330 |
| R&D Systems | 2057-IL-025 | Recombinant Mouse IL-17F (25 UG) | 25 UG | 4150 |
| R&D Systems | 2057-IL-025/CF | Recombinant Mouse IL-17F, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 2058-CY-010 | Recombinant Mouse Legumain/Asparaginyl Endopeptidase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2059-SE-010 | Recombinant Mouse Tryptase epsilon/BSSP-4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 206-GMP-010 | Recombinant Human IL-6 GMP, CF (10 UG) | 10 UG | 3900 |
| R&D Systems | 206-GMP-01M | Recombinant Human IL-6 GMP, CF (1 MG) | 1 MG | 57200 |
| R&D Systems | 206-GMP-050 | Recombinant Human IL-6 GMP, CF (50 UG) | 50 UG | 12350 |
| R&D Systems | 206-IL-010 | Recombinant Human IL-6 (10 UG) | 10 UG | 2980 |
| R&D Systems | 206-IL-200 | Recombinant Human IL-6 (200 UG) | 200 UG | 13120 |
| R&D Systems | 206-IL-050 | Recombinant Human IL-6 (50 UG) | 50 UG | 9480 |
| R&D Systems | 206-IL-010/CF | Recombinant Human IL-6, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 206-IL-001MG/CF | Recombinant Human IL-6, CF (1 MG) | 1 MG | 44200 |
| R&D Systems | 206-IL-200/CF | Recombinant Human IL-6, CF (200 UG) | 200 UG | 13120 |
| R&D Systems | 206-IL-050/CF | Recombinant Human IL-6, CF (50 UG) | 50 UG | 9480 |
| R&D Systems | 2060-SE-010 | Recombinant Human Complement Component C1s, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 2065-S9-050 | Recombinant Mouse S100A9, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2068-S7-050 | Recombinant Human Semaphorin 7A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2069-PR-050 | Recombinant Mouse PRDC/GREM2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2069-PR-050/CF | Recombinant Mouse PRDC/GREM2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 207-GMP-01M | Recombinant Human IL-7 GMP, CF (1 MG) | 1 MG | 87750 |
| R&D Systems | 207-GMP-025 | Recombinant Human IL-7 GMP, CF (25 UG) | 25 UG | 12030 |
| R&D Systems | 207-IL-200 | Recombinant Human IL-7 (200 UG) | 200 UG | 16890 |
| R&D Systems | 207-IL-025 | Recombinant Human IL-7 (25 UG) | 25 UG | 9300 |
| R&D Systems | 207-IL-005 | Recombinant Human IL-7 (5 UG) | 5 UG | 2980 |
| R&D Systems | 207-IL-200/CF | Recombinant Human IL-7, CF (200 UG) | 200 UG | 16890 |
| R&D Systems | 207-IL-025/CF | Recombinant Human IL-7, CF (25 UG) | 25 UG | 9300 |
| R&D Systems | 207-IL-005/CF | Recombinant Human IL-7, CF (5 UG) | 5 UG | 2980 |
| R&D Systems | 2070-GS-025 | Recombinant Human GASP-1/WFIKKNRP (25 UG) | 25 UG | 4150 |
| R&D Systems | 2070-GS-025/CF | Recombinant Human GASP-1/WFIKKNRP, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 2074-FC-050 | Recombinant Mouse Fc gamma RI/CD64, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2077-MB-050 | Recombinant Mouse MBL-1 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2077-MB-050/CF | Recombinant Mouse MBL-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2078-FC-050 | Recombinant Human FCRL5/FcRH5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2078-T4-050 | Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 208-IL-010 | Recombinant Human CXCL8/IL-8 (10 UG) | 10 UG | 1940 |
| R&D Systems | 208-IL-050 | Recombinant Human CXCL8/IL-8 (50 UG) | 50 UG | 6050 |
| R&D Systems | 208-IL-010/CF | Recombinant Human CXCL8/IL-8, CF (10 UG) | 10 UG | 1940 |
| R&D Systems | 208-IL-050/CF | Recombinant Human CXCL8/IL-8, CF (50 UG) | 50 UG | 6050 |
| R&D Systems | 2080-AM-050 | Recombinant Human AMIGO2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2088-LN-050 | Recombinant Human Langerin/CD207, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2089-LY-025 | Recombinant Human LYVE-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 209-IL-010 | Recombinant Human IL-9 (10 UG) | 10 UG | 4150 |
| R&D Systems | 209-IL-050 | Recombinant Human IL-9 (50 UG) | 50 UG | 11900 |
| R&D Systems | 209-IL-010/CF | Recombinant Human IL-9, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 209-IL-050/CF | Recombinant Human IL-9, CF (50 UG) | 50 UG | 11900 |
| R&D Systems | 2090-RG-050 | Recombinant Human Reg1B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2094-S6-050 | Recombinant Human Semaphorin 6B Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2095-S6-050 | Recombinant Human Semaphorin 6D Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2098-RG-050 | Recombinant Mouse Reg2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2099-FB-025 | Recombinant Bovine FGF basic (25 UG) | 25 UG | 2980 |
| R&D Systems | 2099-FB-025/CF | Recombinant Bovine FGF basic, CF (25 UG) | 25 UG | 2980 |
| R&D Systems | 210-GMP-100 | Recombinant Human TNF-alpha GMP, CF (100 UG) | 100 UG | 10600 |
| R&D Systems | 210-GMP-02M | Recombinant Human TNF-alpha GMP, CF (2 MG) | 2 MG | 33800 |
| R&D Systems | 210-TA-100 | Recombinant Human TNF-alpha (100 UG) | 100 UG | 8180 |
| R&D Systems | 210-TA-020 | Recombinant Human TNF-alpha (20 UG) | 20 UG | 2720 |
| R&D Systems | 210-TA-005 | Recombinant Human TNF-alpha (5 UG) | 5 UG | 1290 |
| R&D Systems | 210-TA-100/CF | Recombinant Human TNF-alpha, CF (100 UG) | 100 UG | 8180 |
| R&D Systems | 210-TA-020/CF | Recombinant Human TNF-alpha, CF (20 UG) | 20 UG | 2720 |
| R&D Systems | 210-TA-02M/CF | Recombinant Human TNF-alpha, CF (2 MG) | 2 MG | 26070 |
| R&D Systems | 210-TA-005/CF | Recombinant Human TNF-alpha, CF (5 UG) | 5 UG | 1290 |
| R&D Systems | 2104-TS-050 | Recombinant Human TSG-6, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2105-VI-100 | Recombinant Human Vimentin, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 2106-BF-010 | Recombinant Mouse BAFF/BLyS/TNFSF13B (10 UG) | 10 UG | 2980 |
| R&D Systems | 2106-BF-010/CF | Recombinant Mouse BAFF/BLyS/TNFSF13B, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 2108-S6-050 | Recombinant Mouse Semaphorin 6C, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2109-TC-050 | Recombinant Mouse IL-27 Ra/WSX-1/TCCR Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 211-TBB-010 | Recombinant Human Lymphotoxin-alpha/TNF-beta (10 UG) | 10 UG | 2980 |
| R&D Systems | 211-TBB-050 | Recombinant Human Lymphotoxin-alpha/TNF-beta (50 UG) | 50 UG | 9300 |
| R&D Systems | 211-TBB-010/CF | Recombinant Human Lymphotoxin-alpha/TNF-beta, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 211-TBB-050/CF | Recombinant Human Lymphotoxin-alpha/TNF-beta, CF (50 UG) | 50 UG | 9300 |
| R&D Systems | 2110-WN-010 | Recombinant Mouse Wnt-10b (10 UG) | 10 UG | 4280 |
| R&D Systems | 2110-WN-010/CF | Recombinant Mouse Wnt-10b, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 21100-1 | Human IFN-alpha MAb (Clone MMHA-2) (50 UG) | 50 UG | 4410 |
| R&D Systems | 21100-2 | Human IFN-alpha MAb (Clone MMHA-2) (500 UG) | 500 UG | 7220 |
| R&D Systems | 21110-1 | Human IFN-alpha MAb (Clone MMHA-8) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21112-1 | Human IFN-alpha MAb (Clone MMHA-11) (50 UG) | 50 UG | 3890 |
| R&D Systems | 21112-3 | Human IFN-alpha Fluorescein Mab (Clone MMHA-11) (25 UG) | 25 UG | 4820 |
| R&D Systems | 21116-1 | Human IFN-alpha MAb (Clone MMHA-13) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21118-1 | Human IFN-alpha MAb (Clone MMHA-17) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21125-1 | Human IFN-alpha MAb (Clone MMHA-6) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21127-1 | Human IFN-alpha MAb (Clone MMHA-9) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21129-1 | Human IFN-alpha MAb (Clone MMHA-14) (50 UG) | 50 UG | 2990 |
| R&D Systems | 2117-FL-025 | Recombinant Feline IL-12/IL-23 p40 (25 UG) | 25 UG | 4670 |
| R&D Systems | 2117-FL-025/CF | Recombinant Feline IL-12/IL-23 p40, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 2118-CL-025 | Recombinant Canine IL-12 (25 UG) | 25 UG | 4670 |
| R&D Systems | 2118-CL-025/CF | Recombinant Canine IL-12, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 2119-GP-050 | Recombinant Human Glypican 3 (50 UG) | 50 UG | 4410 |
| R&D Systems | 2119-GP-050/CF | Recombinant Human Glypican 3, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 212-GD-010 | Recombinant Human GDNF (10 UG) | 10 UG | 3890 |
| R&D Systems | 212-GD-050 | Recombinant Human GDNF (50 UG) | 50 UG | 12730 |
| R&D Systems | 212-GD-010/CF | Recombinant Human GDNF, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 212-GD-050/CF | Recombinant Human GDNF, CF (50 UG) | 50 UG | 12730 |
| R&D Systems | 212-GMP-010 | Recombinant Human GDNF GMP, CF (10 UG) | 10 UG | 4540 |
| R&D Systems | 212-GMP-01M | Recombinant Human GDNF GMP, CF (1 MG) | 1 MG | 77740 |
| R&D Systems | 212-GMP-050 | Recombinant Human GDNF GMP, CF (50 UG) | 50 UG | 14300 |
| R&D Systems | 2120-B7-025 | Recombinant Mouse IGFBP-rp1/IGFBP-7, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2125-LY-025 | Recombinant Mouse LYVE-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2126-CH-025 | Recombinant Human CHL-1/L1CAM-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2128-GA-050 | Recombinant Mouse Galectin-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 213-ILB-025 | Recombinant Human IL-13 (25 UG) | 25 UG | 12290 |
| R&D Systems | 213-ILB-005 | Recombinant Human IL-13 (5 UG) | 5 UG | 3890 |
| R&D Systems | 213-ILB-01MG/CF | Recombinant Human IL-13, CF (1 MG) | 1 MG | 74100 |
| R&D Systems | 213-ILB-025/CF | Recombinant Human IL-13, CF (25 UG) | 25 UG | 12290 |
| R&D Systems | 213-ILB-005/CF | Recombinant Human IL-13, CF (5 UG) | 5 UG | 3890 |
| R&D Systems | 2130-SL-050 | Recombinant Human Siglec-10 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2136-GS-025 | Recombinant Human GASP-2/WFIKKN (25 UG) | 25 UG | 4280 |
| R&D Systems | 2136-GS-025/CF | Recombinant Human GASP-2/WFIKKN, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 21395-1 | Human IFN-omega MAb (Clone OMG-4) (100 UG) | 100 UG | 4260 |
| R&D Systems | 214-CS-025 | Recombinant Human G-CSF (25 UG) | 25 UG | 9300 |
| R&D Systems | 214-CS-005 | Recombinant Human G-CSF (5 UG) | 5 UG | 2850 |
| R&D Systems | 214-CS-025/CF | Recombinant Human G-CSF, CF (25 UG) | 25 UG | 9300 |
| R&D Systems | 214-CS-005/CF | Recombinant Human G-CSF, CF (5 UG) | 5 UG | 2850 |
| R&D Systems | 21400-1 | Human IFN-beta MAb (Clone MMHB-3) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21400-3 | Human IFN-beta Fluorescein MAb (Clone MMHB-3) (20 UG) | 20 UG | 3890 |
| R&D Systems | 21405-1 | Human IFN-beta MAb (Clone MMHB-1) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21450-1 | Human IFN-beta MAb (Clone MMHB-12) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21455-1 | Human IFN-beta MAb (Clone MMHB-13) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21460-1 | Human IFN-beta MAb (Clone MMHB-14) (50 UG) | 50 UG | 2990 |
| R&D Systems | 21465-1 | Human IFN-beta MAb (Clone MMHB-15) (50 UG) | 50 UG | 2990 |
| R&D Systems | 2147-CH-025 | Recombinant Mouse CHL-1/L1CAM-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 21470-1 | Human IFN-beta MAb (Clone MMHB-16) (50 UG) | 50 UG | 2990 |
| R&D Systems | 2148-HP-025 | Recombinant Human LDL R (High Purity), CF (25 UG) | 25 UG | 5060 |
| R&D Systems | 2148-LD-025 | Recombinant Human LDL R (25 UG) | 25 UG | 4410 |
| R&D Systems | 2148-LD-025/CF | Recombinant Human LDL R, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 2149-BF-010 | Recombinant Human BAFF/BLyS/TNFSF13B (10 UG) | 10 UG | 2980 |
| R&D Systems | 2149-BF-010/CF | Recombinant Human BAFF/BLyS/TNFSF13B, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 215-GM-010 | Recombinant Human GM-CSF (10 UG) | 10 UG | 2850 |
| R&D Systems | 215-GM-500 | Recombinant Human GM-CSF (500 UG) | 500 UG | 24570 |
| R&D Systems | 215-GM-050 | Recombinant Human GM-CSF (50 UG) | 50 UG | 10390 |
| R&D Systems | 215-GM-010/CF | Recombinant Human GM-CSF, CF (10 UG) | 10 UG | 2850 |
| R&D Systems | 215-GM-050/CF | Recombinant Human GM-CSF, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 215-GMP-010 | Recombinant Human GM-CSF GMP, CF (10 UG) | 10 UG | 3710 |
| R&D Systems | 215-GMP-01M | Recombinant Human GM-CSF GMP, CF (1 MG) | 1 MG | 54600 |
| R&D Systems | 215-GMP-050 | Recombinant Human GM-CSF GMP, CF (50 UG) | 50 UG | 13460 |
| R&D Systems | 2150-C5-025 | Recombinant Mouse Complement Component C (25 UG) | 25 UG | 3760 |
| R&D Systems | 2150-C5-025/CF | Recombinant Mouse Complement Component C, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 2154-B7-050 | Recombinant Mouse B7-H4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2159-FA-050 | Recombinant Rat Fas/TNFRSF6/CD95 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 216-GMP-025 | Recombinant Human M-CSF GMP, CF (25 UG) | 25 UG | 8520 |
| R&D Systems | 216-GMP-500 | Recombinant Human M-CSF GMP, CF (500 UG) | 500 UG | 41600 |
| R&D Systems | 216-GMP-005 | Recombinant Human M-CSF GMP, CF (5 UG) | 5 UG | 2670 |
| R&D Systems | 216-MC-025 | Recombinant Human M-CSF (25 UG) | 25 UG | 6570 |
| R&D Systems | 216-MC-500 | Recombinant Human M-CSF (500 UG) | 500 UG | 32240 |
| R&D Systems | 216-MC-005 | Recombinant Human M-CSF (5 UG) | 5 UG | 2070 |
| R&D Systems | 216-MC-025/CF | Recombinant Human M-CSF, CF (25 UG) | 25 UG | 6570 |
| R&D Systems | 216-MC-005/CF | Recombinant Human M-CSF, CF (5 UG) | 5 UG | 2070 |
| R&D Systems | 216-MCC-010 | Recombinant Human M-CSF (CHO-expressed) (10 UG) | 10 UG | 4280 |
| R&D Systems | 216-MCC-010/CF | Recombinant Human M-CSF (CHO-expressed), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2166-TS-025 | Recombinant Mouse Pentraxin 3/TSG-14 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2166-TS-025/CF | Recombinant Mouse Pentraxin 3/TSG-14, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 217-IL-025 | Recombinant Human IL-10 (25 UG) | 25 UG | 11640 |
| R&D Systems | 217-IL-005 | Recombinant Human IL-10 (5 UG) | 5 UG | 3890 |
| R&D Systems | 217-IL-025/CF | Recombinant Human IL-10, CF (25 UG) | 25 UG | 11640 |
| R&D Systems | 217-IL-005/CF | Recombinant Human IL-10, CF (5 UG) | 5 UG | 3890 |
| R&D Systems | 217-ILB-025 | Recombinant Human IL-10 (25 UG) | 25 UG | 11640 |
| R&D Systems | 217-ILB-005 | Recombinant Human IL-10 (5 UG) | 5 UG | 3890 |
| R&D Systems | 217-ILB-025/CF | Recombinant Human IL-10, CF (25 UG) | 25 UG | 11640 |
| R&D Systems | 217-ILB-005/CF | Recombinant Human IL-10, CF (5 UG) | 5 UG | 3890 |
| R&D Systems | 2175-PI-010 | Recombinant Mouse Serpin E2/PN1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2177-GL-025 | Recombinant Mouse GITR Ligand/TNFSF18 (aa 47-173) (25 UG) | 25 UG | 4410 |
| R&D Systems | 2177-GL-025/CF | Recombinant Mouse GITR Ligand/TNFSF18 (aa 47-173), CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 2179-VC-025 | Recombinant Human VEGF-C (25 UG) | 25 UG | 4150 |
| R&D Systems | 2179-VC-025/CF | Recombinant Human VEGF-C, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 218-GMP-050 | Recombinant Human IL-11 GMP, CF (50 UG) | 50 UG | 27300 |
| R&D Systems | 218-IL-025 | Recombinant Human IL-11 (25 UG) | 25 UG | 10990 |
| R&D Systems | 218-IL-005 | Recombinant Human IL-11 (5 UG) | 5 UG | 3370 |
| R&D Systems | 218-IL-025/CF | Recombinant Human IL-11, CF (25 UG) | 25 UG | 10990 |
| R&D Systems | 218-IL-005/CF | Recombinant Human IL-11, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 2180-CA-050 | Recombinant Human Carbonic Anhydrase I, CF (50 UG) | 50 UG | 3500 |
| R&D Systems | 2184-CA-050 | Recombinant Human Carbonic Anhydrase II, CF (50 UG) | 50 UG | 3500 |
| R&D Systems | 2185-CA-050 | Recombinant Human Carbonic Anhydrase III, CF (50 UG) | 50 UG | 3500 |
| R&D Systems | 2186-CA-010 | Recombinant Human Carbonic Anhydrase IV, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 2187-CA-050 | Recombinant Human Carbonic Anhydrase VIII, CF (50 UG) | 50 UG | 3500 |
| R&D Systems | 2188-CA-010 | Recombinant Human Carbonic Anhydrase IX, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 2189-CA-010 | Recombinant Human Carbonic Anhydrase X/CA10, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 219-GMP-01M | Recombinant Human IL-12 GMP, CF (1 MG) | 1 MG | 123500 |
| R&D Systems | 219-GMP-025 | Recombinant Human IL-12 GMP, CF (25 UG) | 25 UG | 14300 |
| R&D Systems | 219-IL-025 | Recombinant Human IL-12 (25 UG) | 25 UG | 12550 |
| R&D Systems | 219-IL-005 | Recombinant Human IL-12 (5 UG) | 5 UG | 3890 |
| R&D Systems | 219-IL-025/CF | Recombinant Human IL-12, CF (25 UG) | 25 UG | 12550 |
| R&D Systems | 219-IL-005/CF | Recombinant Human IL-12, CF (5 UG) | 5 UG | 3890 |
| R&D Systems | 2190-CA-010 | Recombinant Human Carbonic Anhydrase XII, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 2194-CA-050 | Recombinant Human Carbonic Anhydrase XIII, CF (50 UG) | 50 UG | 3500 |
| R&D Systems | 2195-CA-010 | Recombinant Human Carbonic Anhydrase XIV, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 2196-SE-200 | Human Coagulation Factor II/Thrombin, CF (200 UG) | 200 UG | 1940 |
| R&D Systems | 2197-AD-020 | Recombinant Human ADAMTS1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2198-AD-020 | Recombinant Human ADAMTS5, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2199-CY-010 | Recombinant Human Legumain/Asparaginyl Endopeptidase, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 220-BB-010 | Recombinant Human PDGF-BB, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 220-BB-01M | Recombinant Human PDGF-BB, CF (1 MG) | 1 MG | 55250 |
| R&D Systems | 220-BB-200 | Recombinant Human PDGF-BB, CF (200 UG) | 200 UG | 16890 |
| R&D Systems | 220-BB-050 | Recombinant Human PDGF-BB, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 220-GMP-010 | Recombinant Human PDGF-BB GMP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 220-GMP-01M | Recombinant Human PDGF-BB GMP, CF (1 MG) | 1 MG | 71830 |
| R&D Systems | 220-GMP-050 | Recombinant Human PDGF-BB GMP, CF (50 UG) | 50 UG | 13510 |
| R&D Systems | 2200-SE-050 | Recombinant Human Azurocidin/CAP37/HBP (50 UG) | 50 UG | 4280 |
| R&D Systems | 2200-SE-050/CF | Recombinant Human Azurocidin/CAP37/HBP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2205-CN-025 | Recombinant Human Contactin-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2206-PI-010 | Recombinant Mouse Kininogen HMW (HKa), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2207-HG-025 | Recombinant Mouse HGF (25 UG) | 25 UG | 4150 |
| R&D Systems | 2207-HG-025/CF | Recombinant Mouse HGF, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 2208-MB-050 | Recombinant Mouse MBL-2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2208-MB-050/CF | Recombinant Mouse MBL-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 221-AA-010 | Recombinant Human PDGF-AA, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 221-AA-050 | Recombinant Human PDGF-AA, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 22100-1 | Mouse IFN-alpha MAb (Clone RMMA-1) (250 UG) | 250 UG | 5770 |
| R&D Systems | 22100-3 | Mouse IFN-alpha Fluorescein Mab (Clone RMMA-1) (25 UG) | 25 UG | 5580 |
| R&D Systems | 2215-N2-025 | Recombinant Human Neuropilin-2 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2217-CA-050 | Recombinant Human Cadherin-4/R-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2219-S6-050 | Recombinant Human Semaphorin 6C Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 222-AB-010 | Recombinant Human PDGF-AB, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 222-AB-050 | Recombinant Human PDGF-AB, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 2225-NK-050 | Recombinant Mouse NKp46/NCR1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2226-GA-050 | Recombinant Human Galectin-3BP/MAC-2BP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2229-N2-050 | Recombinant Human Nectin-2/CD112 (50 UG) | 50 UG | 4410 |
| R&D Systems | 2229-N2-050/CF | Recombinant Human Nectin-2/CD112, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 223-2A-025 | Recombinant Human CD25/IL-2 R alpha (25 UG) | 25 UG | 7400 |
| R&D Systems | 223-2A-005 | Recombinant Human CD25/IL-2 R alpha (5 UG) | 5 UG | 2460 |
| R&D Systems | 223-2A-025/CF | Recombinant Human CD25/IL-2 R alpha, CF (25 UG) | 25 UG | 7400 |
| R&D Systems | 223-2A-005/CF | Recombinant Human CD25/IL-2 R alpha, CF (5 UG) | 5 UG | 2460 |
| R&D Systems | 2237-SE-010 | Recombinant Human Tripeptidyl-peptidase I/TPP1, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 2238-KR-050 | Recombinant Human KIR2DL4/CD158d Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2239-PE-020 | Recombinant Mouse PCPE-1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 224-2B-025 | Recombinant Human IL-2 R beta (25 UG) | 25 UG | 7400 |
| R&D Systems | 224-2B-005 | Recombinant Human IL-2 R beta (5 UG) | 5 UG | 2460 |
| R&D Systems | 224-2B-025/CF | Recombinant Human IL-2 R beta, CF (25 UG) | 25 UG | 7400 |
| R&D Systems | 224-2B-005/CF | Recombinant Human IL-2 R beta, CF (5 UG) | 5 UG | 2460 |
| R&D Systems | 2240-CA-050 | Recombinant Human Cadherin-12 (CAD-12) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 22400-1 | Mouse IFN-beta MAb (Clone RMMB-1) (250 UG) | 250 UG | 4760 |
| R&D Systems | 22400-3 | Mouse IFN-beta Fluorescein Mab (Clone RMMB-1) (25 UG) | 25 UG | 4760 |
| R&D Systems | 2244-CM-050 | Recombinant Human CEACAM-1/CD66a, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2246-FG-025 | Recombinant Human FGF-12 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2246-FG-025/CF | Recombinant Human FGF-12, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2249-NK-050 | Recombinant Human NKp44 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2254-DN-050 | Recombinant Mouse DNER Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2255-LD-025 | Recombinant Mouse LDL R (25 UG) | 25 UG | 4280 |
| R&D Systems | 2255-LD-025/CF | Recombinant Mouse LDL R, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2258-VL-050 | Recombinant Mouse VLDL R (Ser297), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2264-S6-050 | Recombinant Mouse Semaphorin 6B Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2265-FR-050 | Recombinant Mouse FGF R4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2267-FA-050 | Recombinant Feline Fas/TNFRSF6/CD95 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2268-SC-025 | Recombinant Feline SCF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2268-SC-025/CF | Recombinant Feline SCF, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2269-IL-050 | Recombinant Human IL-17 RC, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 227-SR-025 | Recombinant Human IL-6 R alpha (25 UG) | 25 UG | 4930 |
| R&D Systems | 227-SR-025/CF | Recombinant Human IL-6 R alpha, CF (25 UG) | 25 UG | 4930 |
| R&D Systems | 2270-ML-050 | Recombinant Mouse IL-17 RC, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2274-ML-025 | Recombinant Mouse IL-17D (25 UG) | 25 UG | 4280 |
| R&D Systems | 2274-ML-025/CF | Recombinant Mouse IL-17D, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2275-IL-050 | Recombinant Human IL-17 RD/SEF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2275-IL-050/CF | Recombinant Human IL-17 RD/SEF, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2275-PC-100 | Human GAPDH/G3PDH Polyclonal Ab (100 UL) | 100 UL | 4270 |
| R&D Systems | 2276-ML-050 | Recombinant Mouse IL-17 RD/SEF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2276-ML-050/CF | Recombinant Mouse IL-17 RD/SEF, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2277-FL-025 | Recombinant Feline CXCL8/IL-8 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2277-FL-025/CF | Recombinant Feline CXCL8/IL-8, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2278-SC-025 | Recombinant Canine SCF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2278-SC-025/CF | Recombinant Canine SCF, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2279-BT-025 | Recombinant Bovine TNF-alpha (25 UG) | 25 UG | 3760 |
| R&D Systems | 2279-BT-025/CF | Recombinant Bovine TNF-alpha, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 228-GP-010 | Recombinant Human Soluble gp130 (10 UG) | 10 UG | 3890 |
| R&D Systems | 228-GP-050 | Recombinant Human Soluble gp130 (50 UG) | 50 UG | 12730 |
| R&D Systems | 228-GP-010/CF | Recombinant Human Soluble gp130, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 228-GP-050/CF | Recombinant Human Soluble gp130, CF (50 UG) | 50 UG | 12730 |
| R&D Systems | 2281-MC-100 | Human/Mouse/Rat Bax MAb (Clone YTH-6A7) (100 UG) | 100 UG | 4270 |
| R&D Systems | 2282-MC-100 | Human Bax MAb (Clone YTH-2D2) (100 UG) | 100 UG | 4270 |
| R&D Systems | 229-PE-010 | Recombinant Human PD-ECGF/Thymidine Phosphorylase (10 UG) | 10 UG | 3110 |
| R&D Systems | 229-PE-050 | Recombinant Human PD-ECGF/Thymidine Phosphorylase (50 UG) | 50 UG | 10650 |
| R&D Systems | 229-PE-010/CF | Recombinant Human PD-ECGF/Thymidine Phosphorylase, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 229-PE-050/CF | Recombinant Human PD-ECGF/Thymidine Phosphorylase, CF (50 UG) | 50 UG | 10650 |
| R&D Systems | 2291-MC-100 | Human Bcl-2 MAb (Clone YTH-8C8) (100 UG) | 100 UG | 4270 |
| R&D Systems | 2295-4L-025 | Recombinant Human 4-1BB Ligand/TNFSF9 (25 UG) | 25 UG | 3500 |
| R&D Systems | 2295-4L-025/CF | Recombinant Human 4-1BB Ligand/TNFSF9, CF (25 UG) | 25 UG | 3500 |
| R&D Systems | 2296-SL-050 | Recombinant Mouse Siglec-2/CD22 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2297-ML-025 | Recombinant Mouse IL-36 alpha/IL-1F6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2297-ML-025/CF | Recombinant Mouse IL-36 alpha/IL-1F6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2298-ML-025 | Recombinant Mouse IL-36 beta/IL-1F8 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2298-ML-025/CF | Recombinant Mouse IL-36 beta/IL-1F8, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2299-CV-050 | Recombinant Mouse Crossveinless-2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2299-CV-050/CF | Recombinant Mouse Crossveinless-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 230-4R-025 | Recombinant Human IL-4 R alpha (25 UG) | 25 UG | 5710 |
| R&D Systems | 230-4R-025/CF | Recombinant Human IL-4 R alpha, CF (25 UG) | 25 UG | 5710 |
| R&D Systems | 230-4RB-025 | Recombinant Human IL-4 R alpha, CF (25 UG) | 25 UG | 5580 |
| R&D Systems | 2300-BG-025 | Recombinant Bovine IFN-gamma (25 UG) | 25 UG | 3760 |
| R&D Systems | 2300-BG-025/CF | Recombinant Bovine IFN-gamma, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 2300-MC-100 | Human/Mouse/Rat Bcl-xL MAb (Clone YTH-2H12) (100 UG) | 100 UG | 4270 |
| R&D Systems | 2304-GP-050 | Recombinant Human Glypican 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2305-FL-025 | Recombinant Feline IL-6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2305-FL-025/CF | Recombinant Feline IL-6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2306-ML-025 | Recombinant Mouse IL-17C (25 UG) | 25 UG | 4280 |
| R&D Systems | 2306-ML-025/CF | Recombinant Mouse IL-17C, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2307-MB-050 | Recombinant Human MBL (50 UG) | 50 UG | 4280 |
| R&D Systems | 2307-MB-050/CF | Recombinant Human MBL, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2308-VN-050 | Recombinant Human Vitronectin, CF (50 UG) | 50 UG | 3110 |
| R&D Systems | 231-BC-025 | Recombinant Human FGF acidic (aa 2-155) (25 UG) | 25 UG | 3110 |
| R&D Systems | 231-BC-025/CF | Recombinant Human FGF acidic (aa 2-155), CF (25 UG) | 25 UG | 3110 |
| R&D Systems | 2318-B3-050 | Recombinant Human B7-H3 (4Ig)/B7-H3b (50 UG) | 50 UG | 4410 |
| R&D Systems | 2318-B3-050/CF | Recombinant Human B7-H3 (4Ig)/B7-H3b, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2319-L3-050 | Recombinant Human LAG-3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 232-FA-025 | Recombinant Human FGF acidic (aa 16-155) (25 UG) | 25 UG | 2330 |
| R&D Systems | 232-FA-025/CF | Recombinant Human FGF acidic (aa 16-155), CF (25 UG) | 25 UG | 2330 |
| R&D Systems | 2320-IL-025 | Recombinant Human IL-36 gamma/IL-1F9 (25 UG) | 25 UG | 4150 |
| R&D Systems | 2320-IL-025/CF | Recombinant Human IL-36 gamma/IL-1F9, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 2324-CM-025 | Recombinant Human Chemerin (25 UG) | 25 UG | 4150 |
| R&D Systems | 2324-CM-025/CF | Recombinant Human Chemerin, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 2325-CM-025 | Recombinant Mouse Chemerin (aa 17-156) (25 UG) | 25 UG | 4280 |
| R&D Systems | 2325-CM-025/CF | Recombinant Mouse Chemerin (aa 17-156), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2326-TS-050 | Recombinant Mouse TSG-6, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2327-PI-050 | Recombinant Human Testican 1/SPOCK1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2328-PI-050 | Recombinant Human Testican 2/SPOCK2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2329-TX-100 | Recombinant Human Thioredoxin 80, CF (100 UG) | 100 UG | 3760 |
| R&D Systems | 233-FB-01M | Recombinant Human FGF basic (146 aa) (1 MG) | 1 MG | 26070 |
| R&D Systems | 233-FB-025 | Recombinant Human FGF basic (146 aa) (25 UG) | 25 UG | 2460 |
| R&D Systems | 233-FB-001MG/CF | Recombinant Human FGF basic (146 aa), CF (1 MG) | 1 MG | 26070 |
| R&D Systems | 233-FB-025/CF | Recombinant Human FGF basic (146 aa), CF (25 UG) | 25 UG | 2460 |
| R&D Systems | 233-GMP-01M | Recombinant Human FGF basic (146 aa) GMP, CF (1 MG) | 1 MG | 33800 |
| R&D Systems | 233-GMP-025 | Recombinant Human FGF basic (146 aa) GMP, CF (25 UG) | 25 UG | 3120 |
| R&D Systems | 2330-AC-050 | Recombinant Mouse Osteoactivin/GPNMB Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2334-ZN-010 | Recombinant Human Aminopeptidase PILS/ARTS1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2335-ZN-010 | Recombinant Mouse Aminopeptidase N/CD13, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2336-CY-010 | Recombinant Mouse Active Cathepsin C/DPPI, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 2337-SE-010 | Recombinant Human Kallikrein 1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2338-SE-010 | Recombinant Human Coagulation Factor VII, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2339-PA-010 | Recombinant Human Coagulation Factor III/Tissue Factor, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 234-FSE-025 | Recombinant Human FGF basic (157 aa) (25 UG) | 25 UG | 3370 |
| R&D Systems | 234-FSE-025/CF | Recombinant Human FGF basic (157 aa), CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 2340-ZN-010 | Recombinant Human Neprilysin-2/MMEL1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2344-CA-010 | Recombinant Mouse Carbonic Anhydrase IX, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 2345-CA-010 | Recombinant Mouse Carbonic Anhydrase XII, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 2346-PI-050 | Recombinant Mouse Testican 3/SPOCK3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2347-VE-025 | Recombinant Human VEGF 162 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2347-VE-025/CF | Recombinant Human VEGF 162, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2348-VN-100 | Bovine Vitronectin, CF (100 UG) | 100 UG | 3240 |
| R&D Systems | 2349-VN-100 | Human Vitronectin, CF (100 UG) | 100 UG | 3240 |
| R&D Systems | 235-F4-025 | Recombinant Human FGF-4 (25 UG) | 25 UG | 3370 |
| R&D Systems | 235-F4-025/CF | Recombinant Human FGF-4, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 2354-RP-100 | Recombinant Mouse IL-1 Rrp2/IL-1 R6 (100 UG) | 100 UG | 4280 |
| R&D Systems | 2354-RP-100/CF | Recombinant Mouse IL-1 Rrp2/IL-1 R6, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 2355-GP-050 | Recombinant Mouse Glypican 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 236-EG-01M | Recombinant Human EGF, CF (1 MG) | 1 MG | 5320 |
| R&D Systems | 236-EG-200 | Recombinant Human EGF, CF (200 UG) | 200 UG | 1680 |
| R&D Systems | 236-GMP-01M | Recombinant Human EGF GMP, CF (1 MG) | 1 MG | 6880 |
| R&D Systems | 236-GMP-200 | Recombinant Human EGF GMP, CF (200 UG) | 200 UG | 2200 |
| R&D Systems | 2364-ER-050 | Recombinant Human Endorepellin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2365-TM-050 | Recombinant Human TIM-3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2366-RB-050 | Recombinant Human ROBO4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2367-FC-050 | Recombinant Human Ficolin-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2368-L2-050 | Recombinant Human LRP-1 Cluster II Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 237-F5-050 | Recombinant Human FGF-5 (50 UG) | 50 UG | 2720 |
| R&D Systems | 237-F5-050/CF | Recombinant Human FGF-5, CF (50 UG) | 50 UG | 2720 |
| R&D Systems | 2376-BP-025 | Recombinant Mouse IL-22BP Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2379-CD-050 | Recombinant Human C1q R1/CD93 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 238-F6-025 | Recombinant Human FGF-6 (25 UG) | 25 UG | 3370 |
| R&D Systems | 238-F6-025/CF | Recombinant Human FGF-6, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 2380-CR-025 | Recombinant Human CREG (25 UG) | 25 UG | 4280 |
| R&D Systems | 2380-CR-025/CF | Recombinant Human CREG, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2388-PS-010 | Recombinant Human Persephin (10 UG) | 10 UG | 4150 |
| R&D Systems | 2388-PS-010/CF | Recombinant Human Persephin, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 239-A-100 | Recombinant Human TGF-alpha, CF (100 UG) | 100 UG | 4150 |
| R&D Systems | 239-A-500 | Recombinant Human TGF-alpha, CF (500 UG) | 500 UG | 12990 |
| R&D Systems | 2390-TH-050 | Recombinant Human Thrombospondin-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2396-DR-050 | Recombinant Human DDR1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2397-CR-050 | Recombinant Human CRISP-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 240-B-010 | Recombinant Human TGF-beta 1 (10 UG) | 10 UG | 10520 |
| R&D Systems | 240-B-002 | Recombinant Human TGF-beta 1 (2 UG) | 2 UG | 3370 |
| R&D Systems | 240-B-010/CF | Recombinant Human TGF-beta 1, CF (10 UG) | 10 UG | 10520 |
| R&D Systems | 240-B-001MG/CF | Recombinant Human TGF-beta 1, CF (1 MG) | 1 MG | 175500 |
| R&D Systems | 240-B-002/CF | Recombinant Human TGF-beta 1, CF (2 UG) | 2 UG | 3370 |
| R&D Systems | 240-GMP-010 | Recombinant Human TGF-beta 1 GMP, CF (10 UG) | 10 UG | 12090 |
| R&D Systems | 240-GMP-01M | Recombinant Human TGF-beta 1 GMP, CF (1 MG) | 1 MG | 201500 |
| R&D Systems | 2404-AC-010 | Recombinant Human CD38, CF (10 UG) | 10 UG | 4020 |
| R&D Systems | 2406-BR-100 | Recombinant Human BMPR-IA/ALK-3 Fc Chimera, CF (100 UG) | 100 UG | 5450 |
| R&D Systems | 2408-NC-050 | Recombinant Human NCAM-1/CD56, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2409-SR-050 | Recombinant Human SREC-I/SCARF1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 241-R2-025 | Recombinant Human TGF-beta RII (25 UG) | 25 UG | 4540 |
| R&D Systems | 241-R2-025/CF | Recombinant Human TGF-beta RII, CF (25 UG) | 25 UG | 4540 |
| R&D Systems | 2414-CA-010 | Recombinant Mouse Carbonic Anhydrase IV, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 2415-CR-025 | Recombinant Human CLC/CNTF R alpha Chimera (25 UG) | 25 UG | 4280 |
| R&D Systems | 2415-CR-025/CF | Recombinant Human CLC/CNTF R alpha Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 242-R3-100 | Recombinant Human TGF-beta RIII (100 UG) | 100 UG | 6620 |
| R&D Systems | 242-R3-100/CF | Recombinant Human TGF-beta RIII, CF (100 UG) | 100 UG | 6620 |
| R&D Systems | 2420-PG-050 | Recombinant Human Progranulin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2424-TL-050 | Recombinant Mouse TREML1/TLT-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2428-FC-050 | Recombinant Human Ficolin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 243-B3-010 | Recombinant Human TGF-beta 3 (10 UG) | 10 UG | 13770 |
| R&D Systems | 243-B3-200 | Recombinant Human TGF-beta 3 (200 UG) | 200 UG | 22740 |
| R&D Systems | 243-B3-002 | Recombinant Human TGF-beta 3 (2 UG) | 2 UG | 4280 |
| R&D Systems | 243-B3-010/CF | Recombinant Human TGF-beta 3, CF (10 UG) | 10 UG | 13770 |
| R&D Systems | 243-B3-200/CF | Recombinant Human TGF-beta 3, CF (200 UG) | 200 UG | 22740 |
| R&D Systems | 243-B3-002/CF | Recombinant Human TGF-beta 3, CF (2 UG) | 2 UG | 4280 |
| R&D Systems | 243-GMP-01M | Recombinant Human TGF-beta 3 GMP, CF (1 MG) | 1 MG | 129470 |
| R&D Systems | 243-GMP-025 | Recombinant Human TGF-beta 3 GMP, CF (25 UG) | 25 UG | 16500 |
| R&D Systems | 2435-DK-010 | Recombinant Mouse Dkk-2 (10 UG) | 10 UG | 4280 |
| R&D Systems | 2435-DK-010/CF | Recombinant Mouse Dkk-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2437-D3-050 | Recombinant Mouse DR3/TNFRSF25 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2438-RM-050 | Recombinant Mouse CD25/IL-2 R alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2440-FZ-050 | Recombinant Mouse Frizzled-9 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2445-NG-050 | Recombinant Rat Nogo-A Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2446-CH-050 | Recombinant Mouse Chitinase 3-like 3/ECF-L, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2447-GR-050 | Recombinant Human IGF-II R, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2449-SU-020 | Recombinant Human Iduronate 2-Sulfatase, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 245-AB-050 | Recombinant Human IFN-alpha/beta R1, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 245-B5-010 | Recombinant Amphibian TGF-beta 5 (10 UG) | 10 UG | 11170 |
| R&D Systems | 245-B5-002 | Recombinant Amphibian TGF-beta 5 (2 UG) | 2 UG | 4280 |
| R&D Systems | 245-B5-010/CF | Recombinant Amphibian TGF-beta 5, CF (10 UG) | 10 UG | 11170 |
| R&D Systems | 245-B5-002/CF | Recombinant Amphibian TGF-beta 5, CF (2 UG) | 2 UG | 4280 |
| R&D Systems | 2458-RG-050 | Recombinant Mouse RGM-A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2459-RM-050 | Recombinant Human RGM-A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 246-LP-025 | Recombinant Human LAP (TGF-beta 1) (25 UG) | 25 UG | 4800 |
| R&D Systems | 246-LP-025/CF | Recombinant Human LAP (TGF-beta 1), CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 2460-SE-010 | Recombinant Human Coagulation Factor XI, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 2464-EV-025 | Recombinant Mouse EG-VEGF/PK1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2464-EV-025/CF | Recombinant Mouse EG-VEGF/PK1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2465-BL-020 | Recombinant Bovine IL-2 (20 UG) | 20 UG | 3760 |
| R&D Systems | 2465-BL-020/CF | Recombinant Bovine IL-2, CF (20 UG) | 20 UG | 3760 |
| R&D Systems | 2466-RA-050 | Recombinant Equine IL-1ra/IL-1F3 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2466-RA-050/CF | Recombinant Equine IL-1ra/IL-1F3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2467-FL-025 | Recombinant Feline Flt-3 Ligand (25 UG) | 25 UG | 4280 |
| R&D Systems | 2467-FL-025/CF | Recombinant Feline Flt-3 Ligand, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2469-BL-025 | Recombinant Bovine IL-4 (25 UG) | 25 UG | 3890 |
| R&D Systems | 2469-BL-025/CF | Recombinant Bovine IL-4, CF (25 UG) | 25 UG | 3890 |
| R&D Systems | 247-GMP-01M | Recombinant Human IL-15 GMP, CF (1 MG) | 1 MG | 78000 |
| R&D Systems | 247-GMP-025 | Recombinant Human IL-15 GMP, CF (25 UG) | 25 UG | 9950 |
| R&D Systems | 247-GMP-005 | Recombinant Human IL-15 GMP, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 247-ILB-025 | Recombinant Human IL-15 Protein (25 UG) | 25 UG | 8650 |
| R&D Systems | 247-ILB-005 | Recombinant Human IL-15 Protein (5 UG) | 5 UG | 2930 |
| R&D Systems | 247-ILB-025/CF | Recombinant Human IL-15 Protein, CF (25 UG) | 25 UG | 8650 |
| R&D Systems | 247-ILB-005/CF | Recombinant Human IL-15 Protein, CF (5 UG) | 5 UG | 2930 |
| R&D Systems | 2470-EL-025 | Recombinant Equine IL-5 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2470-EL-025/CF | Recombinant Equine IL-5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2474-TR-050 | Recombinant Human TfR, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2479-PS-010 | Recombinant Mouse Persephin (10 UG) | 10 UG | 4280 |
| R&D Systems | 2479-PS-010/CF | Recombinant Mouse Persephin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 248-BD-01M | Recombinant Human/Mouse/Rat/Canine/Equine BDNF (1 MG) | 1 MG | 67600 |
| R&D Systems | 248-BD-025 | Recombinant Human/Mouse/Rat/Canine/Equine BDNF (25 UG) | 25 UG | 8650 |
| R&D Systems | 248-BD-005 | Recombinant Human/Mouse/Rat/Canine/Equine BDNF (5 UG) | 5 UG | 2980 |
| R&D Systems | 248-BD-025/CF | Recombinant Human/Mouse/Rat/Canine/Equine BDNF, CF (25 UG) | 25 UG | 8650 |
| R&D Systems | 248-BD-005/CF | Recombinant Human/Mouse/Rat/Canine/Equine BDNF, CF (5 UG) | 5 UG | 2980 |
| R&D Systems | 248-GMP-01M | Recombinant Human/Mouse/Rat/Canine/Equine BDNF GMP, CF (1 MG) | 1 MG | 87090 |
| R&D Systems | 248-GMP-025 | Recombinant Human/Mouse/Rat/Canine/Equine BDNF GMP, CF (25 UG) | 25 UG | 11170 |
| R&D Systems | 248-GMP-005 | Recombinant Human/Mouse/Rat/Canine/Equine BDNF GMP, CF (5 UG) | 5 UG | 3760 |
| R&D Systems | 2484-SUC-010 | Recombinant Human Glucosamine (N-Acetyl)-6-Sulfatase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2485-SU-020 | Recombinant Human Arylsulfatase A/ARSA, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2486-SU-020 | Recombinant Mouse Iduronate 2-sulfatase, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2487-ZN-020 | Recombinant Human Pappalysin-1/PAPP-A (aa 82-1214), CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2487-ZNF-020 | Recombinant Human Pappalysin-1/PAPP-A (aa 82-1627), CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2488-PI-200 | Human Serpin G1/C1 Inhibitor (Plasma), CF (200 UG) | 200 UG | 3370 |
| R&D Systems | 2489-ZN-010 | Recombinant Human Carnosine Dipeptidase 1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 249-LR-050/CF | Recombinant Human LIF R alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2490-ZN-010 | Recombinant Human Aminopeptidase P2/XPNPEP2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2494-ZN-010 | Recombinant Mouse Aminopeptidase P2/XPNPEP2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2495-SE-010 | Recombinant Human Spinesin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2496-ZN-010 | Recombinant Human Insulysin/IDE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2497-SE-010 | Recombinant Human Plasma Kallikrein/KLKB1, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 2498-SE-010 | Recombinant Mouse Plasma Kallikrein/KLKB1, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 2499-ZN-010 | Recombinant Human Aminopeptidase A/ENPEP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2500-ZN-010 | Recombinant Mouse Aminopeptidase PILS/ARTS1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2504-CA-010 | Recombinant Mouse Carbonic Anhydrase XIV, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 2506-KS-010 | Recombinant Human Active GSK-3 beta, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 251-GMP-010 | Recombinant Human KGF/FGF-7 GMP, CF (10 UG) | 10 UG | 4360 |
| R&D Systems | 251-GMP-01M | Recombinant Human KGF/FGF-7 GMP, CF (1 MG) | 1 MG | 77680 |
| R&D Systems | 251-GMP-050 | Recombinant Human KGF/FGF-7 GMP, CF (50 UG) | 50 UG | 12940 |
| R&D Systems | 251-KG-010 | Recombinant Human KGF/FGF-7 (10 UG) | 10 UG | 3760 |
| R&D Systems | 251-KG-050 | Recombinant Human KGF/FGF-7 (50 UG) | 50 UG | 11250 |
| R&D Systems | 251-KG-010/CF | Recombinant Human KGF/FGF-7, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 251-KG-050/CF | Recombinant Human KGF/FGF-7, CF (50 UG) | 50 UG | 11250 |
| R&D Systems | 2516-HV-100 | Recombinant Mouse HVEM/TNFRSF14 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 2519-CD-050 | Recombinant Mouse CD36/SR-B3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 252-PL-250 | Recombinant Human Pleiotrophin/PTN, CF (250 UG) | 250 UG | 10780 |
| R&D Systems | 252-PL-050 | Recombinant Human Pleiotrophin/PTN, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 2520-CH-050 | Recombinant Mouse Chordin-Like 2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2520-CH-050/CF | Recombinant Mouse Chordin-Like 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2524-RL-025 | Recombinant Rat IL-3 (25 UG) | 25 UG | 4150 |
| R&D Systems | 2524-RL-025/CF | Recombinant Rat IL-3, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 2525-BL-025 | Recombinant Bovine IL-5 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2525-BL-025/CF | Recombinant Bovine IL-5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2526-IL-010 | Recombinant Human IL-27 (10 UG) | 10 UG | 4280 |
| R&D Systems | 2526-IL-010/CF | Recombinant Human IL-27, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2527-SR-050 | Recombinant Human SREC-II/SCARF2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2528-AV-050 | Recombinant Human Integrin alpha V beta 5, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2529-CD-050 | Recombinant Human CD97, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 253-5R-025 | Recombinant Human IL-5 R alpha (25 UG) | 25 UG | 5580 |
| R&D Systems | 253-5R-025/CF | Recombinant Human IL-5 R alpha, CF (25 UG) | 25 UG | 5580 |
| R&D Systems | 2530-CD-050 | Recombinant Human CD155/PVR (50 UG) | 50 UG | 4410 |
| R&D Systems | 2530-CD-050/CF | Recombinant Human CD155/PVR, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2534-MR-050 | Recombinant Human MMR/CD206 (50 UG) | 50 UG | 4410 |
| R&D Systems | 2534-MR-050/CF | Recombinant Human MMR/CD206, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2535-MM-050 | Recombinant Mouse MMR/CD206 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2535-MM-050/CF | Recombinant Mouse MMR/CD206, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2536-GT-020 | Recombinant Mouse Exostosin-like 2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2536-LA-025 | Recombinant Human Layilin (25 UG) | 25 UG | 4280 |
| R&D Systems | 2536-LA-025/CF | Recombinant Human Layilin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2538-DR-050 | Recombinant Human DDR2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2539-FG-025 | Recombinant Human FGF-21 (25 UG) | 25 UG | 3890 |
| R&D Systems | 2539-FG-025/CF | Recombinant Human FGF-21, CF (25 UG) | 25 UG | 3890 |
| R&D Systems | 254-XB-025 | Recombinant Human CXCL5/ENA-78 (25 UG) | 25 UG | 4360 |
| R&D Systems | 254-XB-025/CF | Recombinant Human CXCL5/ENA-78, CF (25 UG) | 25 UG | 4360 |
| R&D Systems | 2545-PI-010 | Recombinant Human TFPI-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2547-FG-025 | Recombinant Human FGF-20 (25 UG) | 25 UG | 3760 |
| R&D Systems | 2547-FG-025/CF | Recombinant Human FGF-20, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 2548-RM-025 | Recombinant Rhesus Macaque IL-18/IL-1F4 (25 UG) | 25 UG | 3760 |
| R&D Systems | 2548-RM-025/CF | Recombinant Rhesus Macaque IL-18/IL-1F4, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 255-GMP-010 | Recombinant Human SCF GMP, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 255-GMP-01M | Recombinant Human SCF GMP, CF (1 MG) | 1 MG | 40950 |
| R&D Systems | 255-GMP-050 | Recombinant Human SCF GMP, CF (50 UG) | 50 UG | 10080 |
| R&D Systems | 255-SC-010 | Recombinant Human SCF (10 UG) | 10 UG | 2590 |
| R&D Systems | 255-SC-200 | Recombinant Human SCF (200 UG) | 200 UG | 11690 |
| R&D Systems | 255-SC-050 | Recombinant Human SCF (50 UG) | 50 UG | 7790 |
| R&D Systems | 255-SC-010/CF | Recombinant Human SCF, CF (10 UG) | 10 UG | 2590 |
| R&D Systems | 255-SC-001MG/CF | Recombinant Human SCF, CF (1 MG) | 1 MG | 31200 |
| R&D Systems | 255-SC-200/CF | Recombinant Human SCF, CF (200 UG) | 200 UG | 11690 |
| R&D Systems | 255-SC-050/CF | Recombinant Human SCF, CF (50 UG) | 50 UG | 7790 |
| R&D Systems | 2550-AC-050 | Recombinant Human Osteoactivin/GPNMB Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2554-CD-050 | Recombinant Mouse CD200 R1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2555-CD-050 | Recombinant Mouse CD229/SLAMF3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2557-PG-050 | Recombinant Mouse Progranulin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2558-SA-050 | Recombinant Mouse Pentraxin 2/SAP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2559-BG-050 | Recombinant Mouse beta IG-H3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 256-GF-100 | Recombinant Human beta-NGF (100 UG) | 100 UG | 3760 |
| R&D Systems | 256-GF-100/CF | Recombinant Human beta-NGF, CF (100 UG) | 100 UG | 3760 |
| R&D Systems | 2560-S7-050 | Recombinant Human ST7/LRP12, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2564-K2-050 | Recombinant Human Kirrel2/NEPH3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2565-AM-050 | Recombinant Human AMIGO, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2568-EP-025 | Recombinant Mouse Epimorphin/Syntaxin 2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 257-NT-010 | Recombinant Human CNTF (10 UG) | 10 UG | 2720 |
| R&D Systems | 257-NT-050 | Recombinant Human CNTF (50 UG) | 50 UG | 8440 |
| R&D Systems | 257-NT-010/CF | Recombinant Human CNTF, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 257-NT-050/CF | Recombinant Human CNTF, CF (50 UG) | 50 UG | 8440 |
| R&D Systems | 2570-ND-050 | Recombinant Human Nidogen-1/Entactin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 258-MD-010 | Recombinant Human Midkine, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 258-MD-050 | Recombinant Human Midkine, CF (50 UG) | 50 UG | 5190 |
| R&D Systems | 2580-LM-050 | Recombinant Mouse CD300b/LMIR5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2585-PG-050 | Recombinant Human NG2/MCSP/CSPG4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2586-FT-025 | Recombinant Feline TNF-alpha (25 UG) | 25 UG | 4280 |
| R&D Systems | 2586-FT-025/CF | Recombinant Feline TNF-alpha, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2587-SK-050 | Recombinant Human SLITRK5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2588-MU-050 | Recombinant Mouse ULBP-1/MULT-1 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2588-MU-050/CF | Recombinant Mouse ULBP-1/MULT-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2589-AR-025 | Recombinant Human Artemin (25 UG) | 25 UG | 4150 |
| R&D Systems | 2589-AR-025/CF | Recombinant Human Artemin, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 259-HE-250 | Recombinant Human HB-EGF (250 UG) | 250 UG | 7270 |
| R&D Systems | 259-HE-050 | Recombinant Human HB-EGF (50 UG) | 50 UG | 2330 |
| R&D Systems | 259-HE-250/CF | Recombinant Human HB-EGF, CF (250 UG) | 250 UG | 7270 |
| R&D Systems | 259-HE-050/CF | Recombinant Human HB-EGF, CF (50 UG) | 50 UG | 2330 |
| R&D Systems | 2590-PG-050 | Recombinant Human PGLYRP1/PGRP-S (50 UG) | 50 UG | 4280 |
| R&D Systems | 2590-PG-050/CF | Recombinant Human PGLYRP1/PGRP-S, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2595-VE-025 | Recombinant Mouse VEGF-B 167 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2595-VE-025/CF | Recombinant Mouse VEGF-B 167, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2597-CD-050 | Recombinant Feline sCD4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2599-CH-050 | Recombinant Human Chitinase 3-like 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2604-FG-025 | Recombinant Human FGF-23 (25 UG) | 25 UG | 3760 |
| R&D Systems | 2604-FG-025/CF | Recombinant Human FGF-23, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 2607-G5-050 | Recombinant Human Glypican 5 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2607-G5-050/CF | Recombinant Human Glypican 5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2608-HP-025 | Recombinant Human HAPLN1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 261-CE-010 | Recombinant Human Betacellulin (10 UG) | 10 UG | 3890 |
| R&D Systems | 261-CE-050 | Recombinant Human Betacellulin (50 UG) | 50 UG | 11900 |
| R&D Systems | 261-CE-010/CF | Recombinant Human Betacellulin, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 261-CE-050/CF | Recombinant Human Betacellulin, CF (50 UG) | 50 UG | 11900 |
| R&D Systems | 2616-TR-050 | Recombinant Human TLR2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2619-KB-050 | Recombinant Mouse Klotho beta, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 262-AR-100 | Recombinant Human Amphiregulin (100 UG) | 100 UG | 4280 |
| R&D Systems | 262-AR-100/CF | Recombinant Human Amphiregulin, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 2624-SE-010 | Recombinant Human Kallikrein 7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2625-SE-010 | Recombinant Human Kallikrein 13, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2626-SE-010 | Recombinant Human Kallikrein 14, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2627-PE-020 | Recombinant Human PCPE-1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2629-FG-025 | Recombinant Mouse FGF-23 (25 UG) | 25 UG | 3760 |
| R&D Systems | 2629-FG-025/CF | Recombinant Mouse FGF-23, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 263-2R-050 | Recombinant Human IL-1 RII (50 UG) | 50 UG | 5320 |
| R&D Systems | 263-2R-050/CF | Recombinant Human IL-1 RII, CF (50 UG) | 50 UG | 5320 |
| R&D Systems | 2634-SE-010 | Recombinant Mouse Tryptase-5/Prss32, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2636-GS-050 | Recombinant Human Gas1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2639-AO-010 | Recombinant Human Lysyl Oxidase Homolog 2, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 264-PG-010 | Recombinant Human PlGF (10 UG) | 10 UG | 3890 |
| R&D Systems | 264-PG-050 | Recombinant Human PlGF (50 UG) | 50 UG | 11900 |
| R&D Systems | 264-PG-010/CF | Recombinant Human PlGF, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 264-PG-050/CF | Recombinant Human PlGF, CF (50 UG) | 50 UG | 11900 |
| R&D Systems | 2640-LM-050 | Recombinant Human CD300a/LMIR1 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2644-GS-050 | Recombinant Mouse Gas1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2645-FR-050 | Recombinant Mouse GFR alpha-3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2646-LA-025 | Recombinant Mouse Layilin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2649-CH-050 | Recombinant Mouse Chitinase 3-like 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 265-AN-250 | Recombinant Human Angiogenin (250 UG) | 250 UG | 12990 |
| R&D Systems | 265-AN-050 | Recombinant Human Angiogenin (50 UG) | 50 UG | 4280 |
| R&D Systems | 265-AN-250/CF | Recombinant Human Angiogenin, CF (250 UG) | 250 UG | 12990 |
| R&D Systems | 265-AN-050/CF | Recombinant Human Angiogenin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2659-N4-050 | Recombinant Human Nectin-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 266-IP-010 | Recombinant Human CXCL10/IP-10 (10 UG) | 10 UG | 1550 |
| R&D Systems | 266-IP-050 | Recombinant Human CXCL10/IP-10 (50 UG) | 50 UG | 4800 |
| R&D Systems | 266-IP-010/CF | Recombinant Human CXCL10/IP-10, CF (10 UG) | 10 UG | 1550 |
| R&D Systems | 266-IP-050/CF | Recombinant Human CXCL10/IP-10, CF (50 UG) | 50 UG | 4800 |
| R&D Systems | 2664-LR-050 | Recombinant Human LAIR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2665-LR-050 | Recombinant Human LAIR2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2667-CM-050 | Recombinant Human Biglycan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 267-GMP-01M | Recombinant Human NT-3 GMP, CF (1 MG) | 1 MG | 69550 |
| R&D Systems | 267-GMP-025 | Recombinant Human NT-3 GMP, CF (25 UG) | 25 UG | 9950 |
| R&D Systems | 267-GMP-005 | Recombinant Human NT-3 GMP, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 267-N3-025 | Recombinant Human NT-3 (25 UG) | 25 UG | 8650 |
| R&D Systems | 267-N3-005 | Recombinant Human NT-3 (5 UG) | 5 UG | 2980 |
| R&D Systems | 267-N3-025/CF | Recombinant Human NT-3, CF (25 UG) | 25 UG | 8650 |
| R&D Systems | 267-N3-005/CF | Recombinant Human NT-3, CF (5 UG) | 5 UG | 2980 |
| R&D Systems | 2674-RM-025 | Recombinant Rhesus Macaque IL-13 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2674-RM-025/CF | Recombinant Rhesus Macaque IL-13, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2679-KS-010 | Recombinant Human Active Blk, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 268-GMP-025 | Recombinant Human NT-4 GMP, CF (25 UG) | 25 UG | 9880 |
| R&D Systems | 268-N4-025 | Recombinant Human NT-4 (25 UG) | 25 UG | 8650 |
| R&D Systems | 268-N4-005 | Recombinant Human NT-4 (5 UG) | 5 UG | 2980 |
| R&D Systems | 268-N4-025/CF | Recombinant Human NT-4, CF (25 UG) | 25 UG | 8650 |
| R&D Systems | 268-N4-005/CF | Recombinant Human NT-4, CF (5 UG) | 5 UG | 2980 |
| R&D Systems | 2688-EC-050 | Recombinant Human ESAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2689-G5-050 | Recombinant Mouse Glypican 5 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2689-G5-050/CF | Recombinant Mouse Glypican 5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 269-1R-100 | Recombinant Human IL-1 RI (100 UG) | 100 UG | 6620 |
| R&D Systems | 269-1R-100/CF | Recombinant Human IL-1 RI, CF (100 UG) | 100 UG | 6620 |
| R&D Systems | 2690-CL-050 | Recombinant Human CL-P1/COLEC12, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2694-CL-100/CF | Recombinant Human FABP2/I-FABP, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 2695-SE-010 | Recombinant Human Airway Trypsin-like Protease/HAT, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2696-PG-050 | Recombinant Mouse PGLYRP1/PGRP-S (50 UG) | 50 UG | 4280 |
| R&D Systems | 2696-PG-050/CF | Recombinant Mouse PGLYRP1/PGRP-S, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 270-LD-010 | Recombinant Human CCL3/MIP-1 alpha (10 UG) | 10 UG | 3240 |
| R&D Systems | 270-LD-050 | Recombinant Human CCL3/MIP-1 alpha (50 UG) | 50 UG | 10390 |
| R&D Systems | 270-LD-010/CF | Recombinant Human CCL3/MIP-1 alpha, CF (10 UG) | 10 UG | 3240 |
| R&D Systems | 270-LD-050/CF | Recombinant Human CCL3/MIP-1 alpha, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 2700-ZN-020 | Recombinant Mouse Aminoacylase/ACY1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2706-CL-025 | Recombinant Human CD40 Ligand/TNFSF5 (Histidine-tagged) (25 UG) | 25 UG | 3110 |
| R&D Systems | 2706-CL-025/CF | Recombinant Human CD40 Ligand/TNFSF5 (Histidine-tagged), CF (25 UG) | 25 UG | 3110 |
| R&D Systems | 2707-RM-025 | Recombinant Rhesus Macaque IL-5 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2707-RM-025/CF | Recombinant Rhesus Macaque IL-5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2708-MS-050 | Recombinant Human SR-AI/MSR, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2709-NP-025 | Recombinant Mouse Neuropoietin (25 UG) | 25 UG | 4150 |
| R&D Systems | 2709-NP-025/CF | Recombinant Mouse Neuropoietin, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 271-BME-010 | Recombinant Human CCL4/MIP-1 beta (10 UG) | 10 UG | 3240 |
| R&D Systems | 271-BME-050 | Recombinant Human CCL4/MIP-1 beta (50 UG) | 50 UG | 7010 |
| R&D Systems | 271-BME-010/CF | Recombinant Human CCL4/MIP-1 beta, CF (10 UG) | 10 UG | 3240 |
| R&D Systems | 271-BME-050/CF | Recombinant Human CCL4/MIP-1 beta, CF (50 UG) | 50 UG | 7010 |
| R&D Systems | 27100-1 | Porcine IFN-alpha MAb (Clone K9) (500 UG) | 500 UG | 4550 |
| R&D Systems | 27105-1 | Porcine IFN-alpha MAb (Clone F17) (500 UG) | 500 UG | 4550 |
| R&D Systems | 2714-ML-025 | Recombinant Mouse IL-36Ra/IL-1F5 (25 UG) | 25 UG | 4280 |
| R&D Systems | 2714-ML-025/CF | Recombinant Mouse IL-36Ra/IL-1F5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2715-CA-050 | Recombinant Human Cadherin-6/KCAD Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2716-SD-025 | Recombinant Human/Feline CXCL12/SDF-1 beta (aa 19-93) (25 UG) | 25 UG | 3890 |
| R&D Systems | 2716-SD-025/CF | Recombinant Human/Feline CXCL12/SDF-1 beta (aa 19-93), CF (25 UG) | 25 UG | 3890 |
| R&D Systems | 2717-PG-050 | Recombinant Human pIgR, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 272-I-010 | Recombinant Human CCL1/I-309 (10 UG) | 10 UG | 2720 |
| R&D Systems | 272-I-050 | Recombinant Human CCL1/I-309 (50 UG) | 50 UG | 8130 |
| R&D Systems | 272-I-010/CF | Recombinant Human CCL1/I-309, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 272-I-050/CF | Recombinant Human CCL1/I-309, CF (50 UG) | 50 UG | 8130 |
| R&D Systems | 2724-CD-050 | Recombinant Human CD200 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2728-SL-050 | Recombinant Human SPARC-like 1/SPARCL1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 273-F9-025 | Recombinant Human FGF-9 (25 UG) | 25 UG | 3370 |
| R&D Systems | 273-F9-025/CF | Recombinant Human FGF-9, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 2734-SD-050 | Recombinant Mouse Syndecan-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 274-R1B-050 | Recombinant Human IL-10 R alpha, CF (50 UG) | 50 UG | 5790 |
| R&D Systems | 2744-NG-050 | Recombinant Mouse Netrin-G2a Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2745-LU-050 | Recombinant Mouse Lumican, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2747-HS-050 | Recombinant Mouse Clusterin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 275-GR-010 | Recombinant Human CXCL1/GRO alpha (10 UG) | 10 UG | 2720 |
| R&D Systems | 275-GR-050 | Recombinant Human CXCL1/GRO alpha (50 UG) | 50 UG | 8180 |
| R&D Systems | 275-GR-010/CF | Recombinant Human CXCL1/GRO alpha, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 275-GR-050/CF | Recombinant Human CXCL1/GRO alpha, CF (50 UG) | 50 UG | 8180 |
| R&D Systems | 2754-PB-050 | Recombinant Mouse PIR-B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2755-AS-050 | Recombinant Mouse ASGPR1 (50 UG) | 50 UG | 4410 |
| R&D Systems | 2755-AS-050/CF | Recombinant Mouse ASGPR1, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 276-GB-010 | Recombinant Human CXCL2/GRO beta (10 UG) | 10 UG | 2720 |
| R&D Systems | 276-GB-050 | Recombinant Human CXCL2/GRO beta (50 UG) | 50 UG | 8180 |
| R&D Systems | 276-GB-010/CF | Recombinant Human CXCL2/GRO beta, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 276-GB-050/CF | Recombinant Human CXCL2/GRO beta, CF (50 UG) | 50 UG | 8180 |
| R&D Systems | 2764-WF-050 | Recombinant Human vWF-A2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2765-ZN-010 | Recombinant Mouse Carboxypeptidase A1/CPA1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2767-MF-050 | Recombinant Human MFG-E8, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2769-IL-050 | Recombinant Human IL-31 RA, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 277-GG-010 | Recombinant Human CXCL3/GRO gamma (10 UG) | 10 UG | 2720 |
| R&D Systems | 277-GG-050 | Recombinant Human CXCL3/GRO gamma (50 UG) | 50 UG | 5190 |
| R&D Systems | 277-GG-010/CF | Recombinant Human CXCL3/GRO gamma, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 277-GG-050/CF | Recombinant Human CXCL3/GRO gamma, CF (50 UG) | 50 UG | 5190 |
| R&D Systems | 2770-LR-050 | Recombinant Human IL-22 R alpha 1, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2774-LM-050 | Recombinant Human CD300f/LMIR3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2777-CM-050 | Recombinant Human OBCAM/OPCML, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 278-RN-010 | Recombinant Human CCL5/RANTES (10 UG) | 10 UG | 2980 |
| R&D Systems | 278-RN-050 | Recombinant Human CCL5/RANTES (50 UG) | 50 UG | 8650 |
| R&D Systems | 278-RN-010/CF | Recombinant Human CCL5/RANTES, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 278-RN-050/CF | Recombinant Human CCL5/RANTES, CF (50 UG) | 50 UG | 8650 |
| R&D Systems | 2780-SD-050 | Recombinant Human Syndecan-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2784-CL-050 | Recombinant Mouse CLEC4F/CLECSF13, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 279-MC-010 | Recombinant Human CCL2/MCP-1 (10 UG) | 10 UG | 2720 |
| R&D Systems | 279-MC-050 | Recombinant Human CCL2/MCP-1 (50 UG) | 50 UG | 8440 |
| R&D Systems | 279-MC-010/CF | Recombinant Human CCL2/MCP-1, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 279-MC-001MG/CF | Recombinant Human CCL2/MCP-1, CF (1 MG) | 1 MG | 44200 |
| R&D Systems | 279-MC-050/CF | Recombinant Human CCL2/MCP-1, CF (50 UG) | 50 UG | 8440 |
| R&D Systems | 2790-HN-050 | Recombinant Human HIN-1/SCGB3A1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2794-FL-050 | Recombinant Human FLRT1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2795-FL-050 | Recombinant Human FLRT3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2797-CL-050 | Recombinant Human CD5L, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2799-ML-010 | Recombinant Mouse IL-27 (NS0-expressed) (10 UG) | 10 UG | 4280 |
| R&D Systems | 2799-ML-010/CF | Recombinant Mouse IL-27 (NS0-expressed), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 280-RA-010 | Recombinant Human IL-1ra/IL-1F3 (10 UG) | 10 UG | 3890 |
| R&D Systems | 280-RA-050 | Recombinant Human IL-1ra/IL-1F3 (50 UG) | 50 UG | 12290 |
| R&D Systems | 280-RA-010/CF | Recombinant Human IL-1ra/IL-1F3, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 280-RA-050/CF | Recombinant Human IL-1ra/IL-1F3, CF (50 UG) | 50 UG | 12290 |
| R&D Systems | 2800-PG-050 | Recombinant Mouse pIgR, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2805-MF-050 | Recombinant Mouse MFG-E8 (50 UG) | 50 UG | 4280 |
| R&D Systems | 2805-MF-050/CF | Recombinant Mouse MFG-E8, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 281-CP-010 | Recombinant Human CCL8/MCP-2 (10 UG) | 10 UG | 3110 |
| R&D Systems | 281-CP-050 | Recombinant Human CCL8/MCP-2 (50 UG) | 50 UG | 5190 |
| R&D Systems | 281-CP-010/CF | Recombinant Human CCL8/MCP-2, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 281-CP-050/CF | Recombinant Human CCL8/MCP-2, CF (50 UG) | 50 UG | 5190 |
| R&D Systems | 2810-SE-010 | Recombinant Human Proprotein Convertase 1/PCSK1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 282-P3-010 | Recombinant Human CCL7/MCP-3 (10 UG) | 10 UG | 3110 |
| R&D Systems | 282-P3-050 | Recombinant Human CCL7/MCP-3 (50 UG) | 50 UG | 9480 |
| R&D Systems | 282-P3-010/CF | Recombinant Human CCL7/MCP-3, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 282-P3-050/CF | Recombinant Human CCL7/MCP-3, CF (50 UG) | 50 UG | 9480 |
| R&D Systems | 2824-IL-010 | Recombinant Human IL-31 (10 UG) | 10 UG | 4020 |
| R&D Systems | 2824-IL-010/CF | Recombinant Human IL-31, CF (10 UG) | 10 UG | 4020 |
| R&D Systems | 2826-TI-050 | Recombinant Mouse TIM-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2829-CD-050 | Recombinant Mouse CD2F-10/SLAMF9, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2834-CL-050 | Recombinant Mouse CD5L, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2835-MG-050 | Recombinant Mouse MGL2/CD301b, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2840-A3-050 | Recombinant Human Integrin alpha 3 beta 1/VLA-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2845-GP-050 | Recombinant Human Glypican 6, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2846-LU-050 | Recombinant Human Lumican, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 285-GMP-100 | Recombinant Human IFN-gamma GMP, CF (100 UG) | 100 UG | 5580 |
| R&D Systems | 285-GMP-01M | Recombinant Human IFN-gamma GMP, CF (1 MG) | 1 MG | 20480 |
| R&D Systems | 285-IF-100 | Recombinant Human IFN-gamma (100 UG) | 100 UG | 4280 |
| R&D Systems | 285-IF-100/CF | Recombinant Human IFN-gamma, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 2855-KS-010 | Recombinant Human Active MEK2, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 2856-ZN-010 | Recombinant Human Carboxypeptidase A1/CPA1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2857-SE-010 | Recombinant Mouse Mast Cell Protease-11/Prss34, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2858-SU-020 | Recombinant Mouse Arylsulfatase A/ARSA, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2859-SL-050 | Recombinant Human Siglec-6/CD327 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 286-EP-250 | Recombinant Human Erythropoietin (Ultrapure), CF (250 UN) | 250 UN | 10260 |
| R&D Systems | 2868-FM-050 | Recombinant Mouse FAM3C, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 287-TC-500 | Recombinant Human Erythropoietin (Tissue Culture Grade) (500 UN) | 500 UN | 5530 |
| R&D Systems | 2875-DS-050 | Recombinant Mouse DSPG3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2877-FL-050 | Recombinant Human FLRT2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2878-KR-050 | Recombinant Human KIR3DL2/CD158k Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 288-TP-01M | Recombinant Human Thrombopoietin (1 MG) | 1 MG | 62400 |
| R&D Systems | 288-TP-200 | Recombinant Human Thrombopoietin (200 UG) | 200 UG | 16890 |
| R&D Systems | 288-TP-025 | Recombinant Human Thrombopoietin (25 UG) | 25 UG | 10990 |
| R&D Systems | 288-TP-005 | Recombinant Human Thrombopoietin (5 UG) | 5 UG | 3500 |
| R&D Systems | 288-TP-01M/CF | Recombinant Human Thrombopoietin, CF (1 MG) | 1 MG | 62400 |
| R&D Systems | 288-TP-200/CF | Recombinant Human Thrombopoietin, CF (200 UG) | 200 UG | 16890 |
| R&D Systems | 288-TP-025/CF | Recombinant Human Thrombopoietin, CF (25 UG) | 25 UG | 10990 |
| R&D Systems | 288-TP-005/CF | Recombinant Human Thrombopoietin, CF (5 UG) | 5 UG | 3500 |
| R&D Systems | 288-TPN-025 | Recombinant Human Thrombopoietin (NS0-expressed) (25 UG) | 25 UG | 4150 |
| R&D Systems | 288-TPN-025/CF | Recombinant Human Thrombopoietin (NS0-expressed), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 2880-N1-050 | Recombinant Human Nectin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2884-AD-050 | Recombinant Human Osteoadherin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 289-MF-002 | Recombinant Human MIF (2 UG) | 2 UG | 1420 |
| R&D Systems | 2895-ZN-010 | Recombinant Human Meprin beta Subunit/MEP1B, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2896-ZN-010 | Recombinant Human Carboxypeptidase A2/CPA2, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2897-ZN-010 | Recombinant Human Carboxypeptidase B1/CPB1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2898-ZN-010 | Recombinant Mouse Carboxypeptidase B1/CPB1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2899-ZN-010 | Recombinant Mouse Carboxypeptidase A4/CPA4, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 290-RNS-025 | Recombinant Human IL-9 R (NS0-expressed) (25 UG) | 25 UG | 4280 |
| R&D Systems | 290-RNS-025/CF | Recombinant Human IL-9 R (NS0-expressed), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2900-ZN-020 | Recombinant Human Aminoacylase/ACY1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2904-MP-010 | Recombinant Mouse MMP-8, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2905-SE-010 | Recombinant Human Granzyme A, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2906-SE-010 | Recombinant Human Granzyme B, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2907-SE-020 | Recombinant West Nile Virus NS3 Protease, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2909-AP-010 | Recombinant Human Alkaline Phosphatase/ALPL, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 291-G1-01M | Recombinant Human IGF-I, CF (1 MG) | 1 MG | 7660 |
| R&D Systems | 291-G1-200 | Recombinant Human IGF-I, CF (200 UG) | 200 UG | 2590 |
| R&D Systems | 291-GMP-01M | Recombinant Human IGF-I GMP, CF (1 MG) | 1 MG | 10080 |
| R&D Systems | 291-GMP-200 | Recombinant Human IGF-I GMP, CF (200 UG) | 200 UG | 3380 |
| R&D Systems | 2910-AP-010 | Recombinant Mouse Alkaline Phosphatase/ALPL, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 2914-HT-100MG | Human Holo-Transferrin, CF (100 MG) | 100 MG | 1290 |
| R&D Systems | 2914-HT-001G | Human Holo-Transferrin, CF (1 G) | 1 G | 6750 |
| R&D Systems | 2915-IL-025 | Recombinant Mouse IL-19 (25 UG) | 25 UG | 4410 |
| R&D Systems | 2915-IL-025/CF | Recombinant Mouse IL-19, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 2916-SE-020 | Recombinant Human HTRA1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2918-SD-050 | Recombinant Human Syndecan-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 292-G2-250 | Recombinant Human IGF-II, CF (250 UG) | 250 UG | 8130 |
| R&D Systems | 292-G2-050 | Recombinant Human IGF-II, CF (50 UG) | 50 UG | 2330 |
| R&D Systems | 2926-BP-025 | Recombinant Human BMP-10 (25 UG) | 25 UG | 6360 |
| R&D Systems | 2926-BP-025/CF | Recombinant Human BMP-10, CF (25 UG) | 25 UG | 6360 |
| R&D Systems | 2929-TM-050 | Recombinant Human TIM-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 293-GMP-050 | Recombinant Human VEGF 165 GMP, CF (50 UG) | 50 UG | 15670 |
| R&D Systems | 293-VE-010 | Recombinant Human VEGF 165 (10 UG) | 10 UG | 3760 |
| R&D Systems | 293-VE-500 | Recombinant Human VEGF 165 (500 UG) | 500 UG | 29770 |
| R&D Systems | 293-VE-050 | Recombinant Human VEGF 165 (50 UG) | 50 UG | 11820 |
| R&D Systems | 293-VE-010/CF | Recombinant Human VEGF 165, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 293-VE-001MG/CF | Recombinant Human VEGF 165, CF (1 MG) | 1 MG | 55900 |
| R&D Systems | 293-VE-500/CF | Recombinant Human VEGF 165, CF (500 UG) | 500 UG | 29770 |
| R&D Systems | 293-VE-050/CF | Recombinant Human VEGF 165, CF (50 UG) | 50 UG | 11820 |
| R&D Systems | 2930-K2-050 | Recombinant Mouse Kirrel2/NEPH3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2934-ST-050 | Recombinant Mouse Sortilin, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 2936-EP-025 | Recombinant Human Epimorphin/Syntaxin 2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2937-HS-050 | Recombinant Human Clusterin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2939-CA-010 | Recombinant Human Carbonic Anhydrase VI, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 294-HG-250 | Recombinant Human HGF (250 UG) | 250 UG | 32500 |
| R&D Systems | 294-HG-025 | Recombinant Human HGF (25 UG) | 25 UG | 14240 |
| R&D Systems | 294-HG-005 | Recombinant Human HGF (5 UG) | 5 UG | 4360 |
| R&D Systems | 294-HG-025/CF | Recombinant Human HGF, CF (25 UG) | 25 UG | 14240 |
| R&D Systems | 294-HG-005/CF | Recombinant Human HGF, CF (5 UG) | 5 UG | 4360 |
| R&D Systems | 294-HGN-025 | Recombinant Human HGF (NS0-expressed) (25 UG) | 25 UG | 14240 |
| R&D Systems | 294-HGN-005 | Recombinant Human HGF (NS0-expressed) (5 UG) | 5 UG | 4360 |
| R&D Systems | 294-HGN-025/CF | Recombinant Human HGF (NS0-expressed), CF (25 UG) | 25 UG | 14240 |
| R&D Systems | 294-HGN-005/CF | Recombinant Human HGF (NS0-expressed), CF (5 UG) | 5 UG | 4360 |
| R&D Systems | 2940-CM-050 | Recombinant Human CMG-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2947-CL-050 | Recombinant Human LSECtin/CLEC4G, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2948-SA-025 | Recombinant Mouse Serum Amyloid A1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2949-MC-050 | Recombinant Mouse Mimecan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 295-OM-010 | Recombinant Human Oncostatin M (OSM) (10 UG) | 10 UG | 2720 |
| R&D Systems | 295-OM-050 | Recombinant Human Oncostatin M (OSM) (50 UG) | 50 UG | 11040 |
| R&D Systems | 295-OM-010/CF | Recombinant Human Oncostatin M (OSM), CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 295-OM-050/CF | Recombinant Human Oncostatin M (OSM), CF (50 UG) | 50 UG | 11040 |
| R&D Systems | 2954-HN-050 | Recombinant Mouse HIN-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2955-F2-050 | Recombinant Mouse Periostin/OSF-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2956-MA-050 | Recombinant Mouse MARCO, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 296-HR-050 | Recombinant Human NRG1-alpha/HRG1-alpha EGF Domain (50 UG) | 50 UG | 4280 |
| R&D Systems | 296-HR-050/CF | Recombinant Human NRG1-alpha/HRG1-alpha EGF Domain, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2960-LR-025 | Recombinant Mouse LRP-6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 2965-SD-050 | Recombinant Human Syndecan-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2967-MP-010 | Recombinant Mouse MMP-7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2968-SE-010 | Recombinant Mouse Prostasin/Prss8, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2969-SU-020 | Recombinant Mouse Sulfamidase/SGSH, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 297-VP-005 | Recombinant Human VEGF/PlGF Heterodimer (5 UG) | 5 UG | 4280 |
| R&D Systems | 297-VP-005/CF | Recombinant Human VEGF/PlGF Heterodimer, CF (5 UG) | 5 UG | 4280 |
| R&D Systems | 2970-ZN-010 | Recombinant Human Aminopeptidase P1/XPNPEP1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2974-PI-010 | Recombinant Human TFPI, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 2975-PI-010 | Recombinant Mouse TFPI, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2976-AS-050 | Recombinant Mouse BACE-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 2977-AS-020 | Recombinant Mouse BACE-2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 2978-AD-010 | Recombinant Mouse TACE/ADAM17, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2979-PI-010 | Recombinant Mouse Serpin A1c/alpha-1-Antitrypsin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 298-VS-025 | Recombinant Human VEGF (aa 207-318) (25 UG) | 25 UG | 12080 |
| R&D Systems | 298-VS-005 | Recombinant Human VEGF (aa 207-318) (5 UG) | 5 UG | 3890 |
| R&D Systems | 298-VS-025/CF | Recombinant Human VEGF (aa 207-318), CF (25 UG) | 25 UG | 12080 |
| R&D Systems | 298-VS-005/CF | Recombinant Human VEGF (aa 207-318), CF (5 UG) | 5 UG | 3890 |
| R&D Systems | 2980-PI-010 | Recombinant Human Serpin E2/PN1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2984-SE-010 | Recombinant Human Proprotein Convertase 7/PCSK7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 2985-ZN-010 | Recombinant Mouse TRH-degrading Ectoenzyme/TRHDE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 299-LT-025 | Recombinant Human Latent TGF-beta 1 (25 UG) | 25 UG | 10390 |
| R&D Systems | 299-LT-005 | Recombinant Human Latent TGF-beta 1 (5 UG) | 5 UG | 3760 |
| R&D Systems | 299-LT-025/CF | Recombinant Human Latent TGF-beta 1, CF (25 UG) | 25 UG | 10390 |
| R&D Systems | 299-LT-005/CF | Recombinant Human Latent TGF-beta 1, CF (5 UG) | 5 UG | 3760 |
| R&D Systems | 3005-TR-050 | Recombinant Mouse TLR3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3006-WN-025 | Recombinant Mouse Wnt-5b (25 UG) | 25 UG | 4800 |
| R&D Systems | 3006-WN-025/CF | Recombinant Mouse Wnt-5b, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 3007-BT-050 | Recombinant Mouse BTLA Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3008-WN-025 | Recombinant Human Wnt-7a (25 UG) | 25 UG | 4750 |
| R&D Systems | 3008-WN-025/CF | Recombinant Human Wnt-7a, CF (25 UG) | 25 UG | 4750 |
| R&D Systems | 3009-SK-050 | Recombinant Human SLITRK1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 301-R3-025 | Recombinant Human IL-3 R alpha/CD123 (25 UG) | 25 UG | 5710 |
| R&D Systems | 301-R3-025/CF | Recombinant Human IL-3 R alpha/CD123, CF (25 UG) | 25 UG | 5710 |
| R&D Systems | 3014-NR-025 | Recombinant Human Norrin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3015-KR-050 | Recombinant Human KIR2DL2/CD158b1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3017-MN-050 | Recombinant Human Matrilin-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 302-B2-010 | Recombinant Human TGF-beta 2 (10 UG) | 10 UG | 14890 |
| R&D Systems | 302-B2-002 | Recombinant Human TGF-beta 2 (2 UG) | 2 UG | 4620 |
| R&D Systems | 302-B2-010/CF | Recombinant Human TGF-beta 2, CF (10 UG) | 10 UG | 14890 |
| R&D Systems | 302-B2-002/CF | Recombinant Human TGF-beta 2, CF (2 UG) | 2 UG | 4620 |
| R&D Systems | 3025-BR-050 | Recombinant Human TGF-beta RI/ALK-5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3026-AB-050 | Recombinant Mouse Ameloblastin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3028-ML-010 | Recombinant Mouse IL-31, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 303-CR-050 | Recombinant Human CNTF R alpha (50 UG) | 50 UG | 4670 |
| R&D Systems | 303-CR-050/CF | Recombinant Human CNTF R alpha, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 3030-CN-025 | Recombinant Human Contactin-5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3034-A1-100 | Recombinant Mouse EphA1, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3035-A2-100 | Recombinant Human EphA2, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3036-A5-100 | Recombinant Human EphA5, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3037-A5-100 | Recombinant Mouse EphA5, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3038-B4-100 | Recombinant Human EphB4, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3039-AB-050 | Recombinant Mouse IFN-alpha/beta R1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 304-B3-001 | Recombinant Human TGF-beta 1.2 (1 UG) | 1 UG | 4930 |
| R&D Systems | 304-B3-001/CF | Recombinant Human TGF-beta 1.2, CF (1 UG) | 1 UG | 4930 |
| R&D Systems | 3040-IL-050 | Recombinant Human IL-32 alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3044-MN-050 | Recombinant Human Matrilin-2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 3044-MN-050/CF | Recombinant Human Matrilin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3045-VE-025 | Recombinant Human VEGF 165b (25 UG) | 25 UG | 4280 |
| R&D Systems | 3045-VE-025/CF | Recombinant Human VEGF 165b, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3046-MB-025 | Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1 (25 UG) | 25 UG | 4150 |
| R&D Systems | 3046-MB-025/CF | Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3047-CC-050 | Recombinant Human COCO (50 UG) | 50 UG | 4280 |
| R&D Systems | 3047-CC-050/CF | Recombinant Human COCO, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3048-VG-025 | Recombinant Human VG5Q, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3049-CA-010 | Recombinant Human Carbonic Anhydrase VA, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 305-GR-050 | Recombinant Human IGF-I R (Histidine-tagged), CF (50 UG) | 50 UG | 4800 |
| R&D Systems | 3050-AV-050 | Recombinant Human Integrin alpha V beta 3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 306-IR-050 | Recombinant Human IL-7 R alpha/CD127 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 3064-N3-050 | Recombinant Human Nectin-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3067-SR-050 | Recombinant Mouse SorCS3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 307-ER-050 | Recombinant Human Erythropoietin R (50 UG) | 50 UG | 4670 |
| R&D Systems | 307-ER-050/CF | Recombinant Human Erythropoietin R, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 3074-TH-050 | Recombinant Human Thrombospondin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3076-RB-050 | Recombinant Human ROBO3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 308-FK-025 | Recombinant Human Flt-3 Ligand (25 UG) | 25 UG | 6230 |
| R&D Systems | 308-FK-005 | Recombinant Human Flt-3 Ligand (5 UG) | 5 UG | 1940 |
| R&D Systems | 308-FK-025/CF | Recombinant Human Flt-3 Ligand, CF (25 UG) | 25 UG | 6230 |
| R&D Systems | 308-FK-005/CF | Recombinant Human Flt-3 Ligand, CF (5 UG) | 5 UG | 1940 |
| R&D Systems | 308-FKN-025 | Recombinant Human Flt-3 Ligand (25 UG) | 25 UG | 6230 |
| R&D Systems | 308-FKN-005 | Recombinant Human Flt-3 Ligand (5 UG) | 5 UG | 1940 |
| R&D Systems | 308-FKN-025/CF | Recombinant Human Flt-3 Ligand, CF (25 UG) | 25 UG | 6230 |
| R&D Systems | 308-FKN-005/CF | Recombinant Human Flt-3 Ligand, CF (5 UG) | 5 UG | 1940 |
| R&D Systems | 308-GMP-01M | Recombinant Human Flt-3 Ligand GMP, CF (1 MG) | 1 MG | 78000 |
| R&D Systems | 308-GMP-050 | Recombinant Human Flt-3 Ligand GMP, CF (50 UG) | 50 UG | 15670 |
| R&D Systems | 309-IL-002 | Recombinant Human IL-12/IL-23 p40 Monomer (2 UG) | 2 UG | 1550 |
| R&D Systems | 9006-FB-025 | Recombinant Human Fibulin 5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3095-SE-010 | Recombinant Human Kallikrein 12, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3097-ZN-020 | Bacterial Thermolysin, CF (20 UG) | 20 UG | 1420 |
| R&D Systems | 3098-NG-050 | Recombinant Rat Nogo-A Fc Chimera (aa 1-172), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3104-PO-050 | Recombinant Mouse Podocan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3105-DK-010 | Recombinant Mouse Dkk-4 (10 UG) | 10 UG | 4280 |
| R&D Systems | 3105-DK-010/CF | Recombinant Mouse Dkk-4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3106-AM-050 | Recombinant Mouse AMICA Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3107-RN-025 | Recombinant Human Relaxin-3 (25 UG) | 25 UG | 4150 |
| R&D Systems | 3107-RN-025/CF | Recombinant Human Relaxin-3, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3110-DS-050 | Recombinant Human DSPG3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 31100-1 | Human IFN-alpha Polyclonal Ab (100000 UN) | 100000 UN | 3540 |
| R&D Systems | 31101-1 | Human IFN-alpha Polyclonal Ab (100000 UN) | 100000 UN | 3540 |
| R&D Systems | 31130-1 | Human IFN-alpha Polyclonal Ab (20000 UN) | 20000 UN | 3260 |
| R&D Systems | 3114-DC-050 | Recombinant Human Dectin-2/CLEC6A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3116-N4-050 | Recombinant Mouse Nectin-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3126-FC-050 | Recombinant Human FCRL3/FcRH3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3128-CR-050 | Recombinant Human CRELD1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 313-TI-100 | Recombinant Human Tie-2 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 3130-CL-050 | Recombinant Mouse CL-P1/COLEC12, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3134-CP-050 | Recombinant Human COMP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3135-SP-025 | Recombinant Human F-Spondin/SPON1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 3135-SP-025/CF | Recombinant Human F-Spondin/SPON1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3136-RL-010 | Recombinant Rat IL-23 (10 UG) | 10 UG | 4410 |
| R&D Systems | 3136-RL-010/CF | Recombinant Rat IL-23, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 3137-PL-010 | Recombinant Porcine IL-5 (10 UG) | 10 UG | 3890 |
| R&D Systems | 3137-PL-010/CF | Recombinant Porcine IL-5, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3138-GN-025/CF | Recombinant Human Granulysin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3139-FB-025 | Recombinant Mouse FGF basic (25 UG) | 25 UG | 3370 |
| R&D Systems | 3139-FB-025/CF | Recombinant Mouse FGF basic, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 314-BP-010 | Recombinant Human BMP-4 (10 UG) | 10 UG | 4750 |
| R&D Systems | 314-BP-01M | Recombinant Human BMP-4 (1 MG) | 1 MG | 67600 |
| R&D Systems | 314-BP-050 | Recombinant Human BMP-4 (50 UG) | 50 UG | 12470 |
| R&D Systems | 314-BP-010/CF | Recombinant Human BMP-4, CF (10 UG) | 10 UG | 4750 |
| R&D Systems | 314-BP-050/CF | Recombinant Human BMP-4, CF (50 UG) | 50 UG | 12470 |
| R&D Systems | 314-GMP-010 | Recombinant Human BMP-4 GMP, CF (10 UG) | 10 UG | 5460 |
| R&D Systems | 314-GMP-050 | Recombinant Human BMP-4 GMP, CF (50 UG) | 50 UG | 14300 |
| R&D Systems | 3140-ME-050 | Recombinant Human MEPE/OF45, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 31400-1 | Human IFN-beta Polyclonal Ab (Sheep) (20000 UN) | 20000 UN | 4160 |
| R&D Systems | 31410-1 | Human IFN-beta Polyclonal Ab (Rabbit) (20000 UN) | 20000 UN | 3320 |
| R&D Systems | 3144-JE-025 | Recombinant Rat CCL2/JE/MCP-1 (25 UG) | 25 UG | 4750 |
| R&D Systems | 3144-JE-025/CF | Recombinant Rat CCL2/JE/MCP-1, CF (25 UG) | 25 UG | 4750 |
| R&D Systems | 3146-TM-050 | Recombinant Human TLR4/MD-2 Complex (50 UG) | 50 UG | 4280 |
| R&D Systems | 3146-TM-050/CF | Recombinant Human TLR4/MD-2 Complex, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3147-RB-050 | Recombinant Human ROBO2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 315-BR-100 | Recombinant Human BMPR-IA/ALK-3 Fc Chimera (100 UG) | 100 UG | 5320 |
| R&D Systems | 315-BR-100/CF | Recombinant Human BMPR-IA/ALK-3 Fc Chimera, CF (100 UG) | 100 UG | 5320 |
| R&D Systems | 3154-ST-050 | Recombinant Human Sortilin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3155-RB-050 | Recombinant Mouse ROBO3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3159-NN-050 | Recombinant Mouse Nephrin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 316-IL-025 | Recombinant Human IL-16 (25 UG) | 25 UG | 4800 |
| R&D Systems | 316-IL-002 | Recombinant Human IL-16 (2 UG) | 2 UG | 1940 |
| R&D Systems | 316-IL-025/CF | Recombinant Human IL-16, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 316-IL-002/CF | Recombinant Human IL-16, CF (2 UG) | 2 UG | 1940 |
| R&D Systems | 3160-CA-020 | Recombinant Human Calcineurin, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 317-ILB-050 | Recombinant Human IL-17A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3170-HM-010 | Recombinant Human HO-2/HMOX2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3174-MP-250 | Recombinant Human Myeloperoxidase, CF (250 UG) | 250 UG | 2590 |
| R&D Systems | 3176-CA-010 | Recombinant Human Carbonic Anhydrase VB, CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 3177-CA-050 | Recombinant Human Carbonic Anhydrase VII, CF (50 UG) | 50 UG | 3500 |
| R&D Systems | 3178-PA-010 | Recombinant Mouse Coagulation Factor III/Tissue Factor, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3188-AT-100MG | Human Apo-Transferrin, CF (100 MG) | 100 MG | 1290 |
| R&D Systems | 3188-AT-001G | Human Apo-Transferrin, CF (1 G) | 1 G | 6750 |
| R&D Systems | 319-FG-025 | Recombinant Human FGF-17 (25 UG) | 25 UG | 3370 |
| R&D Systems | 319-FG-025/CF | Recombinant Human FGF-17, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 3190-SD-050 | Recombinant Mouse Syndecan-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3198-PI-010 | Recombinant Human Serpin D1/Heparin Cofactor II, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 320-EO-100 | Recombinant Human CCL11/Eotaxin (100 UG) | 100 UG | 10390 |
| R&D Systems | 320-EO-020 | Recombinant Human CCL11/Eotaxin (20 UG) | 20 UG | 4150 |
| R&D Systems | 320-EO-100/CF | Recombinant Human CCL11/Eotaxin, CF (100 UG) | 100 UG | 10390 |
| R&D Systems | 320-EO-020/CF | Recombinant Human CCL11/Eotaxin, CF (20 UG) | 20 UG | 4150 |
| R&D Systems | 3200-KS-010 | Recombinant Human Active SGK1 (60-end), CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 3206-KS-010 | Recombinant Human Active Lyn B, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 3209-BP-010 | Recombinant Human BMP-9 (10 UG) | 10 UG | 5320 |
| R&D Systems | 3209-BP-010/CF | Recombinant Human BMP-9, CF (10 UG) | 10 UG | 5320 |
| R&D Systems | 321-FL-050 | Recombinant Human VEGF R1/Flt-1 Fc Chimera (50 UG) | 50 UG | 4670 |
| R&D Systems | 321-FL-050/CF | Recombinant Human VEGF R1/Flt-1 Fc Chimera, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 3210-C-025 | Recombinant Mouse CCL6/C10 (Truncated, aa 42-116) (25 UG) | 25 UG | 4280 |
| R&D Systems | 3210-C-025/CF | Recombinant Mouse CCL6/C10 (Truncated, aa 42-116), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 32100-1 | Mouse IFN-alpha Polyclonal Ab (20000 UN) | 20000 UN | 4950 |
| R&D Systems | 3214-EG-100 | Recombinant Rat EGF (100 UG) | 100 UG | 2850 |
| R&D Systems | 3214-EG-100/CF | Recombinant Rat EGF, CF (100 UG) | 100 UG | 2850 |
| R&D Systems | 3215-MF-050 | Recombinant Mouse CX3CL1/Fractalkine (aa 29-102), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3216-RL-025 | Recombinant Rhesus Macaque IL-12 (25 UG) | 25 UG | 4670 |
| R&D Systems | 3216-RL-025/CF | Recombinant Rhesus Macaque IL-12, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 3217-MG-025 | Recombinant Mouse CCL9/10/MIP-1 gamma (Truncated) (25 UG) | 25 UG | 4280 |
| R&D Systems | 3217-MG-025/CF | Recombinant Mouse CCL9/10/MIP-1 gamma (Truncated), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3218-ND-025 | Recombinant Human Nodal (25 UG) | 25 UG | 4280 |
| R&D Systems | 3218-ND-025/CF | Recombinant Human Nodal, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 322-PR-050 | Recombinant Human PDGF R alpha (50 UG) | 50 UG | 4670 |
| R&D Systems | 322-PR-050/CF | Recombinant Human PDGF R alpha, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 3220-ZN-010 | Recombinant Human Meprin alpha Subunit/MEP1A, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3225-FN-100 | Recombinant Human Fibronectin Fragment 2, CF (100 UG) | 100 UG | 2850 |
| R&D Systems | 3229-BM-010 | Recombinant Human BMP-2/BMP-7 Heterodimer (10 UG) | 10 UG | 4930 |
| R&D Systems | 3229-BM-010/CF | Recombinant Human BMP-2/BMP-7 Heterodimer, CF (10 UG) | 10 UG | 4930 |
| R&D Systems | 3230-A5-050 | Recombinant Human Integrin alpha 5 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3234-MN-050 | Recombinant Mouse Matrilin-2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 3234-MN-050/CF | Recombinant Mouse Matrilin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3235-NF-050 | Recombinant Rat Neurofascin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3236-N4-005 | Recombinant Mouse NT-4 (5 UG) | 5 UG | 2980 |
| R&D Systems | 3236-N4-005/CF | Recombinant Mouse NT-4, CF (5 UG) | 5 UG | 2980 |
| R&D Systems | 3237-S3-025 | Recombinant Mouse Semaphorin 3F Fc Chimera (Truncated), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3238-S3-025 | Recombinant Mouse Semaphorin 3E Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 324-HC-010 | Recombinant Human CCL14a/HCC-1 (10 UG) | 10 UG | 2720 |
| R&D Systems | 324-HC-050 | Recombinant Human CCL14a/HCC-1 (50 UG) | 50 UG | 5190 |
| R&D Systems | 324-HC-010/CF | Recombinant Human CCL14a/HCC-1, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 324-HC-050/CF | Recombinant Human CCL14a/HCC-1, CF (50 UG) | 50 UG | 5190 |
| R&D Systems | 32400-1 | Mouse IFN-beta Polyclonal Ab (20000 UN) | 20000 UN | 4760 |
| R&D Systems | 32401-1 | Mouse IFN-beta Polyclonal Ab (20000 UN) | 20000 UN | 5360 |
| R&D Systems | 3244-PL-050 | Recombinant Mouse Podoplanin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3245-MP-010 | Recombinant Rat MMP-8, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3246-PI-010 | Recombinant Human Latexin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 325-CT-200 | Recombinant Human CTLA-4 Fc Chimera (200 UG) | 200 UG | 4800 |
| R&D Systems | 325-CT-200/CF | Recombinant Human CTLA-4 Fc Chimera, CF (200 UG) | 200 UG | 4800 |
| R&D Systems | 3256-LM-050 | Recombinant Human CD300c/LMIR2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3257-RN-025 | Recombinant Human Relaxin-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 3257-RN-025/CF | Recombinant Human Relaxin-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3258-SL-050 | Recombinant Human Siglec-11 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3259-TL-050 | Recombinant Human TREML2/TLT-2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 326-FS-050 | Recombinant Human Fas/TNFRSF6/CD95 Fc Chimera (50 UG) | 50 UG | 4620 |
| R&D Systems | 326-FS-050/CF | Recombinant Human Fas/TNFRSF6/CD95 Fc Chimera, CF (50 UG) | 50 UG | 4620 |
| R&D Systems | 3264-CA-050 | Recombinant Human Cadherin-13 (CAD-13), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3265-MS-050 | Recombinant Human Mesothelin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3266-RS-025 | Recombinant Human R-Spondin 2 (25 UG) | 25 UG | 4280 |
| R&D Systems | 3266-RS-025/CF | Recombinant Human R-Spondin 2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 327-P4-025 | Recombinant Human CCL13/MCP-4 (25 UG) | 25 UG | 3760 |
| R&D Systems | 327-P4-025/CF | Recombinant Human CCL13/MCP-4, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 329-MR-100 | Recombinant Human M-CSF R/CD115 Fc Chimera (100 UG) | 100 UG | 4670 |
| R&D Systems | 329-MR-100/CF | Recombinant Human M-CSF R/CD115 Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 3300-ZN-010 | Recombinant Mouse Meprin beta Subunit/MEP1B, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3305-SE-010 | Recombinant Mouse Coagulation Factor VII, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3308-AD-050 | Recombinant Mouse Osteoadherin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3315-DL-050 | Recombinant Human DSCAM-L1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 332-SR-050/CF | Recombinant Human CD117/c-kit, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 3326-SR-050 | Recombinant Human SorCS3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3327-CD-050 | Recombinant Mouse CD48/SLAMF2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3328-L3-050 | Recombinant Mouse LAG-3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 333-GC-025 | Recombinant Human CXCL6/GCP-2 (25 UG) | 25 UG | 4150 |
| R&D Systems | 333-GC-025/CF | Recombinant Human CXCL6/GCP-2, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3336-CX-050 | Recombinant Human CXADR Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3339-FB-025 | Recombinant Rat FGF basic (25 UG) | 25 UG | 3370 |
| R&D Systems | 3339-FB-025/CF | Recombinant Rat FGF basic, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 334-TK-025 | Recombinant Human CCL25/TECK (25 UG) | 25 UG | 4750 |
| R&D Systems | 334-TK-025/CF | Recombinant Human CCL25/TECK, CF (25 UG) | 25 UG | 4750 |
| R&D Systems | 3340-EL-010 | Recombinant Equine IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3760 |
| R&D Systems | 3340-EL-010/CF | Recombinant Equine IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 33400-1 | Rat IFN-beta Polyclonal Ab (500 UG) | 500 UG | 4260 |
| R&D Systems | 3344-GMP-01M | Recombinant Human Noggin Fc Chimera GMP, CF (1 MG) | 1 MG | 63510 |
| R&D Systems | 3344-GMP-050 | Recombinant Human Noggin Fc Chimera GMP, CF (50 UG) | 50 UG | 4750 |
| R&D Systems | 3344-NG-500 | Recombinant Human Noggin Fc Chimera, CF (500 UG) | 500 UG | 32500 |
| R&D Systems | 3344-NG-050 | Recombinant Human Noggin Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 3345-PS-050 | Recombinant Human PSGL-1/CD162 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3349-SE-010 | Recombinant Human Coagulation Factor XIV/Protein C, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 335-RM-025 | Recombinant Human CCL5/Met-RANTES (25 UG) | 25 UG | 4490 |
| R&D Systems | 335-RM-025/CF | Recombinant Human CCL5/Met-RANTES, CF (25 UG) | 25 UG | 4490 |
| R&D Systems | 3355-CD-050 | Recombinant Mouse CD200 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3356-CC-025 | Recombinant Mouse COCO (25 UG) | 25 UG | 4280 |
| R&D Systems | 3356-CC-025/CF | Recombinant Mouse COCO, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3357-MN-050 | Recombinant Mouse Matrilin-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3358-TC-050 | Recombinant Human Tenascin C, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 336-MD-025 | Recombinant Human CCL22/MDC (25 UG) | 25 UG | 4540 |
| R&D Systems | 336-MD-025/CF | Recombinant Human CCL22/MDC, CF (25 UG) | 25 UG | 4540 |
| R&D Systems | 3365-ST-020 | Recombinant Human CHST15, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 3378-LC-050 | Recombinant Human RBP4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 338-AC-010 | Recombinant Human/Mouse/Rat Activin A (10 UG) | 10 UG | 3370 |
| R&D Systems | 338-AC-01M | Recombinant Human/Mouse/Rat Activin A (1 MG) | 1 MG | 85800 |
| R&D Systems | 338-AC-050 | Recombinant Human/Mouse/Rat Activin A (50 UG) | 50 UG | 9480 |
| R&D Systems | 338-AC-010/CF | Recombinant Human/Mouse/Rat Activin A, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 338-AC-01M/CF | Recombinant Human/Mouse/Rat Activin A, CF (1 MG) | 1 MG | 85800 |
| R&D Systems | 338-AC-050/CF | Recombinant Human/Mouse/Rat Activin A, CF (50 UG) | 50 UG | 9480 |
| R&D Systems | 338-GMP-010 | Recombinant Human/Mouse/Rat Activin A GMP, CF (10 UG) | 10 UG | 3840 |
| R&D Systems | 338-GMP-01M | Recombinant Human/Mouse/Rat Activin A GMP, CF (1 MG) | 1 MG | 98800 |
| R&D Systems | 338-GMP-050 | Recombinant Human/Mouse/Rat Activin A GMP, CF (50 UG) | 50 UG | 10860 |
| R&D Systems | 3380-MN-050 | Recombinant Mouse Matrilin-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3384-B6-200 | Recombinant Human EphB6 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 3385-ND-050 | Recombinant Human Nidogen-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3386-HG-025 | Recombinant Canine HGF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3386-HG-025/CF | Recombinant Canine HGF, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3387-PC-050 | Recombinant Porcine CD31/PECAM-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3388-OX-050 | Recombinant Human OX40/TNFRSF4 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 3389-KS-010 | Recombinant Viral RSV Active Src, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 339-RB-100 | Recombinant Human Activin RIIB Fc Chimera (NS0-expressed) (100 UG) | 100 UG | 4410 |
| R&D Systems | 339-RB-100/CF | Recombinant Human Activin RIIB Fc Chimera (NS0), CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 339-RBB-100 | Recombinant Human Activin RIIB Fc Chimera (Sf 21), CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 340-R2-100 | Recombinant Human Activin RIIA Fc Chimera (100 UG) | 100 UG | 4280 |
| R&D Systems | 340-R2-100/CF | Recombinant Human Activin RIIA Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 340-RC2-100 | Recombinant Human Activin RIIA Fc Chimera (CHO), CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3400-010-01 | Cultrex Mouse Laminin I (1 MG) | 1 MG | 1570 |
| R&D Systems | 3409-BG-050 | Recombinant Human beta IG-H3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 341-BR-050 | Recombinant Human TGF-beta RII Fc Chimera, CF (50 UG) | 50 UG | 5580 |
| R&D Systems | 3410-010-01 | Cultrex Mouse Collagen IV (1 MG) | 1 MG | 1420 |
| R&D Systems | 3410-UR-050 | Recombinant Human URB, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3414-CD-050 | Recombinant Human CD200 R1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 342-CD-200 | Recombinant Human CD28 Fc Chimera, CF (200 UG) | 200 UG | 4930 |
| R&D Systems | 343-E2-025 | Recombinant Human CCL24/Eotaxin-2/MPIF-2 (25 UG) | 25 UG | 4670 |
| R&D Systems | 343-E2-025/CF | Recombinant Human CCL24/Eotaxin-2/MPIF-2, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 3430-PR-050 | Recombinant Human PTPR sigma, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3432-001-01 | Cultrex PathClear Basement Membrane Extract (1 ML) | 1 ML | 480 |
| R&D Systems | 3432-005-01 | Cultrex PathClear Basement Membrane Extract (5 ML) | 5 ML | 2170 |
| R&D Systems | 3432-005-01P | Cultrex PathClear Basement Membrane Extract with Phenol Red (5 ML) | 5 ML | 2170 |
| R&D Systems | 3432-010-01 | Cultrex PathClear Basement Membrane Extract (2 x 5 mL) (10 ML) | 10 ML | 3070 |
| R&D Systems | 3432-010-01P | Cultrex PathClear BME with Phenol Red (2 x 5 mL) (10 ML) | 10 ML | 3070 |
| R&D Systems | 3433-001-01 | Cultrex PathClear Reduced Growth Factor BME (1 ML) | 1 ML | 480 |
| R&D Systems | 3433-005-01 | Cultrex PathClear Reduced Growth Factor BME (5 ML) | 5 ML | 2460 |
| R&D Systems | 3433-005-01P | Cultrex PathClear Reduced Growth Factor BME with Phenol Red (5 ML) | 5 ML | 2460 |
| R&D Systems | 3433-010-01 | Cultrex PathClear Reduced Growth Factor BME (2 x 5 mL) (10 ML) | 10 ML | 3750 |
| R&D Systems | 3433-010-01P | Cultrex PathClear RGF BME with Phenol Red (2 x 5 mL) (10 ML) | 10 ML | 3750 |
| R&D Systems | 3434-001-02 | Cultrex PathClear Stem Cell Qualified BME, Reduced GF (1 ML) | 1 ML | 570 |
| R&D Systems | 3434-005-02 | Cultrex PathClear Stem Cell Qualified BME, Reduced GF (5 ML) | 5 ML | 2870 |
| R&D Systems | 3436-SE-010 | Recombinant Mouse DPP7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3437-ZN-010 | Recombinant Mouse ACE-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3438-100-01 | Cultrex Poly-L-Lysine (100 ML) | 100 ML | 1300 |
| R&D Systems | 3438-200-01 | Cultrex Poly-L-Lysine (2 x 100 mL) (200 ML) | 200 ML | 1910 |
| R&D Systems | 3438-SE-010 | Recombinant Human DPPII/QPP/DPP7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3439-100-01 | Cultrex Poly-D-Lysine (100 ML) | 100 ML | 1300 |
| R&D Systems | 3439-200-01 | Cultrex Poly-D-Lysine (2 x 100 mL) (200 ML) | 200 ML | 1910 |
| R&D Systems | 3439-ZN-010 | Recombinant Human THOP1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 344-ER-050 | Recombinant Human EGF R/ErbB1 Fc Chimera, CF (50 UG) | 50 UG | 4230 |
| R&D Systems | 3440-100-01 | Cultrex Rat Collagen I (100 MG) | 100 MG | 2050 |
| R&D Systems | 3442-050-01 | Cultrex Bovine Collagen I (50 MG) | 50 MG | 2120 |
| R&D Systems | 3443-003-01 | Cultrex Rat Collagen I, Lower Viscosity (3 MG) | 3 MG | 480 |
| R&D Systems | 3443-100-01 | Cultrex Rat Collagen I, Lower Viscosity (100 MG) | 100 MG | 2050 |
| R&D Systems | 3445-001-01 | Cultrex PathClear 3-D Culture Matrix RGF BME (1 ML) | 1 ML | 680 |
| R&D Systems | 3445-005-01 | Cultrex PathClear 3-D Culture Matrix RGF BME (5 ML) | 5 ML | 2930 |
| R&D Systems | 3445-010-01 | Cultrex PathClear 3-D Culture Matrix RGF BME (2 x 5 mL) (10 ML) | 10 ML | 4500 |
| R&D Systems | 3446-005-01 | Cultrex 3D Culture Matrix Laminin I (30 MG) | 30 MG | 9420 |
| R&D Systems | 3447-020-01 | Cultrex 3D Culture Matrix Rat Collagen I (100 MG) | 100 MG | 2250 |
| R&D Systems | 3449-AM-050 | Recombinant Human AMICA Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 345-FG-025 | Recombinant Human FGF-10 (25 UG) | 25 UG | 3370 |
| R&D Systems | 345-FG-025/CF | Recombinant Human FGF-10, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 3450-048-IK | Directed In Vivo Angiogenesis Assay Inhibition Kit (1 KT) | 1 KT | 8630 |
| R&D Systems | 3450-048-K | Directed In Vivo Angiogenesis Assay (1 KT) | 1 KT | 8260 |
| R&D Systems | 3450-048-SK | Directed In Vivo Angiogenesis Assay Starter Kit (1 KT) | 1 KT | 9530 |
| R&D Systems | 3455-096-K | Cultrex BME Cell Invasion Assay, 96 well (1 KT) | 1 KT | 4780 |
| R&D Systems | 3456-096-K | Cultrex Laminin I Cell Invasion Assay, 96 well (1 KT) | 1 KT | 4640 |
| R&D Systems | 3457-024-K | Cultrex Collagen I Cell Invasion Assay, 24 well (1 KT) | 1 KT | 5050 |
| R&D Systems | 3457-096-K | Cultrex Collagen I Cell Invasion Assay, 96 well (1 KT) | 1 KT | 4640 |
| R&D Systems | 3457-SR-050 | Recombinant Human SorCS1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3458-096-K | Cultrex Collagen IV Cell Invasion Assay, 96 well (1 KT) | 1 KT | 4640 |
| R&D Systems | 3459-FZ-050 | Recombinant Human Frizzled-10 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 346-E3-025 | Recombinant Human CCL26/Eotaxin-3 (aa 24-94) (25 UG) | 25 UG | 4490 |
| R&D Systems | 346-E3-025/CF | Recombinant Human CCL26/Eotaxin-3 (aa 24-94), CF (25 UG) | 25 UG | 4490 |
| R&D Systems | 3465-024-K | Cultrex Cell Migration Assay, 24 well (1 KT) | 1 KT | 4300 |
| R&D Systems | 3465-096-K | Cultrex Cell Migration Assay, 96 well (1 KT) | 1 KT | 4440 |
| R&D Systems | 3466-PI-010 | Recombinant Human APP/Protease Nexin II, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3467-MP-010 | Recombinant Mouse MMP-12, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3468-LE-050 | Recombinant Human LEDGF, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 347-DR-100 | Recombinant Human TRAIL R1/TNFRSF10A Fc Chimera (100 UG) | 100 UG | 4540 |
| R&D Systems | 347-DR-100/CF | Recombinant Human TRAIL R1/TNFRSF10A Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 3470-096-K | Cultrex In Vitro Angiogenesis Assay (Tube Formation) 96 well (1 KT) | 1 KT | 3600 |
| R&D Systems | 3471-096-K | Cultrex In Vitro Angiogenesis Assay (EC Invasion), 96 well (1 KT) | 1 KT | 5110 |
| R&D Systems | 3474-RS-050 | Recombinant Mouse R-Spondin 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3475-MN-025 | Recombinant Mouse Meteorin (25 UG) | 25 UG | 4280 |
| R&D Systems | 3475-MN-025/CF | Recombinant Mouse Meteorin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3476-LC-050 | Recombinant Mouse RBP4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 348-RB-050 | Recombinant Human ErbB3/Her3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 3481-096-K | CultreCoat Low BME Cell Invasion Assay, 96 well (1 KT) | 1 KT | 6480 |
| R&D Systems | 3482-096-K | CultreCoat Medium BME Cell Invasion Assay, 96 well (1 KT) | 1 KT | 6480 |
| R&D Systems | 3483-096-K | CultreCoat High BME Cell Invasion Assay, 96 well (1 KT) | 1 KT | 6480 |
| R&D Systems | 3484-096-K | CultreCoat BME Cell Invasion Optimization Assay, 96 well (1 KT) | 1 KT | 6480 |
| R&D Systems | 3485-AN-050 | Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 349-F4-050 | Recombinant Human VEGF R3/Flt-4 Fc Chimera, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 3495-LR-050 | Recombinant Human LRIG3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3497-NR-025 | Recombinant Mouse Norrin (25 UG) | 25 UG | 4280 |
| R&D Systems | 3497-NR-025/CF | Recombinant Mouse Norrin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 350-NS-010 | Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1 alpha (10 UG) | 10 UG | 2980 |
| R&D Systems | 350-NS-050 | Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1 alpha (50 UG) | 50 UG | 9090 |
| R&D Systems | 350-NS-010/CF | Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1a, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 350-NS-050/CF | Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1a, CF (50 UG) | 50 UG | 9090 |
| R&D Systems | 3500-096-K | Cultrex 3D BME Cell Invasion Assay, 96 well (1 KT) | 1 KT | 4030 |
| R&D Systems | 3500-RS-025 | Recombinant Human R-Spondin 3 (25 UG) | 25 UG | 4150 |
| R&D Systems | 3500-RS-025/CF | Recombinant Human R-Spondin 3, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3505-CD-050 | Recombinant Human CD177, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3508-LC-050 | Recombinant Rat Lipocalin-2/NGAL, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 351-FS-010 | Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93) (10 UG) | 10 UG | 2980 |
| R&D Systems | 351-FS-050 | Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93) (50 UG) | 50 UG | 6490 |
| R&D Systems | 351-FS-010/CF | Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93), CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 351-FS-050/CF | Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93), CF (50 UG) | 50 UG | 6490 |
| R&D Systems | 3510-096-K | Cultrex 3D Spheroid Fluorometric Assay, 96 well (1 KT) | 1 KT | 4030 |
| R&D Systems | 3511-096-K | Cultrex 3D Spheroid Colorimetric Assay, 96 well (1 KT) | 1 KT | 4030 |
| R&D Systems | 3514-2B-050 | Recombinant Mouse 2B4/CD244/SLAMF4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3515-NG-050 | Recombinant Human Nogo-A (aa 566-748) Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 3516-FL-050 | Recombinant Human VEGF R1/Flt-1 (aa 27-328) Fc Chimera, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 3519-S4-050 | Recombinant Human IGSF4A/SynCAM1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 352-MCH-010 | Recombinant Human MSP/MST1 (CHO-expressed), CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 352-MS-010 | Recombinant Human MSP/MST1 (10 UG) | 10 UG | 3760 |
| R&D Systems | 352-MS-050 | Recombinant Human MSP/MST1 (50 UG) | 50 UG | 11300 |
| R&D Systems | 352-MS-010/CF | Recombinant Human MSP/MST1, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 352-MS-050/CF | Recombinant Human MSP/MST1, CF (50 UG) | 50 UG | 11300 |
| R&D Systems | 3520-AR-050 | Recombinant Human Apolipoprotein E R2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3525-PR-050 | Recombinant Mouse PILR-beta, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3532-001-02 | Cultrex PathClear BME, Type 2 (1 ML) | 1 ML | 480 |
| R&D Systems | 3532-005-02 | Cultrex PathClear BME, Type 2 (5 ML) | 5 ML | 2050 |
| R&D Systems | 3532-005-02P | Cultrex PathClear BME, Type 2 (w/ Phenol Red) (5 ML) | 5 ML | 2050 |
| R&D Systems | 3532-010-02 | Cultrex PathClear BME, Type 2 (2 x 5 mL) (10 ML) | 10 ML | 3070 |
| R&D Systems | 3532-010-02P | Cultrex PathClear BME, Type 2 (w/ Phenol Red) (2 x 5 mL) (10 ML) | 10 ML | 3070 |
| R&D Systems | 3533-001-02 | Cultrex PathClear Reduced Growth Factor BME, Type 2 (1 ML) | 1 ML | 480 |
| R&D Systems | 3533-005-02 | Cultrex PathClear Reduced Growth Factor BME, Type 2 (5 ML) | 5 ML | 2460 |
| R&D Systems | 3533-005-02P | Cultrex PathClear Reduced Growth Factor BME (w/ Phenol Red) (5 ML) | 5 ML | 2460 |
| R&D Systems | 3533-010-02 | Cultrex PathClear Reduced Growth Factor BME (2 x 5 mL) (10 ML) | 10 ML | 3750 |
| R&D Systems | 3533-010-02P | Cultrex PathClear Reduced GF BME (w/ Phenol Red) (2 x 5 mL) (10 ML) | 10 ML | 3750 |
| R&D Systems | 3535-GA-050 | Recombinant Mouse Galectin-9, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3537-ZN-010 | Recombinant Human Methionine Aminopeptidase 1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3539-SD-050 | Recombinant Human Syndecan-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 354-BP-010 | Recombinant Human BMP-7 (10 UG) | 10 UG | 5270 |
| R&D Systems | 354-BP-010/CF | Recombinant Human BMP-7, CF (10 UG) | 10 UG | 5270 |
| R&D Systems | 354-BP-500/CF | Recombinant Human BMP-7, CF (500 UG) | 500 UG | 50570 |
| R&D Systems | 354-GMP-010 | Recombinant Human BMP-7 GMP, CF (10 UG) | 10 UG | 6050 |
| R&D Systems | 354-GMP-01M | Recombinant Human BMP-7 GMP, CF (1 MG) | 1 MG | 98800 |
| R&D Systems | 3546-TC-050 | Recombinant Mouse TCAM-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3548-F2-050 | Recombinant Human Periostin/OSF-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 355-BEC-010 | Recombinant Human/Mouse/Rat BMP-2 (E. coli-expressed) (10 UG) | 10 UG | 2720 |
| R&D Systems | 355-BEC-010/CF | Recombinant Human/Mouse/Rat BMP-2 (E. coli-expressed), CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 355-BM-010 | Recombinant Human/Mouse/Rat BMP-2 (10 UG) | 10 UG | 4750 |
| R&D Systems | 355-BM-050 | Recombinant Human/Mouse/Rat BMP-2 (50 UG) | 50 UG | 12470 |
| R&D Systems | 355-BM-010/CF | Recombinant Human/Mouse/Rat BMP-2, CF (10 UG) | 10 UG | 4750 |
| R&D Systems | 355-BM-500/CF | Recombinant Human/Mouse/Rat BMP-2, CF (500 UG) | 500 UG | 50570 |
| R&D Systems | 355-BM-050/CF | Recombinant Human/Mouse/Rat BMP-2, CF (50 UG) | 50 UG | 12470 |
| R&D Systems | 355-GMP-010 | Recombinant Human BMP-2 GMP, CF (10 UG) | 10 UG | 5460 |
| R&D Systems | 355-GMP-01M | Recombinant Human BMP-2 GMP, CF (1 MG) | 1 MG | 98800 |
| R&D Systems | 355-GMP-050 | Recombinant Human BMP-2 GMP, CF (50 UG) | 50 UG | 14300 |
| R&D Systems | 3555-CR-050 | Recombinant Human CRELD2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3557-AH-010 | Recombinant Human ASAH2, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3558-AH-010 | Recombinant Mouse ASAH2, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3559-GH-010 | Recombinant Human Chitotriosidase/CHIT1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 356-HV-100 | Recombinant Human HVEM/TNFRSF14 Fc Chimera (100 UG) | 100 UG | 4540 |
| R&D Systems | 356-HV-100/CF | Recombinant Human HVEM/TNFRSF14 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 3560-ZN-010 | Recombinant Human CNDP2/CPGL, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3564-DC-010 | Recombinant Human Dopa Decarboxylase/DDC, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3565-SE-010 | Recombinant Mouse Trypsin 3/PRSS3, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 357-KD-050 | Recombinant Human VEGF R2/KDR Fc Chimera (50 UG) | 50 UG | 4410 |
| R&D Systems | 357-KD-050/CF | Recombinant Human VEGF R2/KDR Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 3575-KS-010 | Recombinant Human Active ASK1 (aa 649-946), CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 358-MT-100 | Recombinant Human HGF R/c-MET Fc Chimera (100 UG) | 100 UG | 4540 |
| R&D Systems | 358-MT-100/CF | Recombinant Human HGF R/c-MET Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 3586-SE-010 | Recombinant Human Trypsin 2/PRSS2, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3587-ZN-010 | Recombinant Human Carboxypeptidase E/CPE, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3589-CA-100 | Recombinant Human Cyclophilin A, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 359-EA-200 | Recombinant Human Ephrin-A3 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 3590-CD-050 | Recombinant Human CD74, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3596-RN-025 | Recombinant Human Relaxin-2 (B-33/A-24) (25 UG) | 25 UG | 4150 |
| R&D Systems | 3596-RN-025/CF | Recombinant Human Relaxin-2 (B-33/A-24), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3597-RG-050 | Recombinant Mouse RGM-B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 360-MP-025 | Recombinant Human CCL20/MIP-3 alpha (25 UG) | 25 UG | 4150 |
| R&D Systems | 360-MP-025/CF | Recombinant Human CCL20/MIP-3 alpha, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3609-GT-010 | Recombinant Human B4GALT1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 361-MI-025 | Recombinant Human CCL19/MIP-3 beta (25 UG) | 25 UG | 4150 |
| R&D Systems | 361-MI-025/CF | Recombinant Human CCL19/MIP-3 beta, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 362-CX-025 | Recombinant Human CX3CL1/Fractalkine (Chemokine Domain) (25 UG) | 25 UG | 4280 |
| R&D Systems | 362-CX-025/CF | Recombinant Human CX3CL1/Fractalkine (Chemokine Domain), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3620-PI-010 | Recombinant Mouse Latexin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3624-FN-050 | Recombinant Human Fibronectin Fragment 4, CF (50 UG) | 50 UG | 2850 |
| R&D Systems | 3625-IL-010 | Recombinant Human IL-33 (10 UG) | 10 UG | 4280 |
| R&D Systems | 3625-IL-010/CF | Recombinant Human IL-33, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3626-ML-010 | Recombinant Mouse IL-33 (10 UG) | 10 UG | 4150 |
| R&D Systems | 3626-ML-010/CF | Recombinant Mouse IL-33, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 3627-GP-050 | Recombinant Human GPVI, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3628-PC-050 | Recombinant Mouse CD31/PECAM-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 363-MG-025 | Recombinant Human CCL15/MIP-1 delta/LKN-1 (92 aa) (25 UG) | 25 UG | 4150 |
| R&D Systems | 363-MG-025/CF | Recombinant Human CCL15/MIP-1 delta/LKN-1 (92 aa), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3630-RG-050 | Recombinant Human RGM-B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3632-001-02 | Cultrex PathClear BME, Type 3 (1 ML) | 1 ML | 480 |
| R&D Systems | 3632-005-02 | Cultrex PathClear BME, Type 3 (5 ML) | 5 ML | 2050 |
| R&D Systems | 3632-005-02P | Cultrex PathClear BME, Type 3 (w/ Phenol Red) (5 ML) | 5 ML | 2050 |
| R&D Systems | 3632-010-02 | Cultrex PathClear BME, Type 3 (2 x 5 mL) (10 ML) | 10 ML | 3070 |
| R&D Systems | 3632-010-02P | Cultrex PathClear BME, Type 3 (w/ Phenol Red) (2 x 5 mL) (10 ML) | 10 ML | 3070 |
| R&D Systems | 3634-RG-050 | Recombinant Mouse RGM-C/Hemojuvelin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3636-CM-050 | Recombinant Mouse CMG-2 (50 UG) | 50 UG | 4280 |
| R&D Systems | 3636-CM-050/CF | Recombinant Mouse CMG-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 364-DN-025 | Recombinant Human CCL17/TARC (25 UG) | 25 UG | 4150 |
| R&D Systems | 364-DN-025/CF | Recombinant Human CCL17/TARC, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3644-CD-050 | Recombinant Human CD48/SLAMF2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3645-S2-025 | Recombinant Human Stabilin-2 (aa 2198-2295) (25 UG) | 25 UG | 4280 |
| R&D Systems | 3645-S2-025/CF | Recombinant Human Stabilin-2 (aa 2198-2295), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3646-DN-050 | Recombinant Human DNER Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3647-TK-050 | Recombinant Human Notch-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 365-FR-025 | Recombinant Human CX3CL1/Fractalkine (Full Length) (25 UG) | 25 UG | 4280 |
| R&D Systems | 365-FR-025/CF | Recombinant Human CX3CL1/Fractalkine (Full Length), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 366-6C-025 | Recombinant Human CCL21/6Ckine (25 UG) | 25 UG | 4150 |
| R&D Systems | 366-6C-025/CF | Recombinant Human CCL21/6Ckine, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3660-CD-050 | Recombinant Human CD44 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3664-AP-050 | Recombinant Human Apolipoprotein A-I, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 3666-DS-050 | Recombinant Human DSCAM, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3667-MP-250 | Recombinant Mouse Myeloperoxidase, CF (250 UG) | 250 UG | 2590 |
| R&D Systems | 3669-WN-025 | Recombinant Mouse Wnt-9b (25 UG) | 25 UG | 4800 |
| R&D Systems | 3669-WN-025/CF | Recombinant Mouse Wnt-9b, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 367-NR-050 | Recombinant Human NGF R/TNFRSF16 Fc Chimera (50 UG) | 50 UG | 4280 |
| R&D Systems | 367-NR-050/CF | Recombinant Human NGF R/TNFRSF16 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3670-PL-050 | Recombinant Human Podoplanin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3677-C3-025 | Recombinant Human Complement Component C3a, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 3678-S4-050 | Recombinant Human IGSF4B/SynCAM3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 368-ST-050 | Recombinant Human Flt-3/Flk-2 Fc Chimera (50 UG) | 50 UG | 4410 |
| R&D Systems | 368-ST-050/CF | Recombinant Human Flt-3/Flk-2 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 3686-CR-050 | Recombinant Mouse CRELD2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3687-CR-050 | Recombinant Mouse CRTAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3688-LR-050 | Recombinant Mouse LRIG1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3689-TM-050 | Recombinant Rat TIM-1/KIM-1/HAVCR, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 369-EA-200 | Recombinant Human Ephrin-A4 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 370-AL-100 | Recombinant Human ALK-1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3704-KS-010 | Recombinant Human Active Lck, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 3705-KS-010 | Recombinant Human Active MAPKAPK2 (46-end), CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 3706-KS-010 | Recombinant Human Active NEK2, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 3709-KS-010 | Recombinant Human Active ZAP70, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 371-MP-025 | Recombinant Human CCL23/MPIF-1 (25 UG) | 25 UG | 4150 |
| R&D Systems | 371-MP-025/CF | Recombinant Human CCL23/MPIF-1, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3710-SE-010 | Recombinant Human Trypsin 3/PRSS3, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3714-SE-010 | Recombinant Human Active Trypsin 3/PRSS3, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3715-SE-010 | Recombinant Human FAP, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3718-FB-01M | Recombinant Human FGF basic (145 aa), CF (1 MG) | 1 MG | 16970 |
| R&D Systems | 3718-GMP-01M | Recombinant Human FGF basic GMP, CF (1 MG) | 1 MG | 19500 |
| R&D Systems | 3718-GMP-025 | Recombinant Human FGF basic GMP, CF (25 UG) | 25 UG | 2600 |
| R&D Systems | 372-RI-050 | Recombinant Human TNF RI/TNFRSF1A Fc Chimera (50 UG) | 50 UG | 4150 |
| R&D Systems | 372-RI-050/CF | Recombinant Human TNF RI/TNFRSF1A Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 3720-RG-050 | Recombinant Human RGM-C/Hemojuvelin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3724-NR-050 | Recombinant Mouse CXADR/CAR Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3725-RB-050 | Recombinant Mouse Activin RIIB Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 3726-AG-100 | Recombinant Human AgRP C-Terminal Fragment, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3727-BP-010 | Recombinant Human BMP-4/BMP-7 Heterodimer (10 UG) | 10 UG | 4930 |
| R&D Systems | 3727-BP-010/CF | Recombinant Human BMP-4/BMP-7 Heterodimer, CF (10 UG) | 10 UG | 4930 |
| R&D Systems | 3728-NG-050 | Recombinant Rat Nogo-A Fc Chimera (aa 1026-1090), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3729-SC-025 | Recombinant Mouse SCGF/CLEC11a (25 UG) | 25 UG | 4280 |
| R&D Systems | 3729-SC-025/CF | Recombinant Mouse SCGF/CLEC11a, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 373-TC-050 | Recombinant Human TrkC Fc Chimera (50 UG) | 50 UG | 4280 |
| R&D Systems | 373-TC-050/CF | Recombinant Human TrkC Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3735-NT-050 | Recombinant Human Notch-2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3736-SE-010 | Recombinant Mouse Mast Cell Protease-6/Mcpt6, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 374-EA-200 | Recombinant Human Ephrin-A5 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 3747-CL-025 | Recombinant Canine IL-1 beta/IL-1F2 (25 UG) | 25 UG | 3760 |
| R&D Systems | 3747-CL-025/CF | Recombinant Canine IL-1 beta/IL-1F2, cf (25 UG) | 25 UG | 3760 |
| R&D Systems | 3748-MN-050 | Recombinant Human MANF, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 375-TEC-010 | Recombinant Human TRAIL/TNFSF10 (E. coli-expressed) (10 UG) | 10 UG | 4150 |
| R&D Systems | 375-TEC-010/CF | Recombinant Human TRAIL/TNFSF10 (E. coli-expressed), CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 375-TL-010 | Recombinant Human TRAIL/TNFSF10 (10 UG) | 10 UG | 4150 |
| R&D Systems | 375-TL-010/CF | Recombinant Human TRAIL/TNFSF10, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 376-CT-025 | Recombinant Human CCL27/CTACK (25 UG) | 25 UG | 4670 |
| R&D Systems | 376-CT-025/CF | Recombinant Human CCL27/CTACK, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 377-HB-050 | Recombinant Human NRG1-beta 1/HRG1-beta 1 ECD (50 UG) | 50 UG | 4280 |
| R&D Systems | 377-HB-050/CF | Recombinant Human NRG1-beta 1/HRG1-beta 1 ECD, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3770-AN-050 | Recombinant Human Annexin A1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3776-HM-020 | Recombinant Human HO-1/HMOX1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 3777-FK-100 | Recombinant Human FKBP12, CF (100 UG) | 100 UG | 3370 |
| R&D Systems | 378-SM-025 | Recombinant Human NRG1 Isoform SMDF (25 UG) | 25 UG | 4280 |
| R&D Systems | 378-SM-025/CF | Recombinant Human NRG1 Isoform SMDF, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3780-PS-050 | Recombinant Human PSP94/MSMB, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3795-ZN-020 | Recombinant Human Methionine Aminopeptidase 2, CF (20 UG) | 20 UG | 4410 |
| R&D Systems | 3796-SE-010 | Recombinant Human Tryptase beta-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3804-KS-010 | Recombinant Human Active PLK1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 381-GR-050 | Recombinant Human G-CSF R/CD114 (50 UG) | 50 UG | 4280 |
| R&D Systems | 381-GR-050/CF | Recombinant Human G-CSF R/CD114, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3814-ZN-010 | Recombinant Human Neurolysin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3815-ZN-010 | Recombinant Human Aminopeptidase N/CD13, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3816-CE-010 | Recombinant Canine Erythropoietin (10 UG) | 10 UG | 4280 |
| R&D Systems | 3816-CE-010/CF | Recombinant Canine Erythropoietin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3817-AV-050 | Recombinant Human Integrin alpha V beta 6, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3818-MR-050 | Recombinant Mouse M-CSF R/CD115 Fc Chimera, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 3819-FR-025 | Recombinant Feline CCL5/RANTES (25 UG) | 25 UG | 3630 |
| R&D Systems | 3819-FR-025/CF | Recombinant Feline CCL5/RANTES, CF (25 UG) | 25 UG | 3630 |
| R&D Systems | 382-CD-100 | Recombinant Human CD27/TNFRSF7 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 3820-MR-025 | Recombinant Mouse Reelin (25 UG) | 25 UG | 4280 |
| R&D Systems | 3820-MR-025/CF | Recombinant Mouse Reelin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 3829-AN-050 | Recombinant Human Angiopoietin-like 3, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 383-CD-050 | Recombinant Human CD14 (50 UG) | 50 UG | 4150 |
| R&D Systems | 383-CD-050/CF | Recombinant Human CD14, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 3830-ZN-010 | Recombinant Human Aminopeptidase LRAP/ERAP2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3837-A4-050 | Recombinant Mouse Laminin alpha 4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 384-RG-050 | Recombinant Human Common gamma Chain (50 UG) | 50 UG | 4670 |
| R&D Systems | 384-RG-050/CF | Recombinant Human Common gamma Chain, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 3845-F5-050 | Recombinant Human Complement Factor H-related 5/CFHR5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3848-SE-010 | Recombinant Human Trypsin 1/PRSS1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 385-PR-100 | Recombinant Human PDGF R beta Fc Chimera (100 UG) | 100 UG | 4670 |
| R&D Systems | 385-PR-100/CF | Recombinant Human PDGF R beta Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 3865-TR-050 | Recombinant Human Tenascin R, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3867-FG-025 | Recombinant Human FGF-22 (25 UG) | 25 UG | 3760 |
| R&D Systems | 3867-FG-025/CF | Recombinant Human FGF-22, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 3868-AV-050 | Recombinant Human Integrin alpha L beta 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3869-N2-050 | Recombinant Mouse Nectin-2/CD112, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 387-NE-025 | Recombinant Human Neurturin (Histidine-tagged) (25 UG) | 25 UG | 4150 |
| R&D Systems | 387-NE-025/CF | Recombinant Human Neurturin (Histidine-tagged), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 3870-N1-025 | Recombinant Human Neuropilin-1, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 3874-T2-100 | Recombinant Rat Tie-2 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 3887-PC-050 | Recombinant Human Plexin C1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3888-SE-010 | Recombinant Human Proprotein Convertase 9/PCSK9, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 389-LR-100 | Recombinant Human Leptin R Fc Chimera (100 UG) | 100 UG | 4540 |
| R&D Systems | 389-LR-100/CF | Recombinant Human Leptin R Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 3894-PA-010 | Recombinant Mouse Thrombomodulin/BDCA-3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3899-CD-050 | Recombinant Mouse CD160, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 390-TN-010 | Recombinant Human TRANCE/RANK L/TNFSF11 (10 UG) | 10 UG | 4150 |
| R&D Systems | 390-TN-010/CF | Recombinant Human TRANCE/RANK L/TNFSF11, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 3900-WN-025 | Recombinant Mouse Wnt-2b (25 UG) | 25 UG | 4800 |
| R&D Systems | 3900-WN-025/CF | Recombinant Mouse Wnt-2b, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 3905-CD-050 | Recombinant Mouse CD99 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3907-RG-050 | Recombinant Mouse Reg3A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 391-GR-050 | Recombinant Human IGF-I R, CF (50 UG) | 50 UG | 4800 |
| R&D Systems | 392-MG-010 | Recombinant Human CXCL9/MIG (10 UG) | 10 UG | 3240 |
| R&D Systems | 392-MG-050 | Recombinant Human CXCL9/MIG (50 UG) | 50 UG | 10390 |
| R&D Systems | 392-MG-010/CF | Recombinant Human CXCL9/MIG, CF (10 UG) | 10 UG | 3240 |
| R&D Systems | 392-MG-050/CF | Recombinant Human CXCL9/MIG, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 393-NP-010 | Recombinant Human CXCL7/NAP-2 (10 UG) | 10 UG | 2980 |
| R&D Systems | 393-NP-050 | Recombinant Human CXCL7/NAP-2 (50 UG) | 50 UG | 5190 |
| R&D Systems | 393-NP-010/CF | Recombinant Human CXCL7/NAP-2, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 393-NP-050/CF | Recombinant Human CXCL7/NAP-2, CF (50 UG) | 50 UG | 5190 |
| R&D Systems | 3934-CM-050 | Recombinant Human CEACAM-6/CD66c, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 3937-EC-050 | Recombinant Human ECM-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3938-FN-050 | Recombinant Human Fibronectin Fragment 3, CF (50 UG) | 50 UG | 2850 |
| R&D Systems | 3939-FA-050 | Recombinant Human FCAR/CD89, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 394-PA-010 | Recombinant Human CCL18/PARC (10 UG) | 10 UG | 3890 |
| R&D Systems | 394-PA-050 | Recombinant Human CCL18/PARC (50 UG) | 50 UG | 7140 |
| R&D Systems | 394-PA-010/CF | Recombinant Human CCL18/PARC, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 394-PA-050/CF | Recombinant Human CCL18/PARC, CF (50 UG) | 50 UG | 7140 |
| R&D Systems | 3940-TS-050 | Recombinant Human Tsukushi/TSK, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3944-ED-010 | Recombinant Human EDA-A1/Ectodysplasin A1 (10 UG) | 10 UG | 4280 |
| R&D Systems | 3944-ED-010/CF | Recombinant Human EDA-A1/Ectodysplasin A1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 3946-SE-010 | Recombinant Human Matriptase/ST14 Catalytic Domain, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3947-PA-010 | Recombinant Human Thrombomodulin/BDCA-3, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 3948-AP-010 | Recombinant Human TRACP/PAP/ACP5, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 3956-BP-050 | Recombinant Human BMP-10 Propeptide, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3957-AO-010 | Recombinant Human VAP-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 396-GMP-01M | Recombinant Human NRG1-beta 1/HRG1-beta 1 EGF Domain GMP, CF (1 MG) | 1 MG | 47780 |
| R&D Systems | 396-GMP-050 | Recombinant Human NRG1-beta 1/HRG1-beta 1 EGF Domain GMP, CF (50 UG) | 50 UG | 4750 |
| R&D Systems | 396-HB-050 | Recombinant Human NRG1-beta 1/HRG1-beta 1 EGF Domain (50 UG) | 50 UG | 4280 |
| R&D Systems | 396-HB-050/CF | Recombinant Human NRG1-beta 1/HRG1-beta 1 EGF Domain, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3960-GT-020 | Recombinant Human B3GNT2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 3968-CD-050 | Recombinant Human CD99 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 3970-DL-050 | Recombinant Rat DLL1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 398-LP-01M | Recombinant Human Leptin, CF (1 MG) | 1 MG | 2720 |
| R&D Systems | 398-LP-05M | Recombinant Human Leptin, CF (5 MG) | 5 MG | 6750 |
| R&D Systems | 3986-NT-050 | Recombinant Mouse NTB-A/SLAMF6 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 400-ML-025 | Recombinant Mouse IL-1 alpha/IL-1F1 (25 UG) | 25 UG | 10600 |
| R&D Systems | 400-ML-005 | Recombinant Mouse IL-1 alpha/IL-1F1 (5 UG) | 5 UG | 3370 |
| R&D Systems | 400-ML-025/CF | Recombinant Mouse IL-1 alpha/IL-1F1, CF (25 UG) | 25 UG | 10600 |
| R&D Systems | 400-ML-005/CF | Recombinant Mouse IL-1 alpha/IL-1F1, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 4000-500-EB | E. coli MutY DNA Glycosylase/Buffer (500 UN) | 500 UN | 4350 |
| R&D Systems | 4007-ZN-010 | Recombinant Mouse Meprin alpha Subunit/MEP1A, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 4008-ZN-010 | Recombinant Human Leukotriene A4 Hydrolase/LTA4H, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4009-BC-050 | Recombinant Human Brevican, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 401-ML-025 | Recombinant Mouse IL-1 beta/IL-1F2 (25 UG) | 25 UG | 10600 |
| R&D Systems | 401-ML-005 | Recombinant Mouse IL-1 beta/IL-1F2 (5 UG) | 5 UG | 3370 |
| R&D Systems | 401-ML-025/CF | Recombinant Mouse IL-1 beta/IL-1F2, CF (25 UG) | 25 UG | 10600 |
| R&D Systems | 401-ML-005/CF | Recombinant Mouse IL-1 beta/IL-1F2, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 4010-DK-010 | Recombinant Rat Dkk-1 (10 UG) | 10 UG | 4280 |
| R&D Systems | 4010-DK-010/CF | Recombinant Rat Dkk-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4014-SP-050 | Recombinant Human IBSP/Sialoprotein II, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4015-AB-050 | Recombinant Human IFN-alpha/beta R2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4016-LR-050 | Recombinant Mouse LAIR1, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 4017-TR-025 | Recombinant Canine TNF RI/TNFRSF1A (25 UG) | 25 UG | 4540 |
| R&D Systems | 4017-TR-025/CF | Recombinant Canine TNF RI/TNFRSF1A, CF (25 UG) | 25 UG | 4540 |
| R&D Systems | 402-ML-100 | Recombinant Mouse IL-2 (100 UG) | 100 UG | 8830 |
| R&D Systems | 402-ML-020 | Recombinant Mouse IL-2 (20 UG) | 20 UG | 2850 |
| R&D Systems | 402-ML-500 | Recombinant Mouse IL-2 (500 UG) | 500 UG | 20930 |
| R&D Systems | 402-ML-100/CF | Recombinant Mouse IL-2, CF (100 UG) | 100 UG | 8830 |
| R&D Systems | 402-ML-020/CF | Recombinant Mouse IL-2, CF (20 UG) | 20 UG | 2850 |
| R&D Systems | 402-ML-500/CF | Recombinant Mouse IL-2, CF (500 UG) | 500 UG | 20930 |
| R&D Systems | 403-ML-010 | Recombinant Mouse IL-3 (10 UG) | 10 UG | 3240 |
| R&D Systems | 403-ML-500 | Recombinant Mouse IL-3 (500 UG) | 500 UG | 32500 |
| R&D Systems | 403-ML-050 | Recombinant Mouse IL-3 (50 UG) | 50 UG | 10390 |
| R&D Systems | 403-ML-010/CF | Recombinant Mouse IL-3, CF (10 UG) | 10 UG | 3240 |
| R&D Systems | 403-ML-500/CF | Recombinant Mouse IL-3, CF (500 UG) | 500 UG | 32500 |
| R&D Systems | 403-ML-050/CF | Recombinant Mouse IL-3, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 404-ML-010 | Recombinant Mouse IL-4 (10 UG) | 10 UG | 2720 |
| R&D Systems | 404-ML-050 | Recombinant Mouse IL-4 (50 UG) | 50 UG | 8830 |
| R&D Systems | 404-ML-010/CF | Recombinant Mouse IL-4, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 404-ML-050/CF | Recombinant Mouse IL-4, CF (50 UG) | 50 UG | 8830 |
| R&D Systems | 4040-100-EB | E. coli Fpg/Buffer (500 UN) | 500 UN | 4350 |
| R&D Systems | 4045-01K-EB | E. coli Endonuclease III/Buffer (1000 UN) | 1000 UN | 3900 |
| R&D Systems | 4045-05K-EB | E. coli Endonuclease III/Buffer (5000 UN) | 5000 UN | 9530 |
| R&D Systems | 4047-AM-050 | Recombinant Human Integrin alpha M beta 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 405-ML-025 | Recombinant Mouse IL-5 (25 UG) | 25 UG | 11900 |
| R&D Systems | 405-ML-005 | Recombinant Mouse IL-5 (5 UG) | 5 UG | 3890 |
| R&D Systems | 405-ML-025/CF | Recombinant Mouse IL-5, CF (25 UG) | 25 UG | 11900 |
| R&D Systems | 405-ML-005/CF | Recombinant Mouse IL-5, CF (5 UG) | 5 UG | 3890 |
| R&D Systems | 4055-CR-050 | Recombinant Human Cyr61/CCN1 Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 406-ML-200 | Recombinant Mouse IL-6 (200 UG) | 200 UG | 18190 |
| R&D Systems | 406-ML-025 | Recombinant Mouse IL-6 (25 UG) | 25 UG | 9950 |
| R&D Systems | 406-ML-005 | Recombinant Mouse IL-6 (5 UG) | 5 UG | 3110 |
| R&D Systems | 406-ML-200/CF | Recombinant Mouse IL-6, CF (200 UG) | 200 UG | 18190 |
| R&D Systems | 406-ML-025/CF | Recombinant Mouse IL-6, CF (25 UG) | 25 UG | 9950 |
| R&D Systems | 406-ML-005/CF | Recombinant Mouse IL-6, CF (5 UG) | 5 UG | 3110 |
| R&D Systems | 4067-GP-050 | Recombinant Human CD42b/GPIb alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 407-ML-200 | Recombinant Mouse IL-7 (200 UG) | 200 UG | 16890 |
| R&D Systems | 407-ML-025 | Recombinant Mouse IL-7 (25 UG) | 25 UG | 9480 |
| R&D Systems | 407-ML-005 | Recombinant Mouse IL-7 (5 UG) | 5 UG | 2980 |
| R&D Systems | 407-ML-200/CF | Recombinant Mouse IL-7, CF (200 UG) | 200 UG | 16890 |
| R&D Systems | 407-ML-025/CF | Recombinant Mouse IL-7, CF (25 UG) | 25 UG | 9480 |
| R&D Systems | 407-ML-005/CF | Recombinant Mouse IL-7, CF (5 UG) | 5 UG | 2980 |
| R&D Systems | 4070-500-EB | Thermostable TDG Protein (Thymine DNA Glycosylase)/Buffer (500 UN) | 500 UN | 4720 |
| R&D Systems | 409-ML-010 | Recombinant Mouse IL-9 (10 UG) | 10 UG | 4150 |
| R&D Systems | 409-ML-050 | Recombinant Mouse IL-9 (50 UG) | 50 UG | 11900 |
| R&D Systems | 409-ML-010/CF | Recombinant Mouse IL-9, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 409-ML-050/CF | Recombinant Mouse IL-9, CF (50 UG) | 50 UG | 11900 |
| R&D Systems | 4090-AS-020 | Recombinant Human Renin, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 4095-EG-025 | Recombinant Mouse Pro-EGF (aa 29-1029) (25 UG) | 25 UG | 4280 |
| R&D Systems | 4095-EG-025/CF | Recombinant Mouse Pro-EGF (aa 29-1029), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4096-MC-050 | Recombinant Human M-Cadherin/Cadherin-15 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4097-AS-020 | Recombinant Human BACE-2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 4099-SE-010 | Recombinant Human Chymase/CMA1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 410-MT-010 | Recombinant Mouse TNF-alpha (aa 80-235) (10 UG) | 10 UG | 2590 |
| R&D Systems | 410-MT-050 | Recombinant Mouse TNF-alpha (aa 80-235) (50 UG) | 50 UG | 8180 |
| R&D Systems | 410-MT-010/CF | Recombinant Mouse TNF-alpha (aa 80-235), CF (10 UG) | 10 UG | 2590 |
| R&D Systems | 410-MT-050/CF | Recombinant Mouse TNF-alpha (aa 80-235), CF (50 UG) | 50 UG | 8180 |
| R&D Systems | 410-TRNC-010 | Recombinant Mouse TNF-alpha (aa 84-235) (10 UG) | 10 UG | 3110 |
| R&D Systems | 410-TRNC-050 | Recombinant Mouse TNF-alpha (aa 84-235) (50 UG) | 50 UG | 9480 |
| R&D Systems | 410-TRNC-010/CF | Recombinant Mouse TNF-alpha (aa 84-235), CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 410-TRNC-050/CF | Recombinant Mouse TNF-alpha (aa 84-235), CF (50 UG) | 50 UG | 9480 |
| R&D Systems | 4104-SE-010 | Recombinant Human Kallikrein 2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4106-RS-025 | Recombinant Mouse R-Spondin 4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 4106-RS-025/CF | Recombinant Mouse R-Spondin 4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 41100-1 | Human IFN-alpha ELISA Kit (1 KT) | 1 KT | 7630 |
| R&D Systems | 41100-2 | Human IFN-alpha ELISA Kit, FivePak (1 PK) | 1 PK | 28510 |
| R&D Systems | 41105-1 | Human IFN-alpha Multi-Subtype ELISA Kit (1 KT) | 1 KT | 9400 |
| R&D Systems | 41105-2 | Human IFN-alpha Multi-Subtype ELISA Kit, FivePak (1 PK) | 1 PK | 36430 |
| R&D Systems | 41110-1 | Human IFN-alpha Serum Sample ELISA Kit (1 KT) | 1 KT | 9810 |
| R&D Systems | 41110-2 | Human IFN-alpha Serum Sample ELISA Kit, FivePak (1 PK) | 1 PK | 37250 |
| R&D Systems | 4114-TC-01M | Recombinant Human FGF basic, 145 aa (TC Grade), CF (1 MG) | 1 MG | 10390 |
| R&D Systems | 4116-CR-050 | Recombinant Mouse CRELD1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4119-GH-010 | Recombinant Human alpha-L-Iduronidase/IDUA, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4120-RS-025 | Recombinant Mouse R-Spondin 3 (25 UG) | 25 UG | 4280 |
| R&D Systems | 4120-RS-025/CF | Recombinant Mouse R-Spondin 3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4128-CM-050 | Recombinant Human CEACAM-5/CD66e, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4129-DM-050 | Recombinant Human DMP-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 413-ML-025 | Recombinant Mouse IL-13 (25 UG) | 25 UG | 11900 |
| R&D Systems | 413-ML-005 | Recombinant Mouse IL-13 (5 UG) | 5 UG | 3630 |
| R&D Systems | 413-ML-025/CF | Recombinant Mouse IL-13, CF (25 UG) | 25 UG | 11900 |
| R&D Systems | 413-ML-005/CF | Recombinant Mouse IL-13, CF (5 UG) | 5 UG | 3630 |
| R&D Systems | 4130-100-EB | Human 8-oxoGuanine DNA Glycosylase (OGG1)/Buffer (100 UN) | 100 UN | 4270 |
| R&D Systems | 4130-BL-050 | Recombinant Mouse IGFBP-L1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4134-RL-010 | Recombinant Rat IL-9 (10 UG) | 10 UG | 4150 |
| R&D Systems | 4134-RL-010/CF | Recombinant Rat IL-9, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 4135-AV-050 | Recombinant Human Integrin alpha V beta 8, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 4136-KR-050 | Recombinant Human KIR3DS1/CD158e2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4137-S4-050 | Recombinant Human S100A4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4138-S4-050 | Recombinant Mouse S100A4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4139-SE-010 | Recombinant Bovine Enteropeptidase/Enterokinase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 41395-1 | Human IFN-omega ELISA Kit (1 KT) | 1 KT | 9730 |
| R&D Systems | 414-CS-025 | Recombinant Mouse G-CSF (25 UG) | 25 UG | 8440 |
| R&D Systems | 414-CS-005 | Recombinant Mouse G-CSF (5 UG) | 5 UG | 2720 |
| R&D Systems | 414-CS-025/CF | Recombinant Mouse G-CSF, CF (25 UG) | 25 UG | 8440 |
| R&D Systems | 414-CS-005/CF | Recombinant Mouse G-CSF, CF (5 UG) | 5 UG | 2720 |
| R&D Systems | 4140-ME-050 | Recombinant Canine HGF R/c-MET, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 41410-1 | Human IFN-beta ELISA Kit (1 KT) | 1 KT | 9190 |
| R&D Systems | 41410-2 | Human IFN-beta ELISA Kit, FivePak (1 PK) | 1 PK | 34110 |
| R&D Systems | 4144-AE-500 | Recombinant Human Apolipoprotein E3, CF (500 UG) | 500 UG | 3110 |
| R&D Systems | 415-ML-010 | Recombinant Mouse GM-CSF (10 UG) | 10 UG | 3370 |
| R&D Systems | 415-ML-050 | Recombinant Mouse GM-CSF (50 UG) | 50 UG | 10390 |
| R&D Systems | 415-ML-010/CF | Recombinant Mouse GM-CSF, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 415-ML-050/CF | Recombinant Mouse GM-CSF, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 4150-PP-050 | Recombinant Human PP2C alpha/PPM1A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 416-ML-010 | Recombinant Mouse M-CSF (10 UG) | 10 UG | 2980 |
| R&D Systems | 416-ML-500 | Recombinant Mouse M-CSF (500 UG) | 500 UG | 32240 |
| R&D Systems | 416-ML-050 | Recombinant Mouse M-CSF (50 UG) | 50 UG | 8650 |
| R&D Systems | 416-ML-010/CF | Recombinant Mouse M-CSF, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 416-ML-050/CF | Recombinant Mouse M-CSF, CF (50 UG) | 50 UG | 8650 |
| R&D Systems | 4160-PD-050 | Recombinant Human Plexin D1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4164-S4-050 | Recombinant Human IGSF4C/SynCAM4 , CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4165-CL-050 | Recombinant Human Collagen XXIII alpha 1/COL23A1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 417-ML-025 | Recombinant Mouse IL-10 (25 UG) | 25 UG | 10600 |
| R&D Systems | 417-ML-005 | Recombinant Mouse IL-10 (5 UG) | 5 UG | 3240 |
| R&D Systems | 417-ML-025/CF | Recombinant Mouse IL-10, CF (25 UG) | 25 UG | 10600 |
| R&D Systems | 417-ML-005/CF | Recombinant Mouse IL-10, CF (5 UG) | 5 UG | 3240 |
| R&D Systems | 4179-TA-050 | Recombinant Human TAFA2/FAM19A2, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 418-ML-025 | Recombinant Mouse IL-11 (25 UG) | 25 UG | 11640 |
| R&D Systems | 418-ML-005 | Recombinant Mouse IL-11 (5 UG) | 5 UG | 3630 |
| R&D Systems | 418-ML-025/CF | Recombinant Mouse IL-11, CF (25 UG) | 25 UG | 11640 |
| R&D Systems | 418-ML-005/CF | Recombinant Mouse IL-11, CF (5 UG) | 5 UG | 3630 |
| R&D Systems | 419-ML-010 | Recombinant Mouse IL-12 (10 UG) | 10 UG | 3370 |
| R&D Systems | 419-ML-500 | Recombinant Mouse IL-12 (500 UG) | 500 UG | 57200 |
| R&D Systems | 419-ML-050 | Recombinant Mouse IL-12 (50 UG) | 50 UG | 10780 |
| R&D Systems | 419-ML-010/CF | Recombinant Mouse IL-12, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 419-ML-500/CF | Recombinant Mouse IL-12, CF (500 UG) | 500 UG | 57200 |
| R&D Systems | 419-ML-050/CF | Recombinant Mouse IL-12, CF (50 UG) | 50 UG | 10780 |
| R&D Systems | 420-ME-100 | Recombinant Mouse CCL11/Eotaxin (100 UG) | 100 UG | 10390 |
| R&D Systems | 420-ME-020 | Recombinant Mouse CCL11/Eotaxin (20 UG) | 20 UG | 4150 |
| R&D Systems | 420-ME-100/CF | Recombinant Mouse CCL11/Eotaxin, CF (100 UG) | 100 UG | 10390 |
| R&D Systems | 420-ME-020/CF | Recombinant Mouse CCL11/Eotaxin, CF (20 UG) | 20 UG | 4150 |
| R&D Systems | 4206-B7-100 | Recombinant Mouse B7-H4 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 4207-DM-025 | Recombinant Human CXCL17/VCC-1 (25 UG) | 25 UG | 4410 |
| R&D Systems | 4207-DM-025/CF | Recombinant Human CXCL17/VCC-1, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 4208-NX-050 | Recombinant Rat Neurexophilin-1/NXPH1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4209-FC-050 | Recombinant Human Ficolin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 421-ML-025 | Recombinant Mouse IL-17A (25 UG) | 25 UG | 2980 |
| R&D Systems | 421-ML-025/CF | Recombinant Mouse IL-17A, CF (25 UG) | 25 UG | 2980 |
| R&D Systems | 42120-1 | Mouse IFN-alpha ELISA Kit (1 KT) | 1 KT | 6870 |
| R&D Systems | 42120-2 | Mouse IFN-alpha ELISA Kit, FivePak (1 PK) | 1 PK | 28920 |
| R&D Systems | 4218-UT-050 | Recombinant Human Uteroglobin, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 423-F8-025 | Recombinant Human/Mouse FGF-8b (25 UG) | 25 UG | 3370 |
| R&D Systems | 423-F8-025/CF | Recombinant Human/Mouse FGF-8b, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 4234-ZN-010 | Recombinant Human PSMA/FOLH1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4236-DI-050 | Recombinant Human P4HB, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4237-SR-050 | Recombinant Mouse SorCS2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4238-SR-050 | Recombinant Human SorCS2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 424-FC-025 | Recombinant Mouse FGF-8c (25 UG) | 25 UG | 3370 |
| R&D Systems | 424-FC-025/CF | Recombinant Mouse FGF-8c, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 42400-1 | Mouse IFN-beta ELISA Kit (1 KT) | 1 KT | 9400 |
| R&D Systems | 42400-2 | Mouse IFN-beta ELISA Kit, FivePak (1 PK) | 1 PK | 36430 |
| R&D Systems | 4245-AD-020 | Recombinant Human ADAMTS13, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 4249-GP-050 | Recombinant Human Glycoprotein V/CD42d, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 425-R1-050 | Recombinant Mouse sTNF RI/TNFRSF1A (50 UG) | 50 UG | 4540 |
| R&D Systems | 425-R1-050/CF | Recombinant Mouse sTNF RI/TNFRSF1A, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 4250-050-01 | CometAssay Lysis Solution (2 x 500 mL) (1 L) | 1 L | 1050 |
| R&D Systems | 4250-050-02 | CometAssay LM Agarose (15 ML) | 15 ML | 570 |
| R&D Systems | 4250-050-K | CometAssay Single Cell Gel Electrophoresis Assay (50 TESTS) | 50 TESTS | 3370 |
| R&D Systems | 4250-200-03 | CometSlide (100 TESTS) | 100 TESTS | 3410 |
| R&D Systems | 4251-050-K | CometAssay Single Cell Gel Electrophoresis Assay-Silver (50 TESTS) | 50 TESTS | 4720 |
| R&D Systems | 4252-02K-01 | CometAssay High Throughput Slides (100 TESTS) | 100 TESTS | 14630 |
| R&D Systems | 4253-096-K | CometAssay 96 (96 TESTS) | 96 TESTS | 3370 |
| R&D Systems | 426-R2-050 | Recombinant Mouse sTNF RII/TNFRSF1B (50 UG) | 50 UG | 4540 |
| R&D Systems | 426-R2-050/CF | Recombinant Mouse sTNF RII/TNFRSF1B, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 4268-KS-010 | Recombinant Human Active PKA C alpha, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 427-FL-025 | Recombinant Mouse Flt-3 Ligand (25 UG) | 25 UG | 6230 |
| R&D Systems | 427-FL-005 | Recombinant Mouse Flt-3 Ligand (5 UG) | 5 UG | 1940 |
| R&D Systems | 427-FL-025/CF | Recombinant Mouse Flt-3 Ligand, CF (25 UG) | 25 UG | 6230 |
| R&D Systems | 427-FL-005/CF | Recombinant Mouse Flt-3 Ligand, CF (5 UG) | 5 UG | 1940 |
| R&D Systems | 4270-DM-025 | Recombinant Mouse CXCL17/VCC-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 4270-DM-025/CF | Recombinant Mouse CXCL17/VCC-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4277-AS-020 | Recombinant Mouse Renin, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 428-P5-025 | Recombinant Mouse CCL12/MCP-5 (25 UG) | 25 UG | 3760 |
| R&D Systems | 428-P5-025/CF | Recombinant Mouse CCL12/MCP-5, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 4289-EG-025 | Recombinant Human Pro-EGF (aa 21-1023) (25 UG) | 25 UG | 4280 |
| R&D Systems | 4289-EG-025/CF | Recombinant Human Pro-EGF (aa 21-1023), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 429-FR-100 | Recombinant Mouse GFR alpha-2 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 4290-S4-050 | Recombinant Human IGSF4D/SynCAM2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4294-MR-050 | Recombinant Mouse IL-22 R alpha 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4295-KR-025 | Recombinant Rat Kremen-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4296-LR-050 | Recombinant Human LRPAP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4297-MG-050 | Recombinant Mouse MGL1/CD301a, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4298-NP-050 | Recombinant Mouse Nephronectin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 430-RI-050 | Recombinant Mouse TNF RI/TNFRSF1A Fc Chimera (50 UG) | 50 UG | 4280 |
| R&D Systems | 430-RI-050/CF | Recombinant Mouse TNF RI/TNFRSF1A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4305-FN-200 | Recombinant Human Fibronectin, CF (200 UG) | 200 UG | 3370 |
| R&D Systems | 4305-GMP-01M | Recombinant Human Fibronectin GMP, CF (1 MG) | 1 MG | 17940 |
| R&D Systems | 4305-GMP-200 | Recombinant Human Fibronectin GMP, CF (200 UG) | 200 UG | 3770 |
| R&D Systems | 4306-MS-010 | Recombinant Human MSP/MST1 (Cys672Ala) (10 UG) | 10 UG | 3760 |
| R&D Systems | 4306-MS-010/CF | Recombinant Human MSP/MST1 (Cys672Ala), CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 4307-AD-020 | Recombinant Human ADAMTS4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 4308-SE-010 | Recombinant Human Prolyl Oligopeptidase/PREP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4309-PA-050 | Recombinant Mouse Plexin A1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 431-MS-100 | Recombinant Mouse MSP R Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 4318-PR-050 | Recombinant Mouse PILR-alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 432-B3-200 | Recombinant Mouse EphB3 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 4320-LM-050 | Recombinant Mouse LAMP-1/CD107a, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4325-FC-050 | Recombinant Human Fc gamma RIIIA/CD16a, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 4326-RG-050 | Recombinant Rat IGF-I, CF (50 UG) | 50 UG | 2330 |
| R&D Systems | 4327-SA-050 | Recombinant Human S100A13, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4328-SA-050 | Recombinant Mouse S100A13, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4329-EG-025 | Recombinant Mouse EGF-L6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 433-MC-025 | Recombinant Mouse LIX (25 UG) | 25 UG | 4150 |
| R&D Systems | 433-MC-025/CF | Recombinant Mouse LIX, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 4330-SL-050 | Recombinant Mouse SLAM/CD150, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4336-100-01 | Poly(ADP-ribose) Polymer/pADPr (100 UL) | 100 UL | 2620 |
| R&D Systems | 4336-APC-050 | PAR Affinity Purified Polyclonal Ab (50 UL) | 50 UL | 5470 |
| R&D Systems | 4338-MC-50 | PARP MAb (Clone C2-10) (50 UG) | 50 UG | 2920 |
| R&D Systems | 434-CT-200 | Recombinant Mouse CTLA-4 Fc Chimera (200 UG) | 200 UG | 4800 |
| R&D Systems | 434-CT-200/CF | Recombinant Mouse CTLA-4 Fc Chimera, CF (200 UG) | 200 UG | 4800 |
| R&D Systems | 4340-NL-050 | Recombinant Rat Neuroligin 1/NLGN1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 435-FA-050 | Recombinant Mouse Fas/TNFRSF6/CD95 Fc Chimera (50 UG) | 50 UG | 4280 |
| R&D Systems | 435-FA-050/CF | Recombinant Mouse Fas/TNFRSF6/CD95 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4354-MC-050 | 8-Hydroxyguanine (8-oxo-dG) MAb (Clone 2E2) (50 UL) | 50 UL | 6220 |
| R&D Systems | 4358-DA-050 | Recombinant Human Sirtuin 2/SIRT2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4359-DA-050 | Recombinant Human Histone Deacetylase 8, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4360-096-K | BPDE Assay (1 KT) | 1 KT | 7430 |
| R&D Systems | 4360-MC-100 | Benzo(A)pyrene-Diol Epoxide/BPDE MAb (Clone 8E11) (100 UG) | 100 UG | 5110 |
| R&D Systems | 437-MR-100 | Recombinant Mouse BMPR-IA/ALK-3 Fc Chimera (100 UG) | 100 UG | 5450 |
| R&D Systems | 437-MR-100/CF | Recombinant Mouse BMPR-IA/ALK-3 Fc Chimera, CF (100 UG) | 100 UG | 5450 |
| R&D Systems | 4376-TG-050 | Recombinant Human Transglutaminase 2/TGM2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 438-CT-010 | Recombinant Mouse Cardiotrophin-1 (CT-1) (10 UG) | 10 UG | 3500 |
| R&D Systems | 438-CT-050 | Recombinant Mouse Cardiotrophin-1 (CT-1) (50 UG) | 50 UG | 11250 |
| R&D Systems | 438-CT-010/CF | Recombinant Mouse Cardiotrophin-1 (CT-1), CF (10 UG) | 10 UG | 3500 |
| R&D Systems | 438-CT-050/CF | Recombinant Mouse Cardiotrophin-1 (CT-1), CF (50 UG) | 50 UG | 11250 |
| R&D Systems | 4380-096-K | HT 8-oxo-dG ELISA II, 1 Plate (1 KT) | 1 KT | 13130 |
| R&D Systems | 4380-192-K | HT 8-oxo-dG ELISA II, 2 Plates (1 KT) | 1 KT | 17940 |
| R&D Systems | 4384-CD-050 | Recombinant Human CDO, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4385-CD-050 | Recombinant Human CD109, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4386-DM-050 | Recombinant Mouse DMP-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4387-ER-050 | Recombinant Mouse ErbB4/Her4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4388-MR-050 | Recombinant Mouse IL-20 R beta Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4389-OR-050 | Recombinant Human OSM R beta, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 439-MD-025 | Recombinant Mouse CCL22/MDC (25 UG) | 25 UG | 4150 |
| R&D Systems | 439-MD-025/CF | Recombinant Mouse CCL22/MDC, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 4394-AS-050 | Recombinant Human ASGPR1, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 4395-SR-050 | Recombinant Mouse SorCS1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4397-EN-010 | Recombinant Human CD39/ENTPD1, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 4398-EN-010 | Recombinant Mouse CD39/ENTPD1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4399-EN-010 | Recombinant Human CD39L2/ENTPD6, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 440-M3-025 | Recombinant Mouse CCL19/MIP-3 beta (25 UG) | 25 UG | 3760 |
| R&D Systems | 440-M3-025/CF | Recombinant Mouse CCL19/MIP-3 beta, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 4400-EN-010 | Recombinant Human CD39L3/ENTPD3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 441-OP-200 | Recombinant Mouse Osteopontin (OPN) (200 UG) | 200 UG | 9090 |
| R&D Systems | 441-OP-050 | Recombinant Mouse Osteopontin (OPN) (50 UG) | 50 UG | 3110 |
| R&D Systems | 441-OP-200/CF | Recombinant Mouse Osteopontin (OPN), CF (200 UG) | 200 UG | 9090 |
| R&D Systems | 441-OP-050/CF | Recombinant Mouse Osteopontin (OPN), CF (50 UG) | 50 UG | 3110 |
| R&D Systems | 4414-NP-050 | Recombinant Human Neuronal Pentraxin R/NPTXR, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4415-SU-010 | Recombinant Human Arylsulfatase B/ARSB, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4416-AD-020 | Recombinant Human ADAM12, CF (20 UG) | 20 UG | 4800 |
| R&D Systems | 442-LK-002 | Recombinant Mouse CXCL15/Lungkine (2 UG) | 2 UG | 3890 |
| R&D Systems | 4422-AMC-100 | Human XPF MAb (Clone 2BE) (100 UL) | 100 UL | 5320 |
| R&D Systems | 4424-AMC-100 | Human ERCC1 MAb (Clone 2C6) (100 UL) | 100 UL | 5320 |
| R&D Systems | 4428-EC-050 | Recombinant Mouse ECM-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4429-PR-050 | Recombinant Mouse PRAT4A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 443-KD-050 | Recombinant Mouse VEGF R2/Flk-1 Fc Chimera (50 UG) | 50 UG | 4280 |
| R&D Systems | 443-KD-050/CF | Recombinant Mouse VEGF R2/Flk-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4434-CK-025 | Recombinant Rat CCL27/CTACK (25 UG) | 25 UG | 4280 |
| R&D Systems | 4434-CK-025/CF | Recombinant Rat CCL27/CTACK, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4435-BD-050 | Recombinant Human beta-Defensin 3, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 4436-DN-050 | Recombinant Mouse DNAM-1/CD226 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 4437-IL-025 | Recombinant Rat IL-17F (25 UG) | 25 UG | 4280 |
| R&D Systems | 4437-IL-025/CF | Recombinant Rat IL-17F, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4439-CN-050 | Recombinant Mouse Contactin-2/TAG1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 444-BNS-100 | Recombinant Mouse BMPR-IB/ALK-6 Fc Chimera (NS0) (100 UG) | 100 UG | 5320 |
| R&D Systems | 444-BNS-100/CF | Recombinant Mouse BMPR-IB/ALK-6 Fc Chimera (NS0), CF (100 UG) | 100 UG | 5320 |
| R&D Systems | 4444-TR-050 | Recombinant Human Thrombopoietin R, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 446-B4-200 | Recombinant Mouse EphB4 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 4460-MG-100 | Recombinant Mouse IgG2A Fc, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 4464-EN-010 | Recombinant Mouse CD39L3/ENTPD3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4467-KS-010 | Recombinant Human Active FAK, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4469-TP-200 | Recombinant TEV Protease, CF (200 UG) | 200 UG | 2070 |
| R&D Systems | 447-ML-010 | Recombinant Mouse IL-15 (10 UG) | 10 UG | 3890 |
| R&D Systems | 447-ML-010/CF | Recombinant Mouse IL-15, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 4480-LR-050 | Recombinant Mouse LRPAP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4481-MR-100 | Recombinant Mouse IL-17 RA/IL-17 R Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 4485-NX-050 | Recombinant Rat Neurexin 1 alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4486-SB-050 | Recombinant Human SIRP gamma/CD172g Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4487-AN-050 | Recombinant Human Angiopoietin-like 4, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 4488-EN-010 | Recombinant Mouse 5'-Nucleotidase/CD73, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 4489-ZN-010 | Recombinant Botulinum Neurotoxin Type A Light Chain, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4490-HP-050 | Recombinant Human Hemopexin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4494-AH-010 | Recombinant Human ASAHL, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 450-MA-010 | Recombinant Mouse CCL3/MIP-1 alpha (10 UG) | 10 UG | 3630 |
| R&D Systems | 450-MA-050 | Recombinant Mouse CCL3/MIP-1 alpha (50 UG) | 50 UG | 7010 |
| R&D Systems | 450-MA-010/CF | Recombinant Mouse CCL3/MIP-1 alpha, CF (10 UG) | 10 UG | 3630 |
| R&D Systems | 450-MA-050/CF | Recombinant Mouse CCL3/MIP-1 alpha, CF (50 UG) | 50 UG | 7010 |
| R&D Systems | 451-MB-010 | Recombinant Mouse CCL4/MIP-1 beta (10 UG) | 10 UG | 3890 |
| R&D Systems | 451-MB-050 | Recombinant Mouse CCL4/MIP-1 beta (50 UG) | 50 UG | 12550 |
| R&D Systems | 451-MB-010/CF | Recombinant Mouse CCL4/MIP-1 beta, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 451-MB-050/CF | Recombinant Mouse CCL4/MIP-1 beta, CF (50 UG) | 50 UG | 12550 |
| R&D Systems | 4516-ZN-010 | Recombinant Rat ACE-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4517-SE-010 | Recombinant Mouse Neutrophil Elastase/ELA2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4518-RB-050 | Recombinant Mouse ErbB3/Her3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4519-GP-050 | Recombinant Human Glypican 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 452-M2-010 | Recombinant Mouse CXCL2/MIP-2 (10 UG) | 10 UG | 3110 |
| R&D Systems | 452-M2-050 | Recombinant Mouse CXCL2/MIP-2 (50 UG) | 50 UG | 9480 |
| R&D Systems | 452-M2-010/CF | Recombinant Mouse CXCL2/MIP-2, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 452-M2-050/CF | Recombinant Mouse CXCL2/MIP-2, CF (50 UG) | 50 UG | 9480 |
| R&D Systems | 4520-096-K | HT PARP in Vivo Pharmacodynamic Assay II (1 KT) | 1 KT | 17060 |
| R&D Systems | 4520-GP-050 | Recombinant Mouse Glypican 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4527-PR-050 | Recombinant Human PEAR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4529-HB-050 | Recombinant Mouse HABP1/C1QBP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 453-KC-010 | Recombinant Mouse CXCL1/KC (10 UG) | 10 UG | 2980 |
| R&D Systems | 453-KC-050 | Recombinant Mouse CXCL1/KC (50 UG) | 50 UG | 9300 |
| R&D Systems | 453-KC-010/CF | Recombinant Mouse CXCL1/KC, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 453-KC-050/CF | Recombinant Mouse CXCL1/KC, CF (50 UG) | 50 UG | 9300 |
| R&D Systems | 454-A8-200 | Recombinant Mouse EphA8 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 4540-KS-010 | Recombinant Human Active Raf-1 (Y340E Y341E, 306-end), CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4544-NS-050 | Recombinant Human INSL3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4545-M2-050 | Recombinant Mouse MESDC2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4546-SA-050 | Recombinant Human SIRP alpha/CD172a Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 4547-SL-050 | Recombinant Mouse SPARC-like 1/SPARCL1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 455-MC-010 | Recombinant Mouse SCF (10 UG) | 10 UG | 4020 |
| R&D Systems | 455-MC-500 | Recombinant Mouse SCF (500 UG) | 500 UG | 24570 |
| R&D Systems | 455-MC-050 | Recombinant Mouse SCF (50 UG) | 50 UG | 13120 |
| R&D Systems | 455-MC-010/CF | Recombinant Mouse SCF, CF (10 UG) | 10 UG | 4020 |
| R&D Systems | 455-MC-500/CF | Recombinant Mouse SCF, CF (500 UG) | 500 UG | 24570 |
| R&D Systems | 455-MC-050/CF | Recombinant Mouse SCF, CF (50 UG) | 50 UG | 13120 |
| R&D Systems | 4550-AM-050 | Recombinant Human Apolipoprotein M, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 4556-SE-010 | Recombinant Mouse Coagulation Factor XI, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4557-PI-010 | Recombinant Mouse Cystatin F, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 456-MC-010 | Recombinant Mouse CCL7/MARC (10 UG) | 10 UG | 3370 |
| R&D Systems | 456-MC-050 | Recombinant Mouse CCL7/MARC (50 UG) | 50 UG | 5580 |
| R&D Systems | 456-MC-010/CF | Recombinant Mouse CCL7/MARC, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 456-MC-050/CF | Recombinant Mouse CCL7/MARC, CF (50 UG) | 50 UG | 5580 |
| R&D Systems | 4562-R2-050 | Recombinant Human ISLR-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 457-6C-025 | Recombinant Mouse CCL21/6Ckine (25 UG) | 25 UG | 4150 |
| R&D Systems | 457-6C-025/CF | Recombinant Mouse CCL21/6Ckine, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 4575-RS-025 | Recombinant Human R-Spondin 4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 4575-RS-025/CF | Recombinant Human R-Spondin 4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4576-CR-050 | Recombinant Mouse CRISP-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 458-MF-025 | Recombinant Mouse CX3CL1/Fractalkine (Chemokine Domain) (25 UG) | 25 UG | 4280 |
| R&D Systems | 458-MF-025/CF | Recombinant Mouse CX3CL1/Fractalkine (Chemokine Domain), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4585-KS-010 | Recombinant Human Active PKC delta, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4586-KS-010 | Recombinant Human Active MAP3K8/Tpl2/COT, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4587-KS-010 | Recombinant Human Active ITK (aa 352-620), CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4588-KS-010 | Recombinant Human Active PIM1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4589-KS-010 | Recombinant Human Active PYK2/FAK2, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 459-MO-100 | Recombinant Mouse Osteoprotegerin/TNFRSF11B Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 4590-KS-010 | Recombinant Human Active ROCK1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4594-KS-010 | Recombinant Human Active SYK, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4595-KS-010 | Recombinant Human Active Src, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4596-KS-010 | Recombinant Human Active PKA C beta, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 4599-SE-010 | Recombinant Human Prostasin/Prss8, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 460-SD-010 | Recombinant Mouse CXCL12/SDF-1 alpha (10 UG) | 10 UG | 2980 |
| R&D Systems | 460-SD-050 | Recombinant Mouse CXCL12/SDF-1 alpha (50 UG) | 50 UG | 9090 |
| R&D Systems | 460-SD-010/CF | Recombinant Mouse CXCL12/SDF-1 alpha, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 460-SD-050/CF | Recombinant Mouse CXCL12/SDF-1 alpha, CF (50 UG) | 50 UG | 9090 |
| R&D Systems | 4600-SU-010 | Recombinant Mouse Arylsulfatase G/ARSG, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4604-TG-050 | Recombinant Human Transglutaminase 3/TGM3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 461-SH-025 | Recombinant Mouse Sonic Hedgehog/Shh, N-Terminus (25 UG) | 25 UG | 3760 |
| R&D Systems | 461-SH-025/CF | Recombinant Mouse Sonic Hedgehog/Shh, N-Terminus, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 4610-TH-010 | Recombinant Human TSH alpha/beta Heterodimer (10 UG) | 10 UG | 4280 |
| R&D Systems | 4610-TH-010/CF | Recombinant Human TSH alpha/beta Heterodimer, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 462-TEC-010 | Recombinant Mouse TRANCE/RANK L/TNFSF11 (E. coli-expressed) (10 UG) | 10 UG | 4150 |
| R&D Systems | 462-TEC-010/CF | Recombinant Mouse TRANCE/RANK L/TNFSF11 (E. coli), CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 462-TR-010 | Recombinant Mouse TRANCE/RANK L/TNFSF11 (10 UG) | 10 UG | 4150 |
| R&D Systems | 462-TR-010/CF | Recombinant Mouse TRANCE/RANK L/TNFSF11, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 4627-CL-050 | Recombinant Mouse Collagen XIII alpha 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4628-SF-050 | Recombinant Mouse CRACC/SLAMF7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4629-DP-050 | Recombinant Human Dermatopontin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 463-MG-025 | Recombinant Mouse CCL9/10/MIP-1 gamma (25 UG) | 25 UG | 4150 |
| R&D Systems | 463-MG-025/CF | Recombinant Mouse CCL9/10/MIP-1 gamma, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 4630-DC-050 | Recombinant Human Desmocollin-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4634-GP-050 | Recombinant Human GPR56, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4635-ML-025 | Recombinant Mouse IL-28A/IFN-lambda 2 (25 UG) | 25 UG | 4150 |
| R&D Systems | 4635-ML-025/CF | Recombinant Mouse IL-28A/IFN-lambda 2, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 4636-NL-050 | Recombinant Mouse Olfactomedin-1/Noelin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 464-SH-200 | Recombinant Mouse Sonic Hedgehog/Shh (C25II) N-Terminus (200 UG) | 200 UG | 14290 |
| R&D Systems | 464-SH-025 | Recombinant Mouse Sonic Hedgehog/Shh (C25II) N-Terminus (25 UG) | 25 UG | 4150 |
| R&D Systems | 464-SH-200/CF | Recombinant Mouse Sonic Hedgehog/Shh (C25II) N-Terminus, CF (200 UG) | 200 UG | 14290 |
| R&D Systems | 464-SH-025/CF | Recombinant Mouse Sonic Hedgehog/Shh (C25II) N-Terminus, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 4644-VS-010 | Recombinant Human VEGF 121 (aa 207-327) (10 UG) | 10 UG | 3760 |
| R&D Systems | 4644-VS-010/CF | Recombinant Human VEGF 121 (aa 207-327), CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 4645-RS-025 | Recombinant Human R-Spondin 1 (25 UG) | 25 UG | 4150 |
| R&D Systems | 4645-RS-01M/CF | Recombinant Human R-Spondin 1, CF (1 MG) | 1 MG | 67600 |
| R&D Systems | 4645-RS-025/CF | Recombinant Human R-Spondin 1, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 4646-VS-050 | Recombinant Human VSIG4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4649-RK-050 | Recombinant Mouse Ryk Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 465-PL-010 | Recombinant Mouse PlGF-2 (10 UG) | 10 UG | 3760 |
| R&D Systems | 465-PL-050 | Recombinant Mouse PlGF-2 (50 UG) | 50 UG | 11430 |
| R&D Systems | 465-PL-010/CF | Recombinant Mouse PlGF-2, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 465-PL-050/CF | Recombinant Mouse PlGF-2, CF (50 UG) | 50 UG | 11430 |
| R&D Systems | 466-CR-010 | Recombinant Mouse CXCL10/IP-10/CRG-2 (10 UG) | 10 UG | 3240 |
| R&D Systems | 466-CR-050 | Recombinant Mouse CXCL10/IP-10/CRG-2 (50 UG) | 50 UG | 10390 |
| R&D Systems | 466-CR-010/CF | Recombinant Mouse CXCL10/IP-10/CRG-2, CF (10 UG) | 10 UG | 3240 |
| R&D Systems | 466-CR-050/CF | Recombinant Mouse CXCL10/IP-10/CRG-2, CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 4668-100-01 | PARP Enzyme High Specific Activity (1000 UN) | 1000 UN | 3670 |
| R&D Systems | 4668-500-01 | PARP Enzyme High Specific Activity (5000 UN) | 5000 UN | 12760 |
| R&D Systems | 467-B2-200 | Recombinant Mouse EphB2 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 4670-500-01 | 6-Biotin-17-NAD (500 UL) | 500 UL | 4420 |
| R&D Systems | 4670-CD-050 | Recombinant Human CD47 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 4674-VS-050 | Recombinant Mouse VSIG4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4675-CR-050 | Recombinant Mouse CRISP-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4677-096-K | PARP Universal Colorimetric Assay Kit (1 KT) | 1 KT | 6670 |
| R&D Systems | 4677-TA-050 | Recombinant Human TAFA3/FAM19A3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 468-MG-100 | Recombinant Mouse gp130 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 4686-FA-025 | Recombinant Mouse FGF acidic (25 UG) | 25 UG | 2330 |
| R&D Systems | 4686-FA-025/CF | Recombinant Mouse FGF acidic, CF (25 UG) | 25 UG | 2330 |
| R&D Systems | 4687-CL-050 | Recombinant Mouse CL-K1/COLEC11, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4688-DC-050 | Recombinant Human Desmocollin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 469-VD-025 | Recombinant Mouse VEGF-D (25 UG) | 25 UG | 4280 |
| R&D Systems | 469-VD-025/CF | Recombinant Mouse VEGF-D, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4690-IL-025/CF | Recombinant Human IL-32 gamma, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4691-096-K | HT Homogeneous PARG Chemiluminescent Inhibition Assay (96 TESTS) | 96 TESTS | 7280 |
| R&D Systems | 4694-S4-050 | Recombinant Human Semaphorin 4A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 470-BC-025 | Recombinant Mouse CXCL13/BLC/BCA-1 (25 UG) | 25 UG | 4150 |
| R&D Systems | 470-BC-025/CF | Recombinant Mouse CXCL13/BLC/BCA-1, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 4700-096-K | Tankyrase 1 Colorimetric Activity Assay (96 TESTS) | 96 TESTS | 14560 |
| R&D Systems | 4700-192-K | Tankyrase 1 Colorimetric Activity Assay (192 TESTS) | 192 TESTS | 19890 |
| R&D Systems | 4701-096-K | Tankyrase 1 Chemiluminescent Activity Assay (96 TESTS) | 96 TESTS | 14560 |
| R&D Systems | 4701-192-K | Tankyrase 1 Chemiluminescent Activity Assay (192 TESTS) | 192 TESTS | 19890 |
| R&D Systems | 4705-FC-050 | Recombinant Human FCRLB/FCRY, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4709-PI-010 | Recombinant Mouse Serpin A3N, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 471-F1-100 | Recombinant Mouse VEGF R1/Flt-1 Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 4710-AC-050 | Recombinant Mouse CD157, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4714-ZN-020 | Recombinant Human Methionine Aminopeptidase 1D, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 472-FF-025 | Recombinant Mouse CX3CL1/Fractalkine (Full Length) (25 UG) | 25 UG | 4280 |
| R&D Systems | 472-FF-025/CF | Recombinant Mouse CX3CL1/Fractalkine (Full Length), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 473-EB-200 | Recombinant Mouse Ephrin-B1 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 4735-SE-010 | Recombinant Mouse Matriptase/ST14 Catalytic Domain, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 4736-AC-050 | Recombinant Human CD157, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 474-MR-025 | Recombinant Mouse IL-10 R alpha (25 UG) | 25 UG | 5320 |
| R&D Systems | 474-MR-025/CF | Recombinant Mouse IL-10 R alpha, CF (25 UG) | 25 UG | 5320 |
| R&D Systems | 4745-F8-050 | Recombinant Human FGF-8a, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4746-F8-050 | Recombinant Human FGF-8e, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4747-GP-050 | Recombinant Human GPR114, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4748-JG-050 | Recombinant Mouse Jagged 2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4749-MR-050 | Recombinant Human MIS RII Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 475-WN-005 | Recombinant Mouse Wnt-4 (5 UG) | 5 UG | 4280 |
| R&D Systems | 475-WN-005/CF | Recombinant Mouse Wnt-4, CF (5 UG) | 5 UG | 4280 |
| R&D Systems | 4750-RG-050 | Recombinant Canine RAGE, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4754-SR-050 | Recombinant Mouse SCARA5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4764-ZA-050 | Recombinant Human ZAG, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 477-MN-025 | Recombinant Mouse Neurturin (25 UG) | 25 UG | 4280 |
| R&D Systems | 477-MN-025/CF | Recombinant Mouse Neurturin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4776-GMP-010 | Recombinant Human Hepsin GMP, CF (10 UG) | 10 UG | 4750 |
| R&D Systems | 4776-SE-010 | Recombinant Human Hepsin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4777-DH-050 | Recombinant Human Desert Hedgehog/Dhh (C23II) N-Terminus, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4778-CR-010 | Recombinant Variola CRMB (10 UG) | 10 UG | 4280 |
| R&D Systems | 4778-CR-010/CF | Recombinant Variola CRMB, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4779-FH-050 | Recombinant Human Complement Factor H (aa 860-1231), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 478-MR-025 | Recombinant Mouse CCL5/RANTES (25 UG) | 25 UG | 3630 |
| R&D Systems | 478-MR-025/CF | Recombinant Mouse CCL5/RANTES, CF (25 UG) | 25 UG | 3630 |
| R&D Systems | 4780-RG-050 | Recombinant Mouse Reg4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4784-TH-050 | Recombinant Mouse THSD1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 479-JE-010 | Recombinant Mouse CCL2/JE/MCP-1 (10 UG) | 10 UG | 2720 |
| R&D Systems | 479-JE-050 | Recombinant Mouse CCL2/JE/MCP-1 (50 UG) | 50 UG | 8130 |
| R&D Systems | 479-JE-010/CF | Recombinant Mouse CCL2/JE/MCP-1, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 479-JE-050/CF | Recombinant Mouse CCL2/JE/MCP-1, CF (50 UG) | 50 UG | 8130 |
| R&D Systems | 480-RM-010 | Recombinant Mouse IL-1ra/IL-1F3 (10 UG) | 10 UG | 3890 |
| R&D Systems | 480-RM-050 | Recombinant Mouse IL-1ra/IL-1F3 (50 UG) | 50 UG | 11690 |
| R&D Systems | 480-RM-010/CF | Recombinant Mouse IL-1ra/IL-1F3, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 480-RM-050/CF | Recombinant Mouse IL-1ra/IL-1F3, CF (50 UG) | 50 UG | 11690 |
| R&D Systems | 4800-30-40 | Tissue Control Slides (2 EA) | 2 EA | 600 |
| R&D Systems | 4800-30-41 | Tissue Control Slides (5 EA) | 5 EA | 1200 |
| R&D Systems | 4800-30-01 | Proteinase K (50 UL) | 50 UL | 530 |
| R&D Systems | 4800-30-06 | Streptavidin-HRP (30 UL) | 30 UL | 820 |
| R&D Systems | 4800-30-14 | Streptavidin-Fluorescein (30 UL) | 30 UL | 970 |
| R&D Systems | 4800-30-16 | TACS Nuclease (15 UL) | 15 UL | 820 |
| R&D Systems | 4800-30-BL | TACS Blue Label Substrate & Blue Streptavidin-HRP Diluent (30 TESTS) | 30 TESTS | 820 |
| R&D Systems | 4800-30-N | TACS Nuclease and Buffer (15 UL) | 15 UL | 900 |
| R&D Systems | 4800-LM-050 | Recombinant Human LAMP-1/CD107a, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4804-S6-050 | Recombinant Mouse SEZ6L, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4808-SE-010 | Recombinant Mouse Prss28, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 481-TK-025 | Recombinant Mouse CCL25/TECK (25 UG) | 25 UG | 4540 |
| R&D Systems | 481-TK-025/CF | Recombinant Mouse CCL25/TECK, CF (25 UG) | 25 UG | 4540 |
| R&D Systems | 4810-30-04 | TdT dNTP Mix (30 UL) | 30 UL | 1420 |
| R&D Systems | 4810-30-05 | Terminal Deoxynucleotidyl Transferase (TdT) Enzyme (30 UL) | 30 UL | 1800 |
| R&D Systems | 4810-30-CK | TdT In Situ Apoptosis Detection Kit - Core Reagents (30 TESTS) | 30 TESTS | 4350 |
| R&D Systems | 4810-30-K | TdT In Situ Apoptosis Detection Kit - DAB (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4810-30-R | TdT In Situ Apoptosis Detection Kit - Replenisher (30 TESTS) | 30 TESTS | 3900 |
| R&D Systems | 4810-90-09 | Cobalt cation (3 x 30 ul) (3 VL) | 3 VL | 520 |
| R&D Systems | 4810-90-10 | Magnesium cation (3 x 30 ul) (3 VL) | 3 VL | 520 |
| R&D Systems | 4810-90-14 | Manganese cation (3 x 30 ul) (3 VL) | 3 VL | 520 |
| R&D Systems | 4811-30-K | TdT In Situ Apoptosis Detection Kit - TACS Blue Label (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4812-30-K | TdT In Situ Apoptosis Detection Kit - Fluorescein (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4815-30-K | TumorTACS In Situ Apoptosis Detection Kit (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4817-60-K | FlowTACS Flow Cytometry Apoptosis Detection Kit (60 TESTS) | 60 TESTS | 5260 |
| R&D Systems | 482-RT-100 | Recombinant Mouse Ret Fc Chimera (100 UG) | 100 UG | 4540 |
| R&D Systems | 482-RT-100/CF | Recombinant Mouse Ret Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 4820-60-01 | NeuroPore (2 x 5 mL) (2 VL) | 2 VL | 1350 |
| R&D Systems | 4822-96-K | TiterTACS In Situ Detection Kit - Colorimetric (96 TESTS) | 96 TESTS | 5410 |
| R&D Systems | 4823-30-K | NeuroTACS In Situ Apoptosis Detection Kit (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4824-L3-050 | Recombinant Human LRP-1 Cluster III Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4826-30-K | VasoTACS in Situ Apoptosis Detection Kit (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4827-30-K | CardioTACS In Situ Apoptosis Detection Kit (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4828-30-BK | TACS-XL In Situ Apoptosis Detection Kit - TACS Blue (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4828-30-DK | TACS-XL In Situ Apoptosis Detection Kit - DAB (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 4828-30-K | TACS-XL In Situ Apoptosis Detection Kit - Basic (30 TESTS) | 30 TESTS | 4420 |
| R&D Systems | 4828-30-R | TACS-XL In Situ Apoptosis Detection Kit - Replenisher (30 TESTS) | 30 TESTS | 3900 |
| R&D Systems | 4829-30-K | DermaTACs In Situ Apoptosis Detection Kit (30 TESTS) | 30 TESTS | 5260 |
| R&D Systems | 483-CD-200 | Recombinant Mouse CD28 Fc Chimera (200 UG) | 200 UG | 4800 |
| R&D Systems | 483-CD-200/CF | Recombinant Mouse CD28 Fc Chimera, CF (200 UG) | 200 UG | 4800 |
| R&D Systems | 4830-01-K | TACS Annexin V-FITC Apoptosis Detection Kit (100 TESTS) | 100 TESTS | 4160 |
| R&D Systems | 4830-250-02 | 10X Binding Buffer (20 ML) | 20 ML | 750 |
| R&D Systems | 4830-250-K | TACS Annexin V-FITC Apoptosis Detection Kit (250 TESTS) | 250 TESTS | 8940 |
| R&D Systems | 4835-01-K | TACS Annexin V-Biotin Apoptosis Detection Kit (100 TESTS) | 100 TESTS | 4640 |
| R&D Systems | 4837-AM-010 | Recombinant Human PAM, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 485-MI-100 | Recombinant Mouse IFN-gamma (100 UG) | 100 UG | 5400 |
| R&D Systems | 485-MI-100/CF | Recombinant Mouse IFN-gamma, CF (100 UG) | 100 UG | 5400 |
| R&D Systems | 4850-20-01 | TACS DNA Laddering Kit Lysis Solution 1 (2 x 1 mL) (2 ML) | 2 ML | 600 |
| R&D Systems | 4858-NM-005 | Recombinant Influenza A Virus H1N1 Neuraminidase, CF (5 UG) | 5 UG | 4280 |
| R&D Systems | 4859-20-K | Apoptotic DNA Laddering Kit - Tissue Supplement (20 TESTS) | 20 TESTS | 970 |
| R&D Systems | 486-LT-025 | Recombinant Mouse XCL1/Lymphotactin (25 UG) | 25 UG | 4280 |
| R&D Systems | 486-LT-025/CF | Recombinant Mouse XCL1/Lymphotactin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4868-FC-050 | Recombinant Mouse FCRLB/FCRY, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 487-C-010 | Recombinant Mouse CCL6/C10 (10 UG) | 10 UG | 2720 |
| R&D Systems | 487-C-050 | Recombinant Mouse CCL6/C10 (50 UG) | 50 UG | 5190 |
| R&D Systems | 487-C-010/CF | Recombinant Mouse CCL6/C10, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 487-C-050/CF | Recombinant Mouse CCL6/C10, CF (50 UG) | 50 UG | 5190 |
| R&D Systems | 4876-05-02 | Cytonin (2 x 5 mL) (2 VL) | 2 VL | 1210 |
| R&D Systems | 4879-AC-010 | Recombinant Human Activin AC Heterodimer (10 UG) | 10 UG | 4410 |
| R&D Systems | 4879-AC-010/CF | Recombinant Human Activin AC Heterodimer, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 488-TO-200 | Recombinant Mouse Thrombopoietin (200 UG) | 200 UG | 16890 |
| R&D Systems | 488-TO-025 | Recombinant Mouse Thrombopoietin (25 UG) | 25 UG | 11640 |
| R&D Systems | 488-TO-005 | Recombinant Mouse Thrombopoietin (5 UG) | 5 UG | 4150 |
| R&D Systems | 488-TO-200/CF | Recombinant Mouse Thrombopoietin, CF (200 UG) | 200 UG | 16890 |
| R&D Systems | 488-TO-025/CF | Recombinant Mouse Thrombopoietin, CF (25 UG) | 25 UG | 11640 |
| R&D Systems | 488-TO-005/CF | Recombinant Mouse Thrombopoietin, CF (5 UG) | 5 UG | 4150 |
| R&D Systems | 4880-AN-050 | Recombinant Mouse Angiopoietin-like 4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4884-CD-050 | Recombinant Mouse CD1d1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4885-SE-010 | Recombinant Mouse Coagulation Factor XIV/Protein C, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4886-AH-010 | Recombinant Mouse ASAHL, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4887-KH-010 | Recombinant Human Kynureninase, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 4888-CL-050 | Recombinant Human CLEC10A/CD301, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4889-FN-025 | Recombinant Human Follistatin (aa 30-344) (25 UG) | 25 UG | 4280 |
| R&D Systems | 4889-FN-025/CF | Recombinant Human Follistatin (aa 30-344), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 489-AC-010 | Recombinant Mouse Activin C (10 UG) | 10 UG | 3760 |
| R&D Systems | 489-AC-010/CF | Recombinant Mouse Activin C, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 4890-025-K | MTT Cell Proliferation/Viability Assay (2500 TESTS) | 2500 TESTS | 3260 |
| R&D Systems | 4890-050-K | MTT Cell Proliferation/Viability Assay (5000 TESTS) | 5000 TESTS | 4900 |
| R&D Systems | 4890-FN-050 | Recombinant Human Follistatin-like 4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4891-025-K | TACS XTT Cell Proliferation/Viability Assay (2500 TESTS) | 2500 TESTS | 4780 |
| R&D Systems | 4892-010-K | Calcein AM Cell Viability Assay (1000 TESTS) | 1000 TESTS | 2770 |
| R&D Systems | 4894-EM-050 | Recombinant Human EMR2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4895-MR-100 | Recombinant Rat IL-1 RI Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 4896-RR-025 | Recombinant Rat IL-9 R (25 UG) | 25 UG | 4280 |
| R&D Systems | 4896-RR-025/CF | Recombinant Rat IL-9 R, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4897-LR-050 | Recombinant Human LRRTM1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4898-LR-050 | Recombinant Human LRRTM3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4899-NR-050 | Recombinant Human NGL-1/LRRC4C, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 490-IR-200/CF | Recombinant Mouse IL-11 R alpha Fc Chimera, CF (200 UG) | 200 UG | 4540 |
| R&D Systems | 4900-SR-050 | Recombinant Human SCARA5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4905-SL-050 | Recombinant Human Siglec-14 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4907-RK-050 | Recombinant Human Ryk Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4908-AD-050 | Recombinant Human ADAM22, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4909-CD-050 | Recombinant Human CD21, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 491-IR-200 | Recombinant Mouse IL-13 R alpha 1 Fc Chimera (200 UG) | 200 UG | 4800 |
| R&D Systems | 491-IR-200/CF | Recombinant Mouse IL-13 R alpha 1 Fc Chimera, CF (200 UG) | 200 UG | 4800 |
| R&D Systems | 4910-K3-050 | Recombinant Human Kirrel3/NEPH2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4914-MG-050 | Recombinant Human MAGP-2/MFAP5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4918-PL-025 | Recombinant Mouse PLTP (25 UG) | 25 UG | 4280 |
| R&D Systems | 4918-PL-025/CF | Recombinant Mouse PLTP, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 492-MM-010 | Recombinant Mouse CXCL9/MIG (10 UG) | 10 UG | 3240 |
| R&D Systems | 492-MM-050 | Recombinant Mouse CXCL9/MIG (50 UG) | 50 UG | 5190 |
| R&D Systems | 492-MM-010/CF | Recombinant Mouse CXCL9/MIG, CF (10 UG) | 10 UG | 3240 |
| R&D Systems | 492-MM-050/CF | Recombinant Mouse CXCL9/MIG, CF (50 UG) | 50 UG | 5190 |
| R&D Systems | 4920-CE-010 | Recombinant Human Carboxylesterase 1/CES1, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 4924-EN-010 | Recombinant Human ENPP-7/Alk-SMase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4925-PL-010 | Recombinant Mouse PLA2G2A, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 493-MV-025 | Recombinant Mouse VEGF 164 (25 UG) | 25 UG | 10780 |
| R&D Systems | 493-MV-005 | Recombinant Mouse VEGF 164 (5 UG) | 5 UG | 3370 |
| R&D Systems | 493-MV-025/CF | Recombinant Mouse VEGF 164, CF (25 UG) | 25 UG | 10780 |
| R&D Systems | 493-MV-005/CF | Recombinant Mouse VEGF 164, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 494-VE-025 | Recombinant Mouse VEGF 120 (25 UG) | 25 UG | 10780 |
| R&D Systems | 494-VE-005 | Recombinant Mouse VEGF 120 (5 UG) | 5 UG | 3370 |
| R&D Systems | 494-VE-025/CF | Recombinant Mouse VEGF 120, CF (25 UG) | 25 UG | 10780 |
| R&D Systems | 494-VE-005/CF | Recombinant Mouse VEGF 120, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 4946-ZN-010 | Recombinant Mouse PSMA/FOLH1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4947-AC-010 | Recombinant Mouse CD38, CF (10 UG) | 10 UG | 4020 |
| R&D Systems | 4949-GT-020 | Recombinant Human Fucosyltransferase 5/FUT5, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 495-MO-025 | Recombinant Mouse Oncostatin M (OSM) (25 UG) | 25 UG | 3370 |
| R&D Systems | 495-MO-025/CF | Recombinant Mouse Oncostatin M (OSM), CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 4950-GT-020 | Recombinant Human Fucosyltransferase 3/FUT3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 4954-AN-050 | Recombinant Human Angiopoietin-like 3 (aa 17-220), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4955-DC-050 | Recombinant Human Desmocollin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4956-HD-050 | Recombinant Human HRP-2 Isoform 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4957-NX-050 | Recombinant Human Neurexophilin-1/NXPH1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4958-PC-050 | Recombinant Human Plexin B3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4959-GL-02M | Recombinant Human Glyoxalase I, CF (2500 UG) | 2500 UG | 3110 |
| R&D Systems | 496-EB-200 | Recombinant Mouse Ephrin-B2 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 4960-AN-025 | Recombinant Mouse Angiopoietin-like 7 (25 UG) | 25 UG | 4280 |
| R&D Systems | 4960-AN-025/CF | Recombinant Mouse Angiopoietin-like 7, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 4969-BA-050 | Recombinant Human BAI1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 497-LR-100 | Recombinant Mouse Leptin R Fc Chimera (100 UG) | 100 UG | 4540 |
| R&D Systems | 497-LR-100/CF | Recombinant Mouse Leptin R Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 4974-AD-050 | Recombinant Human ADAM23, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 498-OB-01M | Recombinant Mouse Leptin, CF (1 MG) | 1 MG | 2720 |
| R&D Systems | 498-OB-05M | Recombinant Mouse Leptin, CF (5 MG) | 5 MG | 6750 |
| R&D Systems | 4989-BC-050 | Recombinant Mouse SEZ6/BSRP-C, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 499-ML-025 | Recombinant Mouse IL-12/IL-23 p40 Homodimer (25 UG) | 25 UG | 4670 |
| R&D Systems | 499-ML-025/CF | Recombinant Mouse IL-12/IL-23 p40 Homodimer, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 4994-MC-050 | Recombinant Human MCEMP1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4995-LR-050 | Recombinant Human LRRC4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 4998-SE-010 | Recombinant Human Active Coagulation Factor XIV/ProteinC, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 4999-FH-050 | Recombinant Mouse Complement Factor H, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5-001-A | Normal Sheep IgG Control (1 MG) | 1 MG | 1080 |
| R&D Systems | 500-RL-025 | Recombinant Rat IL-1 alpha/IL-1F1 (25 UG) | 25 UG | 5190 |
| R&D Systems | 500-RL-005 | Recombinant Rat IL-1 alpha/IL-1F1 (5 UG) | 5 UG | 3370 |
| R&D Systems | 500-RL-025/CF | Recombinant Rat IL-1 alpha/IL-1F1, CF (25 UG) | 25 UG | 5190 |
| R&D Systems | 500-RL-005/CF | Recombinant Rat IL-1 alpha/IL-1F1, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 501-RL-010 | Recombinant Rat IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3760 |
| R&D Systems | 501-RL-050 | Recombinant Rat IL-1 beta/IL-1F2 (50 UG) | 50 UG | 10990 |
| R&D Systems | 501-RL-010/CF | Recombinant Rat IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 501-RL-050/CF | Recombinant Rat IL-1 beta/IL-1F2, CF (50 UG) | 50 UG | 10990 |
| R&D Systems | 5017-CR-050 | Recombinant Mouse CRISP-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5018-PL-010 | Recombinant Human PLA2G1B, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5019-AM-050 | Recombinant Human ASAM, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 502-RL-010 | Recombinant Rat IL-2 (10 UG) | 10 UG | 3110 |
| R&D Systems | 502-RL-050 | Recombinant Rat IL-2 (50 UG) | 50 UG | 9950 |
| R&D Systems | 502-RL-010/CF | Recombinant Rat IL-2, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 502-RL-050/CF | Recombinant Rat IL-2, CF (50 UG) | 50 UG | 9950 |
| R&D Systems | 5020-BP-010 | Recombinant Mouse BMP-4 (10 UG) | 10 UG | 5710 |
| R&D Systems | 5020-BP-010/CF | Recombinant Mouse BMP-4, CF (10 UG) | 10 UG | 5710 |
| R&D Systems | 5024-CD-050 | Recombinant Mouse CD99-L2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5025-CL-050 | Recombinant Human CL-K1/COLEC11, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5026-DL-050 | Recombinant Mouse DLL1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5027-FF-025 | Recombinant Human FGF-8f (25 UG) | 25 UG | 3370 |
| R&D Systems | 5027-FF-025/CF | Recombinant Human FGF-8f, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 5028-KG-025 | Recombinant Mouse KGF/FGF-7 (25 UG) | 25 UG | 4280 |
| R&D Systems | 5028-KG-025/CF | Recombinant Mouse KGF/FGF-7, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5029-RG-100 | Recombinant Rat gp130 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 503-CX-025 | Recombinant Mouse CXCL16 (25 UG) | 25 UG | 4150 |
| R&D Systems | 503-CX-025/CF | Recombinant Mouse CXCL16, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 5030-K1-050 | Recombinant Mouse Kirrel1/NEPH1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5034-R3-050 | Recombinant Mouse TGF-beta RIII, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 5035-TG-025 | Recombinant Guinea Pig TNF-alpha (25 UG) | 25 UG | 4280 |
| R&D Systems | 5035-TG-025/CF | Recombinant Guinea Pig TNF-alpha, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5036-GMP-010 | Recombinant Human Wnt-3a GMP, CF (10 UG) | 10 UG | 3510 |
| R&D Systems | 5036-GMP-01M | Recombinant Human Wnt-3a GMP, CF (1 MG) | 1 MG | 98800 |
| R&D Systems | 5036-GMP-050 | Recombinant Human Wnt-3a GMP, CF (50 UG) | 50 UG | 11510 |
| R&D Systems | 5036-WN-010 | Recombinant Human Wnt-3a (10 UG) | 10 UG | 3110 |
| R&D Systems | 5036-WN-500 | Recombinant Human Wnt-3a (500 UG) | 500 UG | 50570 |
| R&D Systems | 5036-WN-010/CF | Recombinant Human Wnt-3a, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 5036-WN-500/CF | Recombinant Human Wnt-3a, CF (500 UG) | 500 UG | 50570 |
| R&D Systems | 5036-WNP-010 | Recombinant Human Wnt-3a (High Purity) (10 UG) | 10 UG | 9090 |
| R&D Systems | 5036-WNP-010/CF | Recombinant Human Wnt-3a (High Purity), CF (10 UG) | 10 UG | 9090 |
| R&D Systems | 504-RL-025 | Recombinant Rat IL-4 (25 UG) | 25 UG | 8130 |
| R&D Systems | 504-RL-005 | Recombinant Rat IL-4 (5 UG) | 5 UG | 2720 |
| R&D Systems | 504-RL-025/CF | Recombinant Rat IL-4, CF (25 UG) | 25 UG | 8130 |
| R&D Systems | 504-RL-005/CF | Recombinant Rat IL-4, CF (5 UG) | 5 UG | 2720 |
| R&D Systems | 5047-SE-010 | Recombinant Human Tryptase epsilon/BSSP-4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 505-PR-100 | Recombinant Human BMPR-IB/ALK-6 Fc Chimera, CF (100 UG) | 100 UG | 5450 |
| R&D Systems | 5055-MD-050 | Recombinant Human MDGA1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5057-ST-020 | Recombinant Human Heparan Sulfate-6-O-Sulfotransferase-1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 506-RL-010 | Recombinant Rat IL-6 (10 UG) | 10 UG | 2720 |
| R&D Systems | 506-RL-050 | Recombinant Rat IL-6 (50 UG) | 50 UG | 8440 |
| R&D Systems | 506-RL-010/CF | Recombinant Rat IL-6, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 506-RL-050/CF | Recombinant Rat IL-6, CF (50 UG) | 50 UG | 8440 |
| R&D Systems | 507-BP-020 | Recombinant Human BMP-6 (20 UG) | 20 UG | 6230 |
| R&D Systems | 507-BP-020/CF | Recombinant Human BMP-6, CF (20 UG) | 20 UG | 6230 |
| R&D Systems | 508-CK-025 | Recombinant Human CCL23/Ck beta 8-1 (aa 46-137) (25 UG) | 25 UG | 3760 |
| R&D Systems | 508-CK-025/CF | Recombinant Human CCL23/Ck beta 8-1 (aa 46-137), CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 5080-NM-010 | Recombinant C. perfringens Neuraminidase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5084-NM-010 | Recombinant M. viridifaciens Neuraminidase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5086-CT-010 | Recombinant Human g-Glutamylcyclotransferase/CRF21, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5087-AH-050 | Recombinant Human Apolipoprotein H, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 509-MI-025 | Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta (25 UG) | 25 UG | 4750 |
| R&D Systems | 509-MI-025/CF | Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta, CF (25 UG) | 25 UG | 4750 |
| R&D Systems | 5095-AC-050 | Recombinant Mouse Adiponectin/Acrp30, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 5096-BM-005 | Recombinant Human BMP-15 (5 UG) | 5 UG | 3890 |
| R&D Systems | 5097-CD-050 | Recombinant Human CDNF, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 5098-NX-050 | Recombinant Rat Neurexophilin-3/NXPH3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5099-TA-050 | Recombinant Human TAFA4/FAM19A4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 510-RT-010 | Recombinant Rat TNF-alpha (10 UG) | 10 UG | 2980 |
| R&D Systems | 510-RT-050 | Recombinant Rat TNF-alpha (50 UG) | 50 UG | 9090 |
| R&D Systems | 510-RT-010/CF | Recombinant Rat TNF-alpha, CF (10 UG) | 10 UG | 2980 |
| R&D Systems | 510-RT-050/CF | Recombinant Rat TNF-alpha, CF (50 UG) | 50 UG | 9090 |
| R&D Systems | 5100-QB-050 | Recombinant Human QBRICK Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5106-PL-010 | Recombinant Human PLA2G7/PAF-AH/Lp-PLA2, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 5107-ST-020 | Recombinant Human CHST2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5108-ST-020 | Recombinant Mouse CHST7, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 511-MM-010 | Recombinant Human MMP-13, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 5110-RG-050 | Recombinant Mouse Reg3B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5112-CH-050 | Recombinant Human Chitinase 3-like 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 512-GF-010 | Recombinant Rat GDNF (10 UG) | 10 UG | 3890 |
| R&D Systems | 512-GF-050 | Recombinant Rat GDNF (50 UG) | 50 UG | 12290 |
| R&D Systems | 512-GF-010/CF | Recombinant Rat GDNF, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 512-GF-050/CF | Recombinant Rat GDNF, CF (50 UG) | 50 UG | 12290 |
| R&D Systems | 513-MP-010 | Recombinant Human MMP-3, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 514-CD-050 | Recombinant Human sCD4 (50 UG) | 50 UG | 4410 |
| R&D Systems | 514-CD-050/CF | Recombinant Human sCD4, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 5140-SM-050 | Recombinant Human SMOC-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5146-SE-010 | Recombinant Mouse Mast Cell Protease-1/Mcpt1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5148-TA-050 | Recombinant Human TAFA5/FAM19A5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5149-AD-020 | Recombinant Human ADAMTS15, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 515-CN-010 | Recombinant Rat CXCL1/CINC-1 (10 UG) | 10 UG | 2720 |
| R&D Systems | 515-CN-050 | Recombinant Rat CXCL1/CINC-1 (50 UG) | 50 UG | 5190 |
| R&D Systems | 515-CN-010/CF | Recombinant Rat CXCL1/CINC-1, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 515-CN-050/CF | Recombinant Rat CXCL1/CINC-1, CF (50 UG) | 50 UG | 5190 |
| R&D Systems | 5150-GH-010 | Recombinant S. agalactiae Hyaluronan Lyase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5154-TA-050 | Recombinant Human TAFA1/FAM19A1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5155-HB-050 | Recombinant Human HABP1/C1QBP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5156-RM-050 | Recombinant Rat CD25/IL-2 R alpha Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5158-NL-050 | Recombinant Human Neuroligin 4/NLGN4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 516-CA-025 | Recombinant Rat CXCL3/CINC-2 alpha (25 UG) | 25 UG | 3760 |
| R&D Systems | 516-CA-025/CF | Recombinant Rat CXCL3/CINC-2 alpha, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 5160-EN-010 | Recombinant Mouse ENPP-7/Alk-SMase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5164-SE-010 | Recombinant Human Kallikrein 6, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 517-CB-025 | Recombinant Rat CXCL3/CINC-2 beta (25 UG) | 25 UG | 3760 |
| R&D Systems | 517-CB-025/CF | Recombinant Rat CXCL3/CINC-2 beta, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 5170-CL-050 | Recombinant Human CLEC3B/Tetranectin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 518-GM-025 | Recombinant Rat GM-CSF (25 UG) | 25 UG | 4150 |
| R&D Systems | 518-GM-005 | Recombinant Rat GM-CSF (5 UG) | 5 UG | 1680 |
| R&D Systems | 518-GM-025/CF | Recombinant Rat GM-CSF, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 518-GM-005/CF | Recombinant Rat GM-CSF, CF (5 UG) | 5 UG | 1680 |
| R&D Systems | 5184-MD-050 | Recombinant Human MDGA2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5185-CD-050 | Recombinant Human CD99-L2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5186-A6-050 | Recombinant Human Annexin A6, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5187-CD-050 | Recombinant Mouse CDNF, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5188-EA-050 | Recombinant Human EphA10 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5189-B2-050 | Recombinant Human EphB2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5190-GR-050 | Recombinant Human Gremlin, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 5194-IL-025 | Recombinant Human IL-17A/F Heterodimer (25 UG) | 25 UG | 4280 |
| R&D Systems | 5194-IL-025/CF | Recombinant Human IL-17A/F Heterodimer, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5195-ML-010 | Recombinant Mouse IL-34 (10 UG) | 10 UG | 4280 |
| R&D Systems | 5195-ML-010/CF | Recombinant Mouse IL-34, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5196-NT-050 | Recombinant Mouse Notch-2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5197-SL-050 | Recombinant Human Siglec-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5198-SR-050 | Recombinant Mouse SIGNR7/CD209g, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5199-SL-050 | Recombinant Mouse Slit1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 520-BB-050 | Recombinant Rat PDGF-BB (50 UG) | 50 UG | 3500 |
| R&D Systems | 520-BB-050/CF | Recombinant Rat PDGF-BB, CF (50 UG) | 50 UG | 3500 |
| R&D Systems | 521-RL-025 | Recombinant Rat IL-18/IL-1F4 (25 UG) | 25 UG | 2980 |
| R&D Systems | 521-RL-025/CF | Recombinant Rat IL-18/IL-1F4, CF (25 UG) | 25 UG | 2980 |
| R&D Systems | 5210-ST-020 | Recombinant Mouse CHST5, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 522-RL-025 | Recombinant Rat IL-10 (25 UG) | 25 UG | 10390 |
| R&D Systems | 522-RL-005 | Recombinant Rat IL-10 (5 UG) | 5 UG | 3240 |
| R&D Systems | 522-RL-025/CF | Recombinant Rat IL-10, CF (25 UG) | 25 UG | 10390 |
| R&D Systems | 522-RL-005/CF | Recombinant Rat IL-10, CF (5 UG) | 5 UG | 3240 |
| R&D Systems | 5220-GH-050 | Recombinant F. meningosepticum Endo F1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5224-GHB-050 | Recombinant S. plicatus Endo H, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 523-ST-100 | Recombinant Human ST2/IL-1 R4 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 5234-CR-050 | Recombinant Human CRTAC1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5235-S4-050 | Recombinant Mouse Semaphorin 4D/CD100 Fc Chimera, CF (50 UG) | 50 UG | 4230 |
| R&D Systems | 524-GR-050 | Recombinant Mouse GITR/TNFRSF18 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 5247-CD-050 | Recombinant Human CD24 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5249-CH-050 | Recombinant Human Cochlin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 525-C3-025 | Recombinant Rat CXCL2/CINC-3 (25 UG) | 25 UG | 3760 |
| R&D Systems | 525-C3-025/CF | Recombinant Rat CXCL2/CINC-3, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 5255-EN-010 | Recombinant Human ENPP-2/Autotaxin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5257-FL-050 | Recombinant Mouse FGL2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5259-IL-025 | Recombinant Human IL-28B/IFN-lambda 3 (25 UG) | 25 UG | 4280 |
| R&D Systems | 5259-IL-025/CF | Recombinant Human IL-28B/IFN-lambda 3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 526-SA-050 | Recombinant Mouse Fas Ligand/TNFSF6 (50 UG) | 50 UG | 4800 |
| R&D Systems | 526-SA-050/CF | Recombinant Mouse Fas Ligand/TNFSF6, CF (50 UG) | 50 UG | 4800 |
| R&D Systems | 5260-MR-050 | Recombinant Human IL-28 R alpha/IFN-lambda R1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5265-IL-010 | Recombinant Human IL-34 (10 UG) | 10 UG | 4150 |
| R&D Systems | 5265-IL-010/CF | Recombinant Human IL-34, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 5267-TK-050 | Recombinant Mouse Notch-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5268-NX-050 | Recombinant Human Neurexin 1 beta Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5269-NX-050 | Recombinant Human Neurexin 3 beta Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 527-ME-100 | Recombinant Mouse HGF R/c-MET Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 528-MP-025 | Recombinant Mouse CCL24/Eotaxin-2/MPIF-2 (aa 24-119) (25 UG) | 25 UG | 4150 |
| R&D Systems | 528-MP-025/CF | Recombinant Mouse CCL24/Eotaxin-2/MPIF-2 (aa 24-119), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 5280-CE-010 | Recombinant Mouse Carboxylesterase 2/CES2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5284-CE-010 | Recombinant Mouse Carboxylesterase 5/CES5, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 529-TR-025 | Recombinant Mouse CCL17/TARC (25 UG) | 25 UG | 4280 |
| R&D Systems | 529-TR-025/CF | Recombinant Mouse CCL17/TARC, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5297-EN-010 | Recombinant Human CD39L4/ENTPD5, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5298-SK-010 | Recombinant Human Sphingosine Kinase 2/SPHK2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 530-MR-100 | Recombinant Mouse IL-4 R alpha Fc Chimera, CF (100 UG) | 100 UG | 5320 |
| R&D Systems | 531-PA-100 | Recombinant Mouse uPAR Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 5316-ST-020 | Recombinant Human CHST1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5319-FR-050 | Recombinant Human FOLR3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 532-R2-050 | Recombinant Mouse TGF-beta RII/(human) Fc Chimera, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 5325-GH-010 | Recombinant Mouse Chitotriosidase/CHIT1, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 5326-ST-020 | Recombinant Human CHST6, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5329-PB-050 | Recombinant Human Plexin B2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 533-VI-025 | Recombinant Mouse CCL28 (25 UG) | 25 UG | 3760 |
| R&D Systems | 533-VI-025/CF | Recombinant Mouse CCL28, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 5330-RH-050 | Recombinant Mouse TNFRH3/TNFRSF26 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5334-KL-025 | Recombinant Human Klotho (aa 34-981), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 5335-RN-050 | Recombinant Mouse Resistin, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 5336-VE-010 | Recombinant Human VEGF 111 (10 UG) | 10 UG | 3760 |
| R&D Systems | 5336-VE-010/CF | Recombinant Human VEGF 111, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 5346-CL-050 | Recombinant Human Calsyntenin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5348-PD-010 | Recombinant Human SMPD1, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 5349-SA-050 | Recombinant Human SALM4/LRFN3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 535-IN-025 | Recombinant Porcine CXCL8/IL-8 (25 UG) | 25 UG | 4280 |
| R&D Systems | 535-IN-025/CF | Recombinant Porcine CXCL8/IL-8, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5355-ST-020 | Recombinant Mouse CHST1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5356-ST-020 | Recombinant Mouse CHST3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5357-ST-020 | Recombinant Human CHST4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 536-FR-025 | Recombinant Rat CX3CL1/Fractalkine (25 UG) | 25 UG | 4150 |
| R&D Systems | 536-FR-025/CF | Recombinant Rat CX3CL1/Fractalkine, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 5360-NP-050 | Recombinant Human Neuroplastin 65, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5367-PL-050 | Recombinant Mouse PLA2R1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5368-RB-050 | Recombinant Mouse IL-10 R beta Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 537-FT-025 | Recombinant Rat CX3CL1/Fractalkine (Chemokine Domain) (25 UG) | 25 UG | 4150 |
| R&D Systems | 537-FT-025/CF | Recombinant Rat CX3CL1/Fractalkine (Chemokine Domain), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 5370-SD-050 | Recombinant Human USAG1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5374-PL-010 | Recombinant Human PLA2G2A, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5375-PC-050 | Recombinant Mouse Plexin C1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5377-LR-050 | Recombinant Human LRRTM4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 538-MG-100 | Recombinant Rat MAG/Siglec-4a Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5384-MR-050 | Recombinant Mouse IL-28 R alpha/IFN-lambda R1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 539-IR-100 | Recombinant Mouse IL-13 R alpha 2 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5390-IL-025 | Recombinant Mouse IL-17A/F Heterodimer (25 UG) | 25 UG | 4410 |
| R&D Systems | 5390-IL-025/CF | Recombinant Mouse IL-17A/F Heterodimer, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 5394-SR-050 | Recombinant Human Kilon/NEGR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5395-L4-050 | Recombinant Human LRP-1 Cluster IV Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5396-SF-025 | Recombinant Human sFRP-1, CF (25 UG) | 25 UG | 4230 |
| R&D Systems | 5397-A3-050 | Recombinant Human Integrin alpha 4 beta 7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5398-LR-050 | Recombinant Human LRRN3/NLRR-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 540-RM-025 | Recombinant Rat CCL20/MIP-3 alpha (25 UG) | 25 UG | 4280 |
| R&D Systems | 540-RM-025/CF | Recombinant Rat CCL20/MIP-3 alpha, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5405-CD-050 | Recombinant Human CD72 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5406-ST-020 | Recombinant Mouse Heparan Sulfate-6-O-Sulfotransferase-3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 541-A5-200 | Recombinant Rat EphA5 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 5418-TG-010 | Recombinant Mouse Transglutaminase 2/TGM2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5419-SE-010 | Recombinant Human DPP9, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5420-ZN-010 | Recombinant Botulinum Neurotoxin Type B Light Chain, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5424-ZN-010 | Recombinant Botulinum Neurotoxin Type E Light Chain, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5426-TG-010 | Recombinant Human Transglutaminase 7/TGM7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5427-MM-010 | Recombinant Rat MMP-9, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 5428-C4-050 | Recombinant Human C4.4A/LYPD3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5428-CE-010 | Recombinant Mouse Carboxylesterase 3/CES3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 543-RL-025 | Recombinant Rat LIX (25 UG) | 25 UG | 4280 |
| R&D Systems | 543-RL-025/CF | Recombinant Rat LIX, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5437-GP-050 | Recombinant Human GPR115, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5438-A9-050 | Recombinant Human Integrin alpha 9 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5439-DK-010 | Recombinant Human Dkk-1 (10 UG) | 10 UG | 4150 |
| R&D Systems | 5439-DK-100/CF | Recombinant Human Dkk-1, CF (100 UG) | 100 UG | 28600 |
| R&D Systems | 5439-DK-010/CF | Recombinant Human Dkk-1, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 5439-DK-01M/CF | Recombinant Human Dkk-1, CF (1 MG) | 1 MG | 85800 |
| R&D Systems | 5439-GMP-010 | Recombinant Human Dkk-1 GMP, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 5440-S3-025 | Recombinant Mouse Semaphorin 3B Fc Chimera (25 UG) | 25 UG | 4280 |
| R&D Systems | 5440-S3-025/CF | Recombinant Mouse Semaphorin 3B Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5444-SL-050 | Recombinant Mouse Slit2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5445-SA-050 | Recombinant Human SALM3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 545-RL-010 | Recombinant Rat IL-5 (10 UG) | 10 UG | 3890 |
| R&D Systems | 545-RL-010/CF | Recombinant Rat IL-5, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 5455-PK-010 | Recombinant Human PGK-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 546-TR-050 | Recombinant Mouse TSLP R Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5468-ST-020 | Recombinant Human TPST1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5469-GT-020 | Recombinant Human N-Acetylglucosaminyltransferase V/MGAT5 CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 547-RL-010 | Recombinant Rat IL-10 (Cys167Tyr) (10 UG) | 10 UG | 3890 |
| R&D Systems | 547-RL-010/CF | Recombinant Rat IL-10 (Cys167Tyr), CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 5477-KS-010 | Recombinant Human Active P38 alpha, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 548-MM-010 | Recombinant Mouse MMP-3, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 5480-CL-050 | Recombinant Human Calsyntenin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5486-PA-050 | Recombinant Mouse Plexin A2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5487-NL-050 | Recombinant Human NELL1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 549-R3-100 | Recombinant Mouse IL-3 R beta Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5490-CD-050 | Recombinant Mouse CD55/DAF, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5494-CD-050 | Recombinant Mouse CD97v2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5495-CN-050 | Recombinant Mouse Contactin-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5496-MF-050 | Recombinant Mouse FGF R2 alpha (IIIb) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5497-A6-050 | Recombinant Human Integrin alpha 6 (X1) beta 4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5498-PS-050 | Recombinant Human PSP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5499-G6-050 | Recombinant Human G6b Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 550-AG-100 | Recombinant Rat Agrin (100 UG) | 100 UG | 4280 |
| R&D Systems | 550-AG-100/CF | Recombinant Rat Agrin, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5504-CP-050 | Recombinant Human CILP-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 551-MR-100 | Recombinant Mouse IL-15 R alpha Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5517-SE-010 | Recombinant Mouse Tryptase gamma-1/TPSG1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5518-CE-010 | Recombinant Mouse Acetylcholinesterase/ACHE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 552-R1-010 | Recombinant Cotton Rat IL-1 alpha/IL-1F1 (10 UG) | 10 UG | 3370 |
| R&D Systems | 552-R1-010/CF | Recombinant Cotton Rat IL-1 alpha/IL-1F1, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 5527-CE-010 | Recombinant Mouse Butyrylcholinesterase/BCHE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 553-MR-025 | Recombinant Mouse IL-5 R alpha Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5536-SK-010 | Recombinant Human Sphingosine Kinase 1/SPHK1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5539-CN-050 | Recombinant Human Contactin-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5545-ST-020 | Recombinant Human SULT1E1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5546-ST-020 | Recombinant Human SULT1A1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5547-ST-020 | Recombinant Mouse CHST4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5548-GH-010 | Recombinant F. meningosepticum Endo F3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5549-GH-100 | Recombinant S. pneumoniae beta(1-4)-Galactosidase, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 555-TS-010 | Recombinant Mouse TSLP (10 UG) | 10 UG | 4280 |
| R&D Systems | 555-TS-010/CF | Recombinant Mouse TSLP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 555-TSB-010 | Recombinant Mouse TSLP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5550-SM-050 | Recombinant Mouse SMOC-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 556-NG-100 | Recombinant Rat beta-NGF (100 UG) | 100 UG | 3760 |
| R&D Systems | 556-NG-100/CF | Recombinant Rat beta-NGF, CF (100 UG) | 100 UG | 3760 |
| R&D Systems | 5566-BP-010 | Recombinant Mouse BMP-9 (10 UG) | 10 UG | 5320 |
| R&D Systems | 5566-BP-010/CF | Recombinant Mouse BMP-9, CF (10 UG) | 10 UG | 5320 |
| R&D Systems | 5567-C4-050 | Recombinant Mouse C4.4A/LYPD3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5568-CA-025 | Recombinant Mouse CXCL3/DCIP-1 (25 UG) | 25 UG | 3760 |
| R&D Systems | 5568-CA-025/CF | Recombinant Mouse CXCL3/DCIP-1, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 557-NT-010 | Recombinant Rat CNTF (10 UG) | 10 UG | 2200 |
| R&D Systems | 557-NT-050 | Recombinant Rat CNTF (50 UG) | 50 UG | 6620 |
| R&D Systems | 557-NT-010/CF | Recombinant Rat CNTF, CF (10 UG) | 10 UG | 2200 |
| R&D Systems | 557-NT-050/CF | Recombinant Rat CNTF, CF (50 UG) | 50 UG | 6620 |
| R&D Systems | 5570-S3-050 | Recombinant Human Semaphorin 3C Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5576-AO-020 | Recombinant Mouse IL-4I1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 558-CR-050 | Recombinant Rat CNTF R alpha (50 UG) | 50 UG | 4670 |
| R&D Systems | 558-CR-050/CF | Recombinant Rat CNTF R alpha, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 5598-S6-050 | Recombinant Human SEZ6L, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 560-GR-100 | Recombinant Rat GFR alpha-1 Fc Chimera (100 UG) | 100 UG | 4280 |
| R&D Systems | 560-GR-100/CF | Recombinant Rat GFR alpha-1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5604-CA-050 | Recombinant Human Cadherin-20 (CAD-20), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5605-EN-025 | Recombinant Porcine Endoglin/CD105 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5606-A6-050 | Recombinant Human EphA6 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5607-RR-050 | Recombinant Rat IL-7 R alpha Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5608-GA-050 | Recombinant Mouse Galectin-3BP/MAC-2BP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5609-MU-050 | Recombinant Human CA125/MUC16, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 561-R6-025 | Recombinant Cotton Rat IL-6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 561-R6-025/CF | Recombinant Cotton Rat IL-6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5610-SL-050 | Recombinant Mouse Siglec-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5614-NL-050 | Recombinant Human Olfactomedin-2/Noelin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 563-MR-100 | Recombinant Mouse IL-1 RII Fc Chimera, CF (100 UG) | 100 UG | 5320 |
| R&D Systems | 564-RV-010 | Recombinant Rat VEGF 164 (10 UG) | 10 UG | 4150 |
| R&D Systems | 564-RV-050 | Recombinant Rat VEGF 164 (50 UG) | 50 UG | 11820 |
| R&D Systems | 564-RV-010/CF | Recombinant Rat VEGF 164, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 564-RV-050/CF | Recombinant Rat VEGF 164, CF (50 UG) | 50 UG | 11820 |
| R&D Systems | 5645-NL-050 | Recombinant Human Neuroligin 2/NLGN2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5646-FR-050 | Recombinant Human FOLR1, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 565-RG-025 | Recombinant Cotton Rat IFN-gamma (25 UG) | 25 UG | 3760 |
| R&D Systems | 565-RG-025/CF | Recombinant Cotton Rat IFN-gamma, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 5657-CE-010 | Recombinant Human Carboxylesterase 2/CES2, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 5658-CE-010 | Recombinant Mouse Carboxyl Ester Lipase/CEL, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 566-N1-025 | Recombinant Rat Neuropilin-1 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 566-NNS-025 | Recombinant Rat Neuropilin-1 Fc Chimera (NS0-expressed), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5660-DH-010 | Recombinant Human 15-PGDH/HPGD, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5665-NG-050 | Recombinant Mouse Neuroglycan C/CSPG5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5666-BP-010 | Recombinant Mouse BMP-7 (10 UG) | 10 UG | 5320 |
| R&D Systems | 5666-BP-010/CF | Recombinant Mouse BMP-7, CF (10 UG) | 10 UG | 5320 |
| R&D Systems | 5667-B3-050 | Recombinant Human EphB3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5668-A4-050 | Recombinant Human Integrin alpha 4 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5669-SA-050 | Recombinant Human SALM2/LRFN1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 567-N2-025 | Recombinant Rat Neuropilin-2 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5670-TG-025 | Recombinant Rabbit TNF-alpha (25 UG) | 25 UG | 4280 |
| R&D Systems | 5670-TG-025/CF | Recombinant Rabbit TNF-alpha, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5674-NC-050 | Recombinant Mouse L1CAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5679-PI-010 | Recombinant Mouse Serpin A9/Centerin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 568-FR-025 | Recombinant Rat CX3CL1/Fractalkine (aa 22-100) (25 UG) | 25 UG | 4150 |
| R&D Systems | 568-FR-025/CF | Recombinant Rat CX3CL1/Fractalkine (aa 22-100), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 5680-PD-010 | Recombinant Mouse SMPD1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5684-AO-020 | Recombinant Human IL-4I1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5685-NG-050 | Recombinant Human Neuroglycan C/CSPG5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 569-A4-200 | Recombinant Mouse Ephrin-A4 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 5690-CD-050 | Recombinant Mouse CD96, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5697-FR-050 | Recombinant Human FOLR2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5698-A2-050 | Recombinant Human Integrin alpha 2 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 570-ES-050 | Recombinant Mouse Endostatin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5704-GH-050 | Recombinant X. campestris beta(1-3)-Galactosidase, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5705-GH-100 | Recombinant C. perfringens a-N-acetylgalactosaminidase, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5709-PR-050 | Recombinant Human PTH1R/PTHR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 571-MF-025 | Recombinant Mouse CX3CL1/Fractalkine (aa 25-105) (25 UG) | 25 UG | 4280 |
| R&D Systems | 571-MF-025/CF | Recombinant Mouse CX3CL1/Fractalkine (aa 25-105), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 572-MC-025 | Recombinant Mouse CXCL11/I-TAC (25 UG) | 25 UG | 4150 |
| R&D Systems | 572-MC-025/CF | Recombinant Mouse CXCL11/I-TAC, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 5725-CN-050 | Recombinant Human Corneodesmosin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 573-RP-100 | Recombinant Rat IL-1 Rrp2/IL-1 R6 Fc Chimera, CF (100 UG) | 100 UG | 5580 |
| R&D Systems | 574-CD-050 | Recombinant Mouse CD27/TNFRSF7 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 5748-CD-050 | Recombinant Human CD35, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 5749-DP-050 | Recombinant Mouse Dermatopontin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 575-ES-100 | Recombinant Mouse E-Selectin/CD62E Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5750-F6-025 | Recombinant Mouse FGF-6 (25 UG) | 25 UG | 3370 |
| R&D Systems | 5750-F6-025/CF | Recombinant Mouse FGF-6, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 5754-G3-010 | Recombinant Human GDF-3 (10 UG) | 10 UG | 4280 |
| R&D Systems | 5754-G3-010/CF | Recombinant Human GDF-3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5755-AX-050 | Recombinant Human Integrin alpha X beta 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5757-PL-025 | Recombinant Human Placental Lactogen/CSH1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 5757-PL-025/CF | Recombinant Human Placental Lactogen/CSH1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 576-LS-100 | Recombinant Mouse L-Selectin/CD62L Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5760-TG-050 | Recombinant Human Transglutaminase 4/TGM4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5768-GT-020 | Recombinant Human Fucosyltransferase 8/FUT8, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 577-A7-100 | Recombinant Rat ALK-7 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 578-B5-025 | Recombinant Mouse IGFBP-5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 579-R2-020 | Recombinant Cotton Rat IL-2 (Cys146Tyr) (20 UG) | 20 UG | 4280 |
| R&D Systems | 579-R2-020/CF | Recombinant Cotton Rat IL-2 (Cys146Tyr), CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5795-EN-010 | Recombinant Human 5'-Nucleotidase/CD73, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 5796-ZN-010 | Recombinant Mouse ECE-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5797-EN-010 | Recombinant Mouse CD39L1/ENTPD2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 580-RT-010 | Recombinant Rat TIMP-1, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 5800-NC-050 | Recombinant Mouse Neurocan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5806-SL-050 | Recombinant Mouse Siglec-E Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 581-CR-010 | Recombinant Cotton Rat IL-10 (Cys149Tyr) (10 UG) | 10 UG | 3890 |
| R&D Systems | 581-CR-010/CF | Recombinant Cotton Rat IL-10 (Cys149Tyr), CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 582-ML-010 | Recombinant Mouse IL-22 (10 UG) | 10 UG | 4150 |
| R&D Systems | 582-ML-010/CF | Recombinant Mouse IL-22, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 5820-VA-050 | Recombinant Human VAP-A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5828-ST-020 | Recombinant Human SULT2A1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5829-ST-020 | Recombinant Human SULT1A3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 583-IC-050 | Recombinant Rat ICAM-1/CD54 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 5830-GH-010 | Recombinant B. thetaiotaomicron Heparinase I, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5836-FS-025 | Recombinant Human Follistatin 288 (FS-288) (25 UG) | 25 UG | 4280 |
| R&D Systems | 5836-FS-025/CF | Recombinant Human Follistatin 288 (FS-288), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5837-IL-010 | Recombinant Human IL-17A/F Heterodimer (CHO-expressed), CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 5838-LM-050 | Recombinant Mouse CD300c/LMIR2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5839-MB-025 | Recombinant Canine CCL4/MIP-1 beta (25 UG) | 25 UG | 4280 |
| R&D Systems | 5839-MB-025/CF | Recombinant Canine CCL4/MIP-1 beta, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 584-R4-010 | Recombinant Cotton Rat IL-4 (10 UG) | 10 UG | 3890 |
| R&D Systems | 584-R4-010/CF | Recombinant Cotton Rat IL-4, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 5840-S4-050 | Recombinant Human Semaphorin 4G Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5844-CV-010 | Recombinant Feline VEGF, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5845-NF-050 | Recombinant A. caninum NIF, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5846-F4-025 | Recombinant Mouse FGF-4 (25 UG) | 25 UG | 3370 |
| R&D Systems | 5846-F4-025/CF | Recombinant Mouse FGF-4, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 5847-FZ-050 | Recombinant Human Frizzled-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5848-CL-025 | Recombinant Canine IL-17A (25 UG) | 25 UG | 4280 |
| R&D Systems | 5848-CL-025/CF | Recombinant Canine IL-17A, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5849-ML-025 | Recombinant Canine IL-21 (25 UG) | 25 UG | 4280 |
| R&D Systems | 5849-ML-025/CF | Recombinant Canine IL-21, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 585-IF-100 | Recombinant Rat IFN-gamma (100 UG) | 100 UG | 4230 |
| R&D Systems | 585-IF-100/CF | Recombinant Rat IFN-gamma, CF (100 UG) | 100 UG | 4230 |
| R&D Systems | 5850-A3-050 | Recombinant Human Integrin alpha E beta 7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5855-VB-050 | Recombinant Human VAP-B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5856-PA-050 | Recombinant Human Plexin A4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5860-AP-010 | Recombinant Human APRIL/TNFSF13 (HEK293-expressed) (10 UG) | 10 UG | 4150 |
| R&D Systems | 5860-AP-010/CF | Recombinant Human APRIL/TNFSF13 (HEK293-expressed), CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 5865-NT-010 | Recombinant Human NMNAT-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5867-AD-020 | Recombinant Mouse ADAMTS1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5868-AR-010 | Recombinant Human Arginase 1/ARG1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5869-DH-020 | Recombinant Human Aldehyde Dehydrogenase 1-A1/ALDH1A1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 587-RI-050 | Recombinant Mouse TGF-beta RI/ALK-5 Fc Chimera, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 588-PL-025 | Recombinant Porcine IL-18/IL-1F4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 588-PL-025/CF | Recombinant Porcine IL-18/IL-1F4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5889-KB-050 | Recombinant Human Klotho beta, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 5890-CN-050 | Recombinant Mouse Contactin-6, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5894-CL-025 | Recombinant Canine IL-13 (25 UG) | 25 UG | 4280 |
| R&D Systems | 5894-CL-025/CF | Recombinant Canine IL-13, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5895-AB-050 | Recombinant Human Integrin alpha 10 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5896-S5-025 | Recombinant Human Semaphorin Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 5897-DK-010 | Recombinant Mouse Dkk-1 (10 UG) | 10 UG | 4280 |
| R&D Systems | 5897-DK-010/CF | Recombinant Mouse Dkk-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5898-NR-050 | Recombinant Human NRG1/HRG1, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 5905-AP-010 | Recombinant Human Alkaline Phosphatase/ALPP, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 5906-ZN-010 | Recombinant Human Carboxypeptidase A4/CPA4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 591-MR-100 | Recombinant Mouse Mer Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 592-FR-010 | Recombinant Mouse sFRP-3 (10 UG) | 10 UG | 4280 |
| R&D Systems | 592-FR-010/CF | Recombinant Mouse sFRP-3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5925-FS-010 | Recombinant Human FSH alpha/beta (10 UG) | 10 UG | 4410 |
| R&D Systems | 5925-FS-010/CF | Recombinant Human FSH alpha/beta, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 5926-S3-025 | Recombinant Mouse Semaphorin 3A Fc Chimera (25 UG) | 25 UG | 4280 |
| R&D Systems | 5926-S3-025/CF | Recombinant Mouse Semaphorin 3A Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 593-BC-050 | Recombinant Mouse BCMA/TNFRSF17 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 594-ML-010 | Recombinant Mouse IL-21 (10 UG) | 10 UG | 4150 |
| R&D Systems | 594-ML-010/CF | Recombinant Mouse IL-21, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 5940-RG-050 | Recombinant Human Reg3A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5944-GO-010 | Recombinant Human Glyoxalase II, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5948-LR-025 | Recombinant Human LRP-4, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 595-P4-025 | Recombinant Mouse CXCL4/PF4, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 5959-ST-020 | Recombinant Human SULT1B1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 596-MR-100 | Recombinant Mouse IL-21 R Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5964-GT-020 | Recombinant Human Fucosyltransferase 11/FUT11, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5967-ST-010 | Recombinant Human NDST1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 5968-ST-020 | Recombinant Human HS3ST1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 5969-GH-010 | Recombinant Human Cytosolic beta-Glucosidase/GBA3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 597-LM-010 | Recombinant Mouse Limitin/IFN-zeta Fc Chimera, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 598-LP-01M | Recombinant Rat Leptin, CF (1 MG) | 1 MG | 2720 |
| R&D Systems | 598-LP-05M | Recombinant Rat Leptin, CF (5 MG) | 5 MG | 6750 |
| R&D Systems | 5987-BD-050 | Recombinant Mouse beta-Defensin 3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5988-FZ-050 | Recombinant Human Frizzled-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5989-RM-025 | Recombinant Feline IL-18/IL-1F4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 5989-RM-025/CF | Recombinant Feline IL-18/IL-1F4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 599-JG-100 | Recombinant Rat Jagged 1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 5990-LR-050 | Recombinant Mouse LIF R alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 5994-N1-050 | Recombinant Mouse Neuropilin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6-001-A | Normal Rat IgG Control (1 MG) | 1 MG | 1080 |
| R&D Systems | 6-001-F | Normal Rat IgG Control (Azide Free) (1 MG) | 1 MG | 1080 |
| R&D Systems | 600-VA-025 | Recombinant Viral MIP-I (25 UG) | 25 UG | 4280 |
| R&D Systems | 600-VA-025/CF | Recombinant Viral MIP-I, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6007-CY-020 | Recombinant Human UCH-L1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 601-VB-025 | Recombinant Viral MIP-II (25 UG) | 25 UG | 4280 |
| R&D Systems | 601-VB-025/CF | Recombinant Viral MIP-II, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6018-SE-010 | Recombinant Human Proprotein Convertase 2/PCSK2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 602-A1-200 | Recombinant Mouse Ephrin-A1 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 603-A2-200 | Recombinant Mouse Ephrin-A2 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 6030-AO-010 | Recombinant Human IDO, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6037-ZN-010 | Recombinant Botulinum Neurotoxin Type D Light Chain, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6038-BP-025 | Recombinant Mouse BMP-10 (25 UG) | 25 UG | 6230 |
| R&D Systems | 6038-BP-025/CF | Recombinant Mouse BMP-10, CF (25 UG) | 25 UG | 6230 |
| R&D Systems | 6039-GR-050 | Recombinant Mouse G-CSF R alpha/CD114, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6040-FE-050 | Recombinant Mouse CD23/Fc epsilon RIIA, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6044-LE-050 | Recombinant Human LEDGF p52, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6045-CR-025 | Recombinant Canine CCL5/RANTES (25 UG) | 25 UG | 3630 |
| R&D Systems | 6045-CR-025/CF | Recombinant Canine CCL5/RANTES, CF (25 UG) | 25 UG | 3630 |
| R&D Systems | 6046-ED-050 | Recombinant Human EDIL3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6049-CL-050 | Recombinant Human CLEC9a Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6050-CM-050 | Recombinant Mouse CRIM1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6054-A4-050 | Recombinant Mouse Integrin alpha 4 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6055-LR-050 | Recombinant Human LRRC32/GARP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6056-MC-050 | Recombinant Human MAdCAM-1 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 6057-GMP-100 | Recombinant Human Noggin GMP, CF (100 UG) | 100 UG | 11300 |
| R&D Systems | 6057-GMP-01M | Recombinant Human Noggin GMP, CF (1 MG) | 1 MG | 48100 |
| R&D Systems | 6057-GMP-025 | Recombinant Human Noggin GMP, CF (25 UG) | 25 UG | 4750 |
| R&D Systems | 6057-NG-100 | Recombinant Human Noggin (100 UG) | 100 UG | 9820 |
| R&D Systems | 6057-NG-025 | Recombinant Human Noggin (25 UG) | 25 UG | 4150 |
| R&D Systems | 6057-NG-100/CF | Recombinant Human Noggin, CF (100 UG) | 100 UG | 9820 |
| R&D Systems | 6057-NG-025/CF | Recombinant Human Noggin, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6058-SK-010 | Recombinant Mouse Sphingosine Kinase 2/SPHK2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6059-CE-010 | Recombinant Mouse Carboxylesterase 31-like/EG13909, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6069-AO-010 | Recombinant Human Lysyl Oxidase Homolog 3, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 607-A6-200 | Recombinant Mouse EphA6 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 6070-NC-050 | Recombinant Mouse NCAM-1/CD56, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6074-SM-050 | Recombinant Human SMOC-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6075-SM-050 | Recombinant Mouse SMOC-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6076-WN-005 | Recombinant Human Wnt-4 (5 UG) | 5 UG | 3890 |
| R&D Systems | 6076-WN-005/CF | Recombinant Human Wnt-4, CF (5 UG) | 5 UG | 3890 |
| R&D Systems | 608-A7-200 | Recombinant Mouse EphA7 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 6085-ST-020 | Recombinant Human HS3ST4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6086-SK-010 | Recombinant Mouse Sphingosine Kinase 1/SPHK1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6087-EN-010 | Recombinant Human CD39L1/ENTPD2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6107-AO-010 | Recombinant Mouse VAP-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 611-B6-200 | Recombinant Mouse EphB6 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 612-CD-010 | Recombinant Human Cardiotrophin-1 (CT-1) (10 UG) | 10 UG | 3890 |
| R&D Systems | 612-CD-050 | Recombinant Human Cardiotrophin-1 (CT-1) (50 UG) | 50 UG | 12080 |
| R&D Systems | 612-CD-010/CF | Recombinant Human Cardiotrophin-1 (CT-1), CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 612-CD-050/CF | Recombinant Human Cardiotrophin-1 (CT-1), CF (50 UG) | 50 UG | 12080 |
| R&D Systems | 6125-S4-050 | Recombinant Human Semaphorin 4C Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6126-CD-100 | Recombinant Human CD30/TNFRSF8, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 6127-CD-050 | Recombinant Mouse CD44 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6128-SA-025 | Recombinant Mouse Fas Ligand/TNFSF6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6128-SA-025/CF | Recombinant Mouse Fas Ligand/TNFSF6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6129-FZ-050 | Recombinant Human Frizzled-8 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 613-FR-100 | Recombinant Human GFR alpha-2 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 6130-GR-050 | Recombinant Mouse GM-CSF R alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6136-EN-010 | Recombinant Human ENPP-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6137-CE-010 | Recombinant Human Butyrylcholinesterase/BCHE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6140-ST-020 | Recombinant Human CHST10, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6144-GH-020 | Recombinant Human beta-Glucuronidase/GUSB, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6145-GH-010 | Recombinant P. heparinus Heparinase III, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6146-GH-020 | Recombinant Human alpha-Galactosidase A/GLA, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6147-WF-050 | Recombinant Human Brorin/VWC2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6148-DR-025 | Recombinant Human Draxin (25 UG) | 25 UG | 4280 |
| R&D Systems | 6148-DR-025/CF | Recombinant Human Draxin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6149-DR-025 | Recombinant Mouse Draxin (25 UG) | 25 UG | 4280 |
| R&D Systems | 6149-DR-025/CF | Recombinant Mouse Draxin, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 615-BMC-020 | Recombinant Human BMP-5 (CHO-expressed) (20 UG) | 20 UG | 5710 |
| R&D Systems | 615-BMC-020/CF | Recombinant Human BMP-5 (CHO-expressed), CF (20 UG) | 20 UG | 5710 |
| R&D Systems | 6150-ME-050 | Recombinant Mouse MEPE/OF45, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6154-PI-010 | Recombinant Rat Cystatin C, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6155-AS-020 | Recombinant Human Pepsinogen A, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6156-AD-020 | Recombinant Human ADAMTS13 (Full Length), CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6174-ST-020 | Recombinant Human SULT2B1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6176-BM-020 | Recombinant Mouse BMP-5 (20 UG) | 20 UG | 5710 |
| R&D Systems | 6176-BM-020/CF | Recombinant Mouse BMP-5, CF (20 UG) | 20 UG | 5710 |
| R&D Systems | 6177-CD-050 | Recombinant Human CD160, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 6178-FZ-050 | Recombinant Human Frizzled-7 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6179-WN-010 | Recombinant Human Wnt-11 (10 UG) | 10 UG | 4280 |
| R&D Systems | 6179-WN-010/CF | Recombinant Human Wnt-11, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 618-IL-010 | Recombinant Human CXCL8/IL-8 (Endothelial Cell Derived) (10 UG) | 10 UG | 1940 |
| R&D Systems | 618-IL-050 | Recombinant Human CXCL8/IL-8 (Endothelial Cell Derived) (50 UG) | 50 UG | 6230 |
| R&D Systems | 618-IL-010/CF | Recombinant Human CXCL8/IL-8 (Endothelial Cell Derived), CF (10 UG) | 10 UG | 1940 |
| R&D Systems | 618-IL-050/CF | Recombinant Human CXCL8/IL-8 (Endothelial Cell Derived), CF (50 UG) | 50 UG | 6230 |
| R&D Systems | 6180-CY-010 | Recombinant Mouse BLMH/Bleomycin Hydrolase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6186-AS-010 | Recombinant Human Pepsinogen C/PGC, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6187-EN-010 | Recombinant Mouse ENPP-2/Autotaxin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 619-TI-100 | Recombinant Human Tie-1 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 6197-GO-010 | Recombinant Human Hydroxyacid Oxidase-1/HAO-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 620-CM-025 | Recombinant Viral CMV UL146/vCXC1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 620-CM-025/CF | Recombinant Viral CMV UL146/vCXC1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6200-CY-010 | Recombinant Human BLMH/Bleomycin Hydrolase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 622-VD-025 | Recombinant Human VEGF-D (25 UG) | 25 UG | 11820 |
| R&D Systems | 622-VD-005 | Recombinant Human VEGF-D (5 UG) | 5 UG | 4150 |
| R&D Systems | 622-VD-025/CF | Recombinant Human VEGF-D, CF (25 UG) | 25 UG | 11820 |
| R&D Systems | 622-VD-005/CF | Recombinant Human VEGF-D, CF (5 UG) | 5 UG | 4150 |
| R&D Systems | 6220-CL-020 | Recombinant Human Pro-Collagen I alpha 1/COL1A1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6224-FG-025 | Recombinant Mouse FGF-10 (25 UG) | 25 UG | 3370 |
| R&D Systems | 6224-FG-025/CF | Recombinant Mouse FGF-10, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 6225-SP-050 | Recombinant Mouse IBSP/Sialoprotein II, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6226-GL-010 | Recombinant Guinea Pig IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3760 |
| R&D Systems | 6226-GL-010/CF | Recombinant Guinea Pig IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 6227-RC-050 | Recombinant Canine CD25/IL-2 R alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6228-LM-050 | Recombinant Human LAMP-2/CD107b, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6229-LR-050 | Recombinant Mouse LRRC32/GARP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 623-AN-025 | Recombinant Human Angiopoietin-2 (25 UG) | 25 UG | 3760 |
| R&D Systems | 623-AN-01M/CF | Recombinant Human Angiopoietin-2, CF (1 MG) | 1 MG | 60450 |
| R&D Systems | 623-AN-025/CF | Recombinant Human Angiopoietin-2, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 6236-ST-020 | Recombinant Human TPST2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6237-GH-020 | Recombinant Human Hexosaminidase A/HEXA, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6240-AP-010 | Recombinant Human Prostatic Acid Phosphatase/ACPP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6244-MS-025 | Recombinant Mouse MSP/MST1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6244-MS-025/CF | Recombinant Mouse MSP/MST1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6245-CL-050 | Recombinant Human CD40 Ligand/TNFSF5 (aa 108-261) (50 UG) | 50 UG | 4150 |
| R&D Systems | 6245-CL-050/CF | Recombinant Human CD40 Ligand/TNFSF5 (aa 108-261), CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 6246-GT-020 | Recombinant C. difficile Toxin B/TcdB, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6266-SF-050 | Recombinant Human sFRP-5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6267-SD-050 | Recombinant Mouse Syndecan-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6268-WN-010 | Recombinant Human/Mouse Wnt- (10 UG) | 10 UG | 4150 |
| R&D Systems | 6268-WN-010/CF | Recombinant Human/Mouse Wnt-, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 6269-DC-050 | Recombinant Human DCBLD2/ESDN, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 627-CD-100 | Recombinant Human CD6 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 6278-CY-010 | Recombinant Human PGPEP-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6279-NT-010 | Recombinant Human NMNAT-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 628-LK-025 | Recombinant Human CCL15/MIP-1 delta/LKN-1 (68 aa) (25 UG) | 25 UG | 3760 |
| R&D Systems | 628-LK-025/CF | Recombinant Human CCL15/MIP-1 delta/LKN-1 (68 aa), CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 6285-UL-050 | Recombinant Human ULBP-4/RAET1E Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6288-EN-010 | Recombinant Mouse CD39L2/ENTPD6, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 629-LR-100 | Recombinant Human Lymphotoxin beta R (LTbR) Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 630-TR-100 | Recombinant Human TRAIL R3/TNFRSF10C Fc Chimera (100 UG) | 100 UG | 4540 |
| R&D Systems | 630-TR-100/CF | Recombinant Human TRAIL R3/TNFRSF10C Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 6300-100-K | DePsipher Mitochondrial Potential Kit (100 TESTS) | 100 TESTS | 4570 |
| R&D Systems | 6304-TM-010 | Recombinant Mouse TIMP-2, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 631-T2-100 | Recombinant Human TRAIL R2/TNFRSF10B Fc Chimera (100 UG) | 100 UG | 4490 |
| R&D Systems | 631-T2-100/CF | Recombinant Human TRAIL R2/TNFRSF10B Fc Chimera, CF (100 UG) | 100 UG | 4490 |
| R&D Systems | 6325-BM-020 | Recombinant Mouse BMP-6 (20 UG) | 20 UG | 6230 |
| R&D Systems | 6325-BM-020/CF | Recombinant Mouse BMP-6, CF (20 UG) | 20 UG | 6230 |
| R&D Systems | 633-TR-100 | Recombinant Human TRAIL R4/TNFRSF10D Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 6335-ST-020 | Recombinant Human HS2ST1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6336-GH-010 | Recombinant P. heparinus Heparinase II, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6339-SE-010 | Recombinant Mouse Prolyl Oligopeptidase/PREP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 634-AG-100 | Recombinant Mouse AgRP C-Terminal Fragment, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 6340-PR-020 | Recombinant Human POR, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 635-MS-025 | Recombinant Human MSP/MST1 beta Chain (25 UG) | 25 UG | 4540 |
| R&D Systems | 635-MS-025/CF | Recombinant Human MSP/MST1 beta Chain, CF (25 UG) | 25 UG | 4540 |
| R&D Systems | 6356-R2-050 | Recombinant Mouse Activin RIIA Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 6357-AB-050 | Recombinant Human Integrin alpha 11 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6358-LR-050 | Recombinant Mouse LRRTM3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6359-OP-050 | Recombinant Rat Osteopontin (OPN), CF (50 UG) | 50 UG | 3110 |
| R&D Systems | 636-R1-025 | Recombinant Human sTNF RI/TNFRSF1A (25 UG) | 25 UG | 4540 |
| R&D Systems | 636-R1-025/CF | Recombinant Human sTNF RI/TNFRSF1A, CF (25 UG) | 25 UG | 4540 |
| R&D Systems | 6368-ZN-010 | Recombinant Human QPCT, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 637-AR-100 | Recombinant Human Activin RIA/ALK-2 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 639-A2-200 | Recombinant Mouse EphA2 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 640-A3-200 | Recombinant Mouse EphA3 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 6409-GT-020 | Recombinant Human Fucosyltransferase 7/FUT7, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 641-A4-200 | Recombinant Mouse EphA4 Fc Chimera, CF (200 UG) | 200 UG | 3500 |
| R&D Systems | 6410-ZN-010 | Recombinant Human NPEPPS, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6414-NH-010 | Recombinant Human ADP-sugar Pyrophosphatase/NUDT5, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6415-GH-020 | Recombinant E. coli alpha-Galactosidase/a-Gal, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6416-DR-050 | Recombinant Mouse DDR1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6417-A1-050 | Recombinant Human Ephrin-A1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6418-GR-050 | Recombinant Human IGF-II R (aa 43-1365), CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 6419-N1-025 | Recombinant Human Netrin-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6419-N1-025/CF | Recombinant Human Netrin-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6420-CL-025 | Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed) (25 UG) | 25 UG | 3890 |
| R&D Systems | 6420-CL-025/CF | Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed), CF (25 UG) | 25 UG | 3890 |
| R&D Systems | 643-VM-200 | Recombinant Mouse VCAM-1/CD106 Fc Chimera, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | 643-VM-050 | Recombinant Mouse VCAM-1/CD106 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 6436-GH-020 | Recombinant Bovine SPAM1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6437-GT-020 | Recombinant Human POGLUT1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6439-CD-050 | Recombinant Rat sCD4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6440-EN-025 | Recombinant Rat Endoglin/CD105 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6444-A3-050 | Recombinant Human EphA3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 6445-LP-025 | Recombinant Human LBP (Histidine-tagged) (25 UG) | 25 UG | 4280 |
| R&D Systems | 6445-LP-025/CF | Recombinant Human LBP (Histidine-tagged), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6446-NL-050 | Recombinant Human Neuroligin 1v2 (-ssB)/NLGN1v2 (-ssB), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6447-PR-050 | Recombinant Human PRELP, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6448-SD-025 | Recombinant Human CXCL12/SDF-1 gamma (25 UG) | 25 UG | 3890 |
| R&D Systems | 6448-SD-025/CF | Recombinant Human CXCL12/SDF-1 gamma, CF (25 UG) | 25 UG | 3890 |
| R&D Systems | 6449-TEC-010 | Recombinant Human TRANCE/RANK L/TNFSF11 (E. coli-expressed) (10 UG) | 10 UG | 4150 |
| R&D Systems | 6449-TEC-010/CF | Recombinant Human TRANCE/RANK L/TNFSF11 (E. coli), CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 645-WN-010 | Recombinant Human/Mouse Wnt- (10 UG) | 10 UG | 4280 |
| R&D Systems | 645-WN-010/CF | Recombinant Human/Mouse Wnt-, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6450-SE-010 | Recombinant Mouse Furin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6454-BR-020 | Recombinant Human Biliverdin Reductase A/BLVRA, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6455-GT-010 | Recombinant Human GSTP1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6464-GH-020 | Recombinant Human beta-Galactosidase-1/GLB1, CF (20 UG) | 20 UG | 4410 |
| R&D Systems | 6466-AH-010 | Recombinant Human Adenosylhomocysteinease/AHCY, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6468-GT-020 | Recombinant Mouse ST6GALNAC2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6484-PR-050 | Recombinant Human PILR-alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6486-NP-010 | Recombinant Human PNP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6487-PS-010 | Recombinant Human HPGDS, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 649-EN-025 | Recombinant Human CXCL5/ENA-70 (25 UG) | 25 UG | 4360 |
| R&D Systems | 649-EN-025/CF | Recombinant Human CXCL5/ENA-70, CF (25 UG) | 25 UG | 4360 |
| R&D Systems | 6494-GP-050 | Recombinant Human GPR111, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 650-T2-100 | Recombinant Human TROP-2 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 6504-S4-050 | Recombinant Mouse Semaphorin 4G Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6505-GT-020 | Recombinant Human B3GNT6, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6506-RA-100 | Recombinant Mouse Activin RIA/ALK-2 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 6507-IL-010 | Recombinant Human IL-4 (CHO-expressed) (10 UG) | 10 UG | 2720 |
| R&D Systems | 6507-IL-010/CF | Recombinant Human IL-4 (CHO-expressed), CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 6508-NC-050 | Recombinant Human Neurocan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6509-CA-050 | Recombinant Human Protocadherin alpha 4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 651-NA-025 | Recombinant Human CXCL5/ENA-74 (25 UG) | 25 UG | 4410 |
| R&D Systems | 651-NA-025/CF | Recombinant Human CXCL5/ENA-74, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 6510-CA-050 | Recombinant Human Protocadherin-10, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6514-SL-050 | Recombinant Human Slit1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 652-P2-020 | Recombinant Porcine IL-2 (20 UG) | 20 UG | 4280 |
| R&D Systems | 652-P2-020/CF | Recombinant Porcine IL-2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6526-MT-010 | Recombinant Human Glycine N-methyltransferase/GNMT, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6528-PI-010 | Recombinant Human Serpin B3/SSCA1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6529-DH-020 | Recombinant Human Aldo-keto Reductase 1C1/AKR1C1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 653-E3-025 | Recombinant Human CCL26/Eotaxin-3 (25 UG) | 25 UG | 4490 |
| R&D Systems | 653-E3-025/CF | Recombinant Human CCL26/Eotaxin-3, CF (25 UG) | 25 UG | 4490 |
| R&D Systems | 6530-DA-020 | Recombinant Human DDAH1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6535-ZN-010 | Recombinant Tetanus Neurotoxin Type Light Chain, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6537-TN-050 | Recombinant Human C1qTNF9, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 654-P4-025 | Recombinant Porcine IL-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 654-P4-025/CF | Recombinant Porcine IL-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 655-FR-050 | Recombinant Human FGF R1 alpha (IIIb) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6556-GH-020 | Recombinant T. maritima alpha-L-Fucosidase, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6557-PP-010 | Recombinant Human PPA1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 656-AL-100 | Recombinant Human ALCAM Fc Chimera, CF (100 UG) | 100 UG | 4800 |
| R&D Systems | 6568-BR-020 | Recombinant Human Biliverdin Reductase B/BLVRB, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6575-AH-050 | Recombinant Mouse Apolipoprotein H, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 6576-B7-050 | Recombinant Human B7-H4, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 6577-CD-050 | Recombinant Rat CD44 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6578-EN-025 | Recombinant Human Endoglin/CD105 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6579-AV-025 | Recombinant Human Integrin alpha V beta 1, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 658-FR-050 | Recombinant Human FGF R1 alpha (IIIc) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6580-PL-050 | Recombinant Mouse Pleiotrophin/PTN, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 6584-S5-025 | Recombinant Mouse Semaphorin Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6585-SD-050 | Recombinant Mouse Syndecan-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6586-RN-025 | Recombinant Human Relaxin-2 (B-29/A-24) (25 UG) | 25 UG | 4150 |
| R&D Systems | 6586-RN-025/CF | Recombinant Human Relaxin-2 (B-29/A-24), CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 659-AB-025 | Recombinant Human Activin B (25 UG) | 25 UG | 9950 |
| R&D Systems | 659-AB-005 | Recombinant Human Activin B (5 UG) | 5 UG | 3370 |
| R&D Systems | 659-AB-025/CF | Recombinant Human Activin B, CF (25 UG) | 25 UG | 9950 |
| R&D Systems | 659-AB-005/CF | Recombinant Human Activin B, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 6590-GT-020 | Recombinant Human ST8SIA2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 661-FR-050 | Recombinant Human FGF R1 beta (IIIc) Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 6619-TR-050 | Recombinant Human TLR10 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 662-OR-100 | Recombinant Mouse OSM R beta Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 6624-AG-050 | Recombinant Human Agrin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6625-MA-025 | Recombinant Rat CCL3/MIP-1 alpha (25 UG) | 25 UG | 4150 |
| R&D Systems | 6625-MA-025/CF | Recombinant Rat CCL3/MIP-1 alpha, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6626-NC-050 | Recombinant Mouse N-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6627-CA-050 | Recombinant Mouse Cadherin-11 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6628-DK-010 | Recombinant Human Dkk-2 (10 UG) | 10 UG | 4280 |
| R&D Systems | 6628-DK-010/CF | Recombinant Human Dkk-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6629-EP-025 | Recombinant Human Epigen (25 UG) | 25 UG | 4150 |
| R&D Systems | 6629-EP-025/CF | Recombinant Human Epigen, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 663-2R-050 | Recombinant Human IL-1 RII Fc Chimera, CF (50 UG) | 50 UG | 5320 |
| R&D Systems | 663-FR-050 | Recombinant Human FGF R2 alpha (IIIb) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6630-GR-025 | Recombinant Mouse IGF-I R (25 UG) | 25 UG | 4280 |
| R&D Systems | 6630-GR-025/CF | Recombinant Mouse IGF-I R, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6634-KR-050 | Recombinant Human KIR2DL5/CD158f Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6635-LP-025 | Recombinant Mouse LBP (25 UG) | 25 UG | 4280 |
| R&D Systems | 6635-LP-025/CF | Recombinant Mouse LBP, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6636-NX-025 | Recombinant Human Neurexin 2 alpha Isoform 2 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6637-RN-025 | Recombinant Mouse Relaxin-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6637-RN-025/CF | Recombinant Mouse Relaxin-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 664-LI-025 | Recombinant Human LIGHT/TNFSF14 (25 UG) | 25 UG | 4150 |
| R&D Systems | 664-LI-025/CF | Recombinant Human LIGHT/TNFSF14, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 665-FR-050 | Recombinant Human FGF R2 beta (IIIb) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6659-PL-010 | Recombinant Human PLA2G4A, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 666-DN-050 | Recombinant Human DNAM-1/CD226 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 6660-AD-010 | Recombinant Human PADI4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6675-AN-025 | Recombinant Human Angiopoietin-like 5 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6675-AN-025/CF | Recombinant Human Angiopoietin-like 5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6676-CD-050 | Recombinant Cotton Rat sCD4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6677-CA-050 | Recombinant Mouse Cadherin-4/R-Cadherin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6678-FC-050 | Recombinant Human Fc epsilon RI alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6679-MN-025 | Recombinant Mouse Meteorin-like/METRNL, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6680-S5-050 | Recombinant Human Semaphorin 5B Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6684-TG-050 | Recombinant Human Twisted Gastrulation (TSG), CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 6685-VL-050 | Recombinant Mouse VLDL R (Cys297), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 669-FO-025 | Recombinant Human Follistatin 300 (25 UG) | 25 UG | 4280 |
| R&D Systems | 669-FO-025/CF | Recombinant Human Follistatin 300, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6694-PT-050 | Recombinant Human PRL-2/PTP4A2, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 670-FR-100 | Recombinant Human GFR alpha-3 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 6705-DH-020 | Recombinant Human Aldehyde Dehydrogenase 3-A1/ALDH3A1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 671-GP-100 | Recombinant Human gp130 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 6714-ND-050 | Recombinant Human Neudesin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6715-GT-020 | Recombinant Human ST6GALNAC5, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6716-GT-020 | Recombinant Human ST8SIA1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6717-GH-020 | Recombinant Human a-N-acetylgalactosaminidase, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 672-IT-025 | Recombinant Human CXCL11/I-TAC (25 UG) | 25 UG | 4150 |
| R&D Systems | 672-IT-025/CF | Recombinant Human CXCL11/I-TAC, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6720-NT-010 | Recombinant Human CANT1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6724-SE-010 | Recombinant Mouse Coagulation Factor Xa, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6725-SE-010 | Recombinant Mouse Complement Component C2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 673-IR-100 | Recombinant Human IFN-gamma R1 (100 UG) | 100 UG | 4540 |
| R&D Systems | 673-IR-100/CF | Recombinant Human IFN-gamma R1, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 674-B2-025 | Recombinant Human IGFBP-2, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 675-B3-025 | Recombinant Human IGFBP-3, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6756-A7-050 | Recombinant Human EphA7 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6757-FC-050 | Recombinant Mouse FCRL5/FcRH3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6758-GP-050 | Recombinant Mouse GPVI, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6759-RR-050 | Recombinant Rat IL-21 R Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 676-CP-100 | Recombinant Human IL-1 RAcP/IL-1 R3 Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 6760-ND-050 | Recombinant Mouse Nidogen-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6765-PR-050 | Recombinant Human PDGF R alpha Fc Chimera, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 6766-S5-050 | Recombinant Mouse Semaphorin 5B Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6767-UN-050 | Recombinant Human UNC5H1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6768-CA-050 | Recombinant Mouse Cadherin-13 (CAD-13), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6769-IL-025 | Recombinant Human IL-32 beta, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6770-CA-050 | Recombinant Human Cadherin-10 (CAD-10) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6774-CA-050 | Recombinant Human Cadherin-7 (CAD-7), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6775-FC-050 | Recombinant Mouse FCRN, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6776-CL-050 | Recombinant Mouse CLEC9a Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6779-GH-020 | Recombinant B. thetaiotaomicron O-GlcNAcase/OGA, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 679-TX-010 | Recombinant Human Lymphotoxin alpha2/beta1 (10 UG) | 10 UG | 4280 |
| R&D Systems | 679-TX-010/CF | Recombinant Human Lymphotoxin alpha2/beta1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6795-PR-050 | Recombinant Human Protogenin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 680-PI-010 | Recombinant Porcine IL-1 alpha/IL-1F1 (10 UG) | 10 UG | 3370 |
| R&D Systems | 680-PI-010/CF | Recombinant Porcine IL-1 alpha/IL-1F1, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 6808-GT-020 | Recombinant Human B3GAT3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 681-PI-010 | Recombinant Porcine IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3370 |
| R&D Systems | 681-PI-010/CF | Recombinant Porcine IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 682-PL-050 | Recombinant Human Prolactin, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 6820-SE-010 | Recombinant Mouse Testisin/Prss21, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6824-GT-020 | Recombinant Human Blood Group B Transferase/GTB, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6826-CA-050 | Recombinant Mouse Cadherin-6/KCAD, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6827-A4-050 | Recombinant Human EphA4 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 6828-A8-050 | Recombinant Human EphA8 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6829-F6-025 | Recombinant Human FGF-6 (aa 67-208) (25 UG) | 25 UG | 3370 |
| R&D Systems | 6829-F6-025/CF | Recombinant Human FGF-6 (aa 67-208), CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 683-RK-100 | Recombinant Human RANK/TNFRSF11A Fc Chimera, CF (100 UG) | 100 UG | 4490 |
| R&D Systems | 6830-FR-050 | Recombinant Mouse FOLR2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6834-ILB-025 | Recombinant Human IL-36 beta/IL-1F8 (aa 5-157) Protein (25 UG) | 25 UG | 4150 |
| R&D Systems | 6834-ILB-025/CF | Recombinant Human IL-36 beta/IL-1F8 (aa 5-157) Protein, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6835-IL-010 | Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169) (10 UG) | 10 UG | 4280 |
| R&D Systems | 6835-IL-010/CF | Recombinant Human IL-36 gamma/IL-1F9 (aa 18-169), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6836-PB-050 | Recombinant Mouse Plexin B2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6837-PL-025 | Recombinant Human PlGF-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6838-FR-025 | Recombinant Human sFRP-2 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6838-FR-025/CF | Recombinant Human sFRP-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6839-SP-050 | Recombinant Mouse SP-D, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 684-FR-050 | Recombinant Human FGF R2 beta (IIIc) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 685-FR-050 | Recombinant Human FGF R4 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 686-PI-025 | Recombinant Porcine IL-6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 686-PI-025/CF | Recombinant Porcine IL-6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6868-DG-050 | Recombinant Human Dystroglycan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6875-NM-005 | Recombinant Influenza A Virus H3N2 Neuraminidase, CF (5 UG) | 5 UG | 4280 |
| R&D Systems | 6876-GT-010 | Recombinant Human ST6GALNAC4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6877-GH-020 | Recombinant P. vulgaris Chondroitinase ABC, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 688-TK-100 | Recombinant Human TrkB Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 689-GR-100 | Recombinant Human GITR/TNFRSF18 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 6894-GT-010 | Recombinant Human GSTM1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 690-PT-025 | Recombinant Porcine TNF-alpha (25 UG) | 25 UG | 4800 |
| R&D Systems | 690-PT-025/CF | Recombinant Porcine TNF-alpha, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 6904-GH-020 | Recombinant Human Hyaluronidase 4/HYAL4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6905-GT-020 | Recombinant Human ST3GAL1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6907-SE-010 | Recombinant Human Chymotrypsin C/CTRC, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6909-CD-050 | Recombinant Mouse CD155/PVR, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 692-RK-100 | Recombinant Mouse RANK/TNFRSF11A Fc Chimera, CF (100 UG) | 100 UG | 4490 |
| R&D Systems | 693-PI-010 | Recombinant Porcine IL-10 (10 UG) | 10 UG | 3890 |
| R&D Systems | 693-PI-010/CF | Recombinant Porcine IL-10, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 6934-CB-025 | Recombinant Human Cerebellin-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6935-MB-025 | Recombinant Rat CCL4/MIP-1 beta (25 UG) | 25 UG | 4150 |
| R&D Systems | 6935-MB-025/CF | Recombinant Rat CCL4/MIP-1 beta, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6936-FR-050 | Recombinant Mouse FOLR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6937-GD-010 | Recombinant Human GDF-1 (10 UG) | 10 UG | 4410 |
| R&D Systems | 6937-GD-010/CF | Recombinant Human GDF-1, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 6938-GP-050 | Recombinant Mouse Glypican 3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6939-RB-025 | Recombinant Rabbit IL-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6939-RB-025/CF | Recombinant Rabbit IL-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 694-GL-025 | Recombinant Human GITR Ligand/TNFSF18 (25 UG) | 25 UG | 4280 |
| R&D Systems | 694-GL-025/CF | Recombinant Human GITR Ligand/TNFSF18, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6940-CL-025 | Recombinant Cotton Rat IL-13 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6940-CL-025/CF | Recombinant Cotton Rat IL-13, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6944-KR-050 | Recombinant Mouse KLRG1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6945-OS-025 | Recombinant Human Osteoprotegerin/TNFRSF11B (25 UG) | 25 UG | 4800 |
| R&D Systems | 6945-OS-025/CF | Recombinant Human Osteoprotegerin/TNFRSF11B, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 6946-RS-025 | Recombinant Mouse R-Spondin 2 (25 UG) | 25 UG | 4280 |
| R&D Systems | 6946-RS-025/CF | Recombinant Mouse R-Spondin 2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6949-DR-100 | Recombinant Human TRAIL R1/TNFRSF10A Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 695-LT-025 | Recombinant Human XCL1/Lymphotactin (25 UG) | 25 UG | 4150 |
| R&D Systems | 695-LT-025/CF | Recombinant Human XCL1/Lymphotactin, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6957-DH-020 | Recombinant Human Aldo-keto Reductase 1C4/AKR1C4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6958-ZN-010 | Recombinant Rat Insulysin/IDE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 696-CC-025 | Recombinant Viral CCI Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 697-M3-025 | Recombinant Viral MCV-type II Chemokine-like Protein (25 UG) | 25 UG | 3760 |
| R&D Systems | 697-M3-025/CF | Recombinant Viral MCV-type II Chemokine-like Protein, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 6974-GH-020 | Recombinant P. heparinus Chondroitinase B, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6985-DR-050 | Recombinant Mouse DR6/TNFRSF21 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6986-PG-025 | Recombinant Mouse GDF-8 Propeptide Fc Chimera (25 UG) | 25 UG | 4280 |
| R&D Systems | 6986-PG-025/CF | Recombinant Mouse GDF-8 Propeptide Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6987-GL-025 | Recombinant Human GITR Ligand/TNFSF18 (CHO-expressed) (25 UG) | 25 UG | 4280 |
| R&D Systems | 6987-GL-025/CF | Recombinant Human GITR Ligand/TNFSF18 (CHO-expressed), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 6990-GP-050 | Recombinant Mouse Glycoprotein V/CD42d, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 6994-R2-020 | Recombinant Rabbit IL-2 (20 UG) | 20 UG | 4280 |
| R&D Systems | 6994-R2-020/CF | Recombinant Rabbit IL-2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 6995-IL-010 | Recombinant Human IL-36 alpha/IL-1F6 (aa 6-158) (10 UG) | 10 UG | 4410 |
| R&D Systems | 6995-IL-010/CF | Recombinant Human IL-36 alpha/IL-1F6 (aa 6-158), CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 6996-IL-010 | Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164) (10 UG) | 10 UG | 4280 |
| R&D Systems | 6996-IL-010/CF | Recombinant Mouse IL-36 gamma/IL-1F9 (aa 13-164), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 6997-NG-025 | Recombinant Mouse Noggin (aa 28-232) (25 UG) | 25 UG | 4410 |
| R&D Systems | 6997-NG-025/CF | Recombinant Mouse Noggin (aa 28-232) , CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 6998-SC-025 | Recombinant Rat SCF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6998-SC-025/CF | Recombinant Rat SCF, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 6999-TN-050 | Recombinant Human Tenascin XB2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7005-B7-050 | Recombinant Mouse Gi24/VISTA/B7-H5 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 702-C2-010 | Recombinant Human Active Caspase-2 (10 UG) | 10 UG | 4800 |
| R&D Systems | 702-C2-010/CF | Recombinant Human Active Caspase-2, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 7027-GT-020 | Recombinant Human ST8SIA4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7028-PD-050 | Recombinant Mouse IMPAD1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 703-UB-025 | Recombinant Human Ubiquitin+1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7039-GH-010 | Recombinant Human Tissue alpha-L-Fucosidase/FUCA1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 704-AG-002 | Recombinant Human AgRP (2 UG) | 2 UG | 1420 |
| R&D Systems | 7040-GT-010 | Recombinant Human B4GalT1 (Y285L), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7044-CB-050 | Recombinant Human Cerebellin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7048-AD-010 | Recombinant Human Adenosine Deaminase/ADA, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7049-DH-010 | Recombinant Human Isocitrate Dehydrogenase 1/IDH1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 705-C8-010 | Recombinant Human Caspase-8 (10 UG) | 10 UG | 4800 |
| R&D Systems | 705-C8-010/CF | Recombinant Human Caspase-8, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 7054-MR-100 | Recombinant Mouse BMPR-IA/ALK-3 Fc Chimera, CF (100 UG) | 100 UG | 5320 |
| R&D Systems | 7055-CC-025 | Recombinant Viral CCI Fc Chimera (CHO-expressed) (25 UG) | 25 UG | 4280 |
| R&D Systems | 7055-CC-025/CF | Recombinant Viral CCI Fc Chimera (CHO-expressed), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7056-CR-050 | Recombinant Mouse CRISP-3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7057-HG-010 | Recombinant Human HGF Propeptide, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7058-HG-010 | Recombinant Mouse HGF Propeptide, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7059-ML-010 | Recombinant Mouse IL-36 alpha/IL-1F6 (aa 8-160) (10 UG) | 10 UG | 4280 |
| R&D Systems | 7059-ML-010/CF | Recombinant Mouse IL-36 alpha/IL-1F6 (aa 8-160), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 706-GR-050 | Recombinant Human GM-CSF R alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7060-ML-010 | Recombinant Mouse IL-36 beta/IL-1F8 (aa 31-183) (10 UG) | 10 UG | 4280 |
| R&D Systems | 7060-ML-010/CF | Recombinant Mouse IL-36 beta/IL-1F8 (aa 31-183), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7064-AB-025 | Recombinant Human Integrin alpha 1 beta 1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7065-ME-100 | Recombinant Mouse HGF R/c-MET Fc Chimera (NS0-expressed), CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 7066-NL-050 | Recombinant Human Neuroligin 1v2/NLGN1v2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7067-S6-050 | Recombinant Mouse Semaphorin 6D Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 707-C3-010 | Recombinant Human Caspase-3 (10 UG) | 10 UG | 4800 |
| R&D Systems | 707-C3-010/CF | Recombinant Human Caspase-3, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 708-MF-050 | Recombinant Mouse FGF R2 beta (IIIb) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 709-CCH-010 | Human Cytochrome c (Human Heart Tissue), CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 7095-ST-020 | Recombinant Human SULT1C4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7096-GH-020 | Recombinant Human NAGLU, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 710-MF-050 | Recombinant Mouse FGF R3 (IIIc) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7109-NL-050 | Recombinant Mouse NELL1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 711-PG-010 | Recombinant Porcine GM-CSF (10 UG) | 10 UG | 3890 |
| R&D Systems | 711-PG-010/CF | Recombinant Porcine GM-CSF, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 712-FR-050 | Recombinant Human FGF R2 alpha (IIIc) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7126-B7-050 | Recombinant Human Gi24/VISTA/B7-H5 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 714-GR-100 | Recombinant Human GFR alpha-1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 7140-GT-020 | Recombinant Human GALNT1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7144-B7-050 | Recombinant Human B7-H6 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7145-BP-010 | Recombinant Human BMP-2/BMP-6 Heterodimer (10 UG) | 10 UG | 4930 |
| R&D Systems | 7145-BP-010/CF | Recombinant Human BMP-2/BMP-6 Heterodimer, CF (10 UG) | 10 UG | 4930 |
| R&D Systems | 7146-A1-100 | Recombinant Human EphA1 Fc Chimera, CF (100 UG) | 100 UG | 3500 |
| R&D Systems | 7147-IR-100 | Recombinant Human IL-13 R alpha 2 Fc Chimera (CHO), CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 7148-A2-025 | Recombinant Human Integrin alpha 2b beta 3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7149-UL-050 | Recombinant Human ULBP-5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 715-IC-200 | Recombinant Human ICAM-3/CD50 Fc Chimera, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | 715-IC-050 | Recombinant Human ICAM-3/CD50 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 7150-RS-025 | Recombinant Mouse R-Spondin 1 (CHO-expressed) (25 UG) | 25 UG | 4280 |
| R&D Systems | 7150-RS-025/CF | Recombinant Mouse R-Spondin 1 (CHO-expressed), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7154-SA-050 | Recombinant Mouse SIRP alpha/CD172a Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7159-MT-020 | Recombinant Human METTL11A, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 716-MF-050 | Recombinant Mouse FGF R2 beta (IIIc) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7160-SE-010 | Recombinant Mouse Complement Component C1ra, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7164-SE-010 | Recombinant Human PRCP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 717-VC-025 | Recombinant Human CCL28 (25 UG) | 25 UG | 3760 |
| R&D Systems | 717-VC-025/CF | Recombinant Human CCL28, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7174-GT-020 | Recombinant Human GALNT3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7175-AS-020 | Recombinant S. cerevisiae ATP Sulfurylase/MET3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7176-SK-020 | Recombinant P. chrysogenum APS kinase/APSK, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7186-AN-025 | Recombinant Mouse Angiopoietin-2 (25 UG) | 25 UG | 3760 |
| R&D Systems | 7186-AN-025/CF | Recombinant Mouse Angiopoietin-2, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7187-AL-100 | Recombinant Human ALCAM Fc Chimera (HEK293-expressed), CF (100 UG) | 100 UG | 4800 |
| R&D Systems | 7188-BC-050 | Recombinant Mouse Brevican, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7189-CD-050 | Recombinant Porcine CD44 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 719-NG-050 | Recombinant Mouse Noggin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7190-CD-050 | Recombinant Mouse CD320/TCblR/8D6A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7194-IR-050 | Recombinant Human IL-15 R alpha Fc Chimera (HEK293), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7195-SF-050 | Recombinant Mouse sFRP-5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7196-WN-010 | Recombinant Human Wnt-10b (10 UG) | 10 UG | 4280 |
| R&D Systems | 7196-WN-010/CF | Recombinant Human Wnt-10b, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 720-IC-200 | Recombinant Human ICAM-1/CD54 Fc Chimera, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | 720-IC-050 | Recombinant Human ICAM-1/CD54 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 7200-S4-050 | Recombinant Mouse Semaphorin 4F Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7209-GT-010 | Recombinant Human GGT5, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 721-DR-100 | Recombinant Mouse TRAIL R2/TNFRSF10B Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 723-TR-100 | Recombinant Mouse TROY/TNFRSF19 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 7234-UP-010 | Recombinant Human UPP1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7235-SE-010 | Recombinant Mouse Active Trypsin 3/PRSS3, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 7236-SE-010 | Recombinant Mouse Kallikrein 5, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7238-AT-050 | Recombinant Human Attractin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 724-ES-100 | Recombinant Human E-Selectin/CD62E Fc Chimera, CF (100 UG) | 100 UG | 4150 |
| R&D Systems | 7244-PK-020 | Recombinant Human PKM2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7248-GT-020 | Recombinant Human GCNT1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 725-CK-025 | Recombinant Mouse CCL27/CTACK (25 UG) | 25 UG | 4150 |
| R&D Systems | 725-CK-025/CF | Recombinant Mouse CCL27/CTACK, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 726-R2-050 | Recombinant Human TNF RII/TNFRSF1B Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 7267-TG-050 | Recombinant Mouse TIGIT Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7268-CT-100 | Recombinant Human CTLA-4 Fc Chimera, CF (CHO-expressed) (100 UG) | 100 UG | 4930 |
| R&D Systems | 7269-FR-100 | Recombinant Human GFR alpha-3 Fc Chimera (CHO-expressed), CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 727-CD-100 | Recombinant Mouse CD6 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 7270-IL-025 | Recombinant Human IL-6 (HEK293-expressed) (25 UG) | 25 UG | 4930 |
| R&D Systems | 7270-IL-025/CF | Recombinant Human IL-6 (HEK293-expressed), CF (25 UG) | 25 UG | 4930 |
| R&D Systems | 7274-RB-025 | Recombinant Rabbit IL-21 (25 UG) | 25 UG | 4280 |
| R&D Systems | 7274-RB-025/CF | Recombinant Rabbit IL-21, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7275-GT-020 | Recombinant Human ST3GAL2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7276-ST-020 | Recombinant Human HS3ST3B1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 728-LS-100 | Recombinant Human L-Selectin/CD62L Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 7286-FC-050 | Recombinant Mouse FCRL1/FcRH1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7294-CL-020 | Recombinant Human Pro-Collagen III alpha 1/COL3A1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 730-XC-025 | Recombinant Mouse CXCL14/BRAK, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7307-SA-050 | Recombinant Rat SIRP alpha/CD172a, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 731-C3-005 | Recombinant Human Pro-Caspase-3, CF (5 UG) | 5 UG | 4800 |
| R&D Systems | 7310-GH-005 | Recombinant Human Galactosylceramidase/GALC, CF (5 UG) | 5 UG | 4410 |
| R&D Systems | 732-CL-050 | Recombinant Mouse CD30 Ligand/TNFSF8 (50 UG) | 50 UG | 4800 |
| R&D Systems | 732-CL-050/CF | Recombinant Mouse CD30 Ligand/TNFSF8, CF (50 UG) | 50 UG | 4800 |
| R&D Systems | 733-DH-050 | Recombinant Mouse Desert Hedgehog/Dhh (C23II) N-Terminus, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7335-CD-050 | Recombinant Mouse CD90/Thy1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7339-G6-025 | Recombinant Mouse G6b Fc Chimera (25 UG) | 25 UG | 4280 |
| R&D Systems | 7339-G6-025/CF | Recombinant Mouse G6b Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7340-A4-050 | Recombinant Human Laminin alpha 4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7344-LR-025 | Recombinant Mouse LRP-5 (25 UG) | 25 UG | 4280 |
| R&D Systems | 7344-LR-025/CF | Recombinant Mouse LRP-5, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7345-MG-050 | Recombinant Mouse MAGP-2/MFAP5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7346-B2-005 | Recombinant Mouse TGF-beta 2 (5 UG) | 5 UG | 3370 |
| R&D Systems | 7346-B2-005/CF | Recombinant Mouse TGF-beta 2, CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 7347-WN-025 | Recombinant Human Wnt-5b (25 UG) | 25 UG | 4800 |
| R&D Systems | 7347-WN-025/CF | Recombinant Human Wnt-5b, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 735-CL-010 | Recombinant Canine IL-10 (10 UG) | 10 UG | 3890 |
| R&D Systems | 735-CL-010/CF | Recombinant Canine IL-10, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 7356-AM-050 | Recombinant Mouse ASAM, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7358-GH-020 | Recombinant Human Hyaluronidase 1/HYAL1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7359-GT-020 | Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 736-FL-010 | Recombinant Feline IL-10 (10 UG) | 10 UG | 3890 |
| R&D Systems | 736-FL-010/CF | Recombinant Feline IL-10, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 737-PS-200 | Recombinant Mouse P-Selectin/CD62P Fc Chimera, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | 737-PS-050 | Recombinant Mouse P-Selectin/CD62P Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 7375-SV-050 | Recombinant GFP/SNAP25B/VAMP-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7376-AO-010 | Recombinant Human Dopamine beta-Hydroxylase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7379-ZN-010 | Recombinant Botulinum Neurotoxin Type C1 Light Chain, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 738-AN-025 | Recombinant Mouse Angiopoietin-3 (25 UG) | 25 UG | 3760 |
| R&D Systems | 738-AN-025/CF | Recombinant Mouse Angiopoietin-3, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7380-ZN-010 | Recombinant Botulinum Neurotoxin Type F Light Chain, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7386-MT-010 | Recombinant Human COMT, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 739-G9-010 | Recombinant Mouse GDF-9 (10 UG) | 10 UG | 4280 |
| R&D Systems | 739-G9-010/CF | Recombinant Mouse GDF-9, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7390-BC-050 | Recombinant Mouse BCAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7394-CN-050 | Recombinant Human Contactin-6 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7395-EA-050 | Recombinant Mouse Ephrin-A3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7396-EA-050 | Recombinant Mouse Ephrin-A5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7397-EB-050 | Recombinant Human Ephrin-B2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7398-FS-050 | Recombinant Human Fas/TNFRSF6/CD95 (HEK-expr) Fc Chimera, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 7399-F9-025 | Recombinant Mouse FGF-9 (25 UG) | 25 UG | 3370 |
| R&D Systems | 7399-F9-025/CF | Recombinant Mouse FGF-9, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 740-B1-100 | Recombinant Mouse B7-1/CD80 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 7400-FG-025 | Recombinant Mouse FGF-17 (25 UG) | 25 UG | 3370 |
| R&D Systems | 7400-FG-025/CF | Recombinant Mouse FGF-17, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 7404-5R-025 | Recombinant Human IL-5 R alpha (CHO-expressed) (25 UG) | 25 UG | 5580 |
| R&D Systems | 7404-5R-025/CF | Recombinant Human IL-5 R alpha (CHO-expressed), CF (25 UG) | 25 UG | 5580 |
| R&D Systems | 7405-MR-050 | Recombinant Mouse IL-11 R alpha (aa 26-367) Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7406-MR-050 | Recombinant Mouse IL-12 R beta 2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7407-PS-050 | Recombinant Mouse PSGL-1/CD162 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7409-GT-020 | Recombinant Human Protein O-fucosyltransferase 1/POFUT1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 741-B2-100 | Recombinant Mouse B7-2/CD86 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 7410-GH-010 | Recombinant Human Glucosylceramidase/GBA, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 7414-GT-010 | Recombinant Human POMGNT1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7425-GT-010 | Recombinant Human ST6GALNAC6, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 743-R3-100 | Recombinant Mouse VEGF R3/Flt-4 Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 7430-ML-010 | Recombinant Mouse IL-27 p28/IL-30 (10 UG) | 10 UG | 4280 |
| R&D Systems | 7430-ML-010/CF | Recombinant Mouse IL-27 p28/IL-30, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7435-CD-050 | Recombinant Mouse CD163, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7448-CD-050 | Recombinant Human CD161 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7449-SE-010 | Recombinant Human t-Plasminogen Activator/tPA, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 745-ED-050 | Recombinant Mouse EDAR Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7450-ST-020 | Recombinant Human CHST3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7457-ZN-010 | Recombinant Human Carboxypeptidase M, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7458-ST-020 | Recombinant Human SULT1C2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7459-CD-050 | Recombinant Mouse CD84/SLAMF5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 746-LF-025 | Recombinant Human Lefty-A (25 UG) | 25 UG | 4280 |
| R&D Systems | 746-LF-025/CF | Recombinant Human Lefty-A, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7460-F4-025 | Recombinant Human FGF-4 (aa 71-206) (25 UG) | 25 UG | 3370 |
| R&D Systems | 7460-F4-025/CF | Recombinant Human FGF-4 (aa 71-206), CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 7464-RB-010 | Recombinant Rabbit IL-1 beta/IL-1F2 (10 UG) | 10 UG | 3760 |
| R&D Systems | 7464-RB-010/CF | Recombinant Rabbit IL-1 beta/IL-1F2, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 7465-RT-050 | Recombinant Mouse RELT/TNFRSF19L Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7466-SC-010 | Recombinant Human SCF (Mammalian-expressed) (10 UG) | 10 UG | 2590 |
| R&D Systems | 7466-SC-010/CF | Recombinant Human SCF (Mammalian-expressed), CF (10 UG) | 10 UG | 2590 |
| R&D Systems | 7468-BP-050 | Recombinant Human BPI Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 747-MR-050 | Recombinant Mouse IL-7 R alpha/CD127 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7470-S4-050 | Recombinant Human Semaphorin 4D Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7477-AX-050 | Recombinant Mouse Axl Fc Chimera (CHO-expressed), CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 7478-CD-050 | Recombinant Mouse CD74, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7479-DR-050 | Recombinant Mouse DDR2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 748-EC-050 | Recombinant Mouse E-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7480-AV-050 | Recombinant Mouse Integrin alpha V beta 6, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7484-PR-050 | Recombinant human PRAT4A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7485-UL-050 | Recombinant Human ULBP-6/RAET1L, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7486-F4-025 | Recombinant Mouse FGF-4 (aa 67-202) (25 UG) | 25 UG | 3370 |
| R&D Systems | 7486-F4-025/CF | Recombinant Mouse FGF-4 (aa 67-202), CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 7487-LR-050 | Recombinant Human LIF R alpha (Mammalian-expressed), CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7488-DA-050 | Recombinant Human Sirtuin 3/SIRT3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7496-PI-010 | Recombinant Human SPINK1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7501-500-K | HT Superoxide Dismutase Assay Kit (1 KT) | 1 KT | 7660 |
| R&D Systems | 7507-GT-020 | Recombinant Human GALNT2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 751-VE-025 | Recombinant Human VEGF-B 167, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 7510-100-K | Glutathione Reductase Assay (100 TESTS) | 100 TESTS | 6520 |
| R&D Systems | 7511-100-K | High-Throughput Glutathione Assay (384 TESTS) | 384 TESTS | 4720 |
| R&D Systems | 7512-100-K | High-Throughput Glutathione Peroxidase Assay (480 TESTS) | 480 TESTS | 6620 |
| R&D Systems | 7513-500-K | High-Throughput Glutathione Reductase Assay (480 TESTS) | 480 TESTS | 7510 |
| R&D Systems | 7516-CY-010 | Recombinant Human Cathepsin H, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7518-AD-010 | Recombinant Human Adenosine Deaminase 2/CECR1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 752-VC-025 | Recombinant Human VEGF-C (Cys156Ser) (25 UG) | 25 UG | 4280 |
| R&D Systems | 752-VC-025/CF | Recombinant Human VEGF-C (Cys156Ser), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7528-GT-020 | Recombinant Human GALNT4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7529-DH-020 | Recombinant Human Aldo-keto Reductase 1B10/AKR1B10, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7530-GT-020 | Recombinant Human B4GalT2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7537-BF-025 | Recombinant Human BAFF/BLyS/TNFSF13B (CHO-expressed) (25 UG) | 25 UG | 3890 |
| R&D Systems | 7537-BF-025/CF | Recombinant Human BAFF/BLyS/TNFSF13B (CHO-expressed), CF (25 UG) | 25 UG | 3890 |
| R&D Systems | 7538-LR-100 | Recombinant Human LT beta R/TNFRSF3 Fc Chimera (CHO), CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 7539-RG-050 | Recombinant Mouse Reg3A (CHO-expressed), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 754-CL-025 | Recombinant Canine IL-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 754-CL-025/CF | Recombinant Canine IL-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7540-BP-025 | Recombinant Mouse BMP-8a, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7544-MR-050 | Recombinant Mouse Insulin R/CD220, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 755-DA-050 | Recombinant Mouse DAN (50 UG) | 50 UG | 4540 |
| R&D Systems | 755-DA-050/CF | Recombinant Mouse DAN, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 7554-XD-050 | Recombinant Mouse EDA2R/TNFRSF27/XEDAR Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7559-ST-050 | Recombinant Human SECTM1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 756-TG-050 | Recombinant Mouse Twisted Gastrulation (TSG) (50 UG) | 50 UG | 4280 |
| R&D Systems | 756-TG-050/CF | Recombinant Mouse Twisted Gastrulation (TSG), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7567-DH-010 | Recombinant Human NQO-1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7570-GH-005 | Recombinant Human Active Heparanase/HPSE, CF (5 UG) | 5 UG | 4280 |
| R&D Systems | 7574-CE-010 | Recombinant Human Acetylcholinesterase/ACHE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7575-GT-020 | Recombinant Human GALNT10, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7579-CD-050 | Recombinant Human CD7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 758-CN-050 | Recombinant Mouse Chordin (50 UG) | 50 UG | 4280 |
| R&D Systems | 758-CN-050/CF | Recombinant Mouse Chordin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7580-CL-050 | Recombinant Human Collectrin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7584-SF-025 | Recombinant Human sFRP-3 (25 UG) | 25 UG | 4280 |
| R&D Systems | 7584-SF-025/CF | Recombinant Human sFRP-3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7585-IL-025 | Recombinant Human IL-37b/IL-1F7b (25 UG) | 25 UG | 4280 |
| R&D Systems | 7585-IL-025/CF | Recombinant Human IL-37b/IL-1F7b, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7586-MA-050 | Recombinant Human MARCO, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7587-MD-050 | Recombinant Mouse MDGA1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7589-CL-020 | Recombinant Human Pro-Collagen II, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 759-DT-100 | Recombinant Mouse Dtk Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 7597-NM-010 | Recombinant Influenza A Virus H5N1 Neuraminidase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 760-M3-025 | Recombinant Mouse CCL20/MIP-3 alpha (25 UG) | 25 UG | 4280 |
| R&D Systems | 760-M3-025/CF | Recombinant Mouse CCL20/MIP-3 alpha, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 761-MP-050 | Recombinant Mouse P-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 762-T2-100 | Recombinant Mouse Tie-2 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 7620-GT-010 | Recombinant Human ST6GAL1 (aa 44-406), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7625-B2-100 | Recombinant Human B7-2/CD86 Fc Chimera (CHO-expressed), CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 7626-VE-010 | Recombinant Human VEGF 145 (aa 27-171) (10 UG) | 10 UG | 3760 |
| R&D Systems | 7626-VE-010/CF | Recombinant Human VEGF 145 (aa 27-171), CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 7627-PS-020 | Recombinant Human PTGES2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7637-MT-010 | Recombinant Human Histamine N-Methyltransferase/HNMT, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 764-FG-050 | Recombinant Feline IFN-gamma (50 UG) | 50 UG | 3760 |
| R&D Systems | 764-FG-050/CF | Recombinant Feline IFN-gamma, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 7640-TR-050 | Recombinant Mouse TLR11 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 765-FR-050 | Recombinant Human FGF R1 beta (IIIb) Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7654-EB-050 | Recombinant Human Ephrin-B1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7655-EB-050 | Recombinant Mouse Ephrin-B3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7657-ML-050 | Recombinant Mouse Mill2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7658-ZN-010 | Recombinant Human NAALADase-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 766-FR-050 | Recombinant Human FGF R3 (IIIc) Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7665-PT-050 | Recombinant Human PTH, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7666-MB-005 | Recombinant Mouse TGF-beta 1 (5 UG) | 5 UG | 4620 |
| R&D Systems | 7666-MB-005/CF | Recombinant Mouse TGF-beta 1, CF (5 UG) | 5 UG | 4620 |
| R&D Systems | 7667-TM-010 | Recombinant Mouse TIMP-4, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7668-GH-025 | Recombinant Human Growth Hormone 2 (25 UG) | 25 UG | 3760 |
| R&D Systems | 7668-GH-025/CF | Recombinant Human Growth Hormone 2, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7669-CA-050 | Recombinant Human Protocadherin-17, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 767-VE-010 | Recombinant Mouse VEGF-B 186 (10 UG) | 10 UG | 3890 |
| R&D Systems | 767-VE-010/CF | Recombinant Mouse VEGF-B 186, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 7678-DH-020 | Recombinant Human Aldo-keto Reductase 1C3/AKR1C3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 768-F3-050 | Recombinant Mouse Flt-3/Flk-2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7688-SE-010 | Recombinant Mouse Kallikrein 7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7689-ST-010 | Recombinant Human NDST2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 769-FS-025 | Recombinant Mouse Follistatin 288 (FS-288) (25 UG) | 25 UG | 4280 |
| R&D Systems | 769-FS-025/CF | Recombinant Mouse Follistatin 288 (FS-288), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7690-PI-010 | Recombinant Mouse Serpin A1a, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7695-GH-020 | Recombinant F. meningosepticum PNGase F, CF (20 UG) | 20 UG | 2670 |
| R&D Systems | 7695-GHP-020 | Recombinant F. meningosepticum PNGase F' (CystatinA Tag), CF (20 UG) | 20 UG | 2600 |
| R&D Systems | 7696-GT-020 | Recombinant Human B3GNT4, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7698-LM-050 | Recombinant Mouse CD300e/LMIR6 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7699-DM-050 | Recombinant Mouse Desmoglein-2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 770-MA-100 | Recombinant Mouse ALK-1 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 7700-4R-050 | Recombinant Human IL-4 R alpha Fc Chimera, CF (50 UG) | 50 UG | 5270 |
| R&D Systems | 7700-AR-050 | Recombinant Human IL-4 R alpha Fc Chimera, CF (50 UG) | 50 UG | 5270 |
| R&D Systems | 7704-MR-025 | Recombinant Mouse IL-10 R alpha (25 UG) | 25 UG | 5320 |
| R&D Systems | 7704-MR-025/CF | Recombinant Mouse IL-10 R alpha, CF (25 UG) | 25 UG | 5320 |
| R&D Systems | 7705-AV-050 | Recombinant Mouse Integrin alpha V beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7706-AV-050 | Recombinant Mouse Integrin alpha V beta 5, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7707-NP-050 | Recombinant Human Neuronal Pentraxin 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 771-MR-100 | Recombinant Mouse IL-1 RI Fc Chimera, CF (100 UG) | 100 UG | 5450 |
| R&D Systems | 7714-DA-050 | Recombinant Human Sirtuin 1/SIRT1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7719-ST-005 | Recombinant Human GAL3ST2, CF (5 UG) | 5 UG | 4280 |
| R&D Systems | 7727-CG-010 | Recombinant Human CG alpha/beta (HCG) Heterodimer (10 UG) | 10 UG | 4280 |
| R&D Systems | 7727-CG-010/CF | Recombinant Human CG alpha/beta (HCG) Heterodimer, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7728-A5-050 | Recombinant Mouse Integrin alpha 5 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7729-CM-050 | Recombinant Human OCAM/NCAM2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7730-SC-050 | Recombinant Human SCUBE3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7734-LF-100 | Recombinant Human LIF (100 UG) | 100 UG | 12990 |
| R&D Systems | 7734-LF-025 | Recombinant Human LIF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7734-LF-500 | Recombinant Human LIF (500 UG) | 500 UG | 24570 |
| R&D Systems | 7734-LF-100/CF | Recombinant Human LIF, CF (100 UG) | 100 UG | 12990 |
| R&D Systems | 7734-LF-025/CF | Recombinant Human LIF, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7734-LF-500/CF | Recombinant Human LIF, CF (500 UG) | 500 UG | 24570 |
| R&D Systems | 7736-MT-010 | Recombinant Human Nicotinamide N-Methyltransferase/NNMT, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 774-M2-200 | Recombinant Mouse ICAM-2/CD102 Fc Chimera, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | 774-M2-050 | Recombinant Mouse ICAM-2/CD102 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 7748-GT-020 | Recombinant Human GALNT7, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 775-B3-025 | Recombinant Mouse IGFBP-3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7750-GP-050 | Recombinant Human Lgr4/GPR48 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7754-BH-025 | Recombinant Human TGF-beta 1 (Human Cell-expressed) (25 UG) | 25 UG | 10520 |
| R&D Systems | 7754-BH-005 | Recombinant Human TGF-beta 1 (Human Cell-expressed) (5 UG) | 5 UG | 3370 |
| R&D Systems | 7754-BH-025/CF | Recombinant Human TGF-beta 1 (Human Cell-expressed), CF (25 UG) | 25 UG | 10520 |
| R&D Systems | 7754-BH-005/CF | Recombinant Human TGF-beta 1 (Human Cell-expressed), CF (5 UG) | 5 UG | 3370 |
| R&D Systems | 7755-TR-050 | Recombinant Human TLR6 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7756-FL-050 | Recombinant Mouse VEGF R1/Flt-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7757-GP-050 | Recombinant Human alpha 1B-Glycoprotein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7758-PL-025 | Recombinant Human PlGF-3 (25 UG) | 25 UG | 4150 |
| R&D Systems | 7758-PL-025/CF | Recombinant Human PlGF-3, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 776-B6-025 | Recombinant Mouse IGFBP-6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7765-TG-050 | Recombinant Human Transglutaminase 1/TGM1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7766-AP-010 | Recombinant Human ACP6, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7767-PE-010 | Recombinant Human Phosphodiesterase 4A/PDE4A, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 777-NC-100 | Recombinant Human L1CAM Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 7770-GT-020 | Recombinant Human Fucosyltransferase 2/FUT2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 779-G7-010 | Recombinant Mouse GDF-7 (10 UG) | 10 UG | 4280 |
| R&D Systems | 779-G7-010/CF | Recombinant Mouse GDF-7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7790-WN-025 | Recombinant Human Wnt-16b (25 UG) | 25 UG | 4800 |
| R&D Systems | 7790-WN-025/CF | Recombinant Human Wnt-16b, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 7796-MP-010 | Recombinant Human MMP-17, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 780-RA-025 | Recombinant Porcine IL-1ra/IL-1F3 (25 UG) | 25 UG | 4670 |
| R&D Systems | 780-RA-025/CF | Recombinant Porcine IL-1ra/IL-1F3, CF (25 UG) | 25 UG | 4670 |
| R&D Systems | 7800-M3-025 | Recombinant Rat CCL19/MIP-3 beta (25 UG) | 25 UG | 3760 |
| R&D Systems | 7800-M3-025/CF | Recombinant Rat CCL19/MIP-3 beta, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7804-FG-025 | Recombinant Rat FGF-10 (25 UG) | 25 UG | 3370 |
| R&D Systems | 7804-FG-025/CF | Recombinant Rat FGF-10, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 7805-FL-010 | Recombinant Feline IL-15 (10 UG) | 10 UG | 3760 |
| R&D Systems | 7805-FL-010/CF | Recombinant Feline IL-15, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 7807-ML-010 | Recombinant Mouse IL-24 (NS0-expressed) (10 UG) | 10 UG | 3760 |
| R&D Systems | 7807-ML-010/CF | Recombinant Mouse IL-24 (NS0-expressed), CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 7808-AB-050 | Recombinant Mouse Integrin alpha 11 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7809-A6-050 | Recombinant Human Integrin alpha 6 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 781-CG-050 | Recombinant Canine IFN-gamma (50 UG) | 50 UG | 3760 |
| R&D Systems | 781-CG-050/CF | Recombinant Canine IFN-gamma, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 7810-A6-050 | Recombinant Mouse Integrin alpha 6 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7814-LR-050 | Recombinant Mouse Leptin R Fc Chimera, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 7815-NG-025 | Recombinant Rat beta-NGF (CHO-expressed) (25 UG) | 25 UG | 2980 |
| R&D Systems | 7815-NG-025/CF | Recombinant Rat beta-NGF (CHO-expressed), CF (25 UG) | 25 UG | 2980 |
| R&D Systems | 7816-NP-050 | Recombinant Human Neuronal Pentraxin 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7818-NP-050 | Recombinant Mouse Neuroplastin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 782-IL-010 | Recombinant Human IL-22 (10 UG) | 10 UG | 4150 |
| R&D Systems | 782-IL-010/CF | Recombinant Human IL-22, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 7825-AB-050 | Recombinant Mouse Integrin alpha L beta 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7826-A9-050 | Recombinant Mouse Integrin alpha 9 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7827-AB-050 | Recombinant Mouse Integrin alpha 10 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7828-A2-050 | Recombinant Mouse Integrin alpha 2 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 783-CL-050 | Recombinant Mouse CD27 Ligand/TNFSF7 (50 UG) | 50 UG | 4410 |
| R&D Systems | 783-CL-050/CF | Recombinant Mouse CD27 Ligand/TNFSF7, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7836-AM-050 | Recombinant Human alpha 2-Macroglobulin-like 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7837-ST-050 | Recombinant Mouse SECTM1A Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7839-BT-010 | Recombinant Human Biotinidase/BTD, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 784-MR-050 | Recombinant Mouse Common gamma Chain Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7840-GK-020 | Recombinant Human Glucokinase/GCK, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7849-GK-020 | Recombinant E. coli Glycerol Kinase, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7850-GT-020 | Recombinant Human GALNTL1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7854-MT-020 | Recombinant Human PNMT, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 7855-CD-050 | Recombinant Human Endosialin/CD248, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7856-A2-050 | Recombinant Human Ephrin-A2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7857-RL-010 | Recombinant Rat IL-7 (10 UG) | 10 UG | 3890 |
| R&D Systems | 7857-RL-010/CF | Recombinant Rat IL-7, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 7858-MR-050 | Recombinant Rat MMR/CD206, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7859-TH-050 | Recombinant Mouse Thrombospondin-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 786-XB-050 | Recombinant Human XIAP (BIR2), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7860-TH-050 | Recombinant Mouse Thrombospondin-4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7864-TP-025 | Recombinant Rat Thrombopoietin (25 UG) | 25 UG | 5190 |
| R&D Systems | 7864-TP-005 | Recombinant Rat Thrombopoietin (5 UG) | 5 UG | 3500 |
| R&D Systems | 7864-TP-025/CF | Recombinant Rat Thrombopoietin, CF (25 UG) | 25 UG | 5190 |
| R&D Systems | 7864-TP-005/CF | Recombinant Rat Thrombopoietin, CF (5 UG) | 5 UG | 3500 |
| R&D Systems | 788-G8-010 | Recombinant Human/Mouse/Rat GDF-8/Myostatin (10 UG) | 10 UG | 4490 |
| R&D Systems | 788-G8-010/CF | Recombinant Human/Mouse/Rat GDF-8/Myostatin, CF (10 UG) | 10 UG | 4490 |
| R&D Systems | 788-GMP-010 | Recombinant Human/Mouse/Rat GDF-8/Myostatin GMP, CF (10 UG) | 10 UG | 5140 |
| R&D Systems | 788-GMP-01M | Recombinant Human/Mouse/Rat GDF-8/Myostatin GMP, CF (1 MG) | 1 MG | 123500 |
| R&D Systems | 7887-GT-010 | Recombinant Mouse alpha3GalT/GGTA1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7888-CD-050 | Recombinant Rat CD27/TNFRSF7 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7889-AV-050 | Recombinant Mouse Integrin alpha V beta 3, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 789-SM-100 | Recombinant Human SMAC/Diablo, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 7890-LR-025 | Recombinant Human LRG1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7894-ST-050 | Recombinant Human Syntaxin 4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7895-TC-050 | Recombinant Human Transcobalamin II, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7897-GH-010 | Recombinant F. heparinum Heparinase I, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7898-TG-050 | Recombinant Human TIGIT Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7907-AP-010 | Recombinant Mouse APRIL/TNFSF13 (10 UG) | 10 UG | 4150 |
| R&D Systems | 7907-AP-010/CF | Recombinant Mouse APRIL/TNFSF13, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 7909-IL-010 | Recombinant Mouse IL-17E (NS0-expressed) (10 UG) | 10 UG | 4280 |
| R&D Systems | 7909-IL-010/CF | Recombinant Mouse IL-17E (NS0-expressed), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 791-MG-050 | Recombinant Mouse IGF-I, CF (50 UG) | 50 UG | 2330 |
| R&D Systems | 7910-S7-050 | Recombinant Mouse ST7/LRP12, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7914-TM-050 | Recombinant Cynomolgus Monkey TIM-3 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 7915-TR-025 | Recombinant Mouse TLR5 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7916-MV-010 | Recombinant Mouse VEGF 188 (10 UG) | 10 UG | 3760 |
| R&D Systems | 7916-MV-010/CF | Recombinant Mouse VEGF 188, CF (10 UG) | 10 UG | 3760 |
| R&D Systems | 792-MG-050 | Recombinant Mouse IGF-II, CF (50 UG) | 50 UG | 2330 |
| R&D Systems | 7920-PN-050 | Recombinant Human PANP Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7924-EB-050 | Recombinant Human Ephrin-B3 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 7926-CA-050 | Recombinant Mouse Protocadherin-12, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7927-AT-010 | Recombinant Human alpha-Aminoadipate Aminotransferase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7928-SE-025 | Recombinant Mouse Kallikrein 1, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7929-CE-020 | Recombinant Mouse Carboxylesterase 1/CES1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 793-CK-025 | Recombinant Mouse CXCL7/Thymus Chemokine-1 (aa 40-113) (25 UG) | 25 UG | 4280 |
| R&D Systems | 793-CK-025/CF | Recombinant Mouse CXCL7/Thymus Chemokine-1 (aa 40-113), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7930-MG-010 | Recombinant Human Monoglyceride Lipase, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 7949-6C-025 | Recombinant Rat CCL21/6Ckine (25 UG) | 25 UG | 4280 |
| R&D Systems | 7949-6C-025/CF | Recombinant Rat CCL21/6Ckine, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 795-P4-025 | Recombinant Human CXCL4/PF4 (25 UG) | 25 UG | 4150 |
| R&D Systems | 795-P4-025/CF | Recombinant Human CXCL4/PF4, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 7950-SP-050 | Recombinant Mouse F-Spondin/SPON1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7954-GM-010 | Recombinant Human GM-CSF (CHO-expressed) (10 UG) | 10 UG | 2850 |
| R&D Systems | 7954-GM-010/CF | Recombinant Human GM-CSF (CHO-expressed), CF (10 UG) | 10 UG | 2850 |
| R&D Systems | 7954-GM-050/CF | Recombinant Human GM-CSF (CHO-expressed), CF (50 UG) | 50 UG | 10390 |
| R&D Systems | 7955-IL-025 | Recombinant Human IL-17A (Human Cell-expressed) (25 UG) | 25 UG | 3370 |
| R&D Systems | 7955-IL-025/CF | Recombinant Human IL-17A (Human Cell-expressed), CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 7956-ML-025 | Recombinant Mouse IL-17A (CHO-expressed) (25 UG) | 25 UG | 2980 |
| R&D Systems | 7956-ML-025/CF | Recombinant Mouse IL-17A (CHO-expressed), CF (25 UG) | 25 UG | 2980 |
| R&D Systems | 7958-A7-050 | Recombinant Mouse Integrin alpha 7 beta 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7959-AM-050 | Recombinant Mouse Integrin alpha M beta 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 796-IC-050 | Recombinant Mouse ICAM-1/CD54 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 7960-TR-050 | Recombinant Mouse TLR9 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7964-RN-050 | Recombinant Human RNF43 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7968-4B-050 | Recombinant Rat 4-1BB/TNFRSF9 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 797-B2-025 | Recombinant Mouse IGFBP-2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7987-AX-050 | Recombinant Mouse Integrin alpha X beta 2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7988-N2-025 | Recombinant Mouse Neuropilin-2 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7989-P4-025 | Recombinant Human CXCL4/PF4 (Mammalian-expressed) (25 UG) | 25 UG | 3370 |
| R&D Systems | 7989-P4-025/CF | Recombinant Human CXCL4/PF4 (Mammalian-expressed), CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 7990-TR-025 | Recombinant Rat TNF RI/TNFRSF1A Fc Chimera, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 7994-RF-025 | Recombinant Human ZNRF3 Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7996-RR-050 | Recombinant Human Relaxin R1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 7997-MR-025 | Recombinant Mouse IL-17 RE Fc Chimera, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 7999-AH-020 | Recombinant Human Vanin-1/VNN1, CF (20 UG) | 20 UG | 3760 |
| R&D Systems | 800-LN-01M | d-Luciferin (1 MG) | 1 MG | 330 |
| R&D Systems | 800-LN-50M | d-Luciferin (50 MG) | 50 MG | 2980 |
| R&D Systems | 800-LN-05M | d-Luciferin (5 MG) | 5 MG | 720 |
| R&D Systems | 801-CX-025 | Recombinant Human CXCL13/BLC/BCA-1 (25 UG) | 25 UG | 4150 |
| R&D Systems | 801-CX-025/CF | Recombinant Human CXCL13/BLC/BCA-1, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 802-HC-025 | Recombinant Human CCL16/HCC-4 (25 UG) | 25 UG | 4150 |
| R&D Systems | 802-HC-025/CF | Recombinant Human CCL16/HCC-4, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 8020-GK-025 | Recombinant E. coli N-Acetyl-D-Glucosamine Kinase/NAGK, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8024-AK-025 | Recombinant Human Adenosine Kinase/ADK, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 8029-GP-050 | Recombinant Mouse Lgr6 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 803-I2-200 | Recombinant Human ICAM-2/CD102 Fc Chimera, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | 803-I2-050 | Recombinant Human ICAM-2/CD102 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 804-GB-025 | Recombinant Human IGFBP-4, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 8050-KM-025 | Recombinant Human Kynurenine 3-Monooxygenase/KMO, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8066-GB-025 | Recombinant Mouse IGFBP-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 8066-GB-025/CF | Recombinant Mouse IGFBP-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8067-A6-050 | Recombinant Mouse Integrin alpha 6 beta 4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8068-LT-050 | Recombinant Human Latent TGF-beta bp4, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 807-UK-100 | Recombinant Human uPAR (100 UG) | 100 UG | 4540 |
| R&D Systems | 807-UK-100/CF | Recombinant Human uPAR, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 8077-GP-050 | Recombinant Mouse Lgr4/GPR48 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8078-GP-050 | Recombinant Human Lgr5/GPR49 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 808-AR-100 | Recombinant Human Activin RIB/ALK-4 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 8084-B7-050 | Recombinant Human B7-H7 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 8085-C3-025 | Recombinant Mouse Complement Component C3a, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 8086-TR-025 | Recombinant Mouse TLR12 Fc Chimera, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 8087-SE-010 | Recombinant Human DPP3, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8088-PP-050 | Recombinant S. cerevisiae PPA1, CF (50 UG) | 50 UG | 1550 |
| R&D Systems | 8089-ZN-010 | Recombinant Human Aminopeptidase B/RNPEP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 809-VR-200 | Recombinant Human VCAM-1/CD106, CF (200 UG) | 200 UG | 12730 |
| R&D Systems | 809-VR-050 | Recombinant Human VCAM-1/CD106, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8090-ZN-025 | Recombinant Human PHEX, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 811-BR-100 | Recombinant Human/Mouse BMPR-II Fc Chimera, CF (100 UG) | 100 UG | 5320 |
| R&D Systems | 8114-SR-050 | Recombinant Human SR-BI, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8115-SA-025 | Recombinant Human Serpin A10, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8116-GT-020 | Recombinant Mouse EOGT, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8117-DN-200 | Recombinant Drosophila Notch EGF20, CF (200 UG) | 200 UG | 2600 |
| R&D Systems | 8127-B7-050 | Recombinant Mouse B7-H2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8128-CM-050 | Recombinant Mouse Biglycan, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8129-IL-025 | Recombinant Human IL-17B (CHO) (25 UG) | 25 UG | 4280 |
| R&D Systems | 8129-IL-025/CF | Recombinant Human IL-17B (CHO), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 813-CD-100 | Recombinant Human CD30/TNFRSF8 Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 8134-IL-025 | Recombinant Human IL-17E (Human Cell-expressed) (25 UG) | 25 UG | 4410 |
| R&D Systems | 8134-IL-025/CF | Recombinant Human IL-17E (Human Cell-expressed), CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 8144-EC-050 | Recombinant Rat E-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8145-CD-050 | Recombinant Mouse CD7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8146-GD-010 | Recombinant Human GDF-15 (Human Cell-expressed) (10 UG) | 10 UG | 2590 |
| R&D Systems | 8146-GD-025 | Recombinant Human GDF-15 (Human Cell-expressed) (25 UG) | 25 UG | 4540 |
| R&D Systems | 8146-GD-010/CF | Recombinant Human GDF-15 (Human Cell-expressed), CF (10 UG) | 10 UG | 2590 |
| R&D Systems | 8146-GD-025/CF | Recombinant Human GDF-15 (Human Cell-expressed), CF (25 UG) | 25 UG | 4540 |
| R&D Systems | 8147-VE-025 | Recombinant Human VEGF 189 (aa 27-215) (25 UG) | 25 UG | 4280 |
| R&D Systems | 8147-VE-025/CF | Recombinant Human VEGF 189 (aa 27-215), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8148-WN-025 | Recombinant Mouse Wnt-9a (25 UG) | 25 UG | 4800 |
| R&D Systems | 8148-WN-025/CF | Recombinant Mouse Wnt-9a, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 816-LR-100 | Recombinant Human IL-18 R alpha/IL-1 R5 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 817-P2-050 | Recombinant Human cIAP-2 (HIAP-1), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8177-HK-020 | Recombinant Human Ketohexokinase, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8178-HK-020 | Recombinant Human Hexokinase 1, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8179-HK-020 | Recombinant Human Hexokinase 2, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 818-IA-050 | Recombinant Human cIAP-1 (HIAP-2), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8180-TK-050 | Recombinant Human Thymidine Kinase 1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8184-CK-020 | Recombinant Human Choline Kinase beta, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8185-BR-025 | Recombinant Viral B19R, CF (25 UG) | 25 UG | 3250 |
| R&D Systems | 8186-CD-050 | Recombinant Mouse CD177, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8187-HM-050 | Recombinant Human HMGN1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8188-AB-025 | Recombinant Mouse Integrin alpha 1 beta 1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8189-RG-050 | Recombinant Mouse Reg3G, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8206-B7-100 | Recombinant Human B7-H2, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 8207-CR-050 | Recombinant Human Caspr2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8208-NF-050 | Recombinant Human Neurofascin, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8216-PR-050 | Recombinant Human Properdin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 822-XF-050 | Recombinant Human XIAP (Full Length), CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 8225-BR-025 | Recombinant Viral B8R (25 UG) | 25 UG | 3250 |
| R&D Systems | 8225-BR-025/CF | Recombinant Viral B8R, CF (25 UG) | 25 UG | 3250 |
| R&D Systems | 8226-S8-050 | Recombinant Human S100A8/S100A9 Heterodimer, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8228-MB-025 | Recombinant Human CCL4/MIP-1 beta (aa 26-92) (25 UG) | 25 UG | 4280 |
| R&D Systems | 8228-MB-025/CF | Recombinant Human CCL4/MIP-1 beta (aa 26-92), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8229-CD-050 | Recombinant Rat CD40/TNFRSF5 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 823-C7-010 | Recombinant Human Caspase-7 (10 UG) | 10 UG | 4800 |
| R&D Systems | 823-C7-010/CF | Recombinant Human Caspase-7, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 8230-CL-050 | Recombinant Mouse CD40 Ligand/TNFSF5 (HA-tag) (50 UG) | 50 UG | 4280 |
| R&D Systems | 8230-CL-050/CF | Recombinant Mouse CD40 Ligand/TNFSF5 (HA-tag), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8234-MB-010 | Recombinant Mouse IFN-beta (10 UG) | 10 UG | 3110 |
| R&D Systems | 8234-MB-010/CF | Recombinant Mouse IFN-beta, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 8235-CD-050 | Recombinant Human CD2F-10/SLAMF9 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 824-BW-050 | Recombinant Human Bcl-w (minus C-terminus), CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 8249-AN-050 | Recombinant Human Angiopoietin-like 4 N-Terminal Frag, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8250-CN-050 | Recombinant Mouse Corneodesmosin, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8254-CK-025 | Recombinant Viral CKBP (25 UG) | 25 UG | 3250 |
| R&D Systems | 8254-CK-025/CF | Recombinant Viral CKBP, CF (25 UG) | 25 UG | 3250 |
| R&D Systems | 8258-FN-050 | Recombinant Human Fibronectin/Anaslin, CF (50 UG) | 50 UG | 3760 |
| R&D Systems | 8259-GA-050 | Recombinant Human Galectin-3 (Human Cell-expressed), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8260-AB-010 | Recombinant Mouse Activin B (10 UG) | 10 UG | 3370 |
| R&D Systems | 8260-AB-010/CF | Recombinant Mouse Activin B, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 8266-G9-010 | Recombinant Human GDF-9 (10 UG) | 10 UG | 4280 |
| R&D Systems | 8266-G9-010/CF | Recombinant Human GDF-9, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8267-XB-020 | Recombinant Human Xylulokinase/XYLB, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8268-GK-050 | Recombinant Human N-Acetylmannosamine Kinase/GNE, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8269-SU-050 | Recombinant Human GALNS, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 827-BC-050 | Recombinant Human Bcl-2 (minus C-terminus), CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 8270-AC-050 | Recombinant B. pertussis Adenylate Cyclase, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8285-CY-010 | Recombinant Rat Cathepsin C/DPPI, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8288-RG-050 | Recombinant Rat Reg3B, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8289-TF-050 | Recombinant Human TFF1, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8290-TF-050 | Recombinant Human TFF2, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8294-TF-050 | Recombinant Human TFF3, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8295-SF-025 | Recombinant Mouse Serpin F1/PEDF, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8296-IR-050 | Recombinant Human IGFLR1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8297-GG-025 | Recombinant Human CXCL3/GRO gamma (aa 39-107) (25 UG) | 25 UG | 3500 |
| R&D Systems | 8297-GG-025/CF | Recombinant Human CXCL3/GRO gamma (aa 39-107), CF (25 UG) | 25 UG | 3500 |
| R&D Systems | 8298-AO-010 | Recombinant Human ABP1/AOC1, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8310-GS-050 | Recombinant Mouse Gas6 (Full Length), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8314-AV-050 | Recombinant Mouse Integrin alpha V beta 8, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8315-CA-050 | Recombinant Human Protocadherin-18 (50 UG) | 50 UG | 4280 |
| R&D Systems | 8316-TR-050 | Recombinant Human CD28H/IGPR-1 Fc Chimera (50 UG) | 50 UG | 4280 |
| R&D Systems | 8328-RF-050 | Recombinant Mouse ZNRF3 Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8329-GH-025 | Recombinant Human Lysosomal alpha-Glucosidase/GAA, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 8330-GT-025 | Recombinant Human ST6GAL2, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 8334-GT-025 | Recombinant Human N-Acetylglucosaminyltransferase1/MGAT1, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 8335-G1-01M | Recombinant Human LR3 IGF-I, CF (1 MG) | 1 MG | 3890 |
| R&D Systems | 8335-G1-200 | Recombinant Human LR3 IGF-I, CF (200 UG) | 200 UG | 1560 |
| R&D Systems | 8335-GMP-01M | Recombinant Human LR3 IGF-I GMP, CF (1 MG) | 1 MG | 4540 |
| R&D Systems | 8335-GMP-200 | Recombinant Human LR3 IGF-I GMP, CF (200 UG) | 200 UG | 1810 |
| R&D Systems | 8337-PI-025 | Recombinant Human Serpin A12, CF (25 UG) | 25 UG | 2990 |
| R&D Systems | 8337-PI-050 | Recombinant Human Serpin A12, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8338-PI-025 | Recombinant Mouse Serpin A12, CF (25 UG) | 25 UG | 2990 |
| R&D Systems | 8338-PI-050 | Recombinant Mouse Serpin A12, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8339-PI-025 | Recombinant Rat Serpin A12, CF (25 UG) | 25 UG | 2990 |
| R&D Systems | 8339-PI-050 | Recombinant Rat Serpin A12, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 834-CP-010 | Recombinant Human Caspase-10 (Mch 4), CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 8340-G5-050 | Recombinant Human GDF-5, CF (50 UG) | 50 UG | 3580 |
| R&D Systems | 8344-AN-050 | Recombinant Mouse Angiopoietin-like 3 (aa 17-220), CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8345-DC-050 | Recombinant Mouse DC-SIGN/CD209, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8346-IN-010 | Recombinant Mouse Inhibin A (10 UG) | 10 UG | 4150 |
| R&D Systems | 8346-IN-010/CF | Recombinant Mouse Inhibin A, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 8347-RG-050 | Recombinant Rat Reg3A, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8348-R2-050 | Recombinant Rat sTNF RII/TNFRSF1B (50 UG) | 50 UG | 4150 |
| R&D Systems | 8356-A3-050 | Recombinant Mouse Integrin alpha E beta 7, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8357-TN-050 | Recombinant Human C1qTNF4, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8358-MR-050 | Recombinant Human IL-17 RE Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8359-BM-050 | Recombinant Mouse BAMBI/NMA Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8360-P4-050 | Recombinant Rat CXCL4/PF4, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8364-CA-050 | Recombinant Human Protocadherin gamma C3, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8365-EG-050 | Recombinant Mouse Endoglycan/PODXL2, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8366-RB-050 | Recombinant Mouse ROBO2 Fc Chimera Protein, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8379-GT-010 | Recombinant Human Exostosin 1, CF (10 UG) | 10 UG | 4150 |
| R&D Systems | 838-4B-100 | Recombinant Human 4-1BB/TNFRSF9 Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 8380-SU-020 | Recombinant Human Sulfamidase/SGSH, CF (20 UG) | 20 UG | 4150 |
| R&D Systems | 8384-GH-050 | Recombinant P. heparinus Chondroitinase AC, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8385-BT-050 | Recombinant Human BTLA Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8386-G7-050 | Recombinant Human GDF-7, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8387-TC-050 | Recombinant Human GIF, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8388-LR-050 | Recombinant Human LRIT2, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8389-PG-050 | Recombinant Human PGLYRP4/PGRP-I beta, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 839-B1-100 | Recombinant Human IL-12 R beta 1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 8390-TH-050 | Recombinant Human Thrombospondin-3, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8394-S4-050 | Recombinant Mouse Semaphorin 4C Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 8409-FG-025 | Recombinant Mouse FGF-21 (25 UG) | 25 UG | 4280 |
| R&D Systems | 8409-FG-025/CF | Recombinant Mouse FGF-21, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8410-IL-025 | Recombinant Rat IL-17A (25 UG) | 25 UG | 4280 |
| R&D Systems | 8410-IL-025/CF | Recombinant Rat IL-17A, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8414-CL-025 | Recombinant Rat CD40 Ligand/TNFSF5 (HA-tag) (25 UG) | 25 UG | 4280 |
| R&D Systems | 8414-CL-025/CF | Recombinant Rat CD40 Ligand/TNFSF5 (HA-tag), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8415-A2-200 | Recombinant Mouse Ephrin-A2 Fc Chimera, CF (200 UG) | 200 UG | 4280 |
| R&D Systems | 8416-FB-050 | Recombinant Human Fibulin 3 (HA Tag), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8417-IL-025 | Recombinant Human IL-28A/IFN-lambda 2 (HEK293) (25 UG) | 25 UG | 4280 |
| R&D Systems | 8417-IL-025/CF | Recombinant Human IL-28A/IFN-lambda 2 (HEK293), CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8418-X2-025 | Recombinant Human XCL2/SCM-1 beta (25 UG) | 25 UG | 4280 |
| R&D Systems | 8418-X2-025/CF | Recombinant Human XCL2/SCM-1 beta, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8419-WN-010 | Recombinant Mouse Wnt-8a (10 UG) | 10 UG | 4280 |
| R&D Systems | 8419-WN-010/CF | Recombinant Mouse Wnt-8a, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8420-B3-025 | Recombinant Human TGF-beta 3 (CHO-expressed) (25 UG) | 25 UG | 6360 |
| R&D Systems | 8420-B3-005 | Recombinant Human TGF-beta 3 (CHO-expressed) (5 UG) | 5 UG | 2980 |
| R&D Systems | 8420-B3-025/CF | Recombinant Human TGF-beta 3 (CHO-expressed), CF (25 UG) | 25 UG | 6360 |
| R&D Systems | 8420-B3-005/CF | Recombinant Human TGF-beta 3 (CHO-expressed), CF (5 UG) | 5 UG | 2980 |
| R&D Systems | 8424-VF-050 | Recombinant Human PBEF/Visfatin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8425-NR-050 | Recombinant Mouse NrCAM, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8426-NG-050 | Recombinant Mouse NgR3/NgRH2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8427-FM-050 | Recombinant Human FAM20B, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8428-GP-050 | Recombinant Mouse CD42b/GPIb alpha, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8429-T4-050 | Recombinant Human LILRB2/CD85d/ILT4 (50 UG) | 50 UG | 4280 |
| R&D Systems | 8435-CL-050 | Recombinant Human CLEC-2A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8436-PR-050 | Recombinant Human PRDC/GREM2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8437-MK-010 | Recombinant Mouse IFN-kappa (10 UG) | 10 UG | 4280 |
| R&D Systems | 8437-MK-010/CF | Recombinant Mouse IFN-kappa, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8438-CL-050 | Recombinant Mouse MDL-1/CLEC, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8439-NG-025 | Recombinant Human NgR3/NgRH2, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 844-DC-050 | Recombinant Mouse DCC Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8440-VC-025 | Recombinant Human VE-Cadherin, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 8444-VL-025 | Recombinant Human VLDL R, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8446-GT-010 | Recombinant Human O-GlcNAcTransferase/OGT, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8446-GT-050 | Recombinant Human O-GlcNAcTransferase/OGT, CF (50 UG) | 50 UG | 6360 |
| R&D Systems | 845-TC-025 | Recombinant Mouse CCL1/TCA-3 (25 UG) | 25 UG | 4490 |
| R&D Systems | 845-TC-025/CF | Recombinant Mouse CCL1/TCA-3, CF (25 UG) | 25 UG | 4490 |
| R&D Systems | 8454-GT-050 | Recombinant Mouse ST3GAL5/GM3 Synthase, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8455-PT-050 | Recombinant Human PRL-3/PTP4A3, CF (50 UG) | 50 UG | 3710 |
| R&D Systems | 8456-DR-100 | Recombinant Human DHFR, CF (100 UG) | 100 UG | 3240 |
| R&D Systems | 8457-AS-020 | Recombinant Human Pepsinogen A5, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 846-BD-050 | Recombinant Human BID, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 8466-AN-025 | Recombinant Human Angiopoietin-like 6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 8466-AN-025/CF | Recombinant Human Angiopoietin-like 6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8467-BT-050 | Recombinant Human BTN1A1/Butyrophilin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8468-CD-025 | Recombinant Human CD69, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8469-CD-025 | Recombinant Mouse CD69, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 847-PN-010 | Recombinant Human PTEN, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8470-GP-050 | Recombinant Human Lgr6 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8475-OM-010 | Recombinant Human Oncostatin M (HEK-293-expressed) (10 UG) | 10 UG | 2670 |
| R&D Systems | 8475-OM-050 | Recombinant Human Oncostatin M (HEK-293-expressed) (50 UG) | 50 UG | 9480 |
| R&D Systems | 8475-OM-010/CF | Recombinant Human Oncostatin M (HEK-293-expressed), CF (10 UG) | 10 UG | 2670 |
| R&D Systems | 8475-OM-050/CF | Recombinant Human Oncostatin M (HEK-293-expressed), CF (50 UG) | 50 UG | 9480 |
| R&D Systems | 8477-CA-050 | Recombinant Human Protocadherin-12, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8478-SA-050 | Recombinant Mouse Serum Amyloid A2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8479-DT-025 | Recombinant Mouse DcTRAIL R1/TNFRSF23, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8487-T4-025 | Recombinant Human LILRB5/CD85c/LIR-8, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8488-T4-025 | Recombinant Human LILRB4/CD85k/ILT3, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8489-EN-020 | Recombinant Human ENPP-6, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8489-NA-050 | Recombinant Human Napsin A, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8490-PT-050 | Recombinant Human PRL-1/PTP4A1, CF (50 UG) | 50 UG | 3710 |
| R&D Systems | 8498-BP-025 | Recombinant Human IL-22BP Protein (25 UG) | 25 UG | 4280 |
| R&D Systems | 8498-BP-025/CF | Recombinant Human IL-22BP Protein, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8499-IF-010 | Recombinant Human IFN-beta (10 UG) | 10 UG | 3110 |
| R&D Systems | 8499-IF-010/CF | Recombinant Human IFN-beta, CF (10 UG) | 10 UG | 3110 |
| R&D Systems | 8500-SP-050 | Recombinant Mouse Mindin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8504-LR-050 | Recombinant Human LRIG1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8505-EC-050 | Recombinant Human E-Cadherin, CF (50 UG) | 50 UG | 3370 |
| R&D Systems | 8506-AB-010 | Recombinant Human Inhibin A (10 UG) | 10 UG | 4280 |
| R&D Systems | 8506-AB-010/CF | Recombinant Human Inhibin A, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8507-PG-050 | Recombinant Human PGLYRP3/PGRP-I alpha (50 UG) | 50 UG | 4280 |
| R&D Systems | 8509-PD-050 | Recombinant Cynomolgus PD-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 852-CD-100 | Recombinant Mouse CD30/TNFRSF8 Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 853-G5-050 | Recombinant Mouse GDF-5 (50 UG) | 50 UG | 4880 |
| R&D Systems | 853-G5-050/CF | Recombinant Mouse GDF-5, CF (50 UG) | 50 UG | 4880 |
| R&D Systems | 8534-LC-050 | Recombinant Mouse Lipocalin-13, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8535-MO-050 | Recombinant Human MOG, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8536-MO-050 | Recombinant Mouse MOG, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8539-BT-050 | Recombinant Human CD277/BTN3A1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 854-AX-100 | Recombinant Mouse Axl Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 8540-BT-050 | Recombinant Mouse BTN1A1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8544-CL-050 | Recombinant Human MDL-1/CLEC, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8545-PR-050 | Recombinant Mouse Pref-1/DLK1/FA1 (50 UG) | 50 UG | 4280 |
| R&D Systems | 8546-MR-050 | Recombinant Human Reelin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 855-G6-050 | Recombinant Mouse GDF-6/BMP-13 (50 UG) | 50 UG | 4540 |
| R&D Systems | 855-G6-050/CF | Recombinant Mouse GDF-6/BMP-13, CF (50 UG) | 50 UG | 4540 |
| R&D Systems | 8560-GT-050 | Recombinant Human B3GAT1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8564-PI-010 | Recombinant Human LEKTI/SPINK5, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8566-BP-020 | Recombinant Human PFKFB3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8567-GT-020 | Recombinant Human Exostosin 1/2 Heterodimer, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8568-ST-020 | Recombinant Human Heparan Sulfate-6-O-Sulfotransferase-3, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8569-PK-050 | Recombinant Human PKLR, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8575-FB-025 | Recombinant Canine FGF basic Protein (25 UG) | 25 UG | 3370 |
| R&D Systems | 8575-FB-025/CF | Recombinant Canine FGF basic Protein, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 8576-FS-010 | Recombinant Mouse FSH alpha/beta (10 UG) | 10 UG | 4280 |
| R&D Systems | 8576-FS-010/CF | Recombinant Mouse FSH alpha/beta, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 8577-FB-025 | Recombinant Equine FGF basic (25 UG) | 25 UG | 3370 |
| R&D Systems | 8577-FB-025/CF | Recombinant Equine FGF basic, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 8578-PD-050 | Recombinant Cynomolgus PD-1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8579-GA-050 | Recombinant Mouse Galectin-2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8580-MG-100 | Recombinant Mouse MAG/Siglec-4a Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 8584-OX-050 | Recombinant Rat OX40/TNFRSF4 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8585-BB-010 | Recombinant Equine PDGF-BB (10 UG) | 10 UG | 3370 |
| R&D Systems | 8585-BB-010/CF | Recombinant Equine PDGF-BB, CF (10 UG) | 10 UG | 3370 |
| R&D Systems | 859-DK-100 | Recombinant Human Dtk Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 8599-TA-010 | Recombinant Human TNF-alpha (10 UG) | 10 UG | 2720 |
| R&D Systems | 8599-TA-010/CF | Recombinant Human TNF-alpha, CF (10 UG) | 10 UG | 2720 |
| R&D Systems | 860-MB-050 | Recombinant Mouse BID, CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 8600-LF-025 | Recombinant Canine LIF (25 UG) | 25 UG | 3760 |
| R&D Systems | 8600-LF-025/CF | Recombinant Canine LIF, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 8604-MS-050 | Recombinant Mouse Mesothelin, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8605-BT-050 | Recombinant Mouse BTNL2/Butyrophilin-like 2 Protein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8606-FB-050 | Recombinant Mouse Fibulin 7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8607-NE-050 | Recombinant Human Neogenin Protein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8608-IL-050 | Recombinant Human IL-35 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8609-RO-050 | Recombinant Human ROR2 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 861-PC-100 | Recombinant Human P-Cadherin Fc Chimera, CF (100 UG) | 100 UG | 4410 |
| R&D Systems | 8614-MT-100 | Recombinant Human HGF R/c-MET Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 8615-A3-050 | Recombinant Mouse Integrin alpha 4 beta 7, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8616-SL-050 | Recombinant Human Slit2, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8617-B1-010 | Recombinant Equine TGF-beta 1 (10 UG) | 10 UG | 10520 |
| R&D Systems | 8617-B1-010/CF | Recombinant Equine TGF-beta 1, CF (10 UG) | 10 UG | 10520 |
| R&D Systems | 862-VC-100 | Recombinant Human VCAM-1/CD106 Fc Chimera, CF (100 UG) | 100 UG | 4750 |
| R&D Systems | 8636-PC-050 | Recombinant Human CD31/PECAM-1 Fc Chimera Protein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8638-EG-050 | Recombinant Human EGF-L6 Protein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8639-FC-050 | Recombinant Human FCRN, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 864-KS-010 | Recombinant Human Active PDK-1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 8646-DH-050 | Recombinant Human Dihydrolipoamide Dehydrogenase/DLD, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8647-SE-010 | Recombinant Mouse FAP, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 8655-EN-020 | Recombinant Human ENPP-5 Protein, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 8658-PK-050 | Recombinant Human Pyridoxal Kinase Protein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8659-GT-020 | Recombinant Human C1GalT1/C1GalT1C1 Protein, CF (20 UG) | 20 UG | 4280 |
| R&D Systems | 866-CX-025 | Recombinant Human CXCL14/BRAK, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 870-LP-025 | Recombinant Human LBP (25 UG) | 25 UG | 4280 |
| R&D Systems | 870-LP-025/CF | Recombinant Human LBP, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 871-B1-025 | Recombinant Human IGFBP-1, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 872-RP-100 | Recombinant Human IL-1 Rrp2/IL-1 R6 Fc Chimera, CF (100 UG) | 100 UG | 5580 |
| R&D Systems | 873-LP-050 | Recombinant Human LAMP Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 874-RB-100 | Recombinant Human IL-10 R beta Fc Chimera, CF (100 UG) | 100 UG | 5450 |
| R&D Systems | 875-B5-025 | Recombinant Human IGFBP-5, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 876-B6-025 | Recombinant Human IGFBP-6, CF (25 UG) | 25 UG | 4410 |
| R&D Systems | 878-BC-050 | Recombinant Mouse Bcl-xL (minus C-terminus), CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 879-BK-100 | BAK L to A BH3 Synthetic Peptide GQVGRQAAIIGDDINR, CF (100 UG) | 100 UG | 1420 |
| R&D Systems | 881-BA-100 | BAK BH3 Synthetic Peptide GQVGRQLAIIGDDINR, CF (100 UG) | 100 UG | 1420 |
| R&D Systems | 882-B8-050 | Recombinant Human BID (Caspase-8-cleaved), CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 883-M8-050 | Recombinant Mouse BID (Caspase-8-cleaved), CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 885-GSB-050 | Recombinant Human Gas6 Protein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8866-GR-100 | Recombinant Human Glutathione Reductase Protein, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 8870-B7-050 | Recombinant Human B7-H4 Protein Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8874-B3-025 | Recombinant Human IGFBP-3 Protein, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 8875-EC-050 | Recombinant Mouse E-Cadherin Protein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8878-LF-100 | Recombinant Mouse LIF Protein (100 UG) | 100 UG | 8830 |
| R&D Systems | 8878-LF-025 | Recombinant Mouse LIF Protein (25 UG) | 25 UG | 3370 |
| R&D Systems | 8878-LF-500 | Recombinant Mouse LIF Protein (500 UG) | 500 UG | 24570 |
| R&D Systems | 8878-LF-100/CF | Recombinant Mouse LIF Protein, CF (100 UG) | 100 UG | 8830 |
| R&D Systems | 8878-LF-025/CF | Recombinant Mouse LIF Protein, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 8878-LF-500/CF | Recombinant Mouse LIF Protein, CF (500 UG) | 500 UG | 24570 |
| R&D Systems | 8880-IR-025 | Recombinant Human/Mouse/Rat Irisin Protein (25 UG) | 25 UG | 4280 |
| R&D Systems | 8880-IR-025/CF | Recombinant Human/Mouse/Rat Irisin Protein, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8884-LY-025 | Recombinant Human Lymphotoxin alpha1/beta2 Protein (25 UG) | 25 UG | 4280 |
| R&D Systems | 8884-LY-025/CF | Recombinant Human Lymphotoxin alpha1/beta2 Protein, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 8895-MR-050 | Recombinant Human IL-11 R alpha Protein, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8897-LR-050 | Recombinant Rat Lymphotoxin beta R/TNFRSF3 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 8899-LH-010 | Recombinant Human LH alpha/beta Heterodimer Protein (10 UG) | 10 UG | 4280 |
| R&D Systems | 8899-LH-010/CF | Recombinant Human LH alpha/beta Heterodimer Protein, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 891-MR-100 | Recombinant Human Mer Fc Chimera, CF (100 UG) | 100 UG | 4670 |
| R&D Systems | 894-BX-050 | Recombinant Human Bcl-xL (minus C-Terminus), CF (50 UG) | 50 UG | 4670 |
| R&D Systems | 895-XB-050 | Recombinant Human XIAP (BIR3), CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 896-KS-010 | Recombinant Human Active p70 S6 Kinase, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 901-MP-010 | Recombinant Human MMP-1, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 902-MP-010 | Recombinant Human MMP-2, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 902-MPN-010 | Recombinant Human MMP-2 (NS0-expressed), CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 904-CN-100 | Recombinant Human Contactin-1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 906-CB-050 | Recombinant Human Common beta Chain Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 907-MP-010 | Recombinant Human MMP-7, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 908-MP-010 | Recombinant Human MMP-8, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 909-MM-010 | Recombinant Mouse MMP-9, CF (10 UG) | 10 UG | 4930 |
| R&D Systems | 910-MP-010 | Recombinant Human MMP-10, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 911-MP-010 | Recombinant Human MMP-9, CF (10 UG) | 10 UG | 4930 |
| R&D Systems | 911-MPN-010 | Recombinant Human MMP-9 (NS0-expressed), CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 912-PL-025 | Recombinant Porcine IL-12 (25 UG) | 25 UG | 4800 |
| R&D Systems | 912-PL-025/CF | Recombinant Porcine IL-12, CF (25 UG) | 25 UG | 4800 |
| R&D Systems | 914-AN-025 | Recombinant Human Angiopoietin-like 7 (25 UG) | 25 UG | 4280 |
| R&D Systems | 914-AN-025/CF | Recombinant Human Angiopoietin-like 7, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 915-VL-010 | Recombinant Viral EBV IL-10 (10 UG) | 10 UG | 4280 |
| R&D Systems | 915-VL-010/CF | Recombinant Viral EBV IL-10, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 916-MP-010 | Recombinant Human MMP-15/MT2-MMP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 917-MP-010 | Recombinant Human MMP-12, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 918-MP-010 | Recombinant Human MMP-14/MT1-MMP, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 918-MPN-010 | Recombinant Human MMP-14/MT1-MMP (NS0-expressed), CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 921-BM-050 | Recombinant Human BAMBI/NMA Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 922-ED-010 | Recombinant Human EDA-A2 (10 UG) | 10 UG | 4280 |
| R&D Systems | 922-ED-010/CF | Recombinant Human EDA-A2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 923-AN-025 | Recombinant Human Angiopoietin-1 (25 UG) | 25 UG | 3760 |
| R&D Systems | 923-AN-025/CF | Recombinant Human Angiopoietin-1, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 924-MP-010 | Recombinant Mouse/Rat MMP-2, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 925-MD-050 | Recombinant Human MD-1 (50 UG) | 50 UG | 4280 |
| R&D Systems | 925-MD-050/CF | Recombinant Human MD-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 926-AS-050 | Recombinant Human Angiostatin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 928-T2-100 | Recombinant Zebrafish Tie-2 Fc Chimera, CF (100 UG) | 100 UG | 4540 |
| R&D Systems | 929-ZN-010 | Recombinant Human ACE, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 930-ADB-010 | Recombinant Human TACE/ADAM17, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 931-AS-050 | Recombinant Human BACE-1, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 933-ZN-010 | Recombinant Human ACE-2, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 934-CY-010 | Recombinant Human Cathepsin X/Z/P, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 936-AD-020 | Recombinant Human ADAM10, CF (20 UG) | 20 UG | 4800 |
| R&D Systems | 937-4B-050 | Recombinant Mouse 4-1BB/TNFRSF9 Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 938-VC-050 | Recombinant Human VE-Cadherin Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 939-AD-020 | Recombinant Human ADAM9, CF (20 UG) | 20 UG | 4800 |
| R&D Systems | 941-SP-050 | Recombinant Human SPARC, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 942-SP-050 | Recombinant Mouse SPARC, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 943-D3-050 | Recombinant Human DR3/TNFRSF25 Fc Chimera, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 944-DM-100 | Recombinant Human Desmoglein-1 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 946-AD-020 | Recombinant Mouse ADAM10, CF (20 UG) | 20 UG | 4800 |
| R&D Systems | 947-DM-100 | Recombinant Human Desmoglein-2 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 949-AD-020 | Recombinant Mouse ADAM9, CF (20 UG) | 20 UG | 4800 |
| R&D Systems | 9510-01K-EB | TdT Enzyme/Buffer (1000 UN) | 1000 UN | 3000 |
| R&D Systems | 952-CY-010 | Recombinant Human Cathepsin L, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 953-CY-010 | Recombinant Human Cathepsin B, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 954-SE-010 | Recombinant Mouse DPPIV/CD26, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 955-DA-050 | Recombinant Human DAN Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 956-GR-050 | Recombinant Mouse Gremlin (50 UG) | 50 UG | 4410 |
| R&D Systems | 956-GR-050/CF | Recombinant Mouse Gremlin, CF (50 UG) | 50 UG | 4410 |
| R&D Systems | 957-GD-025 | Recombinant Human GDF-15 (25 UG) | 25 UG | 4490 |
| R&D Systems | 957-GD-025/CF | Recombinant Human GDF-15, CF (25 UG) | 25 UG | 4490 |
| R&D Systems | 958-G3-010 | Recombinant Mouse GDF-3, CF (10 UG) | 10 UG | 4410 |
| R&D Systems | 959-ME-010 | Recombinant Mouse Erythropoietin (10 UG) | 10 UG | 4280 |
| R&D Systems | 959-ME-010/CF | Recombinant Mouse Erythropoietin, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 960-EP-050 | Recombinant Human EpCAM/TROP1 Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 9600-5-D | Calf Thymus DNA (5 x 1 mL) (5 ML) | 5 ML | 1350 |
| R&D Systems | 9605-5-D | Herring Sperm DNA (5 x 1 mL) (5 ML) | 5 ML | 1350 |
| R&D Systems | 961-RM-025 | Recombinant Rhesus Macaque IFN-gamma (25 UG) | 25 UG | 3760 |
| R&D Systems | 961-RM-025/CF | Recombinant Rhesus Macaque IFN-gamma, CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 9610-5-D | Salmon Sperm DNA (5 x 1 mL) (5 ML) | 5 ML | 1350 |
| R&D Systems | 962-CL-050 | Recombinant Human CLC (50 UG) | 50 UG | 4280 |
| R&D Systems | 962-CL-050/CF | Recombinant Human CLC, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 963-ER-050 | Recombinant Human Erythropoietin R Fc Chimera, CF (50 UG) | 50 UG | 4930 |
| R&D Systems | 964-AN-025 | Recombinant Human Angiopoietin-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 964-AN-025/CF | Recombinant Human Angiopoietin-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 965-CY-010 | Recombinant Mouse Cathepsin B, CF (10 UG) | 10 UG | 4280 |
| R&D Systems | 966-6C-025 | Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera) (25 UG) | 25 UG | 3760 |
| R&D Systems | 966-6C-025/CF | Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera), CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 968-IL-025 | Recombinant Human CXCL8/IL-8 (Mucin Stalk Chimera) (25 UG) | 25 UG | 3760 |
| R&D Systems | 968-IL-025/CF | Recombinant Human CXCL8/IL-8 (Mucin Stalk Chimera), CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 969-FG-025 | Recombinant Human FGF-19 (25 UG) | 25 UG | 3370 |
| R&D Systems | 969-FG-025/CF | Recombinant Human FGF-19, CF (25 UG) | 25 UG | 3370 |
| R&D Systems | 970-TM-010 | Recombinant Human TIMP-1, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 971-TM-010 | Recombinant Human TIMP-2, CF (10 UG) | 10 UG | 4930 |
| R&D Systems | 972-EMN-050 | Recombinant Human EMMPRIN/CD147 Fc Chimera (NS0), CF (50 UG) | 50 UG | 4930 |
| R&D Systems | 973-TM-010 | Recombinant Human TIMP-3, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 974-TSF-010 | Recombinant Human TIMP-4 (Sf 21-expressed), CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 976-CX-025 | Recombinant Human CXCL16 (25 UG) | 25 UG | 4150 |
| R&D Systems | 976-CX-025/CF | Recombinant Human CXCL16, CF (25 UG) | 25 UG | 4150 |
| R&D Systems | 977-ES-100 | Recombinant Rat E-Selectin/CD62E Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 978-RN-025 | Recombinant Human CCL5/RANTES (Mucin Stalk Chimera) (25 UG) | 25 UG | 3630 |
| R&D Systems | 978-RN-025/CF | Recombinant Human CCL5/RANTES (Mucin Stalk Chimera), CF (25 UG) | 25 UG | 3630 |
| R&D Systems | 979-MC-025 | Recombinant Human CCL2/MCP-1 (Mucin Stalk Chimera) (25 UG) | 25 UG | 3760 |
| R&D Systems | 979-MC-025/CF | Recombinant Human CCL2/MCP-1 (Mucin Stalk Chimera), CF (25 UG) | 25 UG | 3760 |
| R&D Systems | 980-MT-010 | Recombinant Mouse TIMP-1, CF (10 UG) | 10 UG | 4800 |
| R&D Systems | 981-TR-050 | Recombinant Human TSLP R Fc Chimera, CF (50 UG) | 50 UG | 4150 |
| R&D Systems | 982-CD-100 | Recombinant Mouse CD14 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 983-MR-100 | Recombinant Mouse IL-3 R alpha/CD123 Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 984-FL-025 | Recombinant Feline IL-4 (25 UG) | 25 UG | 4280 |
| R&D Systems | 984-FL-025/CF | Recombinant Feline IL-4, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 985-PI-050 | Recombinant Porcine IFN-gamma (50 UG) | 50 UG | 4280 |
| R&D Systems | 985-PI-050/CF | Recombinant Porcine IFN-gamma, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 986-GS-025 | Recombinant Mouse Gas6 (25 UG) | 25 UG | 4280 |
| R&D Systems | 986-GS-025/CF | Recombinant Mouse Gas6, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | 987-FL-010 | Recombinant Feline GM-CSF (10 UG) | 10 UG | 3890 |
| R&D Systems | 987-FL-010/CF | Recombinant Feline GM-CSF, CF (10 UG) | 10 UG | 3890 |
| R&D Systems | 988-VJ-050 | Recombinant Mouse JAM-B/VE-JAM Fc Chimera, CF (50 UG) | 50 UG | 4280 |
| R&D Systems | 989-AR-100 | Recombinant Mouse Amphiregulin (100 UG) | 100 UG | 4280 |
| R&D Systems | 989-AR-100/CF | Recombinant Mouse Amphiregulin, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 990-SG-100 | Recombinant Human SIGIRR Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 991-R2-100 | Recombinant Human IL-21 R Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 992-KS-010 | Recombinant Human Active RSK1, CF (10 UG) | 10 UG | 4680 |
| R&D Systems | 992-SG-100 | Recombinant Mouse SIGIRR Fc Chimera, CF (100 UG) | 100 UG | 4280 |
| R&D Systems | 993-MC-050 | Recombinant Mouse MAdCAM-1 Fc Chimera, CF (50 UG) | 50 UG | 2980 |
| R&D Systems | 994-LF-025 | Recombinant Mouse Lefty-1 (25 UG) | 25 UG | 4280 |
| R&D Systems | 994-LF-025/CF | Recombinant Mouse Lefty-1, CF (25 UG) | 25 UG | 4280 |
| R&D Systems | A-100 | Human Ubiquitin Polyclonal Ab (200 UL) | 200 UL | 2930 |
| R&D Systems | A-101 | Ubiquitin K48 Linkage MAb (Clone 1001C) (50 UG) | 50 UG | 3540 |
| R&D Systems | A-104 | Human Ubiquitin MAb (Clone 83406) (50 UG) | 50 UG | 2580 |
| R&D Systems | A-106 | Human Ubiquitin MAb (Clone FK2) (50 UG) | 50 UG | 2660 |
| R&D Systems | A-110 | Human Phospho-Ubiquitin (S65) Affinity Purified PAb (50 UG) | 50 UG | 3750 |
| R&D Systems | A-115 | Avidin-HRP (200 UL) | 200 UL | 530 |
| R&D Systems | A-306 | Human ISG15 E1/UBE1L Polyclonal Ab (100 UL) | 100 UL | 3210 |
| R&D Systems | A-340 | Human UCH-L1 Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-400 | Human/Mouse/Rat HSP70/HSPA1A MAb (Clone 242707) (50 UG) | 50 UG | 2720 |
| R&D Systems | A-410 | Human/Mouse/Rat HSP40 MAb (Clone 419401) (50 UG) | 50 UG | 2720 |
| R&D Systems | A-420 | Human/Mouse/Rat HSP60 MAb (Clone 264233) (50 UG) | 50 UG | 2720 |
| R&D Systems | A-430 | Human HSP10/EPF MAb (Clone 330629) (50 UG) | 50 UG | 2720 |
| R&D Systems | A-440 | Human HSP90 alpha Affinity Purified Polyclonal Ab (50 UG) | 50 UG | 2720 |
| R&D Systems | A-450 | Human p23/PTGES3 MAb (Clone JJ6) (50 UG) | 50 UG | 2720 |
| R&D Systems | A-500 | Human UFM1 Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-600 | Human ISG15 Polyclonal Ab (100 UL) | 100 UL | 2170 |
| R&D Systems | A-603 | Human UBE2K/E2-25K Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-605 | Human UbcH2/UBE2H Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-610 | Human UbcH3/Cdc34 Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-615 | Human UbcH5/UBE2D Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-630 | Human UbcH6/UBE2E1 Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-640 | Human UbcH7/UBE2L3 Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-650 | Human UbcH10/UBE2C Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-655 | Human UBE2M/Ubc12 Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-714 | Human SUMO Pan Specific MAb (Clone 852721) (100 UG) | 100 UG | 3130 |
| R&D Systems | A-716 | Human SUMO1 MAb (Clone 852620) (100 UG) | 100 UG | 3130 |
| R&D Systems | A-718 | Human SUMO2/3 MAb (Clone 852908) (100 UG) | 100 UG | 3130 |
| R&D Systems | A-720 | Human SUMO3 MAb (Clone 907614) (100 UG) | 100 UG | 3130 |
| R&D Systems | A-722 | Human SUMO1 MAb (Clone 21C7) (50 UG) | 50 UG | 3130 |
| R&D Systems | A-724 | Human SUMO2/3 MAb (Clone 401504) (50 UG) | 50 UG | 2660 |
| R&D Systems | A-800 | Human LC3/MAP1LC3A MAb (Clone 877005) (50 UG) | 50 UG | 2660 |
| R&D Systems | A-802 | Human LC3C/MAP1LC3C Polyclonal Ab (50 UG) | 50 UG | 2660 |
| R&D Systems | A-810 | Human GATE-16 MAb (Clone 853746) (50 UG) | 50 UG | 2660 |
| R&D Systems | A-812 | Human NEDD8 Polyclonal Ab (200 UL) | 200 UL | 2170 |
| R&D Systems | A-830 | Human ISG15 MAb (Clone 851701) (50 UG) | 50 UG | 2660 |
| R&D Systems | A-840 | Human FAT10 MAb (Clone 851505) (50 UG) | 50 UG | 2660 |
| R&D Systems | AB-100-NA | TGF-beta Pan Specific Polyclonal Ab (1 MG) | 1 MG | 5990 |
| R&D Systems | AB-101-C | Normal Chicken IgY Control (1 MG) | 1 MG | 1080 |
| R&D Systems | AB-101-NA | TGF-beta 1/1.2 Polyclonal Ab (1 MG) | 1 MG | 5990 |
| R&D Systems | AB-105-C | Normal Rabbit IgG Control (1 MG) | 1 MG | 1080 |
| R&D Systems | AB-108-C | Normal Goat IgG Control (1 MG) | 1 MG | 1080 |
| R&D Systems | AB-112-NA | TGF-beta 2 Polyclonal Ab (1 MG) | 1 MG | 5450 |
| R&D Systems | AB-12-NA | TGF-beta 2 Polyclonal Ab (Rabbit) (1 MG) | 1 MG | 5450 |
| R&D Systems | AB-20-NA | Human PDGF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-200-NA | Human IL-1 alpha/IL-1F1 Polyclonal Ab (1 MG) | 1 MG | 4350 |
| R&D Systems | AB-201-NA | Human IL-1 beta/IL-1F2 Polyclonal Ab (1 MG) | 1 MG | 4350 |
| R&D Systems | AB-202-NA | Human IL-2 Polyclonal Ab (1 MG) | 1 MG | 4350 |
| R&D Systems | AB-203-NA | Human IL-3 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-204-NA | Human IL-4 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-205-NA | Human IL-5 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-206-NA | Human IL-6 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-207-NA | Human IL-7 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-208-NA | Human CXCL8/IL-8 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-209-NA | Human IL-9 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-210-NA | Human TNF-alpha Polyclonal Ab (1 MG) | 1 MG | 4350 |
| R&D Systems | AB-211-NA | Human Lymphotoxin-alpha/TNF-beta Polyclonal Ab (1 MG) | 1 MG | 4350 |
| R&D Systems | AB-212-NA | Human/Rat GDNF Polyclonal Ab (1 MG) | 1 MG | 5040 |
| R&D Systems | AB-214-NA | Human G-CSF Polyclonal Ab (1 MG) | 1 MG | 5990 |
| R&D Systems | AB-215-NA | Human GM-CSF Polyclonal Ab (1 MG) | 1 MG | 4350 |
| R&D Systems | AB-216-NA | Human M-CSF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-217-NA | Human IL-10 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-218-NA | Human IL-11 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-219-NA | Human IL-12 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-220-NA | Human PDGF-BB Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-221-NA | Human PDGF-AA Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-223-NA | Human CD25/IL-2 R alpha Polyclonal Ab (1 MG) | 1 MG | 5040 |
| R&D Systems | AB-225-PB | Human TNF RI/TNFRSF1A Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-226-PB | Human TNF RII/TNFRSF1B Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-227-NA | Human IL-6 R alpha Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-228-NA | Human gp130 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-229-NA | Human PD-ECGF/Thymidine Phosphorylase Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-23-NA | PDGF Polyclonal Ab (1 MG) | 1 MG | 4350 |
| R&D Systems | AB-230-NA | Human IL-4 R alpha Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-233-NA | Human FGF basic Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-235-NA | Human FGF-4 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-236-NA | Human EGF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-238-NA | Human FGF-6 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-239-NA | Human TGF-alpha Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-244-NA | TGF-beta 3 Polyclonal Ab (1 MG) | 1 MG | 5990 |
| R&D Systems | AB-245-NA | TGF-beta 5 Polyclonal Ab (1 MG) | 1 MG | 5990 |
| R&D Systems | AB-246-NA | Human LAP (TGF-beta 1) Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-247-NA | Human IL-15 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-250-NA | Human LIF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-254-PB | Human CXCL5/ENA-78 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-255-NA | Human SCF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-256-NA | Human beta-NGF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-257-NA | Human CNTF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-261-NA | Human Betacellulin Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-262-NA | Human Amphiregulin Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-264-PB | Human PlGF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-265-NA | Human Angiogenin Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-266-PB | Human CXCL10/IP-10 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-269-NA | Human IL-1 RI Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-270-NA | Human CCL3/MIP-1 alpha Polyclonal Ab (1 MG) | 1 MG | 5040 |
| R&D Systems | AB-271-NA | Human CCL4/MIP-1 beta Polyclonal Ab (1 MG) | 1 MG | 5040 |
| R&D Systems | AB-272-PB | Human CCL1/I-309 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-275-PB | Human CXCL1/GRO alpha Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-278-NA | Human CCL5/RANTES Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-279-NA | Human CCL2/MCP-1 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-280-NA | Human IL-1ra/IL-1F3 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-281-NA | Human CCL8/MCP-2 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-282-NA | Human CCL7/MCP-3 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-285-NA | Human IFN-gamma Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-286-NA | Human Erythropoietin Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-288-NA | Human Thrombopoietin Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-289-PB | Human MIF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-293-NA | Human VEGF 165 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-294-NA | Human HGF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-295-NA | Human Oncostatin M (OSM) Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-32-NA | Bovine FGF acidic Polyclonal Ab (Rabbit) (1 MG) | 1 MG | 5450 |
| R&D Systems | AB-33-NA | Bovine FGF basic Polyclonal Ab (Rabbit) (1 MG) | 1 MG | 5450 |
| R&D Systems | AB-400-NA | Mouse IL-1 alpha/IL-1F1 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-401-NA | Mouse IL-1 beta/IL-1F2 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-402-NA | Mouse IL-2 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-403-NA | Mouse IL-3 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-404-NA | Mouse IL-4 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-405-NA | Mouse IL-5 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-406-NA | Mouse IL-6 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-407-NA | Mouse IL-7 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-409-NA | Mouse IL-9 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-410-NA | Mouse TNF-alpha Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-413-NA | Mouse IL-13 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-414-NA | Mouse G-CSF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-415-NA | Mouse GM-CSF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-416-NA | Mouse M-CSF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-417-NA | Mouse IL-10 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-419-NA | Mouse IL-12 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-449-NA | Mouse LIF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-450-NA | Mouse CCL3/MIP-1 alpha Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-451-NA | Mouse CCL4/MIP-1 beta Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-455-NA | Mouse SCF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-479-NA | Mouse CCL2/JE/MCP-1 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-487-NA | Mouse CCL6/C10 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB-557-NA | Rat CNTF Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB126 | Human Fas Ligand/TNFSF6 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB1537 | TOR Polyclonal Ab (100 UG) | 100 UG | 4350 |
| R&D Systems | AB3010 | Human Porimin Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB3226 | Human Phospho-Smad3 (S423/S425) Polyclonal Ab (250 UL) | 250 UL | 4350 |
| R&D Systems | AB383 | Human CD14 Polyclonal Ab (500 UG) | 500 UG | 4350 |
| R&D Systems | AB4315 | Human DLL3 Polyclonal Ab (100 UG) | 100 UG | 4350 |
| R&D Systems | AB623 | Human Angiopoietin-2 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB626 | Human TRANCE/RANK L/TNFSF11 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB820 | Human Bax Polyclonal Ab (400 UG) | 400 UG | 5450 |
| R&D Systems | AB885 | Human Gas6 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB911 | Human MMP-9 Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB924 | Human/Mouse MMP-24/MT5-MMP Polyclonal Ab (200 UG) | 200 UG | 5450 |
| R&D Systems | AB936 | Human ADAM10 Ectodomain Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | AB946 | Mouse ADAM10 Ectodomain Polyclonal Ab (1 MG) | 1 MG | 4900 |
| R&D Systems | ACFP1063 | Recombinant Human Activated Coagulation Factor Xa, ACFP (25 UG) | 25 UG | 10780 |
| R&D Systems | ACFP218 | Recombinant Human IL-11, ACFP (50 UG) | 50 UG | 12990 |
| R&D Systems | ACFP240 | Recombinant Human TGF-beta 1, ACFP (25 UG) | 25 UG | 12990 |
| R&D Systems | ACFP288 | Recombinant Human Thrombopoietin, ACFP (50 UG) | 50 UG | 12990 |
| R&D Systems | ACFP293 | Recombinant Human VEGF 165, ACFP (50 UG) | 50 UG | 12990 |
| R&D Systems | ACFP302 | Recombinant Human TGF-beta 2, ACFP (25 UG) | 25 UG | 12990 |
| R&D Systems | ACFP308 | Recombinant Human Flt-3 Ligand, ACFP (50 UG) | 50 UG | 12990 |
| R&D Systems | ACFP338 | Recombinant Human/Mouse/Rat Activin A, ACFP (50 UG) | 50 UG | 12990 |
| R&D Systems | ACFP4305 | Recombinant Human Fibronectin, ACFP (50 UG) | 50 UG | 2670 |
| R&D Systems | ADP1-200 | Recombinant Human E-Selectin/CD62E, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | ADP1-050 | Recombinant Human E-Selectin/CD62E, CF (50 UG) | 50 UG | 3240 |
| R&D Systems | ADP2-200 | Recombinant Human L-Selectin/CD62L, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | ADP2-050 | Recombinant Human L-Selectin/CD62L, CF (50 UG) | 50 UG | 3240 |
| R&D Systems | ADP3-200 | Recombinant Human P-Selectin/CD62P, CF (200 UG) | 200 UG | 8830 |
| R&D Systems | ADP3-050 | Recombinant Human P-Selectin/CD62P, CF (50 UG) | 50 UG | 3240 |
| R&D Systems | ADP4-200 | Recombinant Human ICAM-1/CD54, CF (200 UG) | 200 UG | 9950 |
| R&D Systems | ADP4-050 | Recombinant Human ICAM-1/CD54, CF (50 UG) | 50 UG | 4230 |
| R&D Systems | ADP5-200 | Recombinant Human VCAM-1/CD106, CF (200 UG) | 200 UG | 9950 |
| R&D Systems | ADP5-050 | Recombinant Human VCAM-1/CD106, CF (50 UG) | 50 UG | 3890 |
| R&D Systems | ADP6-200 | Recombinant Human CD31/PECAM-1, CF (200 UG) | 200 UG | 10130 |
| R&D Systems | AF-101-NA | TGF-beta 1/1.2 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5450 |
| R&D Systems | AF-101-SP | TGF-beta 1/1.2 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-141-NA | Human B7-2/CD86 Affinity Purified Polyclonal Ab (200 UG) | 200 UG | 3260 |
| R&D Systems | AF-141-SP | Human B7-2/CD86 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-200-NA | Human IL-1 alpha/IL-1F1 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-200-SP | Human IL-1 alpha/IL-1F1 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-201-NA | Human IL-1 beta/IL-1F2 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-201-SP | Human IL-1 beta/IL-1F2 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-202-NA | Human IL-2 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-202-SP | Human IL-2 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-203-NA | Human IL-3 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-203-SP | Human IL-3 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-204-NA | Human IL-4 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-204-SP | Human IL-4 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-205-NA | Human IL-5 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-205-SP | Human IL-5 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-206-NA | Human IL-6 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-206-SP | Human IL-6 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-207-NA | Human IL-7 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-207-SP | Human IL-7 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-208-NA | Human CXCL8/IL-8 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-208-SP | Human CXCL8/IL-8 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-210-NA | Human TNF-alpha Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-210-SP | Human TNF-alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-211-NA | Human Lymphotoxin-alpha/TNF-beta Affinity Purified PAb (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-211-SP | Human Lymphotoxin-alpha/TNF-beta Affinity Purified PAb (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-212-NA | Human/Rat GDNF Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-212-SP | Human/Rat GDNF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-213-NA | Human IL-13 Affinity Purified Polyclonal Ab (250 UG) | 250 UG | 5040 |
| R&D Systems | AF-213-SP | Human IL-13 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-214-NA | Human G-CSF Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-214-SP | Human G-CSF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-215-NA | Human GM-CSF Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-215-SP | Human GM-CSF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-217-NA | Human IL-10 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-217-SP | Human IL-10 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-218-NA | Human IL-11 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-218-SP | Human IL-11 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-219-NA | Human IL-12 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-219-SP | Human IL-12 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-220-NA | Human PDGF-BB Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-220-SP | Human PDGF-BB Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-221-NA | Human PDGF-AA Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-221-SP | Human PDGF-AA Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-223-NA | Human CD25/IL-2 R alpha Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-223-SP | Human CD25/IL-2 R alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-224-NA | Human IL-2 R beta Affinity Purified Polyclonal Ab (250 UG) | 250 UG | 4900 |
| R&D Systems | AF-224-SP | Human IL-2 R beta Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-227-NA | Human IL-6 R alpha Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-227-SP | Human IL-6 R alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-228-NA | Human gp130 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-228-SP | Human gp130 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-230-PB | Human IL-4 R alpha Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-230-SP | Human IL-4 R alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-233-NA | Human FGF basic Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-233-SP | Human FGF basic Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-237-NA | Human FGF-5 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-237-SP | Human FGF-5 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-239-NA | Human TGF-alpha Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-239-SP | Human TGF-alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-241-NA | Human TGF-beta RII Affinity Purified Polyclonal Ab (250 UG) | 250 UG | 4900 |
| R&D Systems | AF-241-SP | Human TGF-beta RII Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-242-PB | Human TGF-beta RIII Affinity Purified Polyclonal Ab (250 UG) | 250 UG | 4900 |
| R&D Systems | AF-242-SP | Human TGF-beta RIII Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-243-NA | TGF-beta 3 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-243-SP | TGF-beta 3 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-246-NA | Human LAP (TGF-beta 1) Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-246-SP | Human LAP (TGF-beta 1) Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-249-NA | Human LIF R alpha Affinity Purified Polyclonal Ab (250 UG) | 250 UG | 4900 |
| R&D Systems | AF-249-SP | Human LIF R alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-250-NA | Human LIF Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-250-SP | Human LIF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-251-NA | Human KGF/FGF-7 Affinity Purified Polyclonal Ab (250 UG) | 250 UG | 4350 |
| R&D Systems | AF-251-SP | Human KGF/FGF-7 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-252-PB | Human Pleiotrophin/PTN Affinity Purified Polyclonal Ab (250 UG) | 250 UG | 4900 |
| R&D Systems | AF-252-SP | Human Pleiotrophin/PTN Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-253-NA | Human IL-5 R alpha Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-253-SP | Human IL-5 R alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-255-NA | Human SCF Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-255-SP | Human SCF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-256-NA | Human beta-NGF Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-256-SP | Human beta-NGF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-257-NA | Human CNTF Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-257-SP | Human CNTF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-258-PB | Human Midkine Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-258-SP | Human Midkine Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-259-NA | Human HB-EGF Affinity Purified Polyclonal Ab (250 UG) | 250 UG | 4900 |
| R&D Systems | AF-259-SP | Human HB-EGF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-261-NA | Human Betacellulin Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-261-SP | Human Betacellulin Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-263-NA | Human IL-1 RII Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-263-SP | Human IL-1 RII Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-264-PB | Human PlGF Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-264-SP | Human PlGF Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-266-NA | Human CXCL10/IP-10 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-266-SP | Human CXCL10/IP-10 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-267-NA | Human NT-3 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-267-SP | Human NT-3 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-268-NA | Human NT-4 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-268-SP | Human NT-4 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-270-NA | Human CCL3/MIP-1 alpha Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-270-SP | Human CCL3/MIP-1 alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-271-NA | Human CCL4/MIP-1 beta Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-271-SP | Human CCL4/MIP-1 beta Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-273-NA | Human FGF-9 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-273-SP | Human FGF-9 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-274-NA | Human IL-10 R alpha Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
| R&D Systems | AF-274-SP | Human IL-10 R alpha Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-278-NA | Human CCL5/RANTES Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 5040 |
| R&D Systems | AF-278-SP | Human CCL5/RANTES Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-279-NA | Human CCL2/MCP-1 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-279-SP | Human CCL2/MCP-1 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-280-NA | Human IL-1ra/IL-1F3 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4980 |
| R&D Systems | AF-280-SP | Human IL-1ra/IL-1F3 Affinity Purified Polyclonal Ab (25 UG) | 25 UG | 1350 |
| R&D Systems | AF-281-NA | Human CCL8/MCP-2 Affinity Purified Polyclonal Ab (100 UG) | 100 UG | 4900 |
我們公司zui大優(yōu)勢是強(qiáng)大的采購，
1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，
2：貨品全，現(xiàn)經(jīng)營過700多個(gè)品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢，
3：提供加急服務(wù)，一般1-2周到貨，超過時(shí)限加急費(fèi)全免
4：價(jià)格公道，絕大部分價(jià)格有優(yōu)勢，當(dāng)然不能保證100%產(chǎn)品都是,因?yàn)橐馕吨鴽]有服務(wù).
5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國藥 ，fisher等500多家公司
6：我們還是Santa,Advanced Biotechnologies Inc, Sorachim ,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. Dako,Inc, GePromegaridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,Sorachim , Polysciences,prospecbi, QA-BIO,quickzyme,FULLERLABS,INC,sterlitech；sysy,TriLink BioTechnologies,Inc；worthington-biochem,zyagen等幾十家國外公司授權(quán)代理。
7：我們還是invitrogen,qiagen,Sorachim am,sigma;Promega,roche,merck, rnd,BD, GE,pierce,BioLegend等*批發(fā)，歡迎合作。
地址：上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實(shí)驗(yàn)試劑有限公司
郵箱：xs1@78bio.com
傳真：021-50724961
電話
QQ咨詢
4006551678
當(dāng)前位置：